A . . . E> A DESIPRAMINE d00145A C F20 Schizophrenia A0 E> A ILOPERIDONE d07441A C F20 Schizophrenia A0 E> A LAMOTRIGINE d03809A C F20 Schizophrenia A0 E> A . . . E>0 A ALLOPURINOL d00023A C- M1A Chronic gout A E>0 A ICOSAPENT d07891A C- I51.9 Heart disease, unspecified A E>0 A METFORMIN d03807A Ap R73.9 Hyperglycemia, unspecified A E>0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A E>0 A POTASSIUM CHLORIDE d00345A C R60.9 Edema, unspecified A E>0 A RAMIPRIL d00728A CDp I10 Essential (primary) hypertension A E>0 A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol A E>0 A SPIRONOLACTONE d00373A C E87.6 I10 Hypokalemia Essential (primary) hypertension A E>0 A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A E>0 A TRAMADOL d03826A C M25.5 Pain in joint A E>@ A . . . E>P A . . . E>` A CLONIDINE d00044A Bz G47.0 Insomnia A0 E>` A DEXTROAMPHETAMINE d00804A Bz G47.41 Narcolepsy A0 E>` A RISPERIDONE d03180A Bz G47.0 Insomnia A0 E>p A . . . E> A . . . E> A . . . E> A . . . E> A . . . E> A ATENOLOL d00004A D I10 Essential (primary) hypertension A E> A BECLOMETHASONE d00760A D J45 Asthma A E> A CLINDAMYCIN d00043A A K04.7 Periapical abscess without sinus A E> A . . . E> A . . . E? A . . . E? A 77777 . . A E? A . . . E?0 A . . . E?@ A . . . E?P A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E?P A LOSARTAN d03821A Cr I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP E?P A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E?P A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E?P A TERAZOSIN d00386A Cr N40 Enlarged prostate AP E?` A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A CDp I10 Essential (primary) hypertension A E?p A . . . E? A . . . E? A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E? A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp R60.9 Edema, unspecified A E? A BRIMONIDINE OPHTHALMIC d04048A B[ H40 Glaucoma A@ E? A DICLOFENAC OPHTHALMIC d03213A B[ H57.8 Other specified disorders of eye and adnexa A@ E? A LOSARTAN d03821A Bz I10 Essential (primary) hypertension A@ E? A PREDNISOLONE d00084A B[ H57.8 Other specified disorders of eye and adnexa A@ E? A CLONAZEPAM d00197A C G47.0 Insomnia A@ E? A CLOPIDOGREL d04258A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A@ E? A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ E? A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E? A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E? A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E? A DOXYCYCLINE d00037A B= L70 Acne A E? A . . . E? A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E? A VERAPAMIL d00048A D I10 Essential (primary) hypertension A E@ A . . . E@ A . . . E@ A . . . E@0 A . . . E@@ A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E@@ A CYCLOBENZAPRINE d00963A B M25.51 Pain in shoulder Ap E@@ A FAMOTIDINE d00141A C K30 Functional dyspepsia Ap E@@ A IBUPROFEN d00015A B M25.51 Pain in shoulder Ap E@@ A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap E@@ A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia Ap E@@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E@P A . . . E@` A . . . E@p A . . . E@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E@ A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified Ap E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E@ A LORATADINE d03050A C T78.40 Allergy, unspecified Ap E@ A NAPROXEN d00019A C M54.9 Dorsalgia, unspecified Ap E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E@ A TIZANIDINE d04102A C M54.9 Dorsalgia, unspecified Ap E@ A . . . E@ A . . . E@ A . . . E@ A . . . E@ A . . . E@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B L70 Acne A E@ A . . . EA A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EA A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP EA A INSULIN GLARGINE d04538A C E10 Type 1 diabetes mellitus AP EA A INSULIN LISPRO d04373A D,3 E10 Type 1 diabetes mellitus AP EA A RAMIPRIL d00728A C I21.P Prevent heart attack/myocardial infarction AP EA A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol AP EA A . . . EA0 A . . . EA@ A PROPRANOLOL d00032A Dc I10 Essential (primary) hypertension A EAP A AMLODIPINE d00689A D I10 Essential (primary) hypertension A EAP A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma A EAP A CLOPIDOGREL d04258A C I49.9 Cardiac arrhythmia, unspecified A EAP A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A EAP A METHOCARBAMOL d00965A C M62.83 Muscle spasm A EAP A PAROXETINE d03157A A F41.9 Anxiety disorder, unspecified A EAP A PHENYTOIN d00143A Dc G40 Epilepsy and recurrent seizures A EAP A TRIAMTERENE d00396A D R60.9 Edema, unspecified A EA` A . . . EAp A . . . EA A . . . EA A . . . EA A NORTRIPTYLINE d00144A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EA A ONDANSETRON d00867A A R11.P Prevent nausea or vomiting A EA A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A EA A . . . EA A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP EA A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP EA A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP EA A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EA A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP EA A CYCLOSPORINE OPHTHALMIC d04836A B< H26.9 Unspecified cataract A@ EA A LORAZEPAM d00149A Cr F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ EA A MELOXICAM d04532A D# M19.9 Osteoarthritis, unspecified site A@ EA A ZOLPIDEM d00910A Dc G47.0 Insomnia A@ EA A . . . EB A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A EB A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia A EB A . . . EB A . . . EB0 A BUPROPION d00181A C F31.9 Bipolar disorder, unspecified A0 EB0 A DIVALPROEX SODIUM d03833A C F31.9 Bipolar disorder, unspecified A0 EB0 A FLUOXETINE d00236A C F31.9 Bipolar disorder, unspecified A0 EB@ A . . . EBP A . . . EB` A CELECOXIB d04380A Ei 99999 A` EB` A DONEPEZIL d04099A Ei G30.9 Alzheimer's disease, unspecified A` EB` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` EB` A OXYBUTYNIN d00328A Ei R35.0 Frequency of micturition A` EB` A PRAMIPEXOLE d04145A Ei 99999 A` EB` A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A` EBp A ATENOLOL d00004A C I10 Essential (primary) hypertension A EBp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EBp A CLONAZEPAM d00197A C G47.9 Sleep disorder, unspecified A EBp A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified A EBp A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A EBp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EBp A PROPRANOLOL d00032A Cr I10 Essential (primary) hypertension A EBp A TRAZODONE d00395A Cr G47.0 Insomnia A EB A 99999 . . A EB A . . . EB A . . . EB A . . . EB A . . . EB A CONJUGATED ESTROGENS d00541A D N95.1 Menopausal and female climacteric states A0 EB A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 EB A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 EB A . . . EB A . . . EC A . . . EC A . . . EC A . . . EC0 A . . . EC@ A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A` EC@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` EC@ A OMEPRAZOLE d00325A C"0 K25 Gastric ulcer A` EC@ A TOPIRAMATE d04115A B G43 Migraine A` EC@ A VERAPAMIL d00048A C I10 Essential (primary) hypertension A` EC@ A VILAZODONE d07740A C F32.9 Major depressive disorder, single episode, unspecified A` ECP A . . . EC` A . . . ECp A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A EC A . . . EC A . . . EC A AMOXICILLIN d00088A Ap J06.9 Acute upper respiratory infection, unspecified A EC A DESONIDE TOPICAL d01290A B= R21 Rash and other nonspecific skin eruption A EC A NYSTATIN TOPICAL d04399A B R21 Rash and other nonspecific skin eruption A EC A BUPROPION d00181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ EC A CLONIDINE d00044A C- I10 Essential (primary) hypertension A@ EC A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ EC A METHADONE d00050A C M54.9 Dorsalgia, unspecified A@ EC A . . . EC A SERTRALINE d00880A C- F90 Attention-deficit hyperactivity disorders A EC A TRAZODONE d00395A CDp F90 Attention-deficit hyperactivity disorders A EC A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension A0 EC A LOSARTAN d03821A0 D I10 Essential (primary) hypertension A0 EC A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia A0 ED A . . . ED A . . . ED A . . . ED0 A . . . ED@ A . . . EDP A . . . ED` A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A EDp A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D 99999 A` EDp A INSULIN REGULAR d04369A D E11 Type 2 diabetes mellitus A` EDp A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` EDp A METOPROLOL d00134A D I10 Essential (primary) hypertension A` EDp A PIOGLITAZONE d04442A Ei E11 Type 2 diabetes mellitus A` EDp A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` ED A DESOGESTREL; ETHINYL ESTRADIOL d03782A C Z79.3 Long term (current) use of hormonal contraceptives A ED A . . . ED A . . . ED A . . . ED A . . . ED A . . . ED A . . . ED A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension AP ED A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified AP ED A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP ED A METOPROLOL d00134A C I10 Essential (primary) hypertension AP ED A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP EE A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A EE A . . . EE A . . . EE0 A AZITHROMYCIN d00091A A@ J20.9 Acute bronchitis, unspecified A EE@ A . . . EEP A ALPRAZOLAM d00168A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A` EEP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` EEP A LEVOTHYROXINE d00278A C E04.9 Nontoxic goiter, unspecified A` EEP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` EEP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` EEP A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EE` A . . . EEp A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A EE A . . . EE A HYDROXYCHLOROQUINE d00817A D* M06.9 Rheumatoid arthritis, unspecified A EE A LEFLUNOMIDE d04349A D# M06.9 Rheumatoid arthritis, unspecified A EE A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EE A METHOTREXATE d00060A D# M06.9 Rheumatoid arthritis, unspecified A EE A MORPHINE d00308A C M48.0 Spinal stenosis A EE A OXYCODONE d00329A C M48.0 M54.9 Spinal stenosis Dorsalgia, unspecified A EE A PANTOPRAZOLE d04514A C K25 Gastric ulcer A EE A PREDNISONE d00350A D* M06.9 Rheumatoid arthritis, unspecified A EE A . . . EE A . . . EE A . . . EE A FLUCONAZOLE d00071A Ap N61 Inflammatory disorders of breast A EE A . . . EE A . . . EF A . . . EF A CICLESONIDE NASAL d05899A B= H57.9 J30.9 Unspecified disorder of eye and adnexa Allergic rhinitis, unspecified A0 EF A MONTELUKAST d04289A B= J30.9 Allergic rhinitis, unspecified A0 EF A OLOPATADINE OPHTHALMIC d04117A B= H10.1 Acute atopic conjunctivitis A0 EF A . . . EF0 A FUROSEMIDE d00070A0 B[ I10 Essential (primary) hypertension A@ EF0 A OMEPRAZOLE d00325A0 B R12 Heartburn A@ EF0 A POTASSIUM CHLORIDE d00345A0 B[ E87.6 Hypokalemia A@ EF0 A TRIAMCINOLONE TOPICAL d03206A0 B R21 Rash and other nonspecific skin eruption A@ EF@ A . . . EFP A BUPROPION d00181A C- 99999 A@ EFP A ESTRADIOL d00537A Cr 99999 A@ EFP A MEGESTROL d01348A Ei 99999 A@ EFP A SERTRALINE d00880A Ei 99999 A@ EF` A IBUPROFEN d00015A B R51 Headache A EFp A . . . EF A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A EF A . . . EF A . . . EF A CARVEDILOL d03847A B[ I38 Endocarditis, valve unspecified Ap EF A CLOBETASOL TOPICAL d01288A C L23 Allergic contact dermatitis Ap EF A HYDROXYZINE d00907A C"0 L20.9 Atopic dermatitis, unspecified Ap EF A LISINOPRIL d00732A B[ I38 Endocarditis, valve unspecified Ap EF A SEVELAMER d04363A C[@ Z99.2 Dependence on renal dialysis Ap EF A TRIAMCINOLONE TOPICAL d03206A B R21 Rash and other nonspecific skin eruption Ap EF A ZOLPIDEM d00910A B= G47.9 Sleep disorder, unspecified Ap EF A . . . EF A 99999 . . AP EF A AMITRIPTYLINE d00146A C M79.2 Neuralgia and neuritis, unspecified AP EF A ESOMEPRAZOLE d04749A C- 99999 AP EF A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus AP EF A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP EF A AMITRIPTYLINE d00146A B G47.0 Insomnia A EF A DIAZEPAM d00148A B G47.0 Insomnia A EF A GABAPENTIN d03182A C G40 Epilepsy and recurrent seizures A EF A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A EF A HYDROXYZINE d00907A B G47.9 Sleep disorder, unspecified A EF A LAMOTRIGINE d03809A B[ G40 Epilepsy and recurrent seizures A EF A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A EF A PROMETHAZINE d00787A Cr R11 Nausea and vomiting A EF A PROPRANOLOL d00032A CDp I10 Essential (primary) hypertension A EF A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EF A . . . EG A . . . EG A METFORMIN d03807A C- E11.P Prevent diabetes A EG A TOLTERODINE d04294A Cr N32.81 Overactive bladder A EG A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified A0 EG A ATENOLOL d00004A B I10 Essential (primary) hypertension A0 EG A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A0 EG0 A CELECOXIB d04380A C M54.9 Dorsalgia, unspecified A EG0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N95.1 Menopausal and female climacteric states A EG@ A . . . EGP A ALBUTEROL d00749A D J45 Asthma AP EGP A AZITHROMYCIN d00091A Ap J20.9 Acute bronchitis, unspecified AP EGP A BISOPROLOL d00709A C I10 Essential (primary) hypertension AP EGP A FLUTICASONE; SALMETEROL d04611A C J45 Asthma AP EGP A METHYLPREDNISOLONE d00293A Ap J20.9 Acute bronchitis, unspecified AP EG` A . . . EGp A . . . EG A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A EG A . . . EG A . . . EG A . . . EG A . . . EG A . . . EG A PRAZOSIN d00138A CDp F43.1 Post-traumatic stress disorder (PTSD) A EG A VALSARTAN d04113A C I10 Essential (primary) hypertension A EG A . . . EH A . . . EH A . . . EH A . . . EH0 A TRIAMCINOLONE TOPICAL d03206A C- L20.9 Atopic dermatitis, unspecified A EH@ A 99999 . . A0 EH@ A ALBUTEROL d00749A B[ R06.2 Wheezing A0 EH@ A ALBUTEROL; IPRATROPIUM d04066A A R06.2 Wheezing A0 EHP A ACETAMINOPHEN; HYDROCODONE d03428A C[@ T14.9 Unspecified injury A EHP A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A EHP A ANASTROZOLE d03873A CDp C50.P Prevent barest cancer A EHP A BUDESONIDE; FORMOTEROL d04795A Cr J45 Asthma A EHP A CLONAZEPAM d00197A B F32.9 Major depressive disorder, single episode, unspecified A EHP A GABAPENTIN d03182A CDp M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A EHP A HYDROXYCHLOROQUINE d00817A C[@ M06.9 Rheumatoid arthritis, unspecified A EHP A METOCLOPRAMIDE d00298A Bz K21 Gastro-esophageal reflux disease A EHP A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A EHP A PAROXETINE d03157A Bz F32.9 Major depressive disorder, single episode, unspecified A EHP A PREDNISONE d00350A B M06.9 Rheumatoid arthritis, unspecified A EHP A TEMAZEPAM d00384A Bz G47.0 Insomnia A EH` A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B Z79.3 Long term (current) use of hormonal contraceptives A EH` A RIFAMPIN d00047A B[ A15.P Prevent tuberculosis A EHp A . . . EH A . . . EH A . . . EH A . . . EH A GLYBURIDE d00248A Bz O24.4 Gestational diabetes mellitus A EH A . . . EH A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A EH A VALSARTAN d04113A0 Cr I10 Essential (primary) hypertension A EH A ALBUTEROL d00749A C[@ J45 Asthma A0 EH A TACROLIMUS TOPICAL d04740A B L20.9 Atopic dermatitis, unspecified A0 EH A TRIAMCINOLONE d00620A B J45 Asthma A0 EH A ALBUTEROL d00749A Ei J45 Asthma A EI A . . . EI A . . . EI A BUDESONIDE d04276A0 C- J42 Unspecified chronic bronchitis A EI A CIPROFLOXACIN d00011A0 B J40 Bronchitis, not specified as acute or chronic A EI A FUROSEMIDE d00070A C- I50.9 Heart failure, unspecified A EI A LEVALBUTEROL d04427A0 C- J42 Unspecified chronic bronchitis A EI A MONTELUKAST d04289A0 B= J42 Unspecified chronic bronchitis A EI A POLYETHYLENE GLYCOL 3350 d05350A0 B= K59.0 Constipation A EI A PREDNISONE d00350A0 A0 J45 Asthma A EI A PROPRANOLOL d00032A C- I49.9 Cardiac arrhythmia, unspecified A EI A RANITIDINE d00021A0 B= K21 Gastro-esophageal reflux disease A EI0 A . . . EI@ A ACETAMINOPHEN; HYDROCODONE d03428A B R52 Pain, unspecified A EI@ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EI@ A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A EI@ A DONEPEZIL d04099A B G30.9 Alzheimer's disease, unspecified A EI@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A EI@ A MELOXICAM d04532A B M13 Other arthritis A EI@ A MIRTAZAPINE d04025A C- F32.9 Major depressive disorder, single episode, unspecified A EI@ A TRAZODONE d00395A C- F32.9 Major depressive disorder, single episode, unspecified A EIP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A EI` A . . . EIp A . . . EI A . . . EI A . . . EI A . . . EI A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A EI A . . . EI A . . . EI A . . . EI A . . . EJ A FLUORIDE TOPICAL d04397A C K02.P Prevent tooth decay A EJ A . . . EJ A . . . EJ0 A . . . EJ@ A CARBAMAZEPINE d00058A CDp G40 Epilepsy and recurrent seizures A EJ@ A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A EJP A . . . EJ` A . . . EJp A METOPROLOL d00134A C I10 Essential (primary) hypertension A EJ A . . . EJ A . . . EJ A . . . EJ A . . . EJ A . . . EJ A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ EJ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A@ EJ A IBUPROFEN d00015A Cr M54.9 Dorsalgia, unspecified A@ EJ A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified A@ EJ A . . . EJ A . . . EK A . . . EK A ATROPINE; DIPHENOXYLATE d03506A0 CDp R19.7 Diarrhea, unspecified A EK A BACLOFEN d00967A0 D G35 Multiple sclerosis A EK A BUPROPION d00181A0 C G43 Migraine A EK A CICLESONIDE NASAL d05899A0 C J30.9 Allergic rhinitis, unspecified A EK A FINGOLIMOD d07692A0 C G35 Multiple sclerosis A EK A FROVATRIPTAN d04776A0 C G43 Migraine A EK A MONTELUKAST d04289A0 C J30.9 Allergic rhinitis, unspecified A EK A NITROFURANTOIN d00112A0 Cr N39.0P Prevent urinary tract infection A EK A PROCHLORPERAZINE d00355A0 C R11.0 Nausea A EK A SOLIFENACIN d05413A0 C- R39.15 Urgency of urination A EK A TELMISARTAN d04364A0 B I10 Essential (primary) hypertension A EK A TOLTERODINE d04294A0 C R32 Unspecified urinary incontinence A EK A . . . EK0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` EK0 A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A` EK0 A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A` EK0 A METOPROLOL d00134A D R00.0 Tachycardia, unspecified A` EK0 A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A` EK0 A OLMESARTAN d04801A D I10 Essential (primary) hypertension A` EK@ A HYDROCORTISONE TOPICAL d03205A0 Ap K64 Hemorrhoids and perianal venous thrombosis A EKP A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP EKP A ATENOLOL d00004A C I10 Essential (primary) hypertension AP EKP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP EKP A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP EKP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP EK` A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A EKp A . . . EK A . . . EK A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A EK A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A EK A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A EK A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A EK A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EK A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EK A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EK A TRAZODONE d00395A C G47.0 Insomnia A EK A . . . EK A . . . EK A BICALUTAMIDE d03850A CDp C61 Malignant neoplasm of prostate A@ EK A CETIRIZINE d03827A CDp J00 Acute nasopharyngitis [common cold] A@ EK A DOXAZOSIN d00726A CDp C80.1 Malignant (primary) neoplasm, unspecified A@ EK A TAMSULOSIN d04121A CDp C61 Malignant neoplasm of prostate A@ EK A . . . EK A . . . EK A . . . EL A . . . EL A ZOLPIDEM d00910A C G47.0 Insomnia A EL A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A EL0 A . . . EL@ A . . . ELP A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A ELP A LEVALBUTEROL d04427A B J45 Asthma A EL` A . . . ELp A ALENDRONATE d03849A A Z47 Orthopedic aftercare A0 ELp A MELOXICAM d04532A B M25.55 Pain in hip A0 ELp A RIVAROXABAN d07356A A D75.9P Prevent blood clots A0 EL A . . . EL A CLOPIDOGREL d04258A Ei 99999 Ap EL A LISINOPRIL d00732A Ei 99999 Ap EL A METFORMIN d03807A D* E11 Type 2 diabetes mellitus Ap EL A METOPROLOL d00134A Ei 99999 Ap EL A RANOLAZINE d05719A Ei 99999 Ap EL A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap EL A SOLIFENACIN d05413A Cr R39.15 Urgency of urination Ap EL A . . . EL A . . . EL A . . . EL A 99999 . . A EL A 99999 . . Ap EL A ASPIRIN d00170A B D75.9P Prevent blood clots Ap EL A CLONIDINE d00044A C I10 Essential (primary) hypertension Ap EL A GLIPIZIDE; METFORMIN d04823A D E11 Type 2 diabetes mellitus Ap EL A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap EL A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap EL A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease Ap EL A . . . EM A ACETAMINOPHEN; HYDROCODONE d03428A Cr G43 M54.2 N94.6 Migraine Cervicalgia Dysmenorrhea, unspecified A EM A CARISOPRODOL d00960A Cr M25.51 M54.2 M62.83 Pain in shoulder Cervicalgia Muscle spasm A EM A . . . EM A . . . EM0 A PREDNISONE d00350A A H66.9 Otitis media, unspecified A EM@ A . . . EMP A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A EMP A MONTELUKAST d04289A B[ J30.9 Allergic rhinitis, unspecified A EM` A . . . EMp A . . . EM A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders A EM A . . . EM A . . . EM A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A EM A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A EM A . . . EM A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A EM A . . . EN A . . . EN A . . . EN A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ EN A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ EN A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EN A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A@ EN0 A CARBIDOPA d00184A C G20 Parkinson's disease A EN0 A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A EN0 A CYANOCOBALAMIN d00413A Cr D50.9 Iron deficiency anemia, unspecified A EN0 A FUROSEMIDE d00070A Cr I50.9 Heart failure, unspecified A EN0 A GABAPENTIN d03182A CP M79.2 Neuralgia and neuritis, unspecified A EN0 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A EN0 A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A EN0 A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A EN0 A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A EN@ A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A EN@ A LORATADINE d03050A C J30.9 Allergic rhinitis, unspecified A ENP A . . . EN` A . . . ENp A GLYBURIDE d00248A B E11 Type 2 diabetes mellitus A0 ENp A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 ENp A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A0 EN A . . . EN A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 EN A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EN A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A0 EN A . . . EN A . . . EN A . . . EN A LORATADINE d03050A0 B 99999 AP EN A NIFEDIPINE d00051A0 C I10 Essential (primary) hypertension AP EN A OMEPRAZOLE d00325A0 Bz K30 Functional dyspepsia AP EN A QUINAPRIL d00365A0 C I10 Essential (primary) hypertension AP EN A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia AP EN A . . . EN A . . . EO A ACETAMINOPHEN; CODEINE d03423A A K08.8 Other specified disorders of teeth and supporting structures A EO A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A EO A . . . EO0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EO@ A TESTOSTERONE d00558A C- E29.1 Testicular hypofunction A EOP A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A C I10 Essential (primary) hypertension A` EOP A BACLOFEN d00967A D M79.1 Myalgia A` EOP A DOXEPIN d00217A C- G47.0 Insomnia A` EOP A HYDROXYZINE d00907A CDp R11 Nausea and vomiting A` EOP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` EOP A TRAMADOL d03826A C M79.7 Fibromyalgia A` EO` A . . . EOp A . . . EO A . . . EO A . . . EO A . . . EO A 99999 . . A0 EO A DIPHENHYDRAMINE d00212A B[ L50 Urticaria A0 EO A HYDROXYZINE d00907A B[ R45.0 Nervousness A0 EO A . . . EO A . . . EO A . . . EO A . . . EP A . . . EP A . . . EP A ALISKIREN d06665A C- I10 Essential (primary) hypertension A EP A ATENOLOL; CHLORTHALIDONE d03258A C- I10 Essential (primary) hypertension A EP0 A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A0 D I10 Essential (primary) hypertension A EP0 A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A EP0 A ETODOLAC d00851A B M19.9 Osteoarthritis, unspecified site A EP0 A EZETIMIBE d04824A0 D E78.0 Pure hypercholesterolemia A EP0 A FLUOXETINE d00236A0 C- F32.9 Major depressive disorder, single episode, unspecified A EP0 A INDAPAMIDE d00260A B[ 99999 A EP0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A EP0 A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A EP0 A METFORMIN d03807A B[ R73 Elevated blood glucose level A EP@ A . . . EPP A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A EPP A CARVEDILOL d03847A C I10 Essential (primary) hypertension A EPP A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A EPP A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A EPP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EPP A LORATADINE d03050A C T78.40 Allergy, unspecified A EPP A PANTOPRAZOLE d04514A B= K21 Gastro-esophageal reflux disease A EPP A SUCRALFATE d00377A B= K25.P Prevent gastric ulcer A EP` A AMLODIPINE d00689A0 CDp I10 Essential (primary) hypertension A0 EP` A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A0 EP` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 EPp A . . . EP A ACETAMINOPHEN; CODEINE d03423A C M54.9 Dorsalgia, unspecified A EP A ALLOPURINOL d00023A C G40 Epilepsy and recurrent seizures A EP A BENAZEPRIL d00730A Cr E11.2 I21.P Type 2 diabetes mellitus with kidney complications Prevent heart attack/myocardial infarction A EP A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A EP A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A EP A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A EP A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A D I10 Essential (primary) hypertension A EP A OMEPRAZOLE d00325A C K30 Functional dyspepsia A EP A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A EP A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A EP A TAMSULOSIN d04121A C N40 Enlarged prostate A EP A TRAMADOL d03826A D M54.9 Dorsalgia, unspecified A EP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EP A . . . EP A . . . EP A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EP A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension A EP A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A EP A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A EP A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A EP A NAPROXEN d00019A C M25.5 Pain in joint A EP A OXYCODONE d00329A C R52 Pain, unspecified A EP A PAROXETINE d03157A CDp F32.9 Major depressive disorder, single episode, unspecified A EP A PROMETHAZINE d00787A Cr R11 Nausea and vomiting A EP A TOPIRAMATE d04115A C G43 Migraine A EP A TRIAZOLAM d00397A CDp G47.0 Insomnia A EP A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified AP EP A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified AP EP A AZITHROMYCIN d00091A AP H66.9 Otitis media, unspecified AP EP A CEFPROZIL d00073A A H66.9 Otitis media, unspecified AP EP A CEFTRIAXONE d00052A A H66.9 Otitis media, unspecified AP EP A . . . EP A . . . EQ A . . . EQ A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A EQ A . . . EQ0 A . . . EQ@ A . . . EQP A . . . EQ` A CYCLOBENZAPRINE d00963A Dc M54.9 M62.83 M79.1 Dorsalgia, unspecified Muscle spasm Myalgia A@ EQ` A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ EQ` A RANITIDINE d00021A D K21 Gastro-esophageal reflux disease A@ EQ` A TRAMADOL d03826A C- M54.9 M79.1 M79.2 Dorsalgia, unspecified Myalgia Neuralgia and neuritis, unspecified A@ EQp A ACETAMINOPHEN; OXYCODONE d03431A C M79.7 Fibromyalgia AP EQp A GABAPENTIN d03182A C M79.7 Fibromyalgia AP EQp A LORAZEPAM d00149A C G47.0 Insomnia AP EQp A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome AP EQp A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP EQ A . . . EQ A . . . EQ A FLUOCINOLONE TOPICAL d01293A A L20.9 Atopic dermatitis, unspecified A EQ A . . . EQ A . . . EQ A . . . EQ A . . . EQ A . . . ER A FLUTICASONE NASAL d04283A CDp R09.89 Other specified symptoms and signs involving the circulatory and respiratory systems A ER A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A ER A . . . ER A BUPROPION d00181A C F17.203 Nicotine dependence unspecified, with withdrawal A0 ER A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 ER A NAPROXEN d00019A C M25.56 Pain in knee A0 ER0 A . . . ER@ A IBUPROFEN d00015A B M19.9 M54.9 Osteoarthritis, unspecified site Dorsalgia, unspecified A@ ER@ A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ ER@ A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A@ ER@ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ ERP A . . . ER` A . . . ERp A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A ERp A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A ER A . . . ER A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 ER A OXCARBAZEPINE d04513A C F31.9 Bipolar disorder, unspecified A0 ER A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 ER A . . . ER A . . . ER A . . . ER A . . . ER A . . . ER A . . . ES A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A CDp G43 R51 Migraine Headache A ES A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A ES A AMOXICILLIN d00088A A@ R19.7 Diarrhea, unspecified A ES A BECLOMETHASONE d00760A C J44.9 Chronic obstructive pulmonary disease, unspecified A ES A CLARITHROMYCIN d00097A A0 B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A ES A DIAZEPAM d00148A C- G47.9 M62.83 Sleep disorder, unspecified Muscle spasm A ES A FENTANYL d00233A CDp M25.56 M54.2 M54.9 Pain in knee Cervicalgia Dorsalgia, unspecified A ES A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A ES A HYDROMORPHONE d00255A CDp M79.1 Myalgia A ES A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A ES A MELOXICAM d04532A B[ M19.9 Osteoarthritis, unspecified site A ES A PROMETHAZINE d00787A Cr R11 Nausea and vomiting A ES A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A` ES A BUSPIRONE d00182A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A` ES A FENOFIBRATE d04286A B E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A` ES A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` ES A QUETIAPINE d04220A D F29 F31.9 Unspecified psychosis not due to a substance or known physiological condition Bipolar disorder, unspecified A` ES A VARENICLINE d05807A Ap F17.203 Nicotine dependence unspecified, with withdrawal A` ES A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` ES A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A` ES A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A D= N95.1 Menopausal and female climacteric states A` ES A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D> I10 Essential (primary) hypertension A` ES A SOLIFENACIN d05413A C- N32.81 Overactive bladder A` ES A VENLAFAXINE d03181A Cr F41.9 N95.1 Anxiety disorder, unspecified Menopausal and female climacteric states A` ES0 A 99999 . . A ES@ A . . . ESP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D N80.9 Endometriosis, unspecified A@ ESP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ ESP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ ESP A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ ES` A . . . ESp A MELOXICAM d04532A Cr M54.9 Dorsalgia, unspecified A0 ESp A NAPROXEN d00019A C M54.9 Dorsalgia, unspecified A0 ESp A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A0 ES A ATENOLOL d00004A C I10 Essential (primary) hypertension A ES A BACLOFEN d00967A Bz M79.1 Myalgia A ES A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A` ES A FLUTICASONE; SALMETEROL d04611A0 B* J44.9 Chronic obstructive pulmonary disease, unspecified A` ES A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A` ES A METFORMIN d03807A0 C[@ E11 Type 2 diabetes mellitus A` ES A METOPROLOL d00134A0 C- I21.P Prevent heart attack/myocardial infarction A` ES A RABEPRAZOLE d04448A0 C K21 Gastro-esophageal reflux disease A` ES A . . . ES A . . . ES A . . . ES A . . . ES A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` ES A AMLODIPINE; VALSARTAN d06662A B I10 Essential (primary) hypertension A` ES A CARVEDILOL d03847A A I10 Essential (primary) hypertension A` ES A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A` ES A FUROSEMIDE d00070A B R60.9 Edema, unspecified A` ES A METFORMIN d03807A A E11 Type 2 diabetes mellitus A` ES A . . . ET A . . . ET A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A0 ET A IBUPROFEN d00015A A0 R50.9 Fever, unspecified A0 ET A PROMETHAZINE d00787A A0 J00 Acute nasopharyngitis [common cold] A0 ET A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A ET0 A . . . ET@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap ET@ A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots Ap ET@ A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction Ap ET@ A NITROGLYCERIN d00321A C- R07.9 Chest pain, unspecified Ap ET@ A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease Ap ET@ A TESTOSTERONE d00558A C- E29.1 Testicular hypofunction Ap ET@ A VALSARTAN d04113A C- I10 Essential (primary) hypertension Ap ETP A . . . ET` A AMOXICILLIN; CLAVULANATE d00089A A0 J40 Bronchitis, not specified as acute or chronic A ET` A FLUTICASONE NASAL d04283A0 C J30.9 Allergic rhinitis, unspecified A ET` A GABAPENTIN d03182A0 CDp F41.9 Anxiety disorder, unspecified A ET` A LACTULOSE d01024A C- K59.0 Constipation A ET` A LORATADINE d03050A0 CDp T78.40 Allergy, unspecified A ET` A LORAZEPAM d00149A0 CDp G47.9 Sleep disorder, unspecified A ET` A MECLIZINE d00859A0 C R42 Dizziness and giddiness A ET` A METHADONE d00050A0 C M54.9 Dorsalgia, unspecified A ET` A OMEPRAZOLE d00325A0 C K21 Gastro-esophageal reflux disease A ET` A ONDANSETRON d00867A0 B R11 Nausea and vomiting A ET` A OXYCODONE d00329A0 D= M54.9 Dorsalgia, unspecified A ET` A RANITIDINE d00021A0 B M54.9 Dorsalgia, unspecified A ET` A SERTRALINE d00880A0 C 99999 A ETp A . . . ET A . . . ET A . . . ET A . . . ET A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A ET A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A ET A CARBIDOPA; ENTACAPONE; LEVODOPA d04877A D G20 Parkinson's disease A ET A CARBIDOPA; LEVODOPA d03473A D G20 Parkinson's disease A ET A DULOXETINE d05355A Cr M79.2 Neuralgia and neuritis, unspecified A ET A LACTULOSE d01024A C K59.0 Constipation A ET A PREGABALIN d05508A Cr M79.2 Neuralgia and neuritis, unspecified A ET A QUETIAPINE d04220A Ei G47.0 Insomnia A ET A RIVASTIGMINE d04537A Cr G31.84 Mild cognitive impairment, so stated A ET A TEMAZEPAM d00384A C G47.0 Insomnia A ET A . . . ET A . . . ET A LEVALBUTEROL d04427A Cr R07.89 Other chest pain A ET A . . . EU A INSULIN LISPRO d04373A C[@ E10 Type 1 diabetes mellitus A0 EU A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A0 EU A METFORMIN d03807A C[@ E10 Type 1 diabetes mellitus A0 EU A CLONAZEPAM d00197A Cr F32.9 Major depressive disorder, single episode, unspecified A EU A CYCLOBENZAPRINE d00963A C- G47.9 Sleep disorder, unspecified A EU A CYCLOBENZAPRINE d00963A Cr I10 Essential (primary) hypertension A EU A FLUVOXAMINE d03804A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EU A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EU A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A EU A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A EU A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A EU A METFORMIN d03807A C- E11.P Prevent diabetes A EU A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A EU0 A . . . EU@ A ACETAMINOPHEN; HYDROCODONE d03428A Ap H66.9 H92.0 Otitis media, unspecified Otalgia A@ EU@ A ANTIPYRINE; BENZOCAINE OTIC d03627A Ap H66.9 Otitis media, unspecified A@ EU@ A CIPROFLOXACIN; HYDROCORTISONE OTIC d04288A Ap H66.9 Otitis media, unspecified A@ EU@ A CLINDAMYCIN d00043A Ap H66.9 Otitis media, unspecified A@ EUP A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A@ EUP A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ EUP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ EUP A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ EU` A . . . EUp A . . . EU A . . . EU A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A EU A . . . EU A . . . EU A . . . EU A . . . EU A . . . EU A IBUPROFEN d00015A D9 M54.2 M54.9 T14.9 Cervicalgia Dorsalgia, unspecified Unspecified injury A EU A LOSARTAN d03821A B I10 Essential (primary) hypertension A EV A DROSPIRENONE; ETHINYL ESTRADIOL d04760A Cr Z79.3 Long term (current) use of hormonal contraceptives A EV A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A EV A . . . EV0 A . . . EV@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` EV@ A ATENOLOL d00004A D I10 Essential (primary) hypertension A` EV@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` EV@ A MELOXICAM d04532A C M13 Other arthritis A` EV@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` EV@ A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A` EVP A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A EV` A . . . EVp A . . . EV A CILOSTAZOL d04382A CDp I70.2 Atherosclerosis of native arteries of extremities A EV A INSULIN ISOPHANE (NPH) d04370A D* E11 Type 2 diabetes mellitus A EV A LORAZEPAM d00149A C G47.9 Sleep disorder, unspecified A EV A LOSARTAN d03821A C- I10 Essential (primary) hypertension A EV A MONTELUKAST d04289A C J45 Asthma A EV A MYCOPHENOLATE MOFETIL d03839A CDp 55555 A EV A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A EV A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A EV A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A EV A TAMSULOSIN d04121A C[@ R35.0 Frequency of micturition A EV A TRAMADOL d03826A C M13 Other arthritis A EV A . . . EV A DIVALPROEX SODIUM d03833A C F31.9 Bipolar disorder, unspecified A` EV A LEVOTHYROXINE d00278A C- 99999 A` EV A LITHIUM d00061A B F31.9 Bipolar disorder, unspecified A` EV A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A` EV A OLANZAPINE d04050A C F31.9 Bipolar disorder, unspecified A` EV A SERTRALINE d00880A C F31.9 Bipolar disorder, unspecified A` EV A . . . EV A . . . EV A . . . EV A . . . EV A . . . EW A . . . EW A . . . EW A . . . EW0 A . . . EW@ A ALLOPURINOL d00023A C M1A Chronic gout AP EW@ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP EW@ A METFORMIN d03807A B= E11 Type 2 diabetes mellitus AP EW@ A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP EW@ A VALSARTAN d04113A C[@ I10 Essential (primary) hypertension AP EWP A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A EWP A DICLOFENAC d00848A B= M13 Other arthritis A EWP A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A EWP A LEVOTHYROXINE d00278A C E04.9 Nontoxic goiter, unspecified A EWP A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A EWP A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A EWP A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A EWP A TRAZODONE d00395A B G47.0 Insomnia A EW` A . . . EWp A 99999 . . A` EWp A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` EWp A CLONIDINE d00044A C- I10 Essential (primary) hypertension A` EWp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` EWp A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` EWp A MINOXIDIL d00135A C I10 Essential (primary) hypertension A` EW A . . . EW A CLOPIDOGREL d04258A C D75.9P I49.9 Prevent blood clots Cardiac arrhythmia, unspecified Ap EW A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap EW A NITROFURANTOIN d00112A C N39.0 Urinary tract infection, site not specified Ap EW A PANTOPRAZOLE d04514A B# K31.9 Disease of stomach and duodenum, unspecified Ap EW A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap EW A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap EW A TRAZODONE d00395A B G47.0 Insomnia Ap EW A . . . EW A ETHINYL ESTRADIOL; ETHYNODIOL d03388A A N92 Excessive, frequent and irregular menstruation A EW A MENOTROPINS d00571A Bz N97.9 Female infertility, unspecified A EW A . . . EW A ARIPIPRAZOLE d04825A CDp F90 Attention-deficit hyperactivity disorders A EW A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A EW A ACETAMINOPHEN; CAFFEINE; ISOMETHEPTENE MUCATE d05644A B= G43 Migraine A EW A AMITRIPTYLINE d00146A B= G43 G47.0 Migraine Insomnia A EW A DICYCLOMINE d00999A B= K58 Irritable bowel syndrome A EW A DULOXETINE d05355A Cr F32.9 M79.1 M79.2 Major depressive disorder, single episode, unspecified Myalgia Neuralgia and neuritis, unspecified A EW A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia A EW A LIDOCAINE TOPICAL d00683A C M25.55 M54.9 M79.2 Pain in hip Dorsalgia, unspecified Neuralgia and neuritis, unspecified A EW A METHOCARBAMOL d00965A CDp M54.9 M79.1 Dorsalgia, unspecified Myalgia A EW A METOCLOPRAMIDE d00298A CDp G43 Migraine A EW A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified A EW A ONDANSETRON d00867A CDp K58 Irritable bowel syndrome A EW A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B N30 Cystitis A EW A . . . EX A . . . EX A . . . EX A . . . EX0 A METFORMIN d03807A B E11 Type 2 diabetes mellitus A EX@ A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A EX@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EXP A . . . EX` A . . . EXp A MOMETASONE TOPICAL d01300A Bz L20.9 R21 Atopic dermatitis, unspecified Rash and other nonspecific skin eruption A EXp A TACROLIMUS TOPICAL d04740A B L20.9 Atopic dermatitis, unspecified A EX A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A EX A AMOXICILLIN d00088A A H10 Conjunctivitis A EX A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` EX A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Dc I10 Essential (primary) hypertension A` EX A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus A` EX A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EX A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` EX A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` EX A . . . EX A . . . EX A . . . EX A CHLORTHALIDONE d00192A D* I10 Essential (primary) hypertension A@ EX A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ EX A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ EX A SIMVASTATIN d00746A C[@ E78.0P Prevent high cholesterol A@ EX A OMEPRAZOLE d00325A Ap K21 Gastro-esophageal reflux disease A EY A . . . EY A . . . EY A . . . EY0 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D= Z79.3 Long term (current) use of hormonal contraceptives A EY@ A . . . EYP A . . . EY` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EY` A RALOXIFENE d04261A D E78.0 Pure hypercholesterolemia A EYp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EY A . . . EY A CLONIDINE d00044A B[ N95.1 Menopausal and female climacteric states A EY A TRAZODONE d00395A B[ G47.9 Sleep disorder, unspecified A EY A . . . EY A ALBUTEROL d00749A B J45 Asthma A@ EY A BECLOMETHASONE d00760A B J45 Asthma A@ EY A LEVALBUTEROL d04427A B J45 Asthma A@ EY A RANITIDINE d00021A A0 K21 Gastro-esophageal reflux disease A@ EY A . . . EY A . . . EY A . . . EY A . . . EZ A . . . EZ A . . . EZ A . . . EZ0 A . . . EZ@ A DIPHENHYDRAMINE d00212A A T63.4 Toxic effect of venom of other arthropods A EZP A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EZP A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A EZ` A CLOPIDOGREL d04258A C 99999 AP EZ` A DUTASTERIDE d04788A C 99999 AP EZ` A METFORMIN; SAXAGLIPTIN d07709A C ` E11 Type 2 diabetes mellitus AP EZ` A METOPROLOL d00134A C 99999 AP EZ` A OLMESARTAN d04801A C 99999 AP EZp A . . . EZ A ATORVASTATIN d04105A0 Cr I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A EZ A CARVEDILOL d03847A0 Cr I50.9 Heart failure, unspecified A EZ A COLCHICINE d00150A0 Cr M1A Chronic gout A EZ A DIGOXIN d00210A0 Cr I50.9 Heart failure, unspecified A EZ A FEBUXOSTAT d07397A0 Cr M10.9 Gout, unspecified A EZ A GLIMEPIRIDE d03864A0 Cr E11 Type 2 diabetes mellitus A EZ A LISINOPRIL d00732A0 Cr I50.9 I63.P Heart failure, unspecified Prevent stroke A EZ A RANOLAZINE d05719A0 Cr I20.9 Angina pectoris, unspecified A EZ A SPIRONOLACTONE d00373A0 Cr R60.9 Edema, unspecified A EZ A TORSEMIDE d03189A0 Cr I50.9 Heart failure, unspecified A EZ A ZOLPIDEM d00910A0 Cr G47.9 Sleep disorder, unspecified A EZ A . . . EZ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A EZ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 EZ A ARMODAFINIL d06842A Cr G47.41 Narcolepsy A0 EZ A METHYLPHENIDATE d00900A C- G47.41 Narcolepsy A0 EZ A . . . EZ A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 EZ A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 EZ A OLOPATADINE NASAL d07132A C J30.9 Allergic rhinitis, unspecified A0 EZ A . . . EZ A . . . E[ A . . . E[ A . . . E[ A . . . E[0 A BUPROPION d00181A C- N94.3 Premenstrual tension syndrome A E[0 A FLUOXETINE d00236A C- F39 N94.3 Unspecified mood [affective] disorder Premenstrual tension syndrome A E[@ A . . . E[P A BRIMONIDINE; BRINZOLAMIDE OPHTHALMIC d08086A C- H40 Glaucoma A E[P A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E[` A . . . E[p A CARVEDILOL d03847A D I10 Essential (primary) hypertension Ap E[p A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level Ap E[p A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap E[p A IPRATROPIUM d00265A C J42 Unspecified chronic bronchitis Ap E[p A METHOTREXATE d00060A C[@ M06.9 Rheumatoid arthritis, unspecified Ap E[p A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E[p A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E[ A . . . E[ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A0 E[ A METFORMIN d03807A A R73.9 Hyperglycemia, unspecified A0 E[ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E[ A FLUTICASONE d01296A Cr J45 Asthma A@ E[ A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A@ E[ A LORATADINE d03050A Cr T78.40 Allergy, unspecified A@ E[ A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A@ E[ A AMITRIPTYLINE d00146A Cr G47.0 Insomnia A E[ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E[ A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A E[ A GABAPENTIN d03182A Cr N95.1 Menopausal and female climacteric states A E[ A HYDROCHLOROTHIAZIDE d00253A Cr M81 Osteoporosis without current pathological fracture A E[ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E[ A OMEPRAZOLE d00325A Cr K25 Gastric ulcer A E[ A TRIAMTERENE d00396A Cr R60.9 Edema, unspecified A E[ A AMITRIPTYLINE d00146A D G43 Migraine A` E[ A AMLODIPINE d00689A C G43.P Prevent migraine A` E[ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E[ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E[ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E[ A NADOLOL d00018A D G43.P Prevent migraine A` E[ A ARIPIPRAZOLE d04825A CDp R45.4 Irritability and anger A E[ A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E[ A . . . E[ A . . . E\ A . . . E\ A AZITHROMYCIN d00091A AP H66.9 Otitis media, unspecified A E\ A . . . E\0 A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A@ E\0 A INSULIN ASPART d04697A C"0 E11 Type 2 diabetes mellitus A@ E\0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E\0 A WARFARIN d00022A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A@ E\@ A ALBUTEROL d00749A C J45 Asthma A E\P A . . . E\` A GUANFACINE d00717A Bz F90 Attention-deficit hyperactivity disorders A E\` A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E\p A ACETAMINOPHEN; OXYCODONE d03431A C M19.9 Osteoarthritis, unspecified site AP E\p A ALLOPURINOL d00023A CDp M1A Chronic gout AP E\p A CARVEDILOL d03847A C I50.9 Heart failure, unspecified AP E\p A HYDRALAZINE d00132A C I10 Essential (primary) hypertension AP E\p A PREDNISONE d00350A C- M1A Chronic gout AP E\ A . . . E\ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E\ A . . . E\ A . . . E\ A . . . E\ A CIPROFLOXACIN d00011A Ap J42 Unspecified chronic bronchitis A E\ A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E\ A ACETAMINOPHEN; HYDROCODONE d03428A Cr M25.56 Pain in knee A@ E\ A DIAZEPAM d00148A Cr F41.9 M62.83 Anxiety disorder, unspecified Muscle spasm A@ E\ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A@ E\ A MECLIZINE d00859A CDp R42 Dizziness and giddiness A@ E\ A . . . E] A HYDROCHLOROTHIAZIDE d00253A B* I10 Essential (primary) hypertension A E] A AMITRIPTYLINE d00146A B F41.9 Anxiety disorder, unspecified A@ E] A BENZTROPINE d00175A CDp T88.7 Unspecified adverse effect of drug or medicament A@ E] A QUETIAPINE d04220A C G47.0 Insomnia A@ E] A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E] A . . . E]0 A . . . E]@ A ACETAMINOPHEN; HYDROCODONE d03428A0 B T14.9 Unspecified injury A@ E]@ A ALBUTEROL d00749A D& J45 Asthma A@ E]@ A IBUPROFEN d00015A B= T14.9 Unspecified injury A@ E]@ A PREDNISONE d00350A0 B J45 Asthma A@ E]P A . . . E]` A . . . E]p A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A` E]p A CHLORZOXAZONE d00962A C M25.51 T14.9 Pain in shoulder Unspecified injury A` E]p A FLUTICASONE; SALMETEROL d04611A C- J44.9 Chronic obstructive pulmonary disease, unspecified A` E]p A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A` E]p A TIOTROPIUM d04829A C- J44.9 Chronic obstructive pulmonary disease, unspecified A` E]p A TRAMADOL d03826A C M25.51 T14.9 Pain in shoulder Unspecified injury A` E] A . . . E] A . . . E] A . . . E] A . . . E] A . . . E] A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E] A . . . E] A ALPRAZOLAM d00168A C R45.0 Nervousness A` E] A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E] A GLIMEPIRIDE d03864A B[ E11 Type 2 diabetes mellitus A` E] A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A` E] A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E] A VILAZODONE d07740A C F32.9 Major depressive disorder, single episode, unspecified A` E^ A ATENOLOL d00004A B I10 Essential (primary) hypertension A@ E^ A CIMETIDINE d00140A B R12 Heartburn A@ E^ A DIPHENHYDRAMINE d00212A B L23 Allergic contact dermatitis A@ E^ A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A@ E^ A . . . E^ A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E^0 A BUPROPION d00181A B= F32.9 Major depressive disorder, single episode, unspecified A E^@ A . . . E^P A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 Dorsalgia, unspecified A E^P A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E^P A DILTIAZEM d00045A C[@ E78.0 Pure hypercholesterolemia A E^P A DOXAZOSIN d00726A C[@ R39.15 Urgency of urination A E^P A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E^P A GEMFIBROZIL d00245A C[@ E78.0 Pure hypercholesterolemia A E^P A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E^P A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E^P A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E^P A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A E^P A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E^P A OXYBUTYNIN d00328A C[@ R35.0 Frequency of micturition A E^P A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E^P A RANITIDINE d00021A C[@ K21 K25 R12 Gastro-esophageal reflux disease Gastric ulcer Heartburn A E^P A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E^` A . . . E^p A . . . E^ A . . . E^ A . . . E^ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E^ A . . . E^ A ALLOPURINOL d00023A C[@ M1A Chronic gout A E^ A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A E^ A DICYCLOMINE d00999A C R10.83 Colic A E^ A ETODOLAC d00851A Cr M1A Chronic gout A E^ A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E^ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 Essential (primary) hypertension A E^ A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A E^ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E^ A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E^ A . . . E^ A . . . E^ A . . . E_ A . . . E_ A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A0 E_ A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A0 E_ A PRAZOSIN d00138A B G47.0 Insomnia A0 E_ A . . . E_0 A . . . E_@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E_@ A AMOXICILLIN d00088A B= K04.7 Periapical abscess without sinus A E_@ A DARIFENACIN d05422A B N39.4 Other specified urinary incontinence A E_@ A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E_@ A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E_@ A POTASSIUM CITRATE d01423A C- N20.0 Calculus of kidney A E_@ A SULINDAC d00033A C- N20.0 Calculus of kidney A E_@ A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E_@ A TRAMADOL d03826A C- M54.9 R51 Dorsalgia, unspecified Headache A E_P A . . . E_` A . . . E_p A . . . E_ A . . . E_ A . . . E_ A . . . E_ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ei I10 Essential (primary) hypertension A@ E_ A METFORMIN d03807A Ei 99999 A@ E_ A OMEPRAZOLE d00325A C 99999 A@ E_ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E_ A ACETAZOLAMIDE d00161A CDp H40 Glaucoma A E_ A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E_ A BECLOMETHASONE d00760A B J45 Asthma Ap E_ A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified Ap E_ A EMOLLIENTS TOPICAL d03770A B[ L20.9 Atopic dermatitis, unspecified Ap E_ A HYDROXYZINE d00907A CDp L20.9 Atopic dermatitis, unspecified Ap E_ A MONTELUKAST d04289A Cr J45 Asthma Ap E_ A MUPIROCIN TOPICAL d01267A A L20.9 Atopic dermatitis, unspecified Ap E_ A TRIAMCINOLONE TOPICAL d03206A C L85.3 Xerosis cutis Ap E_ A OXYBUTYNIN d00328A D N32.81 N39.4 R39.15 Overactive bladder Other specified urinary incontinence Urgency of urination A0 E_ A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A0 E_ A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia A0 E_ A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap E_ A ANTI-INFECTIVES - UNSPECIFIED c00001A A0 J18.9 Pneumonia, unspecified organism Ap E_ A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension Ap E_ A CLOPIDOGREL d04258A Cr I63.P Prevent stroke Ap E_ A DICLOFENAC d00848A B M25.55 Pain in hip Ap E_ A GABAPENTIN d03182A B= M79.2 Neuralgia and neuritis, unspecified Ap E_ A METHOCARBAMOL d00965A B M62.83 Muscle spasm Ap E` A ALLOPURINOL d00023A C 99999 Ap E` A ALPRAZOLAM d00168A B[ F41.9 Anxiety disorder, unspecified Ap E` A FUROSEMIDE d00070A C 99999 Ap E` A METOPROLOL d00134A C 99999 Ap E` A NIFEDIPINE d00051A C 99999 Ap E` A SPIRONOLACTONE d00373A C 99999 Ap E` A ZALEPLON d04452A C 99999 Ap E` A . . . E` A . . . E`0 A . . . E`@ A . . . E`P A . . . E`` A . . . E`p A . . . E` A . . . E` A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A@ E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E` A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- Z79.3 Long term (current) use of hormonal contraceptives A E` A . . . E` A . . . E` A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E` A . . . E` A ALENDRONATE d03849A0 C[@ M81 Osteoporosis without current pathological fracture A E` A ATENOLOL d00004A0 D I10 Essential (primary) hypertension A E` A ATORVASTATIN d04105A0 C[@ E78.0 Pure hypercholesterolemia A E` A EZETIMIBE d04824A0 C[@ E78.0 Pure hypercholesterolemia A E` A LISINOPRIL d00732A0 D I10 Essential (primary) hypertension A E` A NITROFURANTOIN d00112A0 C[@ N39.0 Urinary tract infection, site not specified A E` A OMEPRAZOLE d00325A0 C[@ K21 Gastro-esophageal reflux disease A E` A POLYETHYLENE GLYCOL 3350 d05350A0 C[@ K59.0 Constipation A E` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 C[@ N39.0 Urinary tract infection, site not specified A Ea A . . . Ea A . . . Ea A DIGOXIN d00210A CDp I49.9 Cardiac arrhythmia, unspecified A Ea A DILTIAZEM d00045A CDp R00.0 Tachycardia, unspecified A Ea A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified A Ea A ESOMEPRAZOLE d04749A C[@ K22.1 Ulcer of esophagus A Ea A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A Ea A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified A Ea A RISEDRONATE d04300A Cr M81 Osteoporosis without current pathological fracture A Ea A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A Ea0 A . . . Ea@ A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A EaP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ EaP A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ EaP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ EaP A TAMSULOSIN d04121A C"0 N42.9 Disorder of prostate, unspecified A@ Ea` A . . . Eap A AMLODIPINE; BENAZEPRIL d03829A C- 99999 A` Eap A LEUPROLIDE d01353A C[@ C61 Malignant neoplasm of prostate A` Eap A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` Eap A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` Eap A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A` Eap A TAMSULOSIN d04121A C- N40 Enlarged prostate A` Ea A . . . Ea A ALBUTEROL d00749A C J45 Asthma A Ea A CLINDAMYCIN; TRETINOIN TOPICAL d05973A Bz L70 Acne A0 Ea A CLOBETASOL TOPICAL d01288A B= L40 Psoriasis A0 Ea A PIMECROLIMUS TOPICAL d04784A B= 55555 A0 Ea A . . . Ea A . . . Ea A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Ea A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ Ea A HYDROXYCHLOROQUINE d00817A C- M35.0 Sicca syndrome [Sjgren] A@ Ea A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ Ea A . . . Ea A CETIRIZINE d03827A B J30.9 Allergic rhinitis, unspecified Ap Ea A DIAZEPAM d00148A B F41.9 Anxiety disorder, unspecified Ap Ea A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension Ap Ea A LOVASTATIN d00280A B E78.0 Pure hypercholesterolemia Ap Ea A NITROFURANTOIN d00112A B N30 Cystitis Ap Ea A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap Ea A TRAMADOL d03826A B M54.9 Dorsalgia, unspecified Ap Eb A . . . Eb A . . . Eb A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension AP Eb A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Eb A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus AP Eb A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP Eb A TAMSULOSIN d04121A Cr R39.15 Urgency of urination AP Eb0 A ALBUTEROL d00749A Cr J42 Unspecified chronic bronchitis A0 Eb0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 Eb0 A PREDNISONE d00350A C[@ J42 Unspecified chronic bronchitis A0 Eb@ A . . . EbP A ALBUTEROL d00749A D J44.9 Chronic obstructive pulmonary disease, unspecified A EbP A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A EbP A CARVEDILOL d03847A B I10 Essential (primary) hypertension A EbP A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified A EbP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EbP A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A EbP A OXYCODONE d00329A C M25.56 M54.2 M54.9 Pain in knee Cervicalgia Dorsalgia, unspecified A EbP A OXYGEN a54115A Cr G47.30 Sleep apnea, unspecified A EbP A SIMVASTATIN d00746A C I21.P Prevent heart attack/myocardial infarction A EbP A WARFARIN d00022A Dc D75.9P Prevent blood clots A Eb` A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified A Ebp A . . . Eb A . . . Eb A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Eb A CARISOPRODOL d00960A Cr M79.1 Myalgia Ap Eb A ESOMEPRAZOLE d04749A C K27 Peptic ulcer, site unspecified Ap Eb A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap Eb A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia Ap Eb A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap Eb A TEMAZEPAM d00384A Cr G47.9 Sleep disorder, unspecified Ap Eb A TRAMADOL d03826A C M13 Other arthritis Ap Eb A ALBUTEROL d00749A D J45 Asthma A Eb A AMOXICILLIN d00088A A0 K04.7 Periapical abscess without sinus A Eb A . . . Eb A . . . Eb A . . . Eb A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A` Eb A BRINZOLAMIDE OPHTHALMIC d04301A C H40 Glaucoma A` Eb A GLIPIZIDE d00246A CP E11 Type 2 diabetes mellitus A` Eb A OMEPRAZOLE d00325A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A` Eb A PIOGLITAZONE d04442A CP E11 Type 2 diabetes mellitus A` Eb A TRAVOPROST OPHTHALMIC d04753A C H40 Glaucoma A` Ec A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Ec A . . . Ec A . . . Ec0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 Ec0 A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A0 Ec0 A SOTALOL d00371A C I49.9 Cardiac arrhythmia, unspecified A0 Ec@ A ALBUTEROL d00749A Cr J45 Asthma A Ec@ A BECLOMETHASONE d00760A Cr J45 Asthma A EcP A . . . Ec` A . . . Ecp A . . . Ec A AMITRIPTYLINE d00146A Ap R51 Headache A0 Ec A NAPROXEN d00019A Ap R51 Headache A0 Ec A SUMATRIPTAN d03160A Ap R51 Headache A0 Ec A BUPROPION d00181A B F17.203 F41.9 Nicotine dependence unspecified, with withdrawal Anxiety disorder, unspecified A Ec A . . . Ec A ALBUTEROL d00749A B* R05 Cough A Ec A FLUTICASONE NASAL d04283A B* J30.9 Allergic rhinitis, unspecified A Ec A . . . Ec A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A Ec A CLONIDINE d00044A C- I10 Essential (primary) hypertension A Ec A DULOXETINE d05355A CDp F32.9 Major depressive disorder, single episode, unspecified A Ec A GABAPENTIN d03182A C- M06.9 Rheumatoid arthritis, unspecified A Ec A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A Ec A HYDROCODONE d03075A CDp M79.1 Myalgia A Ec A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Ec A OMEPRAZOLE d00325A C- K25 Gastric ulcer A Ec A PRAVASTATIN d00348A C- E78.0P Prevent high cholesterol A Ec A TEMAZEPAM d00384A C- G47.0 Insomnia A Ec A DEXTROMETHORPHAN; PROMETHAZINE d03360A C[@ R09.81 Nasal congestion A Ec A FENOFIBRATE d04286A CDp M1A Chronic gout A Ec A . . . Ed A . . . Ed A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A0 Ed A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 Ed A VALACYCLOVIR d03838A C B02 Zoster [herpes zoster] A0 Ed A CIMETIDINE d00140A C[@ K30 Functional dyspepsia A@ Ed A NEBIVOLOL d05265A B= I10 Essential (primary) hypertension A@ Ed A TAMSULOSIN d04121A B= N40 Enlarged prostate A@ Ed A VENLAFAXINE d03181A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ed0 A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A Ed0 A VENLAFAXINE d03181A B F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A Ed@ A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ed@ A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ed@ A ISONIAZID d00101A B A15.P Prevent tuberculosis A@ Ed@ A OMEPRAZOLE d00325A C- K21 R12 Gastro-esophageal reflux disease Heartburn A@ EdP A . . . Ed` A ALISKIREN d06665A C- I10 Essential (primary) hypertension A0 Ed` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 Ed` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Edp A . . . Ed A . . . Ed A CLOPIDOGREL d04258A C I63 Cerebral infarction A` Ed A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A` Ed A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` Ed A METOPROLOL d00134A Bz I10 Essential (primary) hypertension A` Ed A NIFEDIPINE d00051A CP I10 Essential (primary) hypertension A` Ed A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ed A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A@ Ed A CELECOXIB d04380A C M79.1 T14.9 Myalgia Unspecified injury A@ Ed A CETIRIZINE d03827A C J30.1 Allergic rhinitis due to pollen A@ Ed A CONJUGATED ESTROGENS d00541A D ^ N95.1 Menopausal and female climacteric states A@ Ed A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders AP Ed A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified AP Ed A CLONAZEPAM d00197A C G47.0 Insomnia AP Ed A ESCITALOPRAM d04812A C- F39 Unspecified mood [affective] disorder AP Ed A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease AP Ed A . . . Ed A ATOMOXETINE d04827A CDp F90 Attention-deficit hyperactivity disorders A Ed A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A Ed A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ed A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A Ed A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A Ed A ESCITALOPRAM d04812A D* F32.9 Major depressive disorder, single episode, unspecified A Ed A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified A Ed A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension A Ed A INSULIN GLARGINE d04538A Cr R73 Elevated blood glucose level A Ed A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A Ed A NATEGLINIDE d04743A B R73 Elevated blood glucose level A Ed A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A` Ed A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` Ed A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` Ed A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` Ed A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` Ed A WARFARIN d00022A C D75.9P Prevent blood clots A` Ee A . . . Ee A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A Ee A INDOMETHACIN d00039A B[ M54.9 Dorsalgia, unspecified A Ee A . . . Ee0 A SEX HORMONES - UNSPECIFIED c00101A C"0 N95.1 Menopausal and female climacteric states A0 Ee0 A TESTOSTERONE d00558A C"0 N95.1 Menopausal and female climacteric states A0 Ee0 A THYROID DESICCATED d00655A C"0 E03.9 Hypothyroidism, unspecified A0 Ee@ A . . . EeP A . . . Ee` A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ Ee` A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Dc I10 Essential (primary) hypertension A@ Ee` A PANTOPRAZOLE d04514A Dc K31.9 Disease of stomach and duodenum, unspecified A@ Ee` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Eep A . . . Ee A . . . Ee A . . . Ee A . . . Ee A . . . Ee A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A Ee A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ee A . . . Ee A . . . Ee A . . . Ef A . . . Ef A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Ef A . . . Ef0 A . . . Ef@ A . . . EfP A . . . Ef` A AMLODIPINE d00689A CP I10 Essential (primary) hypertension A Ef` A BACLOFEN d00967A Cr G81.1 Spastic hemiplegia A Ef` A CARISOPRODOL d00960A B[ M62.83 Muscle spasm A Ef` A CARVEDILOL d03847A C I48.91 Unspecified atrial fibrillation A Ef` A FUROSEMIDE d00070A C R60.9 Edema, unspecified A Ef` A HYDROMORPHONE d00255A Bz M54.2 M79.1 Cervicalgia Myalgia A Ef` A INSULIN ASPART d04697A Dc E10 Type 1 diabetes mellitus A Ef` A LORAZEPAM d00149A Dc G47.0 G47.9 Insomnia Sleep disorder, unspecified A Ef` A MECLIZINE d00859A B[ R42 Dizziness and giddiness A Ef` A METHYLPREDNISOLONE d00293A D= J44.9 J45 J84.10 Chronic obstructive pulmonary disease, unspecified Asthma Pulmonary fibrosis, unspecified A Ef` A MOMETASONE TOPICAL d01300A C L29.9 Pruritus, unspecified A Ef` A MONTELUKAST d04289A C J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A Ef` A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A Ef` A ONDANSETRON d00867A Cr R11.P Prevent nausea or vomiting A Ef` A SERTRALINE d00880A B[ F32.9 Major depressive disorder, single episode, unspecified A Efp A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A ALBUTEROL d00749A B R05 Cough A0 Ef A AZITHROMYCIN d00091A A0 J18.9 Pneumonia, unspecified organism A0 Ef A PROMETHAZINE d00787A A` R05 Cough A0 Ef A AZITHROMYCIN d00091A AP J02 Acute pharyngitis A Ef A AZITHROMYCIN d00091A AP J01.9 Acute sinusitis, unspecified A Ef A ESCITALOPRAM d04812A D F41.9 Anxiety disorder, unspecified A Ef A CELECOXIB d04380A0 B= M06.9 Rheumatoid arthritis, unspecified A` Ef A GLIMEPIRIDE d03864A0 C E11 Type 2 diabetes mellitus A` Ef A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A0 C I10 Essential (primary) hypertension A` Ef A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A` Ef A SULFASALAZINE d00379A0 C M45 Ankylosing spondylitis A` Ef A TRIAMCINOLONE NASAL d04233A0 C- J30.9 Allergic rhinitis, unspecified A` Eg A . . . Eg A TRAMADOL d03826A A M79.2 Neuralgia and neuritis, unspecified A Eg A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A Eg A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A Eg0 A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A Eg@ A . . . EgP A ACETAMINOPHEN; CODEINE d03423A B M79.7 Fibromyalgia Ap EgP A CYCLOBENZAPRINE d00963A B G47.0 Insomnia Ap EgP A DULOXETINE d05355A Cr M79.7 Fibromyalgia Ap EgP A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease Ap EgP A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified Ap EgP A NABUMETONE d00310A B M79.1 Myalgia Ap EgP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap Eg` A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A Eg` A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A Egp A . . . Eg A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Eg A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ Eg A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Eg A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Eg A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Eg A . . . Eg A HYDROCORTISONE TOPICAL d03205A CDp L20.9 Atopic dermatitis, unspecified A Eg A . . . Eg A ALBUTEROL d00749A Cr J45 Asthma A0 Eg A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A0 Eg A MONTELUKAST d04289A Cr J45 Asthma A0 Eg A . . . Eg A FLUOXETINE d00236A B F39 Unspecified mood [affective] disorder A Eg A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A Eh A . . . Eh A AMOXICILLIN d00088A B K04.7 Periapical abscess without sinus AP Eh A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified AP Eh A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP Eh A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures AP Eh A QUETIAPINE d04220A C F32.9 F39 F43.1 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Post-traumatic stress disorder (PTSD) AP Eh A . . . Eh0 A . . . Eh@ A . . . EhP A IBUPROFEN d00015A C M19.9 M25.56 M54.9 Osteoarthritis, unspecified site Pain in knee Dorsalgia, unspecified A` EhP A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A` EhP A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A` EhP A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A` EhP A NAPROXEN d00019A C M19.9 M25.56 M54.9 Osteoarthritis, unspecified site Pain in knee Dorsalgia, unspecified A` EhP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Eh` A . . . Ehp A . . . Eh A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia A Eh A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A Eh A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A Eh A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A Eh A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A Eh A METFORMIN d03807A C[@ R73.9 Hyperglycemia, unspecified A Eh A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A Eh A TOLTERODINE d04294A C[@ N39.4 Other specified urinary incontinence A Eh A TRAZODONE d00395A C[@ F41.9 Anxiety disorder, unspecified A Eh A VENLAFAXINE d03181A C[@ F32.9 Major depressive disorder, single episode, unspecified A Eh A . . . Eh A . . . Eh A TRAMADOL d03826A Ap M25.56 Pain in knee A Eh A OXYCODONE d00329A B= M25.56 Pain in knee A Eh A RANITIDINE d00021A Cr K30 Functional dyspepsia A Eh A AZITHROMYCIN d00091A B J20.9 Acute bronchitis, unspecified A Eh A VENLAFAXINE d03181A B F41.9 Anxiety disorder, unspecified A Eh A ACYCLOVIR d00001A Bz B02 Zoster [herpes zoster] A Eh A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A Eh A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eh A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A Eh A CLOPIDOGREL d04258A Dc I48.91 Unspecified atrial fibrillation A Eh A DONEPEZIL d04099A CDp R41.3 Other amnesia A Eh A HYDROXYCHLOROQUINE d00817A B= M06.9 Rheumatoid arthritis, unspecified A Eh A IRBESARTAN d04222A D=O I10 Essential (primary) hypertension A Eh A LORATADINE d03050A B T78.40 Allergy, unspecified A Eh A MEMANTINE d04899A CDp G31.9 Degenerative disease of nervous system, unspecified A Eh A OLOPATADINE NASAL d07132A Bz J30.9 Allergic rhinitis, unspecified A Eh A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C E05.9 Z79.3 Thyrotoxicosis, unspecified Long term (current) use of hormonal contraceptives A Ei A . . . Ei A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A Ei A . . . Ei0 A . . . Ei@ A . . . EiP A . . . Ei` A RANITIDINE d00021A B K30 Functional dyspepsia A Eip A ARIPIPRAZOLE d04825A C- F31.9 F32.9 F90 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Attention-deficit hyperactivity disorders A Eip A HYDROXYZINE d00907A C[@ F41.9 G47.0 Anxiety disorder, unspecified Insomnia A Eip A LANSOPRAZOLE d03828A Ei K30 Functional dyspepsia A Eip A MELOXICAM d04532A A M54.9 Dorsalgia, unspecified A Eip A OXCARBAZEPINE d04513A Ei F31.9 F39 Bipolar disorder, unspecified Unspecified mood [affective] disorder A Eip A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A Eip A RISPERIDONE d03180A C- F29 Unspecified psychosis not due to a substance or known physiological condition A Eip A TOPIRAMATE d04115A C G43 Migraine A Eip A TRIHEXYPHENIDYL d00970A Ei G25.0 Essential tremor A Eip A VALACYCLOVIR d03838A Cr A60.9 Anogenital herpesviral infection, unspecified A Ei A ALBUTEROL; IPRATROPIUM d04066A C- J44.9 Chronic obstructive pulmonary disease, unspecified A Ei A CLOPIDOGREL d04258A A D75.9P Prevent blood clots A Ei A GABAPENTIN d03182A C- R45.0 Nervousness A Ei A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A Ei A MELOXICAM d04532A C- M06.9 Rheumatoid arthritis, unspecified A Ei A METOPROLOL d00134A C- I50.9 Heart failure, unspecified A Ei A NICOTINE d00316A A F17.203 Nicotine dependence unspecified, with withdrawal A Ei A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A Ei A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A Ei A SERTRALINE d00880A A F41.9 Anxiety disorder, unspecified A Ei A CIPROFLOXACIN OTIC d04287A A H66.9 Otitis media, unspecified A Ei A PREDNISONE d00350A B H66.9 Otitis media, unspecified A Ei A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A Ei A IMIPRAMINE d00259A C- R32 Unspecified urinary incontinence A Ei A . . . Ei A . . . Ei A LEVALBUTEROL d04427A Cr J45 Asthma A Ei A MONTELUKAST d04289A Cr J45 Asthma A Ei A IBUPROFEN d00015A CDp R52 Pain, unspecified A@ Ei A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ Ei A METOCLOPRAMIDE d00298A C[@ R14.0 Abdominal distension (gaseous) A@ Ei A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Ei A BIMATOPROST OPHTHALMIC d04754A D H40 Glaucoma A Ei A BRIMONIDINE OPHTHALMIC d04048A D H40 Glaucoma A Ej A . . . Ej A . . . Ej A . . . Ej0 A . . . Ej@ A . . . EjP A . . . Ej` A GUANFACINE d00717A C"0 F90 Attention-deficit hyperactivity disorders A0 Ej` A METFORMIN d03807A B* F50.9 Eating disorder, unspecified A0 Ej` A QUETIAPINE d04220A B* F39 Unspecified mood [affective] disorder A0 Ejp A . . . Ej A . . . Ej A . . . Ej A BENZTROPINE d00175A C- F32.9 Major depressive disorder, single episode, unspecified A0 Ej A DIVALPROEX SODIUM d03833A C- F31.9 Bipolar disorder, unspecified A0 Ej A OLANZAPINE d04050A C- F31.9 Bipolar disorder, unspecified A0 Ej A NAPROXEN d00019A Cr M19.9 M54.2 M79.1 Osteoarthritis, unspecified site Cervicalgia Myalgia A Ej A . . . Ej A . . . Ej A . . . Ej A CLONIDINE d00044A C"0 G47.0 Insomnia A@ Ej A DESMOPRESSIN d00583A C"0 F98.0 Enuresis not due to a substance or known physiological condition A@ Ej A GUANFACINE d00717A C"0 F90 Attention-deficit hyperactivity disorders A@ Ej A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A@ Ek A . . . Ek A . . . Ek A . . . Ek0 A EZETIMIBE d04824A CDp R35.1 Nocturia AP Ek0 A GLYBURIDE d00248A CDp R73.9 Hyperglycemia, unspecified AP Ek0 A METFORMIN d03807A CDp R73.9 Hyperglycemia, unspecified AP Ek0 A PIOGLITAZONE d04442A CDp R73.9 Hyperglycemia, unspecified AP Ek0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP Ek@ A ESOMEPRAZOLE d04749A C R12 Heartburn A Ek@ A SOLIFENACIN d05413A C- N39.4 Other specified urinary incontinence A EkP A . . . Ek` A . . . Ekp A . . . Ek A . . . Ek A METHOTREXATE d00060A Cr M06.9 Rheumatoid arthritis, unspecified A Ek A . . . Ek A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 Essential (primary) hypertension A Ek A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Ek A . . . Ek A . . . Ek A . . . Ek A . . . El A FUROSEMIDE d00070A C 99999 AP El A METOPROLOL d00134A C 99999 AP El A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP El A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP El A SPIRONOLACTONE d00373A C 99999 AP El A . . . El A 77777 . . A El0 A AMOXICILLIN d00088A A J02 Acute pharyngitis A El@ A . . . ElP A . . . El` A . . . Elp A . . . El A FLUTICASONE d01296A C[@ J45 Asthma A0 El A LEVALBUTEROL d04427A C[@ J45 Asthma A0 El A LEVOCETIRIZINE d05851A C- T78.40 Allergy, unspecified A0 El A . . . El A . . . El A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ El A INSULIN GLARGINE d04538A CDp E10 Type 1 diabetes mellitus A@ El A INSULIN REGULAR d04369A Cr E10 Type 1 diabetes mellitus A@ El A LIRAGLUTIDE d07466A B= E10 E66 Type 1 diabetes mellitus Overweight and obesity A@ El A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A El A ALPRAZOLAM d00168A Ap F41.9 Anxiety disorder, unspecified A0 El A MECLIZINE d00859A B R42 Dizziness and giddiness A0 El A MELOXICAM d04532A C M25.56 Pain in knee A0 El A . . . El A . . . Em A DIAZEPAM d00148A B R42 Dizziness and giddiness A0 Em A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 Em A OMEPRAZOLE d00325A A K21 Gastro-esophageal reflux disease A0 Em A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A Em A . . . Em0 A . . . Em@ A . . . EmP A 99999 . . A Em` A . . . Emp A ACETAMINOPHEN; HYDROCODONE d03428A C M06.9 Rheumatoid arthritis, unspecified A Emp A ALLOPURINOL d00023A0 C M1A Chronic gout A Emp A ATENOLOL d00004A0 C I10 Essential (primary) hypertension A Emp A DOCUSATE d01021A0 C K59.0 Constipation A Emp A GABAPENTIN d03182A0 C 99999 A Emp A LOVASTATIN d00280A C 99999 A Emp A NIFEDIPINE d00051A0 C 99999 A Emp A OMEPRAZOLE d00325A0 C 99999 A Emp A TIZANIDINE d04102A B M62.83 Muscle spasm A Emp A WARFARIN d00022A0 C 99999 A Em A . . . Em A . . . Em A . . . Em A ACETAMINOPHEN; HYDROCODONE d03428A Ap M54.9 Dorsalgia, unspecified A0 Em A CIPROFLOXACIN d00011A Ap N34.1 Nonspecific urethritis A0 Em A CYCLOBENZAPRINE d00963A Ap M62.83 Muscle spasm A0 Em A . . . Em A . . . Em A . . . Em A . . . En A . . . En A . . . En A . . . En0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A En0 A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A En@ A . . . EnP A ALBUTEROL d00749A CDp J45 Asthma A En` A . . . Enp A 55555 A C E78.0 Pure hypercholesterolemia A Enp A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A Enp A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Enp A CLOPIDOGREL d04258A Ei 99999 A Enp A EXENATIDE d05529A B E11 Type 2 diabetes mellitus A Enp A FENOFIBRATE d04286A C- 99999 A Enp A INSULIN REGULAR d04369A C E11 Type 2 diabetes mellitus A Enp A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Enp A METOPROLOL d00134A C- I50.9 Heart failure, unspecified A Enp A SPIRONOLACTONE d00373A Ei I10 Essential (primary) hypertension A Enp A VALSARTAN d04113A Ei I10 Essential (primary) hypertension A En A ATENOLOL d00004A Cr R07.9 Chest pain, unspecified A@ En A DOXAZOSIN d00726A C- N40 Enlarged prostate A@ En A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ En A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ En A . . . En A . . . En A FINASTERIDE d00563A C N40 Enlarged prostate A0 En A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 En A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 En A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 En A LETROZOLE d04156A Cr C50 Malignant neoplasm of breast A0 En A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 En A . . . En A . . . En A ALBUTEROL d00749A B J20.9 Acute bronchitis, unspecified A En A MOMETASONE NASAL d04223A B J30.9 Allergic rhinitis, unspecified A Eo A ACETAMINOPHEN; HYDROCODONE d03428A Bz M54.9 Dorsalgia, unspecified A0 Eo A CYCLOBENZAPRINE d00963A Bz M62.83 Muscle spasm A0 Eo A GABAPENTIN d03182A B= M79.2 Neuralgia and neuritis, unspecified A0 Eo A ATENOLOL d00004A C 99999 A` Eo A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A` Eo A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A` Eo A LOSARTAN d03821A C 99999 A` Eo A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` Eo A SIMVASTATIN d00746A C 99999 A` Eo A . . . Eo0 A . . . Eo@ A . . . EoP A . . . Eo` A . . . Eop A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A Eop A TRAZODONE d00395A C F32.9 Major depressive disorder, single episode, unspecified A Eo A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A Bz 55555 A Eo A . . . Eo A . . . Eo A LISDEXAMFETAMINE d06663A C R41.840 Attention and concentration deficit A Eo A . . . Eo A . . . Eo A . . . Eo A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A Eo A BROMOCRIPTINE d00178A C E11 Type 2 diabetes mellitus A Eo A CILOSTAZOL d04382A B Z79.02 Long term (current) use of antithrombotics/antiplatelets A Eo A DESOGESTREL; ETHINYL ESTRADIOL d03782A Dc Z79.3 Long term (current) use of hormonal contraceptives A Eo A EXENATIDE d05529A B* E11 Type 2 diabetes mellitus A Eo A INSULIN GLARGINE d04538A B[ E11 Type 2 diabetes mellitus A Eo A LOSARTAN d03821A B[ I21.P Prevent heart attack/myocardial infarction A Eo A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A Eo A PHENTERMINE; TOPIRAMATE d07881A Ap E66 Overweight and obesity A Ep A . . . Ep A . . . Ep A . . . Ep0 A ALBUTEROL d00749A C T78.40 Allergy, unspecified A Ep0 A FLUTICASONE; SALMETEROL d04611A C T78.40 Allergy, unspecified A Ep@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B[ I10 Essential (primary) hypertension A EpP A . . . Ep` A . . . Epp A ACETAMINOPHEN; OXYCODONE d03431A C- B02 Zoster [herpes zoster] A Epp A ATROPINE; DIPHENOXYLATE d03506A C R19.7 Diarrhea, unspecified A Epp A BENZONATATE d00796A B R05 Cough A Epp A CLONAZEPAM d00197A Cr G47.0 Insomnia A Epp A DOXEPIN d00217A C G47.0 Insomnia A Epp A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A Epp A GABAPENTIN d03182A C- B02 Zoster [herpes zoster] A Epp A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A Epp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Epp A ONDANSETRON d00867A C- R11 R42 Nausea and vomiting Dizziness and giddiness A Epp A ORPHENADRINE d00966A C M25.51 M54.2 Pain in shoulder Cervicalgia A Epp A OXYCODONE d00329A B= T14.9 Unspecified injury A Epp A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A Epp A VERAPAMIL d00048A D I10 Essential (primary) hypertension A Ep A AMITRIPTYLINE d00146A CDp R51 Headache A Ep A HYDROCHLOROTHIAZIDE d00253A B N20.0 Calculus of kidney A Ep A . . . Ep A FLUCONAZOLE d00071A A` L22 Diaper dermatitis A Ep A NYSTATIN TOPICAL d04399A A` L22 Diaper dermatitis A Ep A FLUTICASONE NASAL d04283A B[ J01.9 Acute sinusitis, unspecified A Ep A . . . Ep A . . . Ep A 99999 . . A Ep A . . . Eq A . . . Eq A ACETAMINOPHEN; HYDROCODONE d03428A A@ G89.18 Other acute postprocedural pain A Eq A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A Eq A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Eq0 A . . . Eq@ A . . . EqP A BECLOMETHASONE d00760A Ap J45 Asthma A EqP A PREDNISOLONE d00084A Ap J45 Asthma A Eq` A ALENDRONATE d03849A0 B M81 Osteoporosis without current pathological fracture A@ Eq` A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A@ Eq` A LEVOTHYROXINE d00278A0 C E04.1 Nontoxic single thyroid nodule A@ Eq` A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A@ Eqp A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified Ap Eqp A BUPROPION d00181A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap Eqp A GABAPENTIN d03182A CD` G43 Migraine Ap Eqp A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified Ap Eqp A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap Eqp A MIRTAZAPINE d04025A B G47.0 Insomnia Ap Eqp A ROPINIROLE d04215A C G25.81 Restless legs syndrome Ap Eq A . . . Eq A . . . Eq A . . . Eq A HYDROCHLOROTHIAZIDE d00253A C 99999 A Eq A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eq A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ Eq A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A@ Eq A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A@ Eq A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A@ Eq A . . . Eq A . . . Eq A . . . Er A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A D E11 Type 2 diabetes mellitus A0 Er A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 Er A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A0 Er A ATENOLOL d00004A Dc I51.9 Heart disease, unspecified A@ Er A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ Er A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ Er A RAMIPRIL d00728A C I10 Essential (primary) hypertension A@ Er A . . . Er0 A ACETAMINOPHEN; OXYCODONE d03431A C[@ R10.9 Unspecified abdominal pain A Er0 A BACITRACIN; HYDROCORTISONE; NEOMYCIN; POLYMYXIN B TOPICAL d04196A B= H93.9 Unspecified disorder of ear A Er0 A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A C R21 Rash and other nonspecific skin eruption A Er0 A BUMETANIDE d00179A C[@ I50.9 Heart failure, unspecified A Er0 A COLESTIPOL d00744A C[@ R19.7 Diarrhea, unspecified A Er0 A FEXOFENADINE d04040A C[@ T78.40 Allergy, unspecified A Er0 A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified A Er0 A GABAPENTIN d03182A C[@ N95.1 Menopausal and female climacteric states A Er0 A ISOSORBIDE MONONITRATE d00269A C[@ R07.9 Chest pain, unspecified A Er0 A MEDROXYPROGESTERONE d00284A C[@ N92 Excessive, frequent and irregular menstruation A Er0 A METOPROLOL d00134A C[@ I50.9 Heart failure, unspecified A Er0 A NITROGLYCERIN d00321A C[@ I20.9 Angina pectoris, unspecified A Er0 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A Er0 A SAXAGLIPTIN d07467A C E11 Type 2 diabetes mellitus A Er@ A 99999 . . A ErP A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D- Z79.3 Long term (current) use of hormonal contraceptives A ErP A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Er` A . . . Erp A . . . Er A . . . Er A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A Er A BUPROPION d00181A Dc F32.9 F43.1 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) A Er A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A Er A CITALOPRAM d04332A C F39 Unspecified mood [affective] disorder A Er A CLOTRIMAZOLE TOPICAL d04395A D@) B35.9 Dermatophytosis, unspecified A Er A CYPROHEPTADINE d00790A B[ G47.0 Insomnia A Er A FINASTERIDE d00563A Cr N40 Enlarged prostate A Er A GABAPENTIN d03182A B= M79.2 Neuralgia and neuritis, unspecified A Er A HYDROXYZINE d00907A C[@ F41.9 Anxiety disorder, unspecified A Er A MECLIZINE d00859A C R42 Dizziness and giddiness A Er A METHOCARBAMOL d00965A C- M62.83 Muscle spasm A Er A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Er A TERAZOSIN d00386A C N40 Enlarged prostate A Er A . . . Er A . . . Er A . . . Er A . . . Er A . . . Es A FLUOXETINE d00236A D# F32.9 Major depressive disorder, single episode, unspecified A@ Es A HYDROXYZINE d00907A Ap F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ Es A NABUMETONE d00310A Ap T14.9 Unspecified injury A@ Es A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ Es A . . . Es A . . . Es0 A . . . Es@ A . . . EsP A ALBUTEROL d00749A Cr J45 Asthma A EsP A ALBUTEROL d00749A C J45 Asthma A EsP A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A EsP A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A EsP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A EsP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EsP A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A Dc E11 Type 2 diabetes mellitus A EsP A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A EsP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EsP A LORATADINE d03050A Cr T78.40 Allergy, unspecified A EsP A METOPROLOL d00134A C I10 Essential (primary) hypertension A Es` A . . . Esp A . . . Es A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A Es A NYSTATIN d01233A A B37.0 Candidal stomatitis A Es A MINOCYCLINE d00110A B L70 Acne A Es A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A Es A CYCLOBENZAPRINE d00963A Bz M62.83 Muscle spasm A Es A IBUPROFEN d00015A CDp M25.56 Pain in knee A Es A LEVALBUTEROL d04427A CDp J45 Asthma A Es A LORATADINE d03050A Cr T78.40 Allergy, unspecified A Es A MECLIZINE d00859A C R42 Dizziness and giddiness A Es A NAPROXEN d00019A Bz M79.1 Myalgia A Es A SERTRALINE d00880A CDp F43.1 Post-traumatic stress disorder (PTSD) A Es A . . . Es A ALBUTEROL d00749A0 C J43 Emphysema A Es A CLOPIDOGREL d04258A0 C Z95.5 Presence of coronary angioplasty implant and graft A Es A FUROSEMIDE d00070A0 C I10 R60.9 Essential (primary) hypertension Edema, unspecified A Es A GLIPIZIDE d00246A0 C R73 Elevated blood glucose level A Es A INDACATEROL d07651A0 B[ J43 Emphysema A Es A ISOSORBIDE MONONITRATE d00269A0 B[ R07.9 Chest pain, unspecified A Es A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A Es A NEBIVOLOL d05265A0 C- I10 Essential (primary) hypertension A Es A POTASSIUM CHLORIDE d00345A0 C[@ E87.6 Hypokalemia A Es A RANITIDINE d00021A0 C K30 Functional dyspepsia A Es A ROSUVASTATIN d04851A0 Dc E78.0 Pure hypercholesterolemia A Es A VALSARTAN d04113A0 C- I10 Essential (primary) hypertension A Es A WARFARIN d00022A0 CP D75.9P Prevent blood clots A Es A . . . Es A . . . Et A . . . Et A . . . Et A . . . Et0 A . . . Et@ A . . . EtP A . . . Et` A . . . Etp A . . . Et A LOSARTAN d03821A C I10 Essential (primary) hypertension A Et A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A Et A . . . Et A . . . Et A IBUPROFEN d00015A C- M25.56 Pain in knee A Et A . . . Et A ACETAMINOPHEN; OXYCODONE d03431A C- M79.7 R68.84 Fibromyalgia Jaw pain Ap Et A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified Ap Et A BUSPIRONE d00182A D F32.9 Major depressive disorder, single episode, unspecified Ap Et A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm Ap Et A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified Ap Et A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap Et A TEMAZEPAM d00384A C- G47.9 Sleep disorder, unspecified Ap Et A . . . Eu A . . . Eu A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` Eu A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A` Eu A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` Eu A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A` Eu A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` Eu A PREGABALIN d05508A C- E11.4 Type 2 diabetes mellitus with neurological complications A` Eu A . . . Eu0 A . . . Eu@ A . . . EuP A . . . Eu` A . . . Eup A CIPROFLOXACIN d00011A0 C B18.2 Chronic viral hepatitis C Ap Eup A FUROSEMIDE d00070A0 C R60.9 Edema, unspecified Ap Eup A LACTULOSE d01024A0 C K72.9 Hepatic failure, unspecified Ap Eup A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia Ap Eup A PROPRANOLOL d00032A0 C I48.91 Unspecified atrial fibrillation Ap Eup A RIFAXIMIN d05294A0 C K76.9 Liver disease, unspecified Ap Eup A SPIRONOLACTONE d00373A0 C R60.9 Edema, unspecified Ap Eu A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A Eu A BECLOMETHASONE d00760A CDp J45 Asthma A Eu A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A Eu A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Eu A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A Eu A PREDNISONE d00350A D- L93 Lupus erythematosus A Eu A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A Eu A VERAPAMIL d00048A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A Eu A WARFARIN d00022A D I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A Eu A ACETAMINOPHEN; HYDROCODONE d03428A C- M54.9 Dorsalgia, unspecified A Eu A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A Eu A ASPIRIN d00170A C[@ I21.P Prevent heart attack/myocardial infarction A Eu A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension A Eu A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A Eu A IBUPROFEN d00015A D T14.9 Unspecified injury A Eu A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A Eu A INSULIN GLULISINE d05278A Cr E11 Type 2 diabetes mellitus A Eu A LEVETIRACETAM d04499A CDp G40 Epilepsy and recurrent seizures A Eu A METOPROLOL d00134A C- I10 Essential (primary) hypertension A Eu A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A Eu A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A0 Eu A LORATADINE d03050A C T78.40 Allergy, unspecified A0 Eu A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 Eu A . . . Eu A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A0 Eu A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A0 Eu A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A0 Eu A . . . Eu A CEPHALEXIN d00096A A A49.9 L20.9 Bacterial infection, unspecified Atopic dermatitis, unspecified A Ev A 99999 A D I99.9 Unspecified disorder of circulatory system A0 Ev A ARIPIPRAZOLE d04825A C- F39 Unspecified mood [affective] disorder A0 Ev A METHYLPHENIDATE d00900A D& F90 Attention-deficit hyperactivity disorders A0 Ev A . . . Ev A AMOXICILLIN d00088A AP J02 Acute pharyngitis A Ev A IBUPROFEN d00015A A@ G89.18 K05.6 Other acute postprocedural pain Periodontal disease, unspecified A Ev0 A AMLODIPINE d00689A Ap I10 Essential (primary) hypertension A Ev@ A . . . EvP A . . . Ev` A . . . Evp A . . . Ev A . . . Ev A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` Ev A ATORVASTATIN d04105A Ap E78.0 Pure hypercholesterolemia A` Ev A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` Ev A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A` Ev A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A Cr I10 Essential (primary) hypertension A` Ev A METOPROLOL d00134A B I10 Essential (primary) hypertension A` Ev A . . . Ev A . . . Ev A CAPTOPRIL d00006A C I10 Essential (primary) hypertension A Ev A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A Ev A ALBUTEROL d00749A CP J45 Asthma A0 Ev A ALBUTEROL d00749A CP J45 Asthma A0 Ev A BUDESONIDE d04276A CP J45 Asthma A0 Ev A . . . Ev A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A` Ev A BENZONATATE d00796A0 Dc 55555 A` Ev A CITALOPRAM d04332A0 Cr F32.9 Major depressive disorder, single episode, unspecified A` Ev A METOPROLOL d00134A0 Dc I10 Essential (primary) hypertension A` Ev A RALOXIFENE d04261A0 Dc M81 Osteoporosis without current pathological fracture A` Ev A TRIAMTERENE d00396A0 Dc I10 Essential (primary) hypertension A` Ew A . . . Ew A . . . Ew A . . . Ew0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP Ew0 A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified AP Ew0 A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified AP Ew0 A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia AP Ew0 A SUMATRIPTAN d03160A C G43 Migraine AP Ew@ A . . . EwP A DIGOXIN d00210A Ei I48.91 Unspecified atrial fibrillation A EwP A ETODOLAC d00851A Bz M54.9 Dorsalgia, unspecified A EwP A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A EwP A LOVASTATIN d00280A Ei E78.0 Pure hypercholesterolemia A EwP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EwP A METOPROLOL d00134A Ei I48.91 Unspecified atrial fibrillation A EwP A WARFARIN d00022A CDp I48.91 Unspecified atrial fibrillation A EwP A WARFARIN d00022A Cr I48.91 Unspecified atrial fibrillation A Ew` A . . . Ewp A . . . Ew A . . . Ew A 77777 . . A Ew A . . . Ew A . . . Ew A ALLOPURINOL d00023A Cr M25.5 Pain in joint AP Ew A ATORVASTATIN d04105A C E78.1 Pure hyperglyceridemia AP Ew A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus AP Ew A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP Ew A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP Ew A . . . Ew A NORTRIPTYLINE d00144A Bz F41.9 Anxiety disorder, unspecified A Ew A . . . Ex A . . . Ex A . . . Ex A . . . Ex0 A . . . Ex@ A . . . ExP A . . . Ex` A 77777 . . A0 Ex` A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 Ex` A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 Exp A . . . Ex A . . . Ex A . . . Ex A . . . Ex A . . . Ex A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A Ex A . . . Ex A DIFLUPREDNATE OPHTHALMIC d07298A A H57.8 Other specified disorders of eye and adnexa A Ex A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A Ex A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A Dc Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A Ex A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C H81.0 Mnire's disease A Ey A . . . Ey A . . . Ey A . . . Ey0 A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified AP Ey0 A DEXLANSOPRAZOLE d07395A C K30 Functional dyspepsia AP Ey0 A LUBIPROSTONE d05736A Bz K58 Irritable bowel syndrome AP Ey0 A MEGESTROL d01348A B E63.9 Nutritional deficiency, unspecified AP Ey0 A MONTELUKAST d04289A B J45 Asthma AP Ey@ A . . . EyP A . . . Ey` A ACETAMINOPHEN; HYDROCODONE d03428A A T14.9 Unspecified injury A0 Ey` A CITALOPRAM d04332A C[@ F41.9 Anxiety disorder, unspecified A0 Ey` A IBUPROFEN d00015A A T14.9 Unspecified injury A0 Eyp A . . . Ey A . . . Ey A . . . Ey A AMLODIPINE d00689A B I10 Essential (primary) hypertension A Ey A BIMATOPROST OPHTHALMIC d04754A D H40 Glaucoma A Ey A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A D H40 Glaucoma A Ey A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A Ey A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A Ey A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A Ey A NITROGLYCERIN d00321A B R07.9 Chest pain, unspecified A Ey A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A Ey A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A Ey A . . . Ey A . . . Ey A ALBUTEROL d00749A C J45 Asthma A@ Ey A ALBUTEROL d00749A C- J45 Asthma A@ Ey A MONTELUKAST d04289A A0 J45 Asthma A@ Ey A TRIAMCINOLONE d00620A Ap J45 Asthma A@ Ey A . . . Ey A METHADONE d00050A C M54.9 Dorsalgia, unspecified A@ Ey A NABUMETONE d00310A C M54.9 Dorsalgia, unspecified A@ Ey A OXYCODONE d00329A C M54.9 Dorsalgia, unspecified A@ Ey A PREGABALIN d05508A C M79.7 Fibromyalgia A@ Ez A . . . Ez A INSULIN DETEMIR d05436A Bz E11 Type 2 diabetes mellitus AP Ez A LIRAGLUTIDE d07466A Bz E11 Type 2 diabetes mellitus AP Ez A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension AP Ez A METFORMIN d03807A A0 E11 Type 2 diabetes mellitus AP Ez A PRAVASTATIN d00348A Bz E78.0 Pure hypercholesterolemia AP Ez A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A0 Ez A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A0 Ez A PROPRANOLOL d00032A C- F41.9 Anxiety disorder, unspecified A0 Ez0 A . . . Ez@ A PHENTERMINE d00806A B= E66.3 Overweight A EzP A AMITRIPTYLINE d00146A C G43.P Prevent migraine A EzP A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A EzP A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A EzP A LORATADINE d03050A B T78.40 Allergy, unspecified A EzP A LOSARTAN d03821A B E87.6 Hypokalemia A EzP A LOVASTATIN d00280A Bz E78.0 Pure hypercholesterolemia A EzP A METAXALONE d00964A B M79.1 Myalgia A EzP A METOPROLOL d00134A Bz 99999 A EzP A MONTELUKAST d04289A Ei 99999 A Ez` A CYCLOBENZAPRINE d00963A CDp M62.83 Muscle spasm A` Ez` A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A` Ez` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` Ez` A METOPROLOL d00134A B[ I49.9 Cardiac arrhythmia, unspecified A` Ez` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ez` A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A` Ezp A . . . Ez A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ez A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus AP Ez A OMEPRAZOLE d00325A CDp K27 Peptic ulcer, site unspecified AP Ez A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP Ez A SITAGLIPTIN d05896A B[ E11 Type 2 diabetes mellitus AP Ez A . . . Ez A . . . Ez A DICLOFENAC d00848A B[ M54.9 Dorsalgia, unspecified A Ez A TRAMADOL d03826A B= M54.9 M79.1 Dorsalgia, unspecified Myalgia A Ez A . . . Ez A . . . Ez A . . . Ez A BECLOMETHASONE d00760A CDp J45 Asthma A@ Ez A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A@ Ez A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A@ Ez A OMEPRAZOLE d00325A C K25.P Prevent gastric ulcer A@ E{ A SUMATRIPTAN d03160A C G43 Migraine A E{ A . . . E{ A . . . E{0 A . . . E{@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E{@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E{@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E{@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E{P A . . . E{` A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified A E{` A TROSPIUM d04929A C N32.81 Overactive bladder A E{p A . . . E{ A . . . E{ A . . . E{ A ABATACEPT d05694A0 C M06.9 Rheumatoid arthritis, unspecified A E{ A ACETAMINOPHEN; HYDROCODONE d03428A0 C M06.9 Rheumatoid arthritis, unspecified A E{ A ALENDRONATE d03849A0 C M81 Osteoporosis without current pathological fracture A E{ A CETIRIZINE d03827A0 C T78.40 Allergy, unspecified A E{ A FLUTICASONE NASAL d04283A0 C J30.1 Allergic rhinitis due to pollen A E{ A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A E{ A IBUPROFEN d00015A0 C M06.9 Rheumatoid arthritis, unspecified A E{ A METHOTREXATE d00060A0 C M06.9 Rheumatoid arthritis, unspecified A E{ A OLOPATADINE OPHTHALMIC d04117A0 C T78.40 Allergy, unspecified A E{ A . . . E{ A . . . E{ A . . . E{ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E{ A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A@ E{ A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A@ E{ A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A@ E{ A . . . E| A . . . E| A . . . E| A . . . E|0 A . . . E|@ A . . . E|P A ACETAMINOPHEN; CODEINE d03423A A M79.2 Neuralgia and neuritis, unspecified A E|P A AMIODARONE d00002A D I49.9 Cardiac arrhythmia, unspecified A E|P A DULOXETINE d05355A C M79.2 Neuralgia and neuritis, unspecified A E|P A LEVOTHYROXINE d00278A C E04.9 Nontoxic goiter, unspecified A E|P A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E|P A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E|P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E|P A WARFARIN d00022A B I49.9 Cardiac arrhythmia, unspecified A E|` A . . . E|p A . . . E| A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E| A PENICILLIN V POTASSIUM d07730A B K04.7 Periapical abscess without sinus A E| A . . . E| A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E| A MONTELUKAST d04289A C J45 Asthma A E| A ALLOPURINOL d00023A D* M10.9 Gout, unspecified A E| A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E| A LORAZEPAM d00149A B= F41.9 Anxiety disorder, unspecified A E| A . . . E| A . . . E} A . . . E} A . . . E} A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A` E} A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A` E} A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E} A CLOPIDOGREL d04258A C[@ I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` E} A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A` E} A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E}0 A . . . E}@ A . . . E}P A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A E}P A BENZTROPINE d00175A Cr G25.0 Essential tremor A E}P A CLONIDINE d00044A Cr F41.9 Anxiety disorder, unspecified A E}P A DIVALPROEX SODIUM d03833A Cr F39 Unspecified mood [affective] disorder A E}P A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia A E}P A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A E}P A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E}P A LABETALOL d00016A Cr I10 Essential (primary) hypertension A E}P A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E}P A RISPERIDONE d03180A Cr F20 Schizophrenia A E}` A . . . E}p A . . . E} A . . . E} A . . . E} A . . . E} A . . . E} A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E} A . . . E} A . . . E} A . . . E~ A ALBUTEROL d00749A C R06.9 Unspecified abnormalities of breathing A E~ A AMLODIPINE d00689A0 CDp 99999 A E~ A CITALOPRAM d04332A0 C[@ 99999 A E~ A CLOPIDOGREL d04258A0 CDp I10 Essential (primary) hypertension A E~ A ENALAPRIL d00013A0 C[@ 99999 A E~ A FENOFIBRATE d04286A0 CDp 99999 A E~ A FLUTICASONE; SALMETEROL d04611A0 CDp R06.9 Unspecified abnormalities of breathing A E~ A HYDROCODONE; IBUPROFEN d04225A0 C[@ M54.9 Dorsalgia, unspecified A E~ A METOPROLOL d00134A0 CDp I10 Essential (primary) hypertension A E~ A NITROGLYCERIN d00321A0 C I51.9 Heart disease, unspecified A E~ A POTASSIUM CHLORIDE d00345A C- 99999 A E~ A SIMVASTATIN d00746A0 C- E78.0 Pure hypercholesterolemia A E~ A TIOTROPIUM d04829A0 CDp R06.9 Unspecified abnormalities of breathing A E~ A . . . E~ A . . . E~0 A DOXYCYCLINE d00037A B L03.90 Cellulitis, unspecified A E~@ A DESIPRAMINE d00145A0 C G47.0 Insomnia A` E~@ A FLUTICASONE NASAL d04283A0 C J30.9 Allergic rhinitis, unspecified A` E~@ A LOSARTAN d03821A0 Ei I10 Essential (primary) hypertension A` E~@ A MELOXICAM d04532A0 C M25.51 Pain in shoulder A` E~@ A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia A` E~@ A TRAZODONE d00395A0 C G47.0 Insomnia A` E~P A METFORMIN d03807A C& E11 Type 2 diabetes mellitus AP E~P A NAPROXEN d00019A C[@ M25.51 Pain in shoulder AP E~P A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E~P A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E~P A TAMSULOSIN d04121A Cr R39.15 Urgency of urination AP E~` A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A0 E~` A HYDROCORTISONE TOPICAL d03205A C[@ R21 Rash and other nonspecific skin eruption A0 E~` A MELOXICAM d04532A C"0 M54.9 Dorsalgia, unspecified A0 E~p A ALLOPURINOL d00023A Dc M1A Chronic gout A E~p A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E~ A . . . E~ A . . . E~ A . . . E~ A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A E~ A . . . E~ A . . . E~ A . . . E~ A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A0 M19.9 M25.55 Osteoarthritis, unspecified site Pain in hip Ap E A CEPHALEXIN d00096A A0 N39.0 Urinary tract infection, site not specified Ap E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C R12 Heartburn Ap E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E0 A . . . E@ A AMOXICILLIN d00088A B= J42 Unspecified chronic bronchitis A E@ A CETIRIZINE d03827A B T78.40 Allergy, unspecified A EP A . . . E` A PENICILLIN V POTASSIUM d07730A A K02.7 Dental root caries A Ep A ANTI-INFECTIVES - UNSPECIFIED c00001A AP J02 Acute pharyngitis A E A . . . E A FLUTICASONE NASAL d04283A B R09.81 Nasal congestion A` E A FLUTICASONE; SALMETEROL d04611A B R06.2 Wheezing A` E A HYDROCORTISONE d00254A C E27.9 Disorder of adrenal gland, unspecified A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A TAMSULOSIN d04121A C R35.0 Frequency of micturition A` E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A FENOFIBRATE d04286A Cr 99999 A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A E A INSULIN ASPART d04697A C- R73 Elevated blood glucose level A E A INSULIN DETEMIR d05436A C- R73 Elevated blood glucose level A E A METFORMIN d03807A D R73 Elevated blood glucose level A E A RANITIDINE d00021A D K21 Gastro-esophageal reflux disease A E A SITAGLIPTIN d05896A Cr R73 Elevated blood glucose level A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ L70 Acne A E A ACETAMINOPHEN; HYDROCODONE d03428A Bz M54.9 Dorsalgia, unspecified A E A CYCLOBENZAPRINE d00963A B[ M79.1 Myalgia A E A DIGOXIN d00210A D I48.91 Unspecified atrial fibrillation A E A FINASTERIDE d00563A Cr N40 Enlarged prostate A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A METOPROLOL d00134A D I48.91 Unspecified atrial fibrillation A E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A E A WARFARIN d00022A Dc I48.91 Unspecified atrial fibrillation A E A . . . E A . . . E A . . . E A CAPECITABINE d04311A B C18 Malignant neoplasm of colon A@ E A CAPTOPRIL d00006A C I21.P Prevent heart attack/myocardial infarction A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A METHIMAZOLE d00290A C E05.9 Thyrotoxicosis, unspecified A@ E0 A . . . E@ A . . . EP A ALLOPURINOL d00023A D1 M1A Chronic gout A` EP A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A` EP A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A` EP A NAPROXEN d00019A C M25.56 Pain in knee A` EP A SIMVASTATIN d00746A C Z79.P Prophylactic medication A` E` A ALBUTEROL d00749A Cr J45 Asthma A E` A BUDESONIDE d04276A Cr J45 Asthma A E` A CETIRIZINE d03827A Ei J45 T78.40 Asthma Allergy, unspecified A E` A IPRATROPIUM d00265A C- J42 J44.9 R07.89 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified Other chest pain A E` A LORAZEPAM d00149A C[@ G40 Epilepsy and recurrent seizures A E` A OXYGEN a54115A C J44.9 Chronic obstructive pulmonary disease, unspecified A E` A PHENOBARBITAL d00340A C G40 Epilepsy and recurrent seizures A E` A POLYETHYLENE GLYCOL 3350 d05350A C[@ K59.0 Constipation A E` A TIZANIDINE d04102A Cr G47.9 Sleep disorder, unspecified A Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 Ep A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 Ep A METFORMIN d03807A Cr R73 Elevated blood glucose level A0 E A CYCLOBENZAPRINE d00963A C M54.9 Dorsalgia, unspecified Ap E A DOCUSATE d01021A C- K59.0 Constipation Ap E A FINASTERIDE d00563A C- N40 Enlarged prostate Ap E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E A PHENTERMINE d00806A B E66.9 Obesity, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A . . . E A BENZONATATE d00796A C J42 Unspecified chronic bronchitis A` E A FLUOXETINE d00236A D# F32.9 Major depressive disorder, single episode, unspecified A` E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A` E A OMEPRAZOLE d00325A C Z98.84 Bariatric surgery status A` E A PREDNISONE d00350A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A` E A AMLODIPINE d00689A D I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A` E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A D Z79.02 Long term (current) use of antithrombotics/antiplatelets A` E A DIGOXIN d00210A D I51.9 Heart disease, unspecified A` E A FUROSEMIDE d00070A D I10 Essential (primary) hypertension A` E A WARFARIN d00022A D Z79.02 Long term (current) use of antithrombotics/antiplatelets A` E A CEPHALEXIN d00096A B# A49.9P Prevent bacterial infection A` E A DIAZEPAM d00148A B# M62.83 Muscle spasm A` E A DIVALPROEX SODIUM d03833A CDp G43 Migraine A` E A HYDROCODONE d03075A B# G89.18 Other acute postprocedural pain A` E A MIRTAZAPINE d04025A C G43 Migraine A` E A OXYCODONE d00329A B# G89.18 Other acute postprocedural pain A` E A LINAGLIPTIN d07767A B= E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C R73.9 Hyperglycemia, unspecified AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A . . . E A ALBUTEROL d00749A B J45 Asthma A E A FORMOTEROL; MOMETASONE d07660A B J45 R05 R06.2 Asthma Cough Wheezing A E A . . . E A . . . E A . . . E0 A CARBIDOPA; LEVODOPA d03473A C[@ G20 Parkinson's disease AP E0 A FLUOXETINE d00236A C[@ F41.9 Anxiety disorder, unspecified AP E0 A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified AP E0 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease AP E0 A PRAMIPEXOLE d04145A Cr G20 Parkinson's disease AP E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A A R06.2 Wheezing A0 E A FLUOXETINE d00236A A F32.9 Major depressive disorder, single episode, unspecified A0 E A TRAMADOL d03826A A M25.56 Pain in knee A0 E A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A . . . E A ALBUTEROL d00749A B# J45 Asthma A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A . . . E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A E A OXYBUTYNIN d00328A CDp N32.9 Bladder disorder, unspecified A E A . . . E A ALLOPURINOL d00023A D# E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GLYBURIDE d00248A CDp R73 Elevated blood glucose level AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified AP E0 A . . . E@ A TRANEXAMIC ACID d00529A C N92 Excessive, frequent and irregular menstruation A EP A . . . E` A BENZOYL PEROXIDE TOPICAL d01246A C- L70 Acne A E` A CLINDAMYCIN TOPICAL d01241A C[@ L70 Acne A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A B* K21 Gastro-esophageal reflux disease A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A Ap R00.9 Unspecified abnormalities of heart beat A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A . . . E A TADALAFIL d04896A CP N52.9 Male erectile dysfunction, unspecified A E A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension Ap EP A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus Ap EP A LORATADINE d03050A D T78.40 Allergy, unspecified Ap EP A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap EP A PIOGLITAZONE d04442A CDp R73 Elevated blood glucose level Ap EP A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia Ap EP A SITAGLIPTIN d05896A CDp R73 Elevated blood glucose level Ap E` A . . . Ep A . . . E A DUTASTERIDE d04788A CDp N40 Enlarged prostate A@ E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A TERAZOSIN d00386A D I10 R39.15 Essential (primary) hypertension Urgency of urination A@ E A . . . E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E A . . . E A . . . E A BUDESONIDE; FORMOTEROL d04795A Cr J45 Asthma A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E0 A . . . E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E@ A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension A EP A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A EP A DOXYCYCLINE d00037A BF A09 Infectious gastroenteritis and colitis, unspecified A E` A FLUORIDE TOPICAL d04397A C K02.P Prevent tooth decay A Ep A EFAVIRENZ; EMTRICITABINE; TENOFOVIR d05847A C- B20 Human immunodeficiency virus [HIV] disease A E A . . . E A . . . E A . . . E A . . . E A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A A@ H10 Conjunctivitis A E A . . . E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A LIOTHYRONINE d00658A B E03.9 Hypothyroidism, unspecified A0 E A PREDNISONE d00350A Ap R09.81 Nasal congestion A0 E A . . . E A . . . E A . . . E A FLUOXETINE d00236A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A LISINOPRIL d00732A D ^ I10 Essential (primary) hypertension A E0 A . . . E@ A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A EP A . . . E` A AMOXICILLIN d00088A A L03.90 Cellulitis, unspecified A Ep A ALBUTEROL d00749A Cr J45 Asthma A Ep A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A NAPROXEN d00019A CDp M19.9 Osteoarthritis, unspecified site A E A BUPROPION d00181A C R41.840 Attention and concentration deficit A0 E A SERTRALINE d00880A C9 F32.9 Major depressive disorder, single episode, unspecified A0 E A VALACYCLOVIR d03838A D A60.9 Anogenital herpesviral infection, unspecified A0 E A . . . E A . . . E0 A . . . E@ A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP E@ A METOPROLOL d00134A C"0 I48.91 Unspecified atrial fibrillation AP E@ A SODIUM CHLORIDE d00438A B[ E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified AP E@ A SPIRONOLACTONE d00373A B= I10 Essential (primary) hypertension AP E@ A WARFARIN d00022A C"0 I48.91 Unspecified atrial fibrillation AP EP A . . . E` A . . . Ep A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A@ Ep A DIAZEPAM d00148A C[@ F41.9 Anxiety disorder, unspecified A@ Ep A PAROXETINE d03157A C- F41.9 Anxiety disorder, unspecified A@ Ep A PROPRANOLOL d00032A CDp G43 Migraine A@ E A MELOXICAM d04532A B= M54.9 Dorsalgia, unspecified A E A . . . E A . . . E A FENTANYL d00233A B[ M54.9 Dorsalgia, unspecified A E A SERTRALINE d00880A A0 F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A . . . E A . . . E A AMLODIPINE d00689A Cr 99999 A` E A FENOFIBRATE d04286A Cr 99999 A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr 99999 A` E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E A PIOGLITAZONE d04442A Cr E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E0 A AMOXICILLIN d00088A A M27.2 Inflammatory conditions of jaws A E@ A . . . EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E` A . . . Ep A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A C- I63.P Prevent stroke A` E A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A` E A TERAZOSIN d00386A C- N40 Enlarged prostate A` E A . . . E A . . . E A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A0 E A GRISEOFULVIN d00100A A B35.4 Tinea corporis A0 E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A0 E A ACETAMINOPHEN; HYDROCODONE d03428A AP G89.18 Other acute postprocedural pain A E A RANITIDINE d00021A B K30 Functional dyspepsia A E A . . . E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C- E78.0P Prevent high cholesterol A0 E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A0 E A . . . E0 A ENALAPRIL d00013A CDp I10 Essential (primary) hypertension A E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A ACETAMINOPHEN; HYDROCODONE d03428A CDp M43.9 Deforming dorsopathy, unspecified A EP A AMLODIPINE d00689A A E78.0 Pure hypercholesterolemia Ap EP A ATENOLOL; CHLORTHALIDONE d03258A C9 I10 Essential (primary) hypertension Ap EP A BENZTROPINE d00175A B F29 Unspecified psychosis not due to a substance or known physiological condition Ap EP A LABETALOL d00016A A I10 Essential (primary) hypertension Ap EP A LISINOPRIL d00732A A I10 Essential (primary) hypertension Ap EP A QUETIAPINE d04220A C G47.0 Insomnia Ap EP A RISPERIDONE d03180A C G47.0 Insomnia Ap E` A CYPROHEPTADINE d00790A C[@ Z91.01 Food allergy status A0 E` A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A0 E` A RISPERIDONE d03180A C[@ F90 Attention-deficit hyperactivity disorders A0 Ep A HYDROCODONE d03075A C- M54.9 Dorsalgia, unspecified A E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A A M54.9 Dorsalgia, unspecified A E A DICLOFENAC d00848A A M54.9 M79.1 Dorsalgia, unspecified Myalgia A E A . . . E A FLUTICASONE NASAL d04283A C[@ J32.9 Chronic sinusitis, unspecified A@ E A LORATADINE d03050A C[@ R09.81 Nasal congestion A@ E A MELOXICAM d04532A B M19.9 Osteoarthritis, unspecified site A@ E A METHOCARBAMOL d00965A B< M62.83 Muscle spasm A@ E A . . . E A . . . E A . . . E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A@ E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A` E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 E28.2 Type 2 diabetes mellitus Polycystic ovarian syndrome A` E A SPIRONOLACTONE d00373A C Z79.52 Long term (current) use of systemic steroids A` E0 A . . . E@ A . . . EP A . . . E` A GEMFIBROZIL d00245A D E78.0 Pure hypercholesterolemia A E` A VERAPAMIL d00048A D I10 Essential (primary) hypertension A Ep A AMOXICILLIN d00088A A R05 Cough A Ep A OFLOXACIN OTIC d04265A B H66.9P Prevent ear infection A E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.4 Partial loss of teeth A E A AMOXICILLIN d00088A A K08.4 Partial loss of teeth A E A METOPROLOL d00134A B I10 Essential (primary) hypertension A E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A PROPRANOLOL d00032A Cr R25.1 Tremor, unspecified A` E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A E0 A LETROZOLE d04156A CDp C80.1 Malignant (primary) neoplasm, unspecified A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E@ A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E@ A FINASTERIDE d00563A D# N40 Enlarged prostate Ap E@ A HYOSCYAMINE d00985A Cr K58 Irritable bowel syndrome Ap E@ A SILODOSIN d07354A C R35.0 Frequency of micturition Ap E@ A VALSARTAN d04113A C I51.9 Heart disease, unspecified Ap EP A . . . E` A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ EP A CARVEDILOL d03847A Cr 99999 A@ EP A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A@ EP A PANTOPRAZOLE d04514A Cr 99999 A@ E` A FEXOFENADINE d04040A B T78.40 Allergy, unspecified A` E` A FLUCONAZOLE d00071A Ap B37.3 Candidiasis of vulva and vagina A` E` A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A` E` A NABUMETONE d00310A B* M25.56 Pain in knee A` E` A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap N39.0 Urinary tract infection, site not specified A` Ep A IBUPROFEN d00015A B T14.9 Unspecified injury A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A VALSARTAN d04113A C I10 Essential (primary) hypertension A@ E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A CP D75.9P Prevent blood clots A E A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A B= R60.9 Edema, unspecified A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LIRAGLUTIDE d07466A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A CP I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A SERTRALINE d00880A C- F32.9 R45.4 Major depressive disorder, single episode, unspecified Irritability and anger A E A SPIRONOLACTONE d00373A B* R60.9 Edema, unspecified A E A . . . E A . . . E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A K04.7 Periapical abscess without sinus A E A . . . E0 A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E0 A SOTALOL d00371A Cr I49.9 Cardiac arrhythmia, unspecified A E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL; IPRATROPIUM d04066A D J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A ALLOPURINOL d00023A Dc M1A Chronic gout A Ep A BUDESONIDE d04276A B= J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A CYANOCOBALAMIN d00413A C D50.9 Iron deficiency anemia, unspecified A Ep A DILTIAZEM d00045A C 99999 A Ep A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A Ep A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A B[ E11 Type 2 diabetes mellitus A Ep A IPRATROPIUM d00265A B= J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A LOSARTAN d03821A Dc 99999 A Ep A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A Ep A OMEPRAZOLE d00325A D R12 Heartburn A Ep A PRAMIPEXOLE d04145A D G25.81 Restless legs syndrome A Ep A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A Ep A WARFARIN d00022A B[ I49.9 Cardiac arrhythmia, unspecified A E A ALPRAZOLAM d00168A C"0 F32.9 Major depressive disorder, single episode, unspecified A E A CITALOPRAM d04332A C"0 F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A MEDROXYPROGESTERONE d00284A C N93.9 R63.4 Abnormal uterine and vaginal bleeding, unspecified Abnormal weight loss A E A NAPROXEN d00019A A T14.9 Unspecified injury A E A ALENDRONATE d03849A B M81 Osteoporosis without current pathological fracture AP E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D* I10 Essential (primary) hypertension AP E A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified AP E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A . . . E A . . . E0 A LISDEXAMFETAMINE d06663A C[@ F90 Attention-deficit hyperactivity disorders A E@ A CLONIDINE d00044A B G47.0 Insomnia A0 E@ A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E@ A HYDROXYZINE d00907A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 EP A . . . E` A . . . Ep A TRETINOIN TOPICAL d01244A A L70 Acne A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A . . . E A . . . E A METHADONE d00050A C F11.23 Opioid dependence with withdrawal A E A ASPIRIN d00170A D I21.P Prevent heart attack/myocardial infarction AP E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A . . . E A . . . E A . . . E A MEMANTINE d04899A C R41.3 Other amnesia A E A . . . E A . . . E0 A . . . E@ A ACETAMINOPHEN; OXYCODONE d03431A CDp M54.2 Cervicalgia A EP A ANTI-INFECTIVES - UNSPECIFIED c00001A A H66.9 Otitis media, unspecified A E` A . . . Ep A HYDROCHLOROTHIAZIDE d00253A Dc I10 R60.9 Essential (primary) hypertension Edema, unspecified A Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A Ap I49.9 Cardiac arrhythmia, unspecified A0 E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A PROMETHAZINE d00787A A R11 Nausea and vomiting A E A . . . E A ALBUTEROL d00749A C J45 Asthma Ap E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A D K30 Functional dyspepsia Ap E A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A E0 A . . . E@ A BENZTROPINE d00175A0 Ei R46.4 Slowness and poor responsiveness A E@ A DIVALPROEX SODIUM d03833A0 Ei F39 Unspecified mood [affective] disorder A E@ A FLUPHENAZINE d00237A0 Ei F20 Schizophrenia A E@ A HYDROCHLOROTHIAZIDE d00253A0 Ei I10 Essential (primary) hypertension A E@ A POLYETHYLENE GLYCOL 3350 d05350A0 Ei K59.0 Constipation A E@ A SENNA d01013A0 Ei K59.0 Constipation A E@ A SOLIFENACIN d05413A0 Ei N39.4 Other specified urinary incontinence A E@ A TRAZODONE d00395A0 Ei F20 Schizophrenia A E@ A ZOLPIDEM d00910A0 Ei G47.0 Insomnia A EP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` EP A CARVEDILOL d03847A D I20.9 Angina pectoris, unspecified A` EP A FUROSEMIDE d00070A D N28.9 Disorder of kidney and ureter, unspecified A` EP A HYDRALAZINE d00132A D I10 Essential (primary) hypertension A` EP A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` EP A ISOSORBIDE DINITRATE d00268A D I20.9 Angina pectoris, unspecified A` E` A AMOXICILLIN; CLAVULANATE d00089A Ap J01 Acute sinusitis A0 E` A CLINDAMYCIN TOPICAL d01241A B L70 Acne A0 E` A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A0 Ep A BUPROPION d00181A B[ F32.9 Major depressive disorder, single episode, unspecified A Ep A TOPIRAMATE d04115A B F31.9 Bipolar disorder, unspecified A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E A LANSOPRAZOLE d03828A Cr K30 Functional dyspepsia A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A ANTI-INFECTIVES - UNSPECIFIED c00001A Ap A49.9 Bacterial infection, unspecified A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A CLONAZEPAM d00197A D= F30 Manic episode A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A GEMFIBROZIL d00245A B E78.1 Pure hyperglyceridemia A E A PHENTERMINE d00806A B E66 Overweight and obesity A E A . . . E A . . . E A . . . E A ISOTRETINOIN d01245A B L70 Acne A E0 A . . . E@ A ALBUTEROL d00749A Cr J45 Asthma A EP A CARVEDILOL d03847A A I10 Essential (primary) hypertension A E` A . . . Ep A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A C I10 Essential (primary) hypertension A0 E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia A E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B[ I10 Essential (primary) hypertension A E A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A PHENTERMINE d00806A B[ E66.3 Overweight A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A TACROLIMUS d03752A C T86.9P Prevent transplanted organ and tissue rejection A E A WARFARIN d00022A C D75.9P I26 I80.3 Prevent blood clots Pulmonary embolism Phlebitis and thrombophlebitis of lower extremities, unspecified A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E A PREDNISONE d00350A Bz J42 Unspecified chronic bronchitis A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A PHENTERMINE d00806A B- E66.3 Overweight A E A AMOXICILLIN; CLAVULANATE d00089A Ap J20.9 Acute bronchitis, unspecified A E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A E A 77777 . . A E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A Dc J45 Asthma A0 E A MOMETASONE d05262A C J45 Asthma A0 E A SIMVASTATIN d00746A D E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A0 E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A 99999 . . A E A . . . E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C"0 R51 Headache A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A` E A NEBIVOLOL d05265A C I10 Essential (primary) hypertension A` E A PROMETHAZINE d00787A B R11 Nausea and vomiting A` E A SUMATRIPTAN d03160A B G43 Migraine A` E A ACETAMINOPHEN; HYDROCODONE d03428A B M54.2 M54.9 Cervicalgia Dorsalgia, unspecified Ap E A BACLOFEN d00967A B M54.2 M79.1 Cervicalgia Myalgia Ap E A FAMOTIDINE d00141A B K31.9 Disease of stomach and duodenum, unspecified Ap E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus Ap E A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified Ap E A . . . E A CLONAZEPAM d00197A C[@ G40 Epilepsy and recurrent seizures A@ E A OLOPATADINE OPHTHALMIC d04117A Cr H40 Glaucoma A@ E A TRAMADOL d03826A C[@ R51 Headache A@ E A VENLAFAXINE d03181A C[@ G43.P Prevent migraine A@ E A . . . E A . . . E0 A . . . E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E@ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP E@ A CLOPIDOGREL d04258A Cr I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified AP E@ A LABETALOL d00016A C[@ I10 Essential (primary) hypertension AP E@ A NITROGLYCERIN d00321A D I20.9 Angina pectoris, unspecified AP EP A FEXOFENADINE d04040A Cr T78.40 Allergy, unspecified A` EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A` EP A NAPROXEN d00019A C M25.56 Pain in knee A` EP A QUINAPRIL d00365A C I10 Essential (primary) hypertension A` EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A Ep A . . . E A PROPRANOLOL d00032A B R51 Headache A E A . . . E A . . . E A . . . E A . . . E A INSULIN ASPART d04697A C E10 Type 1 diabetes mellitus A E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E A LEVOFLOXACIN d04109A Ap N30 Cystitis A0 E A MELOXICAM d04532A B M54.9 Dorsalgia, unspecified A0 E A TAMSULOSIN d04121A Ap R39.15 Urgency of urination A0 E A CLONIDINE d00044A Cr F17.203 Nicotine dependence unspecified, with withdrawal AP E A FAMOTIDINE d00141A Cr R12 Heartburn AP E A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A Cr I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A Cr R12 Heartburn AP E A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension AP E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D Z79.3 Long term (current) use of hormonal contraceptives A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A DEXTROMETHORPHAN; PROMETHAZINE d03360A A R05 Cough A E0 A . . . E@ A . . . EP A AMLODIPINE d00689A B I10 Essential (primary) hypertension A EP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E` A BENZTROPINE d00175A0 C G25.0 Essential tremor A@ E` A CHLORPROMAZINE d00064A0 C F31.9 Bipolar disorder, unspecified A@ E` A OLANZAPINE d04050A0 C F20 Schizophrenia A@ E` A RANITIDINE d00021A0 C K21 Gastro-esophageal reflux disease A@ Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A E A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A E A NAPROXEN d00019A B= M54.9 Dorsalgia, unspecified A E A . . . E A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A` E A AMIODARONE d00002A B= I49.9 Cardiac arrhythmia, unspecified A` E A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A METOPROLOL d00134A C I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A` E A SERTRALINE d00880A Cr F32.9 F41.9 M79.2 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A` E A WARFARIN d00022A B= D75.9P Prevent blood clots A` E A . . . E A . . . E A . . . E A . . . E A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A C E78.0 Pure hypercholesterolemia A0 E A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A Cr I10.P Prevent hypertension A0 E A PEPSIN d03085A C- Z87.11 Personal history of peptic ulcer disease A0 E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E A FUROSEMIDE d00070A DNk I50.9 Heart failure, unspecified A E A GABAPENTIN d03182A B[ E11.4 Type 2 diabetes mellitus with neurological complications A E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Bz I10 Essential (primary) hypertension A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A NORTRIPTYLINE d00144A Ap M79.2 Neuralgia and neuritis, unspecified A E A TOPIRAMATE d04115A CDp M79.2 Neuralgia and neuritis, unspecified A E A . . . E0 A DULOXETINE d05355A CP F32.9 Major depressive disorder, single episode, unspecified Ap E0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CP I10 Essential (primary) hypertension Ap E0 A OMEPRAZOLE d00325A CP K21 Gastro-esophageal reflux disease Ap E0 A PIROXICAM d00343A CP M13 Other arthritis Ap E0 A ROPINIROLE d04215A CP G20 Parkinson's disease Ap E0 A ROSUVASTATIN d04851A CP E78.0 Pure hypercholesterolemia Ap E0 A ZOLPIDEM d00910A CP G47.0 Insomnia Ap E@ A . . . EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EP A WARFARIN d00022A Cr D75.9P Prevent blood clots A E` A BENZTROPINE d00175A0 Ei G20 Parkinson's disease A E` A CARBAMAZEPINE d00058A0 Ei F29 Unspecified psychosis not due to a substance or known physiological condition A E` A CLONAZEPAM d00197A0 Ei G47.0 Insomnia A E` A DICLOFENAC d00848A0 Ei M13 Other arthritis A E` A DOCUSATE d01021A0 Ei K59.0 Constipation A E` A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A0 Ei I10 Essential (primary) hypertension A E` A LEVOTHYROXINE d00278A0 Ei E03.9 Hypothyroidism, unspecified A E` A MONTELUKAST d04289A0 Ei J20.9 Acute bronchitis, unspecified A E` A NYSTATIN d01233A0 Ei B37.9 Candidiasis, unspecified A E` A OLANZAPINE d04050A0 Ei F29 Unspecified psychosis not due to a substance or known physiological condition A E` A PERPHENAZINE d00855A0 Ei F29 Unspecified psychosis not due to a substance or known physiological condition A E` A ZOLPIDEM d00910A0 Ei G47.0 Insomnia A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A D E78.1 Pure hyperglyceridemia A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D7 I10 Essential (primary) hypertension A@ E A NIACIN d00314A D E78.1 Pure hyperglyceridemia A@ E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A@ E A BIMATOPROST OPHTHALMIC d04754A Cr 99999 A` E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A Cr H40 Glaucoma A` E A DUTASTERIDE d04788A CDp N40 Enlarged prostate A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A` E A . . . E A . . . E A AZITHROMYCIN d00091A AP J20.9 J40 Acute bronchitis, unspecified Bronchitis, not specified as acute or chronic A E0 A . . . E@ A 99999 . . AP E@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E@ A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C E11 Type 2 diabetes mellitus AP E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E@ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP EP A . . . E` A . . . Ep A . . . E A . . . E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A . . . E A 77777 . . A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A B J45 Asthma A E A FLUTICASONE d01296A B J45 Asthma A E A . . . E A . . . E0 A ADALIMUMAB d04835A C K51 Ulcerative colitis A0 E0 A CIPROFLOXACIN d00011A C A09 Infectious gastroenteritis and colitis, unspecified A0 E0 A FLUOXETINE d00236A Cr G43 Migraine A0 E@ A . . . EP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E` A ANTI-INFECTIVES - UNSPECIFIED c00001A Ap J02 J09 Acute pharyngitis Influenza due to certain identified influenza viruses A Ep A . . . E A GLIPIZIDE d00246A Bz R73.9 Hyperglycemia, unspecified A0 E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Bz R73.9 Hyperglycemia, unspecified A0 E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Ap K08.8 Other specified disorders of teeth and supporting structures AP E A OMEPRAZOLE d00325A Cr K25 K30 Gastric ulcer Functional dyspepsia AP E A ONDANSETRON d00867A C R11 Nausea and vomiting AP E A SUCRALFATE d00377A C[@ K27 Peptic ulcer, site unspecified AP E A VENLAFAXINE d03181A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A@ E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E A LOSARTAN d03821A D I10 Essential (primary) hypertension A@ E A METOCLOPRAMIDE d00298A B[ K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A . . . E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A RANITIDINE d00021A Cr K30 Functional dyspepsia A E A . . . E A ALBUTEROL d00749A A J45 Asthma A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A E A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A CARVEDILOL d03847A C- I21.P Prevent heart attack/myocardial infarction A` E A FEXOFENADINE d04040A Bz T78.40 Allergy, unspecified A` E A ISOSORBIDE MONONITRATE d00269A C- I20.9 Angina pectoris, unspecified A` E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` E A ROSUVASTATIN d04851A C- E78.0P Prevent high cholesterol A` E A FAMOTIDINE d00141A Cr K30 Functional dyspepsia A E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; OXYCODONE d03431A0 Cr M54.9 Dorsalgia, unspecified A EP A AMLODIPINE d00689A0 B I10 Essential (primary) hypertension A EP A CLOPIDOGREL d04258A0 CDp Z95.5 Presence of coronary angioplasty implant and graft A EP A FINASTERIDE d00563A0 Cr N40 Enlarged prostate A EP A GLYBURIDE d00248A0 C E11 Type 2 diabetes mellitus A EP A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A EP A LIDOCAINE TOPICAL d00683A0 Cr M54.5 Low back pain A EP A LIRAGLUTIDE d07466A0 CDp E11 Type 2 diabetes mellitus A EP A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A0 Ei 99999 A EP A PANTOPRAZOLE d04514A0 B[ K21 Gastro-esophageal reflux disease A EP A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia A EP A SOLIFENACIN d05413A0 Cr N32.81 Overactive bladder A E` A . . . Ep A . . . E A ALBUTEROL d00749A C J45 Asthma A E A BECLOMETHASONE d00760A C J45 Asthma A E A BACLOFEN d00967A B M62.83 Muscle spasm A0 E A IBUPROFEN d00015A C- M13 Other arthritis A0 E A TRAMADOL d03826A B M79.1 Myalgia A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A H93.9 Unspecified disorder of ear A E A ALLOPURINOL d00023A DE M10.9 Gout, unspecified A E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A E A DICLOFENAC d00848A C- M79.1 Myalgia A E A EZETIMIBE d04824A D E78.0P Prevent high cholesterol A E A FLUTICASONE d01296A C J42 R06.2 Unspecified chronic bronchitis Wheezing A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METRONIDAZOLE TOPICAL d03208A CP L20.9 Atopic dermatitis, unspecified A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A TRAVOPROST OPHTHALMIC d04753A Cr H40 Glaucoma A E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified AP E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A VALSARTAN d04113A CDp I10 Essential (primary) hypertension AP E A CARBAMAZEPINE d00058A D# M79.2 Neuralgia and neuritis, unspecified A` E A DONEPEZIL d04099A C[@ G31.9 Degenerative disease of nervous system, unspecified A` E A FLUDROCORTISONE d00608A B I95.9 Hypotension, unspecified A` E A GABAPENTIN d03182A D# M79.2 Neuralgia and neuritis, unspecified A` E A LORATADINE; PSEUDOEPHEDRINE d03818A DGJ T78.40 Allergy, unspecified A` E A MEMANTINE d04899A B I95.9 Hypotension, unspecified A` E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A GABAPENTIN d03182A Cr M79.606 Pain in leg, unspecified A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A D F90 Attention-deficit hyperactivity disorders A E A ESOMEPRAZOLE d04749A B K21 Gastro-esophageal reflux disease A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp N92 Excessive, frequent and irregular menstruation AP E A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A CDp E11.2 Type 2 diabetes mellitus with kidney complications AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A VALACYCLOVIR d03838A C- B00.1 Herpesviral vesicular dermatitis AP E A . . . E A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A METHYLPHENIDATE d00900A C F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A . . . E A . . . E A . . . E0 A IBUPROFEN d00015A C- M25.56 Pain in knee A E@ A . . . EP A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A@ EP A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A@ EP A SERTRALINE d00880A C F41.9 F90 Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A@ EP A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A@ E` A . . . Ep A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A FLUOXETINE d00236A C F39 Unspecified mood [affective] disorder A E A TRAZODONE d00395A CDp F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A DUTASTERIDE d04788A C N40 Enlarged prostate A E A LEVOTHYROXINE d00278A D9 E07.9 Disorder of thyroid, unspecified A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified Ap E A INSULIN ISOPHANE (NPH) d04370A D E11 Type 2 diabetes mellitus Ap E A INSULIN REGULAR d04369A D E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C 99999 Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A . . . E A . . . E A AMOXICILLIN d00088A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A0 E A ETONOGESTREL d04772A C- Z79.3 Long term (current) use of hormonal contraceptives A0 E A NORETHINDRONE d00555A B N92 Excessive, frequent and irregular menstruation A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D* I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A0 E A ARIPIPRAZOLE d04825A C[@ F39 Unspecified mood [affective] disorder A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E0 A . . . E@ A . . . EP A CLOPIDOGREL d04258A CDp I21.P Prevent heart attack/myocardial infarction A@ EP A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ EP A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A@ EP A SIMVASTATIN d00746A CDp E78.0P Prevent high cholesterol A@ E` A . . . Ep A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E A . . . E A PHENYTOIN d00143A Dc G40 Epilepsy and recurrent seizures A E A MELOXICAM d04532A B M19.90 Unspecified osteoarthritis, unspecified site A E A OMEPRAZOLE d00325A B[ R12 Heartburn A E A IBUPROFEN d00015A C K08.8 R50.9 Other specified disorders of teeth and supporting structures Fever, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE; BENAZEPRIL d03829A B= I10 Essential (primary) hypertension A0 E` A MEGESTROL d01348A B= R39.9 Unspecified symptoms and signs involving the genitourinary system A0 E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Ep A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E0 A . . . E@ A . . . EP A . . . E` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A Ep A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A BETAXOLOL OPHTHALMIC d04038A Cr H40 Glaucoma A E A DICLOFENAC d00848A C M54.9 T14.9 Dorsalgia, unspecified Unspecified injury A E A ESTRADIOL d00537A D9 Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A C"0 R73.9 Hyperglycemia, unspecified A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A E A DIAZEPAM d00148A B[ F41.9 Anxiety disorder, unspecified AP E A ETHINYL ESTRADIOL; NORGESTREL d03241A Cr N80.9 Endometriosis, unspecified AP E A PROMETHAZINE d00787A B R11 Nausea and vomiting AP E A TIZANIDINE d04102A C M62.83 M79.1 Muscle spasm Myalgia AP E A TRAMADOL d03826A CDp M54.2 Cervicalgia AP E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C- M54.9 Dorsalgia, unspecified A E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E A INSULIN GLARGINE d04538A B[ E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A@ E A METFORMIN; SITAGLIPTIN d06720A B[ E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A TAPENTADOL d07453A B M25.55 Pain in hip A E A . . . E A . . . E0 A . . . E@ A . . . EP A ALBUTEROL d00749A0 Ei J43 Emphysema A EP A ENALAPRIL d00013A0 CDp I50.9 Heart failure, unspecified A EP A FLUTICASONE; SALMETEROL d04611A0 CDp J43 Emphysema A EP A FUROSEMIDE d00070A0 CDp I50.9 Heart failure, unspecified A EP A NITROGLYCERIN d00321A0 Ei R07.9 Chest pain, unspecified A EP A OXYGEN a54115A0 Ei J43 Emphysema A EP A PRAVASTATIN d00348A0 Ei E78.0 Pure hypercholesterolemia A EP A PREDNISONE d00350A0 Ei J44.9 Chronic obstructive pulmonary disease, unspecified A EP A SPIRONOLACTONE d00373A0 CDp I50.9 Heart failure, unspecified A EP A TAMSULOSIN d04121A0 Ei R35.0 Frequency of micturition A EP A TIOTROPIUM d04829A0 CDp J43 Emphysema A E` A . . . Ep A . . . E A IBUPROFEN d00015A Ap K08.8 Other specified disorders of teeth and supporting structures A E A PROMETHAZINE d00787A A J00 Acute nasopharyngitis [common cold] A E A . . . E A . . . E A . . . E A ALENDRONATE d03849A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A@ E A LANSOPRAZOLE d03828A Cr K30 Functional dyspepsia A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E@ A AMOXICILLIN d00088A C L70 Acne A EP A . . . E` A ETHINYL ESTRADIOL; ETHYNODIOL d03388A Dc Z79.3 Long term (current) use of hormonal contraceptives A0 E` A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A0 Ep A . . . E A . . . E A LISDEXAMFETAMINE d06663A C"0 F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A METFORMIN; SAXAGLIPTIN d07709A B E11 Type 2 diabetes mellitus A E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A BECLOMETHASONE d00760A C- J45 Asthma A0 E A 99999 . . A E A ALBUTEROL d00749A0 Cr J45 Asthma A E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A E A BUDESONIDE; FORMOTEROL d04795A0 C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A HYDROCODONE d03075A D M54.9 Dorsalgia, unspecified A E A IBUPROFEN d00015A B R51 Headache A E A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified A E A ZOLPIDEM d00910A0 C G47.0 Insomnia A E A . . . E A ACETAMINOPHEN; TRAMADOL d04766A B M13 T14.9 Other arthritis Unspecified injury A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A E A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E A BIMATOPROST OPHTHALMIC d04754A Cr H40 Glaucoma A E A BRIMONIDINE OPHTHALMIC d04048A C- H40 Glaucoma A E A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma A E A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A KETOROLAC OPHTHALMIC d03214A B= Z48.810 Encounter for surgical aftercare following surgery on the sense organs A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A MECLIZINE d00859A C- R42 Dizziness and giddiness A E A MEMANTINE d04899A C- R41.3 Other amnesia A E A ASPIRIN d00170A C D75.9P Prevent blood clots A E A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified A E A ENALAPRIL d00013A C E11.2P Prevent diabetic kidney disease A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A HYDROCODONE d03075A C- M19.9 M75.1 Osteoarthritis, unspecified site Rotator cuff tear or rupture, not specified as traumatic A E A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C E11 Type 2 diabetes mellitus A E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E@ A VILAZODONE d07740A C F32.9 Major depressive disorder, single episode, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A0 E A INSULIN GLULISINE d05278A B E11 Type 2 diabetes mellitus A0 E A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A0 E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ATROPINE; DIPHENOXYLATE d03506A0 Bz I95.9 Hypotension, unspecified A E@ A ERYTHROMYCIN d00046A0 C K31.9 Disease of stomach and duodenum, unspecified A E@ A ESCITALOPRAM d04812A0 Cr F32.9 Major depressive disorder, single episode, unspecified A E@ A HYDROCODONE d03075A0 C- M54.9 Dorsalgia, unspecified A E@ A INSULIN DETEMIR d05436A0 C[@ E11 Type 2 diabetes mellitus A E@ A INSULIN LISPRO d04373A0 C[@ E11 Type 2 diabetes mellitus A E@ A LEVOTHYROXINE d00278A0 Cr E03.9 Hypothyroidism, unspecified A E@ A MIDODRINE d04047A0 C I95.9 Hypotension, unspecified A E@ A OXYCODONE d00329A0 C M79.1 Myalgia A E@ A PANTOPRAZOLE d04514A0 C- K30 Functional dyspepsia A E@ A SEVELAMER d04363A0 B E83.3 Disorders of phosphorus metabolism and phosphatases A E@ A SUCRALFATE d00377A0 C K27 Peptic ulcer, site unspecified A EP A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B[ F90 Attention-deficit hyperactivity disorders A E` A . . . Ep A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A E A AMOXICILLIN d00088A Ap B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ E A CLARITHROMYCIN d00097A Ap B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ E A LANSOPRAZOLE d03828A Ap B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ E A NYSTATIN d01233A Dc B37.0 Candidal stomatitis A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E0 A DOXYCYCLINE d00037A CDp L70 Acne A0 E0 A INFLIXIMAB d04342A CDp L40.5 M06.9 Arthropathic psoriasis Rheumatoid arthritis, unspecified A0 E0 A METHOTREXATE d00060A CDp L40.5 M06.9 Arthropathic psoriasis Rheumatoid arthritis, unspecified A0 E@ A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 Migraine A@ E@ A ACETAMINOPHEN; OXYCODONE d03431A Cr T14.9 Unspecified injury A@ E@ A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E@ A PHENTERMINE d00806A C E66.3 Overweight A@ EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A D"8 M79.1 Myalgia AP Ep A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction AP Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP Ep A QUININE d00366A D M62.83 Muscle spasm AP Ep A TIZANIDINE d04102A D M79.1 Myalgia AP E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A B M1A Chronic gout A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A APIXABAN d07804A B D75.9P Prevent blood clots A E A CARVEDILOL d03847A D"8 I48.91 Unspecified atrial fibrillation A E A CLONIDINE d00044A Dc I10 Essential (primary) hypertension A E A COLCHICINE d00150A C[@ M1A Chronic gout A E A FUROSEMIDE d00070A Dc N28.9 Disorder of kidney and ureter, unspecified A E A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A B I50.9 Heart failure, unspecified A E A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia A E A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C C61 Malignant neoplasm of prostate A E A ALBUTEROL d00749A A R05 Cough A E A BACLOFEN d00967A CDp M54.9 Dorsalgia, unspecified A0 E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A0 E A OXYCODONE d00329A Cr M54.9 Dorsalgia, unspecified A0 E A ACETAMINOPHEN; HYDROCODONE d03428A B M79.1 Myalgia A E A CYCLOBENZAPRINE d00963A B T14.9 Unspecified injury A E A PRAVASTATIN d00348A Bz E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A Ap E03.9 Hypothyroidism, unspecified A E A LOVASTATIN d00280A C"0 E78.0 Pure hypercholesterolemia A E A . . . E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C- I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A0 E A TRAMADOL d03826A Ap M25.51 Pain in shoulder A0 E0 A THYROID DESICCATED d00655A C- E03.9 Hypothyroidism, unspecified A E@ A ALENDRONATE d03849A Dc M81 Osteoporosis without current pathological fracture A` E@ A BRINZOLAMIDE OPHTHALMIC d04301A C- H04.12 Dry eye syndrome A` E@ A OMEPRAZOLE d00325A Cr K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A` E@ A PAROXETINE d03157A Cr F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A` E@ A POLYETHYLENE GLYCOL 3350 d05350A CDp K59.0 Constipation A` E@ A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A` EP A NAPROXEN d00019A C- T14.9 Unspecified injury A E` A . . . Ep A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E A . . . E A FAMOTIDINE d00141A C K30 Functional dyspepsia A E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A@ E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ E` A BUDESONIDE; FORMOTEROL d04795A C[@ J42 Unspecified chronic bronchitis A@ E` A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A@ E` A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A@ Ep A ATENOLOL; CHLORTHALIDONE d03258A D7 I10 Essential (primary) hypertension Ap Ep A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap Ep A DIGOXIN d00210A B= I49.9 Cardiac arrhythmia, unspecified Ap Ep A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus Ap Ep A LISINOPRIL d00732A Dc I21.P Prevent heart attack/myocardial infarction Ap Ep A SPIRONOLACTONE d00373A Dc I50.9 Heart failure, unspecified Ap Ep A WARFARIN d00022A D I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A MECLIZINE d00859A Dc H81.1 Benign paroxysmal vertigo A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A CELECOXIB d04380A C M06.9 Rheumatoid arthritis, unspecified AP E@ A CETIRIZINE d03827A D J30.1 Allergic rhinitis due to pollen AP E@ A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia AP E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E@ A TERAZOSIN d00386A C N40 Enlarged prostate AP EP A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E` A ANASTROZOLE d03873A C50 C50.P Prevent barest cancer A E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ep A . . . E A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A0 E A PANTOPRAZOLE d04514A C- K27 Peptic ulcer, site unspecified A0 E A VENLAFAXINE d03181A C[@ F41.9 Anxiety disorder, unspecified A0 E A . . . E A IMIPRAMINE d00259A D9 F41.9 Anxiety disorder, unspecified A E A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A DOXYCYCLINE d00037A Cr L71 Rosacea A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A AMLODIPINE d00689A C) I10 Essential (primary) hypertension A@ E A ETHINYL ESTRADIOL; ETHYNODIOL d03388A Dc Z79.3 Long term (current) use of hormonal contraceptives A@ E A METOPROLOL d00134A C> I10 Essential (primary) hypertension A@ E A SPIRONOLACTONE d00373A C) E26.9 Hyperaldosteronism, unspecified A@ E A ISOSORBIDE MONONITRATE d00269A0 C I10 Essential (primary) hypertension A E A METOPROLOL d00134A0 C- I10 Essential (primary) hypertension A E A NITROGLYCERIN d00321A0 C R06.02 R07.9 Shortness of breath Chest pain, unspecified A E A PRAMIPEXOLE d04145A0 C G25.81 Restless legs syndrome A E A RAMIPRIL d00728A0 C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A0 Dc E78.0 Pure hypercholesterolemia A E A TRAZODONE d00395A0 Cr G47.9 Sleep disorder, unspecified A E A ZOLEDRONIC ACID d04708A0 C M81 Osteoporosis without current pathological fracture A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Ep A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E A . . . E A . . . E A . . . E A . . . E A CITALOPRAM d04332A D F31.9 Bipolar disorder, unspecified A0 E A GABAPENTIN d03182A C M79.7 Fibromyalgia A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A LANSOPRAZOLE d03828A Cr K30 Functional dyspepsia A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E A . . . E0 A . . . E@ A CELECOXIB d04380A C M13 M54.2 Other arthritis Cervicalgia A@ E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E@ A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A@ EP A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A@ EP A EZETIMIBE; SIMVASTATIN d05348A C E78.0 Pure hypercholesterolemia A@ EP A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A@ EP A METOPROLOL d00134A C I50.9 Heart failure, unspecified A@ E` A ATORVASTATIN d04105A C"0 E11 Type 2 diabetes mellitus A` E` A FUROSEMIDE d00070A B E87.7 Fluid overload A` E` A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A` E` A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E` A METOPROLOL d00134A B I10 Essential (primary) hypertension A` E` A TRAMADOL d03826A B[ R52 Pain, unspecified A` Ep A . . . E A ARIPIPRAZOLE d04825A C"@ F31.9 Bipolar disorder, unspecified Ap E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified Ap E A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus Ap E A INSULIN REGULAR d04369A C E11 Type 2 diabetes mellitus Ap E A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C R73 Elevated blood glucose level Ap E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP E A MELOXICAM d04532A C- L40.5 Arthropathic psoriasis AP E A PANTOPRAZOLE d04514A C[@ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia AP E A RAMIPRIL d00728A C I10 Essential (primary) hypertension AP E A SOTALOL d00371A C[@ I48.91 Unspecified atrial fibrillation AP E A CARBAMAZEPINE d00058A B F43.1 Post-traumatic stress disorder (PTSD) AP E A HYDROXYZINE d00907A B* F41.9 Anxiety disorder, unspecified AP E A LANSOPRAZOLE d03828A C K30 Functional dyspepsia AP E A LEVOMILNACIPRAN d08114A A F32.9 Major depressive disorder, single episode, unspecified AP E A ZOLPIDEM d00910A B* G47.0 Insomnia AP E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A . . . E A . . . E A SERTRALINE d00880A Bz F41.9 Anxiety disorder, unspecified A E A ALBUTEROL d00749A C J45 Asthma A E A ALENDRONATE d03849A C M85.80 Other specified disorders of bone density and structure, unspecified site A E A LISINOPRIL d00732A B R80.9 Proteinuria, unspecified A E0 A . . . E@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Bz I10 Essential (primary) hypertension A E@ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A MINOCYCLINE d00110A B L71 Rosacea A E A . . . E A LEVOTHYROXINE d00278A C E03.9 R60.9 Hypothyroidism, unspecified Edema, unspecified A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A EP A LEVOTHYROXINE d00278A Cr E04.9 Nontoxic goiter, unspecified A E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma AP E A IBUPROFEN d00015A D M79.1 Myalgia AP E A LORATADINE d03050A CDp T78.40 Allergy, unspecified AP E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders AP E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders AP E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Excessive, frequent and irregular menstruation A0 E A FLUDROCORTISONE d00608A CDp E27.1 Primary adrenocortical insufficiency A0 E A HYDROCORTISONE d00254A CDp E27.1 Primary adrenocortical insufficiency A0 E A . . . E A HYDROCODONE d03075A B T14.9 Unspecified injury A E A . . . E A CHOLESTYRAMINE d00193A CDp E78.0 Pure hypercholesterolemia A0 E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A ALBUTEROL d00749A B J45 Asthma A E A . . . E A . . . E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A C[@ R51 Headache A@ E0 A BUPROPION d00181A CDp F30 Manic episode A@ E0 A METHYLPHENIDATE d00900A C- F32.9 Major depressive disorder, single episode, unspecified A@ E0 A RISPERIDONE d03180A C[@ F31.9 Bipolar disorder, unspecified A@ E@ A . . . EP A . . . E` A NAPROXEN d00019A C M54.9 Dorsalgia, unspecified A E` A OXCARBAZEPINE d04513A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ep A . . . E A ALBUTEROL d00749A B= J45 Asthma A E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A E A . . . E A TRAZODONE d00395A CDp G47.0 Insomnia A E A FLUTICASONE d01296A CP J45 Asthma A E A . . . E A . . . E A TRIAMCINOLONE d00620A Bz J42 Unspecified chronic bronchitis A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A AMLODIPINE d00689A DGJ I10 Essential (primary) hypertension A` E A BETHANECHOL d01427A Dc N31.9 Neuromuscular dysfunction of bladder, unspecified A` E A DONEPEZIL d04099A C- G31.9 Degenerative disease of nervous system, unspecified A` E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A` E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E0 A ALISKIREN; HYDROCHLOROTHIAZIDE d07077A C I10 Essential (primary) hypertension A@ E0 A CLONIDINE d00044A C I10 Essential (primary) hypertension A@ E0 A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A@ E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E@ A RANITIDINE d00021A C K30 Functional dyspepsia A EP A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A EP A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E` A BUPROPION d00181A C F17.203 Nicotine dependence unspecified, with withdrawal AP E` A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP E` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E` A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified AP E` A MONTELUKAST d04289A C- R06.9 Unspecified abnormalities of breathing AP Ep A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCODONE d03075A B[ T14.9 Unspecified injury A E A NEOMYCIN; POLYMYXIN B SULFATE TOPICAL d03526A A0 L03.90 Cellulitis, unspecified A E A . . . E A BUSPIRONE d00182A C"0 F32.9 Major depressive disorder, single episode, unspecified A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A LEVETIRACETAM d04499A C"0 G40 Epilepsy and recurrent seizures A E A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A E A OXYCODONE d00329A C"0 T14.9 Unspecified injury A E A PANTOPRAZOLE d04514A C"0 K31.9P Prevent stomach problem A E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E A RAMIPRIL d00728A C"0 I10 Essential (primary) hypertension A E A SERTRALINE d00880A C"0 F32.9 Major depressive disorder, single episode, unspecified A E A TIZANIDINE d04102A C"0 M62.83 Muscle spasm A E A TRAZODONE d00395A C"0 G47.9 Sleep disorder, unspecified A E A WARFARIN d00022A C"0 D75.9P Prevent blood clots A E A ZOLPIDEM d00910A C"0 G47.9 Sleep disorder, unspecified A E A . . . E A . . . E A AMOXICILLIN d00088A AP J01.9 Acute sinusitis, unspecified A0 E A CETIRIZINE d03827A A T78.40 Allergy, unspecified A0 E A IBUPROFEN d00015A AP R51 Headache A0 E A . . . E0 A . . . E@ A ENALAPRIL d00013A C I10 Essential (primary) hypertension AP E@ A METFORMIN d03807A C R73 Elevated blood glucose level AP E@ A OLANZAPINE d04050A D= F20 Schizophrenia AP E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E@ A TRIAMCINOLONE TOPICAL d03206A Cr L20.9 L40 Atopic dermatitis, unspecified Psoriasis AP EP A ALLOPURINOL d00023A Cr M1A Chronic gout A EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EP A ASPIRIN d00170A B Z79.02 Long term (current) use of antithrombotics/antiplatelets A EP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EP A CARVEDILOL d03847A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A EP A CARVEDILOL d03847A D I10 Essential (primary) hypertension A EP A FUROSEMIDE d00070A D J98.9 Respiratory disorder, unspecified A EP A ISOSORBIDE d00653A Cr R07.9P Prevent chest pain A EP A LISINOPRIL d00732A D I10 Essential (primary) hypertension A EP A PANTOPRAZOLE d04514A C K92.9 Disease of digestive system, unspecified A EP A PRASUGREL d07409A C D75.9P Prevent blood clots A E` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A@ E` A SULFASALAZINE d00379A C- K51 Ulcerative colitis A@ Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C E78.0P Prevent high cholesterol A0 E A PSEUDOEPHEDRINE; TRIPROLIDINE d03316A C J30.1 Allergic rhinitis due to pollen A0 E A . . . E A . . . E A CANDESARTAN d04322A0 B= I10 Essential (primary) hypertension A` E A ESOMEPRAZOLE d04749A0 B= B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E A FAMOTIDINE d00141A0 B= B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E A MESALAMINE d01031A0 B= K50 Crohn's disease [regional enteritis] A` E A METFORMIN d03807A0 Bz R73.9 Hyperglycemia, unspecified A` E A PRAVASTATIN d00348A0 C E78.0 Pure hypercholesterolemia A` E A . . . E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C[@ I10 Essential (primary) hypertension A@ EP A HYDROCODONE d03075A C M54.9 Dorsalgia, unspecified A@ EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ EP A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A@ E` A . . . Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A BENZONATATE d00796A B= J42 Unspecified chronic bronchitis Ap E A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma Ap E A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm Ap E A ESOMEPRAZOLE d04749A CP K21 Gastro-esophageal reflux disease Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension Ap E A TOLTERODINE d04294A C R32 Unspecified urinary incontinence Ap E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ACETAMINOPHEN; CODEINE d03423A Cr M19.9 Osteoarthritis, unspecified site A E A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A C- I10 Essential (primary) hypertension A E A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A E A MOMETASONE NASAL d04223A B[ J30.9 Allergic rhinitis, unspecified A E A NEBIVOLOL d05265A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A B= M19.9 Osteoarthritis, unspecified site A E A ZOLPIDEM d00910A C G47.0 Insomnia A E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A0 E A . . . E A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A . . . EP A . . . E` A ALBUTEROL d00749A CDp J45 Asthma Ap E` A BACLOFEN d00967A CDp M79.1 Myalgia Ap E` A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma Ap E` A GLYCOPYRROLATE d00992A CDp K11.7 Disturbances of salivary secretion Ap E` A GRISEOFULVIN d00100A B B35.9 Dermatophytosis, unspecified Ap E` A LANSOPRAZOLE d03828A CDp K21 Gastro-esophageal reflux disease Ap E` A POLYETHYLENE GLYCOL 3350 d05350A CDp K59.0 Constipation Ap Ep A . . . E A LITHIUM d00061A D* F31.9 Bipolar disorder, unspecified A E A . . . E A CLONAZEPAM d00197A C- F43.1 Post-traumatic stress disorder (PTSD) A E A CONJUGATED ESTROGENS d00541A Cr Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A ETODOLAC d00851A C M79.2 Neuralgia and neuritis, unspecified A E A FEXOFENADINE d04040A Cr T78.40 Allergy, unspecified A E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A E A LAMOTRIGINE d03809A C- F31.9 G50.0 Bipolar disorder, unspecified Trigeminal neuralgia A E A TRAZODONE d00395A Cr F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A METOPROLOL d00134A B= I48.91 Unspecified atrial fibrillation A E A RIVAROXABAN d07356A B= I26 Pulmonary embolism A E A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A0 E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A0 E A OLMESARTAN d04801A Cr I10 Essential (primary) hypertension A0 E A LANSOPRAZOLE d03828A B[ K30 Functional dyspepsia A E A MEFENAMIC ACID d00285A CDp N94.6 Dysmenorrhea, unspecified A E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A TERAZOSIN d00386A C N40 Enlarged prostate AP E A MONTELUKAST d04289A B= J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A CHOLESTYRAMINE d00193A C K31.9 Disease of stomach and duodenum, unspecified A0 E@ A HYDROCHLOROTHIAZIDE d00253A A I10 Essential (primary) hypertension A0 E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EP A . . . E` A ACETAMINOPHEN; CODEINE d03423A B K46 R07.9 Unspecified abdominal hernia Chest pain, unspecified A@ E` A ACETAMINOPHEN; HYDROCODONE d03428A B K46 R07.9 Unspecified abdominal hernia Chest pain, unspecified A@ E` A ONDANSETRON d00867A C"0 R11 Nausea and vomiting A@ E` A TRAMADOL d03826A C R07.9 Chest pain, unspecified A@ Ep A GLIPIZIDE d00246A D* E10 Type 1 diabetes mellitus A` Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D* I10 Essential (primary) hypertension A` Ep A METFORMIN d03807A D* 99999 A` Ep A NAPROXEN d00019A D* 99999 A` Ep A PIOGLITAZONE d04442A D* 99999 A` Ep A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A . . . E A NALTREXONE d01406A CDp M19.9 Osteoarthritis, unspecified site A E A . . . E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A0 E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A0 E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A FENOFIBRATE d04286A Bz E78.0 Pure hypercholesterolemia A@ E@ A LINAGLIPTIN d07767A B E11 Type 2 diabetes mellitus A@ E@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E@ A METFORMIN d03807A C[@ R73 Elevated blood glucose level A@ EP A . . . E` A ESTRADIOL; NORGESTIMATE d04506A B N93.9 Abnormal uterine and vaginal bleeding, unspecified A Ep A AMLODIPINE d00689A0 C[@ I10 Essential (primary) hypertension A Ep A CLOPIDOGREL d04258A0 C D75.9P Prevent blood clots A Ep A DIAZEPAM d00148A0 Cr F41.9 Anxiety disorder, unspecified A Ep A LEVOTHYROXINE d00278A0 C C73 Malignant neoplasm of thyroid gland A Ep A METOPROLOL d00134A0 C I49.9 Cardiac arrhythmia, unspecified A Ep A OMEPRAZOLE d00325A0 Cr K21 Gastro-esophageal reflux disease A Ep A PRAVASTATIN d00348A0 C E78.0 Pure hypercholesterolemia A Ep A TRAZODONE d00395A0 Cr G47.9 Sleep disorder, unspecified A E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A0 E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A CETIRIZINE d03827A C"0 T78.40 Allergy, unspecified A E A MOMETASONE NASAL d04223A C"0 T78.40 Allergy, unspecified A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A CLONAZEPAM d00197A CDp G47.9 Sleep disorder, unspecified A@ E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ E A OXYCODONE d00329A Cr R52 Pain, unspecified A@ E A PHENYTOIN d00143A Cr G40 Epilepsy and recurrent seizures A@ E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E0 A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A@ E0 A CLONAZEPAM d00197A C G25.81 Restless legs syndrome A@ E0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A@ E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E@ A . . . EP A . . . E` A . . . Ep A BISOPROLOL d00709A Cr I10.P Prevent hypertension A@ Ep A GABAPENTIN d03182A C G25.81 Restless legs syndrome A@ Ep A HYDROCODONE d03075A C M54.9 Dorsalgia, unspecified A@ Ep A ROPINIROLE d04215A C G25.81 Restless legs syndrome A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A NORETHINDRONE d00555A B[ N95.1 Menopausal and female climacteric states A E A . . . E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E0 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A E@ A . . . EP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ EP A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A@ EP A PREGABALIN d05508A C E11.4 Type 2 diabetes mellitus with neurological complications A@ EP A TRAMADOL d03826A C T14.9 Unspecified injury A@ E` A . . . Ep A BUDESONIDE d04276A C- Q99.9 Chromosomal abnormality, unspecified Ap Ep A CLONIDINE d00044A Cr G47.9 Sleep disorder, unspecified Ap Ep A DORNASE ALFA d03173A Bz Q99.9 Chromosomal abnormality, unspecified Ap Ep A GABAPENTIN d03182A C- G47.9 Sleep disorder, unspecified Ap Ep A LIDOCAINE; PRILOCAINE TOPICAL d03655A C- 55555 Ap Ep A RISPERIDONE d03180A C F91.9 Conduct disorder, unspecified Ap Ep A URSODIOL d01005A B K82.9 Disease of gallbladder, unspecified Ap E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A GLIPIZIDE d00246A C R73 Elevated blood glucose level AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E A ISOSORBIDE MONONITRATE d00269A B I21.P Prevent heart attack/myocardial infarction AP E A AZITHROMYCIN d00091A0 Ap J40 Bronchitis, not specified as acute or chronic A E A BENZONATATE d00796A0 B J40 Bronchitis, not specified as acute or chronic A E A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E A AMOXICILLIN d00088A A0 H66.9 Otitis media, unspecified A E A . . . E A CHOLESTYRAMINE d00193A0 B E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A0 B E03.9 Hypothyroidism, unspecified A E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A0 E A ALBUTEROL d00749A B J45 Asthma A E A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ASPIRIN d00170A B D75.9P Prevent blood clots A E A ATORVASTATIN d04105A D= E78.0 Pure hypercholesterolemia A E A DIVALPROEX SODIUM d03833A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A DULOXETINE d05355A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A INSULIN d00262A0 D= E11 Type 2 diabetes mellitus A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A D= E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A D= E11.P Prevent diabetes A E A PANTOPRAZOLE d04514A0 C- K21 Gastro-esophageal reflux disease A E A TOPIRAMATE d04115A C R60.9 Edema, unspecified A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A NAPROXEN d00019A Ap N94.6 Dysmenorrhea, unspecified A E A . . . E0 A BUDESONIDE d04276A B J45 Asthma A E@ A . . . EP A . . . E` A ALBUTEROL d00749A C J45 Asthma A E` A ALBUTEROL d00749A C J45 Asthma A Ep A . . . E A . . . E A BUPROPION d00181A A F41.9 Anxiety disorder, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A CDp T14.9 Unspecified injury A@ E A ATENOLOL; CHLORTHALIDONE d03258A C[@ I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A@ E A INTERFERON BETA-1A d04011A C G35 Multiple sclerosis A E A DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE d07697A Dc Z79.3 Long term (current) use of hormonal contraceptives A E A RIZATRIPTAN d04328A D G43 Migraine A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D Z79.3 Long term (current) use of hormonal contraceptives A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia Ap E A EZETIMIBE d04824A D* E78.0 Pure hypercholesterolemia Ap E A FINASTERIDE d00563A Cr N40 Enlarged prostate Ap E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A D* I50.9 Heart failure, unspecified Ap E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E A SPIRONOLACTONE d00373A D* R60.9 Edema, unspecified Ap E A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified A E A AMITRIPTYLINE d00146A Bz M79.2 Neuralgia and neuritis, unspecified A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A CICLOPIROX TOPICAL d01272A Bz B35.1 Tinea unguium A E A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A E A LAMOTRIGINE d03809A C F31.9 Bipolar disorder, unspecified A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A MIRTAZAPINE d04025A B F32.9 Major depressive disorder, single episode, unspecified A E A MONTELUKAST d04289A C J45 Asthma A E A RANITIDINE d00021A C R12 Heartburn A E A ROPINIROLE d04215A B M79.673 Pain in unspecified foot A E0 A AMLODIPINE; BENAZEPRIL d03829A0 D= I10 Essential (primary) hypertension A` E0 A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A0 C H40 Glaucoma A` E0 A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus A` E0 A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma A` E0 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A` E0 A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A` E@ A . . . EP A . . . E` A CLONIDINE d00044A C- G47.9 Sleep disorder, unspecified A@ E` A IMIPRAMINE d00259A C- F98.0 Enuresis not due to a substance or known physiological condition A@ E` A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A@ E` A QUETIAPINE d04220A B F31.9 G47.9 Bipolar disorder, unspecified Sleep disorder, unspecified A@ Ep A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A Ep A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A Ep A CARVEDILOL d03847A C I10 Essential (primary) hypertension A Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Ep A INSULIN GLARGINE d04538A CP E11 Type 2 diabetes mellitus A Ep A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ep A VALSARTAN d04113A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A BUMETANIDE d00179A C I10 Essential (primary) hypertension A E A CALCIUM ACETATE d03689A C E83.3 Disorders of phosphorus metabolism and phosphatases A E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A E A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction A E A LACTULOSE d01024A C- K59.0 Constipation A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A PANCRELIPASE d01002A C K92.9 Disease of digestive system, unspecified A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A CARDIOVASCULAR AGENTS - UNSPECIFIED c00040A CDp R00.9 Unspecified abnormalities of heart beat B E A CYCLOSPORINE OPHTHALMIC d04836A C H04.12 Dry eye syndrome B E A DOXYCYCLINE d00037A B R06.9 Unspecified abnormalities of breathing B E A EXENATIDE d05529A CDp E11 Type 2 diabetes mellitus B E A FLUTICASONE; SALMETEROL d04611A B= R06.9 Unspecified abnormalities of breathing B E A FUROSEMIDE d00070A B R06.9 Unspecified abnormalities of breathing B E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus B E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus B E A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus B E A LEVALBUTEROL d04427A B R06.9 Unspecified abnormalities of breathing B E A LISINOPRIL d00732A C 99999 B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A METOCLOPRAMIDE d00298A C K21 Gastro-esophageal reflux disease B E A MONTELUKAST d04289A C- 99999 B E A NIACIN d00314A CDp 99999 B E A PIOGLITAZONE d04442A C 99999 B E A POTASSIUM CHLORIDE d00345A B[ R60.9 Edema, unspecified B E A ROSUVASTATIN d04851A C 99999 B E A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified B E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C[@ I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A . . . E0 A . . . E@ A ALBUTEROL d00749A B J45 Asthma Ap E@ A DEXAMETHASONE d00206A Bz J45 Asthma Ap E@ A FORMOTEROL; MOMETASONE d07660A C J45 Asthma Ap E@ A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified Ap E@ A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A B I10 Essential (primary) hypertension Ap E@ A MONTELUKAST d04289A Cr J45 R06.2 Asthma Wheezing Ap E@ A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia Ap EP A . . . E` A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A Ep A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ Ep A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A@ Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A TAMOXIFEN d00381A B= C50.P Prevent barest cancer AP E A IBUPROFEN d00015A C N94.6 Dysmenorrhea, unspecified A E A . . . E A . . . E A . . . E A . . . E A CARBAMAZEPINE d00058A CDp F31.9 Bipolar disorder, unspecified Ap E A CITALOPRAM d04332A CDp F31.9 Bipolar disorder, unspecified Ap E A MIRTAZAPINE d04025A B F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia Ap E A TRIHEXYPHENIDYL d00970A C- F31.9 Bipolar disorder, unspecified Ap E A ZIPRASIDONE d04747A C[@ F31.9 Bipolar disorder, unspecified Ap E A . . . E A ARIPIPRAZOLE d04825A Cr F20 Schizophrenia A` E A CLOZAPINE d00199A Cr F20 Schizophrenia A` E A LAMOTRIGINE d03809A Cr G40 Epilepsy and recurrent seizures A` E A RANITIDINE d00021A Cr R12 Heartburn A` E A SITAGLIPTIN d05896A Cr E11.P Prevent diabetes A` E A TELMISARTAN d04364A Cr I10 Essential (primary) hypertension A` E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A E A CLOPIDOGREL d04258A B I49.9 Cardiac arrhythmia, unspecified A E A DILTIAZEM d00045A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A B R07.9 Chest pain, unspecified A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A C[@ J45 Asthma A E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E A ROFLUMILAST d07684A A J44.9 Chronic obstructive pulmonary disease, unspecified A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A THEOPHYLLINE d00142A C J45 Asthma A E A ALLOPURINOL d00023A Cr M1A Chronic gout A E A COLCHICINE d00150A Cr M1A Chronic gout A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A NIACIN d00314A Cr E78.0 Pure hypercholesterolemia A E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension A E A CLONAZEPAM d00197A C[@ F41.9 Anxiety disorder, unspecified A` E A CLONIDINE d00044A C- F90 Attention-deficit hyperactivity disorders A` E A CLONIDINE d00044A C- F41.9 Anxiety disorder, unspecified A` E A DIPHENHYDRAMINE d00212A C[@ G47.0 Insomnia A` E A LITHIUM d00061A C- F91.9 Conduct disorder, unspecified A` E A MINOCYCLINE d00110A B L70 Acne A` E A . . . E A PENICILLIN V POTASSIUM d07730A AP K04.7 Periapical abscess without sinus A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A FINASTERIDE d00563A C R35.1 Nocturia A E A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A SILDENAFIL d04299A B N52.9 Male erectile dysfunction, unspecified A E A TAMSULOSIN d04121A B R39.15 Urgency of urination A E A TRAZODONE d00395A C[@ G47.0 Insomnia A E A VENLAFAXINE d03181A C[@ F43.1 Post-traumatic stress disorder (PTSD) A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A FLUTICASONE; SALMETEROL d04611A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A SIMVASTATIN d00746A CDp E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A0 E A TIOTROPIUM d04829A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A E A BENAZEPRIL d00730A C I21.P Prevent heart attack/myocardial infarction A E A IBUPROFEN d00015A Dc M19.9 Osteoarthritis, unspecified site A E A METOPROLOL d00134A CDp I21.P Prevent heart attack/myocardial infarction A E A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol A E A SERTRALINE d00880A C G47.9 Sleep disorder, unspecified A E A SOLIFENACIN d05413A B[ N39.4 Other specified urinary incontinence A E A TAMSULOSIN d04121A B[ R32 Unspecified urinary incontinence A E A AMLODIPINE d00689A Ap I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A@ E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A@ E A ALBUTEROL d00749A C[@ R06.9 Unspecified abnormalities of breathing B E A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture B E A ALPRAZOLAM d00168A Cr R45.0 Nervousness B E A AMITRIPTYLINE d00146A Cr G47.0 Insomnia B E A AMLODIPINE d00689A D I10 Essential (primary) hypertension B E A BUDESONIDE; FORMOTEROL d04795A C[@ R06.9 Unspecified abnormalities of breathing B E A CYCLOBENZAPRINE d00963A Cr M62.83 Muscle spasm B E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified B E A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified B E A LORATADINE d03050A D# T78.40 Allergy, unspecified B E A LOVASTATIN d00280A CDp 99999 B E A MELOXICAM d04532A C- E78.0 Pure hypercholesterolemia B E A MONTELUKAST d04289A Cr R06.9 Unspecified abnormalities of breathing B E A OXYBUTYNIN d00328A C- N39.4 Other specified urinary incontinence B E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease B E A ROFLUMILAST d07684A C- R06.9 Unspecified abnormalities of breathing B E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified B E A . . . E A . . . E A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A E0 A AMITRIPTYLINE d00146A C G47.0 Insomnia AP E0 A ATENOLOL; CHLORTHALIDONE d03258A D I10 Essential (primary) hypertension AP E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E0 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E0 A NIFEDIPINE d00051A C I10 Essential (primary) hypertension AP E@ A . . . EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E` A RANITIDINE d00021A Dc K30 Functional dyspepsia A Ep A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B[ I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension AP E A MELOXICAM d04532A B[ M79.1 Myalgia AP E A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease AP E A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A D"8 E03.9 Hypothyroidism, unspecified A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap E A AZILSARTAN d07754A CDp I10 Essential (primary) hypertension Ap E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified Ap E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E A FLUTICASONE NASAL d04283A C J30.1 Allergic rhinitis due to pollen A0 E A LISINOPRIL d00732A Cr E11.2P Prevent diabetic kidney disease A0 E0 A . . . E@ A LISINOPRIL d00732A0 Bz I10 Essential (primary) hypertension A EP A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E` A ALBUTEROL d00749A0 D J45 Asthma A Ep A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders A0 E A CEFDINIR d04256A Ap A49.9 Bacterial infection, unspecified A0 E A POLYMYXIN B SULFATE d00344A Ap H10 Conjunctivitis A0 E A . . . E A . . . E0 A . . . E@ A . . . EP A ALBUTEROL d00749A Bz J45 Asthma A0 EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A E A TAMOXIFEN d00381A CDp C50.P Prevent barest cancer A E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A RISPERIDONE d03180A CDp F91.9 Conduct disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ALBUTEROL d00749A C R06.2 Wheezing AP E0 A FLUTICASONE d01296A C R06.2 Wheezing AP E0 A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified AP E0 A MONTELUKAST d04289A C J45 Asthma AP E0 A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses AP E@ A . . . EP A ALENDRONATE d03849A CDp M85.80 Other specified disorders of bone density and structure, unspecified site A EP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A EP A ANASTROZOLE d03873A CDp C50.P Prevent barest cancer A EP A FLUVOXAMINE d03804A D* F31.9 Bipolar disorder, unspecified A EP A HYDROCODONE d03075A Cr M79.2 Neuralgia and neuritis, unspecified A EP A LIOTHYRONINE d00658A Cr E03.9 Hypothyroidism, unspecified A EP A LITHIUM d00061A D* F31.9 Bipolar disorder, unspecified A EP A ZIPRASIDONE d04747A D F31.9 Bipolar disorder, unspecified A E` A . . . Ep A . . . E A ATENOLOL d00004A C"0 I49.9 Cardiac arrhythmia, unspecified A` E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A` E A GABAPENTIN d03182A C"0 I10 Essential (primary) hypertension A` E A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A` E A NAPROXEN d00019A C"0 M79.1 Myalgia A` E A OMEPRAZOLE d00325A C"0 K21 Gastro-esophageal reflux disease A` E A ATENOLOL d00004A D I10 Essential (primary) hypertension A` E A ATROPINE; HYOSCYAMINE; PHENOBARBITAL; SCOPOLAMINE d03485A C K30 Functional dyspepsia A` E A CYCLOBENZAPRINE d00963A B M54.9 Dorsalgia, unspecified A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A` E A IBUPROFEN d00015A CDp M54.9 N94.6 Dorsalgia, unspecified Dysmenorrhea, unspecified A` E A PREDNISONE d00350A Cr J45 Asthma A` E A . . . E A . . . E A CETIRIZINE d03827A B J30.9 Allergic rhinitis, unspecified A E A CHOLESTYRAMINE d00193A A Z77.120 Contact with and (suspected) exposure to mold (toxic) A E A CYCLOBENZAPRINE d00963A C[@ M62.83 M79.1 Muscle spasm Myalgia A E A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A E A IBUPROFEN d00015A Cr M79.1 Myalgia A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54.9 Dorsalgia, unspecified A0 E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E0 A . . . E@ A FLUOXETINE d00236A C[@ F41.9 Anxiety disorder, unspecified A E@ A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A EP A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A EP A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E` A . . . Ep A AMITRIPTYLINE d00146A0 CDp G47.0 Insomnia Ap Ep A HYDROCODONE d03075A0 B[ M54.9 M79.1 Dorsalgia, unspecified Myalgia Ap Ep A LEVOTHYROXINE d00278A0 D* E03.9 Hypothyroidism, unspecified Ap Ep A LISINOPRIL d00732A0 CDp I10 Essential (primary) hypertension Ap Ep A POTASSIUM CHLORIDE d00345A0 C M79.673 Pain in unspecified foot Ap Ep A ROPINIROLE d04215A0 B G25.81 Restless legs syndrome Ap Ep A TRIAMTERENE d00396A CDp I10 Essential (primary) hypertension Ap E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A FINASTERIDE d00563A C N40 Enlarged prostate A` E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A` E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A` E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C"0 R73.9 Hyperglycemia, unspecified A0 E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension Ap E A CLONAZEPAM d00197A B F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia Ap E A CYCLOBENZAPRINE d00963A C M54.2 M62.83 Cervicalgia Muscle spasm Ap E A LISINOPRIL d00732A B I10 Essential (primary) hypertension Ap E A MIRTAZAPINE d04025A C G47.0 Insomnia Ap E A NAPROXEN d00019A B T14.9 Unspecified injury Ap E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified Ap E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A CARVEDILOL d03847A Dc I50.9 Heart failure, unspecified Ap E A DIGOXIN d00210A C I50.9 Heart failure, unspecified Ap E A FUROSEMIDE d00070A Dc I50.9 Heart failure, unspecified Ap E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A D' K21 Gastro-esophageal reflux disease Ap E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia Ap E A WARFARIN d00022A Dc D75.9P I48.91 Prevent blood clots Unspecified atrial fibrillation Ap E0 A . . . E@ A ATAZANAVIR d04882A D% B20 Human immunodeficiency virus [HIV] disease Ap E@ A AZITHROMYCIN d00091A D% B20 Human immunodeficiency virus [HIV] disease Ap E@ A EMTRICITABINE; TENOFOVIR d05352A D% B20 Human immunodeficiency virus [HIV] disease Ap E@ A NAPROXEN d00019A C- M79.1 Myalgia Ap E@ A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap E@ A RITONAVIR d03984A D% B20 Human immunodeficiency virus [HIV] disease Ap E@ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A D% B20 Human immunodeficiency virus [HIV] disease Ap EP A . . . E` A . . . Ep A CETIRIZINE d03827A C T78.40 Allergy, unspecified A Ep A FLUTICASONE d01296A B J45 Asthma A E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A WARFARIN d00022A D D75.9P Prevent blood clots A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A ATORVASTATIN d04105A Ei 99999 A E A CITALOPRAM d04332A C 99999 A E A INSULIN GLARGINE d04538A Ei E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A Ei E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A Ei 99999 A E A LINACLOTIDE d07902A B K59.0 Constipation A E A LISINOPRIL d00732A Ei 99999 A E A OMEPRAZOLE; SODIUM BICARBONATE d05770A B K30 Functional dyspepsia A E A OXYCODONE d00329A C M54.9 M79.603 Dorsalgia, unspecified Pain in arm, unspecified A E A TIZANIDINE d04102A C M62.83 Muscle spasm A E A ZOLPIDEM d00910A Ei G47.9 Sleep disorder, unspecified A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified A0 E A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension A0 E A RABEPRAZOLE d04448A C[@ K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E° A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A GRISEOFULVIN d00100A A` B35.4 Tinea corporis A E A . . . E A MICONAZOLE TOPICAL d03195A A B37.3 Candidiasis of vulva and vagina A E A FAMOTIDINE d00141A Dc 99999 A E A . . . E A AMOXICILLIN; CLAVULANATE d00089A Ap J40 Bronchitis, not specified as acute or chronic A E A . . . E0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E@ A . . . EP A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A EP A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A EP A DIGOXIN d00210A Cr I50.9 Heart failure, unspecified A EP A FINASTERIDE d00563A C N40 Enlarged prostate A EP A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EP A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A EP A TERAZOSIN d00386A C N40 Enlarged prostate A EP A WARFARIN d00022A C D75.9P Prevent blood clots A E` A FAMOTIDINE d00141A Cr K30 Functional dyspepsia A Ep A . . . EÀ A . . . EÐ A . . . Eà A . . . Eð A . . . E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A FAMOTIDINE d00141A B K30 Functional dyspepsia A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A0 E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A RANITIDINE d00021A Cr K30 Functional dyspepsia A EP A . . . E` A AMLODIPINE d00689A B I10 Essential (primary) hypertension AP E` A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease AP E` A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia AP E` A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP E` A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP Ep A ALENDRONATE; CHOLECALCIFEROL d05526A Cr M81 Osteoporosis without current pathological fracture A Ep A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A Ep A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A Cr H40 Glaucoma A Ep A BRINZOLAMIDE OPHTHALMIC d04301A Cr H40 Glaucoma A Ep A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A Ep A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A Ep A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A Ep A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A Ep A RABEPRAZOLE d04448A Cr K30 Functional dyspepsia A EĀ A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A0 EĀ A MECLIZINE d00859A B= H81.1 Benign paroxysmal vertigo A0 EĀ A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A0 EĐ A ALBUTEROL d00749A C- J42 J45 Unspecified chronic bronchitis Asthma A EĠ A . . . Eİ A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E A METOPROLOL d00134A B= I49.9 Cardiac arrhythmia, unspecified A E A . . . E A . . . E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A0 E A THYROID DESICCATED d00655A C- E04.1 Nontoxic single thyroid nodule A0 E A . . . E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A` E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A` E A CYCLOBENZAPRINE d00963A B= M79.1 Myalgia A` E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A` E A QUETIAPINE d04220A C- F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A` E A TRAZODONE d00395A C"0 G47.9 Sleep disorder, unspecified A` E0 A . . . E@ A BUSPIRONE d00182A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E@ A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A0 E@ A FAMOTIDINE d00141A B K30 Functional dyspepsia A0 EP A PITAVASTATIN d07637A B= E78.0 Pure hypercholesterolemia A E` A TERAZOSIN d00386A B= N40 Enlarged prostate A Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A Ep A CYPROHEPTADINE d00790A C"0 R63.0 Anorexia A Eŀ A ATENOLOL d00004A C 99999 A0 Eŀ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Eŀ A WARFARIN d00022A C A41.9 Sepsis, unspecified organism A0 EŐ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EŠ A . . . EŰ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A EŰ A RIZATRIPTAN d04328A Bz G43 Migraine A E A AMIODARONE d00002A C I49.9 Cardiac arrhythmia, unspecified A@ E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C K25 Gastric ulcer A@ E A SIMVASTATIN d00746A C 55555 A@ E A . . . E A ARIPIPRAZOLE d04825A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E A CARBAMAZEPINE d00058A C G40 Epilepsy and recurrent seizures A0 E A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension A E0 A ESCITALOPRAM d04812A Dc F41.9 G43 Anxiety disorder, unspecified Migraine A E@ A . . . EP A ESTRADIOL d00537A C[@ N95.1 Menopausal and female climacteric states A0 EP A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A0 EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E` A ATORVASTATIN d04105A CDp E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ep A GABAPENTIN d03182A C F41.9 M54.9 Anxiety disorder, unspecified Dorsalgia, unspecified AP Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ep A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures AP Eƀ A . . . EƐ A . . . EƠ A . . . Eư A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ALPRAZOLAM d00168A C G47.9 Sleep disorder, unspecified A` E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C- I49.9 Cardiac arrhythmia, unspecified A` E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A` E A METOCLOPRAMIDE d00298A CDp K21 Gastro-esophageal reflux disease A` E A PANTOPRAZOLE d04514A A K21 Gastro-esophageal reflux disease A` E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A` E A ACETAZOLAMIDE d00161A B I10 Essential (primary) hypertension Ap E A BIMATOPROST OPHTHALMIC d04754A B H40 Glaucoma Ap E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A B H40 Glaucoma Ap E A BRINZOLAMIDE OPHTHALMIC d04301A B H40 Glaucoma Ap E A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp E78.0 Pure hypercholesterolemia Ap E A LOTEPREDNOL OPHTHALMIC d04292A B H57.8 Other specified disorders of eye and adnexa Ap E A . . . E A . . . E0 A EZETIMIBE d04824A CDp E78.0 Pure hypercholesterolemia A@ E0 A FAMOTIDINE d00141A C[@ K21 Gastro-esophageal reflux disease A@ E0 A FLUTICASONE; SALMETEROL d04611A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E0 A TIOTROPIUM d04829A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A@ E@ A . . . EP A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A EP A AMIODARONE d00002A C- I49.9 Cardiac arrhythmia, unspecified A EP A AMIODARONE d00002A CDp I49.9 Cardiac arrhythmia, unspecified A EP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A EP A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A EP A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified A EP A LANSOPRAZOLE d03828A C[@ 99999 A EP A MELOXICAM d04532A C- M79.1 Myalgia A EP A NAPROXEN d00019A CDp M13 M54.9 M79.1 Other arthritis Dorsalgia, unspecified Myalgia A EP A NITROGLYCERIN d00321A Dc R07.9 Chest pain, unspecified A EP A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A E` A MINOCYCLINE d00110A C L70 Acne A Ep A . . . Eǀ A . . . Eǐ A CARVEDILOL d03847A C R07.9 Chest pain, unspecified A Eǐ A FUROSEMIDE d00070A B I10 Essential (primary) hypertension A Eǐ A ISOSORBIDE d00653A C 99999 A Eǐ A LISINOPRIL d00732A Ei 99999 A Eǐ A PANTOPRAZOLE d04514A C 99999 A Eǐ A PRAVASTATIN d00348A Ei 99999 A Eǐ A RIVAROXABAN d07356A B I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A Eǐ A SPIRONOLACTONE d00373A Ei 99999 A EǠ A . . . Eǰ A . . . E A . . . E A GLIMEPIRIDE d03864A CDp I10 Essential (primary) hypertension A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A LORAZEPAM d00149A Cr G47.9 Sleep disorder, unspecified A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METHOTREXATE d00060A C 99999 A E A METOPROLOL d00134A C 99999 A E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C 99999 A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C T14.9 Unspecified injury A E A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A E A BUPROPION d00181A C F17.203 F32.9 Nicotine dependence unspecified, with withdrawal Major depressive disorder, single episode, unspecified A E A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified A E A VERAPAMIL d00048A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E A ZOLPIDEM d00910A CDp G47.9 Sleep disorder, unspecified A E A . . . E A . . . E0 A ALBUTEROL d00749A0 C J42 Unspecified chronic bronchitis A` E0 A ALBUTEROL; IPRATROPIUM d04066A0 C R05 Cough A` E0 A FLUTICASONE NASAL d04283A0 C J30.1 Allergic rhinitis due to pollen A` E0 A FLUTICASONE; SALMETEROL d04611A0 C J45 Asthma A` E0 A NITROGLYCERIN d00321A0 C R07.9 Chest pain, unspecified A` E0 A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A` E@ A . . . EP A . . . E` A . . . Ep A . . . EȀ A . . . EȐ A . . . EȠ A . . . EȰ A . . . E A . . . E A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B[ I10 Essential (primary) hypertension A` E A METOPROLOL d00134A D* I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E A SERTRALINE d00880A Cr F41.9 Anxiety disorder, unspecified A` E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M79.7 Fibromyalgia A E A ALPRAZOLAM d00168A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A E A ESTRADIOL d00537A CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A MECLIZINE d00859A C R42 Dizziness and giddiness A E A MONTELUKAST d04289A D* J45 Asthma A E A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A E A PREGABALIN d05508A C M79.7 Fibromyalgia A E A VILAZODONE d07740A C- F32.9 Major depressive disorder, single episode, unspecified A E A ZOLPIDEM d00910A CDp G47.0 Insomnia A E A FLUTICASONE d01296A C- J45 Asthma A E0 A . . . E@ A . . . EP A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A EP A IBUPROFEN d00015A Ap K08.8 Other specified disorders of teeth and supporting structures A E` A FLUCONAZOLE d00071A Ap B37.3 Candidiasis of vulva and vagina A Ep A ALBUTEROL d00749A CDp J45 Asthma A0 Ep A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 Ep A ATENOLOL; CHLORTHALIDONE d03258A C[@ I10 Essential (primary) hypertension A0 Eɀ A . . . Eɐ A . . . Eɠ A DOXYCYCLINE d00037A AP L98.9 Disorder of the skin and subcutaneous tissue, unspecified A@ Eɠ A LAMOTRIGINE d03809A C[@ F39 Unspecified mood [affective] disorder A@ Eɠ A SERTRALINE d00880A C[@ F39 Unspecified mood [affective] disorder A@ Eɠ A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A@ Eɰ A . . . E A . . . E A . . . E A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eʀ A . . . Eʐ A . . . Eʠ A . . . Eʰ A . . . E A . . . E A DULOXETINE d05355A C M79.2 Neuralgia and neuritis, unspecified A0 E A IBUPROFEN d00015A C G43 M54.9 Migraine Dorsalgia, unspecified A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A E A ZOLPIDEM d00910A CDp G47.0 Insomnia A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eˀ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` Eˀ A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A` Eˀ A FLUOXETINE d00236A C F39 Unspecified mood [affective] disorder A` Eˀ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` Eˀ A NAPROXEN d00019A C[@ M79.1 Myalgia A` Eˀ A TAMSULOSIN d04121A B R39.15 Urgency of urination A` Eː A 77777 . . A Eː A ATENOLOL d00004A Ei 99999 A Eː A ATORVASTATIN d04105A Ei 99999 A Eː A DABIGATRAN d07137A C D75.9P Z79.02 Prevent blood clots Long term (current) use of antithrombotics/antiplatelets A Eː A DONEPEZIL d04099A Ei 99999 A Eː A GABAPENTIN d03182A Ei 99999 A Eː A MEMANTINE d04899A Ei F32.9 Major depressive disorder, single episode, unspecified A Eː A VENLAFAXINE d03181A Ei 99999 A Eˠ A . . . E˰ A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A FINASTERIDE d00563A C N40 Enlarged prostate A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A@ E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B R41.840 Attention and concentration deficit A E A CYCLOBENZAPRINE d00963A B[ T14.9 Unspecified injury A E A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A@ E A EZETIMIBE; SIMVASTATIN d05348A Cr E78.0 Pure hypercholesterolemia A@ E A METOPROLOL d00134A Cr I48.91 Unspecified atrial fibrillation A@ E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E A QUININE d00366A A0 M62.83 Muscle spasm A E A . . . E A VERAPAMIL d00048A C[@ I48.91 I49.9 Unspecified atrial fibrillation Cardiac arrhythmia, unspecified A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . È A ALLOPURINOL d00023A C N20.0 Calculus of kidney A È A ATENOLOL d00004A D I49.9 Cardiac arrhythmia, unspecified A È A DICLOFENAC d00848A C M25.56 Pain in knee A È A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A È A ESOMEPRAZOLE d04749A Dc K21 Gastro-esophageal reflux disease A È A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A È A METFORMIN d03807A C E11 Type 2 diabetes mellitus A È A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E̐ A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A@ E̐ A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A@ E̐ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E̐ A NEBIVOLOL d05265A B I49.9 Cardiac arrhythmia, unspecified A@ E̠ A ALBUTEROL d00749A C J45 Asthma A Ḛ A ACETAMINOPHEN; PSEUDOEPHEDRINE d03289A CDp M54.9 Dorsalgia, unspecified A Ḛ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A Bz K21 Gastro-esophageal reflux disease A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E0 A . . . E@ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E@ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A EP A QUETIAPINE d04220A C G47.9 Sleep disorder, unspecified A E` A FLUTICASONE NASAL d04283A B= J30.9 Allergic rhinitis, unspecified A E` A PHENTERMINE d00806A B E66 Overweight and obesity A Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Ep A DIAZEPAM d00148A Ap M62.83 Muscle spasm A@ Ep A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ Ep A OLMESARTAN d04801A B I10 Essential (primary) hypertension A@ È A . . . E͐ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E͐ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E͠ A . . . EͰ A ACETAMINOPHEN; HYDROCODONE d03428A B R10.9 Unspecified abdominal pain A E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E0 A . . . E@ A ACETAMINOPHEN; OXYCODONE d03431A CDp M1A Chronic gout A0 E@ A COLCHICINE d00150A D M1A Chronic gout A0 E@ A SIMVASTATIN d00746A C E78.1 Pure hyperglyceridemia A0 EP A . . . E` A ACYCLOVIR d00001A Cr A60.9 Anogenital herpesviral infection, unspecified A Ep A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A LIOTHYRONINE d00658A C- E04.9 Nontoxic goiter, unspecified A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 Eΐ A . . . EΠ A AMOXICILLIN d00088A C A49.9P Prevent bacterial infection A Eΰ A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 Eΰ A METFORMIN d03807A C[@ E11.P Prevent diabetes A0 Eΰ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A DONEPEZIL d04099A B= G31.9 Degenerative disease of nervous system, unspecified A E A FENOFIBRATE d04286A Ei E78.0 Pure hypercholesterolemia A E A HYOSCYAMINE d00985A Ei R10.83 R19.7 Colic Diarrhea, unspecified A E A LEVOTHYROXINE d00278A D,3 E03.9 Hypothyroidism, unspecified A E A OLANZAPINE d04050A A G47.0 Insomnia A E A RALOXIFENE d04261A Ei M81 Osteoporosis without current pathological fracture A E A SIMVASTATIN d00746A Ei I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A E A . . . E0 A ATENOLOL d00004A Dc I10 Essential (primary) hypertension Ap E0 A BENAZEPRIL d00730A CDp E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension Ap E0 A CYCLOBENZAPRINE d00963A B= M54.9 Dorsalgia, unspecified Ap E0 A DICLOFENAC d00848A C"0 M25.56 M54.9 Pain in knee Dorsalgia, unspecified Ap E0 A DULOXETINE d05355A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E0 A FENOFIBRIC ACID d07371A Dc E78.0 Pure hypercholesterolemia Ap E0 A METFORMIN d03807A CDp E11.P Prevent diabetes Ap E@ A . . . EP A CEFUROXIME d00056A Ap J01.9 Acute sinusitis, unspecified A@ EP A CITALOPRAM d04332A Ap F41.9 Anxiety disorder, unspecified A@ EP A DIAZEPAM d00148A Ap F41.9 Anxiety disorder, unspecified A@ EP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A` E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E` A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` Ep A . . . Eπ A . . . Eϐ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A EϠ A ATOMOXETINE d04827A B= F90 Attention-deficit hyperactivity disorders AP EϠ A BUPROPION d00181A Dc F90 Attention-deficit hyperactivity disorders AP EϠ A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia AP EϠ A GABAPENTIN d03182A CDp G50.0 Trigeminal neuralgia AP EϠ A TIZANIDINE d04102A B R51 Headache AP Eϰ A . . . E A . . . E A . . . E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A CP G47.0 M54.9 Insomnia Dorsalgia, unspecified A E A . . . E A FLUTICASONE NASAL d04283A B= J30.9 Allergic rhinitis, unspecified A E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A B M19.9 Osteoarthritis, unspecified site Ap E@ A FUROSEMIDE d00070A Ei N18.9 Chronic kidney disease, unspecified Ap E@ A LISINOPRIL d00732A Ei N19 Unspecified kidney failure Ap E@ A METOCLOPRAMIDE d00298A Ei K21 Gastro-esophageal reflux disease Ap E@ A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease Ap E@ A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia Ap E@ A TRAMADOL d03826A Ei M54.9 Dorsalgia, unspecified Ap EP A . . . E` A . . . Ep A . . . EЀ A . . . EА A . . . EР A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A EР A IBUPROFEN d00015A Cr M54.9 Dorsalgia, unspecified A Eа A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A Eа A CLOPIDOGREL d04258A0 C D75.9P Prevent blood clots A Eа A ESTRADIOL d00537A0 CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A Eа A ETANERCEPT d04365A0 Dc M06.9 Rheumatoid arthritis, unspecified A Eа A FORMOTEROL d04572A0 C- J45 Asthma A Eа A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A Eа A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A Eа A METHOTREXATE d00060A0 D M06.9 Rheumatoid arthritis, unspecified A Eа A MOMETASONE d05262A0 C J45 Asthma A E A LEVALBUTEROL d04427A B J45 Asthma A E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A MELOXICAM d04532A C M54.9 Dorsalgia, unspecified A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension AP E A NAPROXEN d00019A Ei M06.9 Rheumatoid arthritis, unspecified AP E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia AP E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eр A . . . Eѐ A DOCUSATE d01021A0 C K58 Irritable bowel syndrome A Eѐ A DOXYCYCLINE d00037A C L71 Rosacea A Eѐ A LISINOPRIL d00732A C N28.9 Disorder of kidney and ureter, unspecified A Eѐ A MESALAMINE d01031A0 C K50 Crohn's disease [regional enteritis] A Eѐ A METFORMIN d03807A0 C[@ E11 Type 2 diabetes mellitus A Eѐ A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A Eѐ A TRAZODONE d00395A0 C G47.0 Insomnia A Eѐ A VARDENAFIL d04893A0 C N52.9 Male erectile dysfunction, unspecified A Eѐ A ZOLPIDEM d00910A0 C G47.0 Insomnia A EѠ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives AP EѠ A METHYLPREDNISOLONE d00293A A L23.7 Allergic contact dermatitis due to plants, except food AP EѠ A METHYLPREDNISOLONE d00293A A` L23.7 Allergic contact dermatitis due to plants, except food AP EѠ A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified AP EѠ A MONTELUKAST d04289A C J30.9 J45 Allergic rhinitis, unspecified Asthma AP EѰ A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A` EѰ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` EѰ A NITROFURANTOIN d00112A Cr N39.0 Urinary tract infection, site not specified A` EѰ A ROPINIROLE d04215A Ap G25.81 Restless legs syndrome A` EѰ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` EѰ A TOLTERODINE d04294A Cr N32.81 Overactive bladder A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E0 A . . . E@ A . . . EP A . . . E` A CLONAZEPAM d00197A C G47.0 Insomnia A@ E` A LACOSAMIDE d07349A B= G40 Epilepsy and recurrent seizures A@ E` A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A@ E` A PANTOPRAZOLE d04514A Cr K27 Peptic ulcer, site unspecified A@ Ep A AMLODIPINE d00689A D I10 Essential (primary) hypertension A Ep A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A EҀ A . . . EҐ A . . . EҠ A . . . EҰ A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A . . . E A PIROXICAM d00343A C- M19.9 Osteoarthritis, unspecified site A E A . . . E A CITALOPRAM d04332A Cr M79.2 Neuralgia and neuritis, unspecified A E A CYCLOBENZAPRINE d00963A Cr M79.1 Myalgia A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A HYDROCODONE d03075A D* G43 Migraine A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A SUMATRIPTAN d03160A C G43 Migraine A E A TERAZOSIN d00386A Cr N40 Enlarged prostate A E A ZOLPIDEM d00910A C G47.0 Insomnia A E A ALBUTEROL d00749A C- J45 Asthma A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL; IPRATROPIUM d04066A C J44.9 Chronic obstructive pulmonary disease, unspecified B Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension B Ep A DOCUSATE d01021A CDp K59.0 Constipation B Ep A DORZOLAMIDE OPHTHALMIC d03805A Dc H40 Glaucoma B Ep A FORMOTEROL d04572A Dc J44.9 Chronic obstructive pulmonary disease, unspecified B Ep A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified B Ep A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus B Ep A HYDROCHLOROTHIAZIDE d00253A C I51.9 Heart disease, unspecified B Ep A INSULIN ISOPHANE; INSULIN REGULAR d04374A Dc E11 Type 2 diabetes mellitus B Ep A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma B Ep A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified B Ep A LORATADINE d03050A Dc T78.40 Allergy, unspecified B Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension B Ep A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus B Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension B Ep A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease B Ep A OXYBUTYNIN d00328A C[@ N32.81 Overactive bladder B Ep A OXYCODONE d00329A D M19.9 M54.9 Osteoarthritis, unspecified site Dorsalgia, unspecified B Ep A PRAZOSIN d00138A D I10 Essential (primary) hypertension B Ep A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia B Ep A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified B Ep A TESTOSTERONE d00558A C- E29.1 Testicular hypofunction B Ep A WARFARIN d00022A C"0 D75.9P Prevent blood clots B EӀ A . . . EӐ A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A EӠ A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ EӠ A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ EӠ A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension A@ EӠ A PIROXICAM d00343A B M79.1 S76.9 Myalgia Injury of unspecified muscles, fascia and tendons at thigh level A@ EӰ A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A ESTRADIOL d00537A C- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A0 E A LAMOTRIGINE d03809A C F32.9 Major depressive disorder, single episode, unspecified A0 E A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E0 A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified A E0 A PREDNISONE d00350A A L23.7 Allergic contact dermatitis due to plants, except food A E@ A . . . EP A . . . E` A LEVOTHYROXINE d00278A C 99999 A Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EԀ A AMPHETAMINE d00803A C R41.840 Attention and concentration deficit A0 EԀ A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A0 EԀ A LAMOTRIGINE d03809A CP G40 Epilepsy and recurrent seizures A0 EԐ A . . . EԠ A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E0 A ASPIRIN d00170A C- I63.P Prevent stroke A@ E0 A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A@ E0 A METFORMIN; SITAGLIPTIN d06720A Dc E11.P Prevent diabetes A@ E0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E@ A ENALAPRIL d00013A C- I10 Essential (primary) hypertension AP E@ A INSULIN ISOPHANE; INSULIN REGULAR d04374A C- E11 Type 2 diabetes mellitus AP E@ A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia AP E@ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E@ A NIFEDIPINE d00051A C- 99999 AP EP A . . . E` A 99999 . . A0 E` A GLIPIZIDE d00246A C"0 E11 Type 2 diabetes mellitus A0 E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 Ep A . . . EՀ A . . . EՐ A OMEPRAZOLE d00325A C K30 Functional dyspepsia A Eՠ A . . . Eհ A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ Eհ A METFORMIN; PIOGLITAZONE d05635A C E11 Type 2 diabetes mellitus A@ Eհ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Eհ A SITAGLIPTIN d05896A C R73 Elevated blood glucose level A@ E A . . . E A ALBUTEROL d00749A C- J45 Asthma A0 E A FLUTICASONE d01296A B J45 Asthma A0 E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A LEVOTHYROXINE d00278A C[@ E07.9 Disorder of thyroid, unspecified A E A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A FLUTICASONE NASAL d04283A B= J30.9 Allergic rhinitis, unspecified A EP A LEVOTHYROXINE d00278A D; E03.9 Hypothyroidism, unspecified A E` A . . . Ep A . . . Eր A ATORVASTATIN d04105A Cr 99999 A` Eր A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A` Eր A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A` Eր A LISINOPRIL d00732A Cr 99999 A` Eր A METFORMIN d03807A Cr 99999 A` Eր A WARFARIN d00022A D I63 Cerebral infarction A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E֠ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ E֠ A OMEPRAZOLE d00325A Cr K21 K25.P R12 Gastro-esophageal reflux disease Prevent gastric ulcer Heartburn A@ E֠ A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E֠ A RAMIPRIL d00728A C I10 Essential (primary) hypertension A@ Eְ A ASPIRIN d00170A C- D75.9P Prevent blood clots A` Eְ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` Eְ A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A` Eְ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` Eְ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` Eְ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A MEDROXYPROGESTERONE d00284A B N92 Excessive, frequent and irregular menstruation A E A AMITRIPTYLINE d00146A D# G47.0 Insomnia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A OXYCODONE d00329A B= M54.9 Dorsalgia, unspecified A Ep A . . . E׀ A INSULIN ISOPHANE (NPH) d04370A CDp E11 Type 2 diabetes mellitus A E׀ A INSULIN REGULAR d04369A C E11 Type 2 diabetes mellitus A Eא A FENOFIBRATE d04286A C- E78.1 Pure hyperglyceridemia A0 Eא A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 Eא A VALSARTAN d04113A C- I10 Essential (primary) hypertension A0 Eנ A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap Eנ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia Ap Eנ A ESTRADIOL d00537A D9 Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels Ap Eנ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap Eנ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap Eנ A LOSARTAN d03821A B I10 Essential (primary) hypertension Ap Eנ A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia Ap Eװ A CLONAZEPAM d00197A Cr F32.9 Major depressive disorder, single episode, unspecified A0 Eװ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 Eװ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ALLOPURINOL d00023A C M1A Chronic gout A` E0 A ENALAPRIL d00013A CDp I10 Essential (primary) hypertension A` E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E0 A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A` E0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E@ A . . . EP A ASPIRIN d00170A Cr I51.9 Heart disease, unspecified A EP A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A EP A DICYCLOMINE d00999A A R10.83 Colic A EP A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A EP A GABAPENTIN d03182A C M79.7 Fibromyalgia A EP A IBUPROFEN d00015A C- R52 Pain, unspecified A EP A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A EP A MECLIZINE d00859A B R42 Dizziness and giddiness A EP A TOPIRAMATE d04115A B G43 Migraine A E` A FLUTICASONE d01296A C J45 Asthma A Ep A DICLOFENAC d00848A CDp 99999 A@ Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ Ep A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ Ep A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A` E A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A` E A CITALOPRAM d04332A Cr 99999 A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E A MELOXICAM d04532A Ap R52 Pain, unspecified A` E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` Eؐ A CLONIDINE d00044A C G47.0 Insomnia A Eؠ A . . . Eذ A METHOTREXATE d00060A CDp L40.5 Arthropathic psoriasis A E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A Bz I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E A WARFARIN d00022A C- I49.9 Cardiac arrhythmia, unspecified A E A ALBUTEROL d00749A D J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMITRIPTYLINE d00146A Cr G47.0 Insomnia A E A CLONAZEPAM d00197A C[@ R45.0 Nervousness A E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E A FLUTICASONE; SALMETEROL d04611A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A E A LORATADINE d03050A C[@ T78.40 Allergy, unspecified A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A ONDANSETRON d00867A CDp R11.0 Nausea A E A TIOTROPIUM d04829A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A TRAZODONE d00395A Cr G47.0 Insomnia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E A LABETALOL d00016A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C 99999 A@ E A . . . E A . . . E0 A . . . E@ A . . . EP A ALLOPURINOL d00023A C- M1A Chronic gout A EP A ARIPIPRAZOLE d04825A Cr R45.86 Emotional lability A E` A . . . Ep A . . . Eـ A . . . Eِ A . . . E٠ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A Eٰ A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ Eٰ A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A@ Eٰ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ Eٰ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A FINASTERIDE d00563A Dc I51.9 Heart disease, unspecified A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A D K30 Functional dyspepsia A@ E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C N41.0 Acute prostatitis A@ E A . . . E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A DIVALPROEX SODIUM d03833A C- G43 Migraine A E A AMOXICILLIN d00088A A@ J20.9 Acute bronchitis, unspecified A E0 A . . . E@ A RESPIRATORY AGENTS - UNSPECIFIED c00122A C- J45 Asthma A EP A CLOMIPHENE d00569A C- N97.9 Female infertility, unspecified A E` A . . . Ep A . . . Eڀ A CIPROFLOXACIN d00011A A0 N39.0 Urinary tract infection, site not specified A Eڐ A . . . Eڠ A . . . Eڰ A . . . E A RANITIDINE d00021A C K30 Functional dyspepsia A E A ANTI-INFECTIVES - UNSPECIFIED c00001A A0 J00 Acute nasopharyngitis [common cold] A0 E A ASPIRIN d00170A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A ESOMEPRAZOLE d04749A C- R12 Heartburn A E A . . . E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A@ E A LISINOPRIL d00732A0 Cr I10 Essential (primary) hypertension A@ E A METFORMIN; SITAGLIPTIN d06720A0 Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E A TAMSULOSIN d04121A0 Cr N40 Enlarged prostate A@ E A . . . E A DOXYCYCLINE d00037A A A49.9P L70 Prevent bacterial infection Acne A E0 A . . . E@ A . . . EP A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A EP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E` A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E` A METHADONE d00050A C N23 Unspecified renal colic Ap E` A NIFEDIPINE d00051A B= I10 Essential (primary) hypertension Ap E` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E` A PROCHLORPERAZINE d00355A B R11 Nausea and vomiting Ap E` A TERAZOSIN d00386A C N40 Enlarged prostate Ap E` A TRAZODONE d00395A C- G47.0 Insomnia Ap Ep A . . . Eۀ A . . . Eې A . . . E۠ A . . . E۰ A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction AP E A COLESTIPOL d00744A C E78.0 Pure hypercholesterolemia AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A RISEDRONATE d04300A Cr M81 Osteoporosis without current pathological fracture AP E A METOPROLOL d00134A C R01.1 Cardiac murmur, unspecified A0 E A SIMVASTATIN d00746A Cr R01.1 Cardiac murmur, unspecified A0 E A VALSARTAN d04113A C R01.1 Cardiac murmur, unspecified A0 E A ATORVASTATIN d04105A B= 99999 A` E A FLUOXETINE d00236A CDp 99999 A` E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C E11 Type 2 diabetes mellitus A` E A POTASSIUM CHLORIDE d00345A C[@ 99999 A` E A RIVAROXABAN d07356A CDp 99999 A` E A SPIRONOLACTONE d00373A B= 99999 A` E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E A ASPIRIN d00170A C D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction AP E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension AP E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E0 A METFORMIN d03807A C[@ R73.9 Hyperglycemia, unspecified A@ E0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ E0 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A D M54.2 M54.9 M79.2 Cervicalgia Dorsalgia, unspecified Neuralgia and neuritis, unspecified A Ep A ALBUTEROL d00749A Ei J45 Asthma A Ep A FLUTICASONE; SALMETEROL d04611A Ei J45 Asthma A Ep A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A Ep A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Ei I10 Essential (primary) hypertension A Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Ep A LOVASTATIN d00280A Cr E78.0P Prevent high cholesterol A Ep A MORPHINE d00308A C[@ G89.4 Chronic pain syndrome A Ep A PANTOPRAZOLE d04514A Ei K21 K25.P Gastro-esophageal reflux disease Prevent gastric ulcer A Ep A SERTRALINE d00880A Ei F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A Ep A TIZANIDINE d04102A C M54.2 M54.9 M62.83 Cervicalgia Dorsalgia, unspecified Muscle spasm A Ep A WARFARIN d00022A D I48.91 I80.3 Unspecified atrial fibrillation Phlebitis and thrombophlebitis of lower extremities, unspecified A E܀ A . . . Eܐ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A Eܐ A SOTALOL d00371A C I49.9 Cardiac arrhythmia, unspecified A Eܠ A . . . Eܰ A . . . E A . . . E A . . . E A CLINDAMYCIN TOPICAL d01241A Cr L70 Acne A E A TRETINOIN TOPICAL d01244A Cr L70 Acne A E A . . . E A . . . E A ZOLPIDEM d00910A C[@ G47.0 Insomnia A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; OXYCODONE d03431A Ap K08.4 Partial loss of teeth A Ep A METFORMIN d03807A C R73.9 Hyperglycemia, unspecified A E݀ A . . . Eݐ A . . . Eݠ A . . . Eݰ A GEMFIBROZIL d00245A CDp E78.1 Pure hyperglyceridemia A Eݰ A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A E A AZITHROMYCIN d00091A A J02 Acute pharyngitis A E A ACETAMINOPHEN; OXYCODONE d03431A D M54.9 Dorsalgia, unspecified A E A METOCLOPRAMIDE d00298A Cr K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A OMEPRAZOLE d00325A D K30 Functional dyspepsia A E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROXYZINE d00907A A@ F41.9 Anxiety disorder, unspecified A0 E A QUETIAPINE d04220A A@ G47.0 Insomnia A0 E A . . . E0 A . . . E@ A ALPRAZOLAM d00168A B G47.9 Sleep disorder, unspecified A E@ A MIRTAZAPINE d04025A Ap F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EP A . . . E` A AMOXICILLIN d00088A A R05 Cough A Ep A SEX HORMONES - UNSPECIFIED c00101A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A Eހ A . . . Eސ A . . . Eޠ A . . . Eް A ACETAMINOPHEN; OXYCODONE d03431A C M54.2 M54.9 Cervicalgia Dorsalgia, unspecified AP Eް A ALPRAZOLAM d00168A CDp R45.0 Nervousness AP Eް A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Eް A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm AP Eް A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E0 A ALBUTEROL d00749A CDp J45 Asthma AP E0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E0 A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma AP E0 A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified AP E0 A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia AP E@ A . . . EP A . . . E` A . . . Ep A ATORVASTATIN d04105A0 Cr E78.0 Pure hypercholesterolemia Ap Ep A EZETIMIBE d04824A0 Cr E78.0 Pure hypercholesterolemia Ap Ep A HYDROCHLOROTHIAZIDE d00253A0 B= I10 Essential (primary) hypertension Ap Ep A IBANDRONATE d05357A Cr M81 Osteoporosis without current pathological fracture Ap Ep A LETROZOLE d04156A0 C- C50 Malignant neoplasm of breast Ap Ep A METFORMIN d03807A0 B R73 Elevated blood glucose level Ap Ep A VALSARTAN d04113A0 C I10 Essential (primary) hypertension Ap E߀ A . . . Eߐ A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A` Eߐ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` Eߐ A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A` Eߐ A DOCUSATE d01021A CDp K92.9 Disease of digestive system, unspecified A` Eߐ A LORATADINE d03050A CDp T78.40 Allergy, unspecified A` Eߐ A NORTRIPTYLINE d00144A CDp F32.9 Major depressive disorder, single episode, unspecified A` Eߠ A . . . E߰ A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E A CYCLOSPORINE OPHTHALMIC d04836A B H04.12 Dry eye syndrome A0 E A ESOMEPRAZOLE d04749A Ap K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A NIFEDIPINE d00051A C[@ I10 Essential (primary) hypertension A@ E A . . . E A ASPIRIN d00170A B I21.P Prevent heart attack/myocardial infarction A@ E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C- I10 Essential (primary) hypertension A@ E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A CDp I10 Essential (primary) hypertension A E0 A AMOXICILLIN; CLAVULANATE d00089A A K08.8 Other specified disorders of teeth and supporting structures A E0 A NAPROXEN d00019A A K08.8 Other specified disorders of teeth and supporting structures A E@ A . . . EP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EP A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma A E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E` A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E` A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E` A GLIPIZIDE d00246A C 99999 A E` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E` A HYDROXYZINE d00907A C 99999 A E` A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A E` A LISINOPRIL d00732A C 99999 A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E` A PALIPERIDONE d06297A C F29 Unspecified psychosis not due to a substance or known physiological condition A E` A PRAVASTATIN d00348A C 99999 A E` A PRIMIDONE d00352A C G25.0 Essential tremor A E` A TRAMADOL d03826A C M06.9 Rheumatoid arthritis, unspecified A Ep A COLESEVELAM d04695A CDp E78.0 Pure hypercholesterolemia A Ep A METFORMIN d03807A C- E34.9 Endocrine disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E@ A LISDEXAMFETAMINE d06663A B G47.9 Sleep disorder, unspecified A EP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 EP A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D I10 Essential (primary) hypertension A0 EP A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 E` A . . . Ep A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A . . . E A DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03354A A0 R05 Cough A E A HYDROCODONE d03075A C[@ M25.5 Pain in joint A@ E A IBUPROFEN d00015A C[@ M25.5 T14.9 Pain in joint Unspecified injury A@ E A OMEPRAZOLE d00325A C[@ K31.9 Disease of stomach and duodenum, unspecified A@ E A TRAMADOL d03826A C[@ M62.83 Muscle spasm A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A NAPROXEN d00019A A M54.9 Dorsalgia, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E A LAMOTRIGINE d03809A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A0 E@ A LEVOBUNOLOL OPHTHALMIC d01187A C H40 Glaucoma A0 E@ A TRAVOPROST OPHTHALMIC d04753A C H40 Glaucoma A0 EP A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E` A . . . Ep A CYCLOSPORINE OPHTHALMIC d04836A Dc H04.12 Dry eye syndrome A Ep A DONEPEZIL d04099A CDp G31.9 Degenerative disease of nervous system, unspecified A Ep A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A Ep A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A Ep A PAROXETINE d03157A D F32.9 Major depressive disorder, single episode, unspecified A Ep A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A Ep A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A Ep A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A CITALOPRAM d04332A B[ F41.9 Anxiety disorder, unspecified A E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A D I49.9 Cardiac arrhythmia, unspecified Ap E A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified Ap E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E A TRANDOLAPRIL d04008A C I10 Essential (primary) hypertension Ap E A AZITHROMYCIN d00091A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol A0 E A SERTRALINE d00880A C G47.0 Insomnia A0 E A WARFARIN d00022A C3P I26 Pulmonary embolism A0 E0 A . . . E@ A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E@ A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A E@ A CINACALCET d05218A C"0 Z99.2 Dependence on renal dialysis A E@ A PREDNISONE d00350A B[ M06.9 Rheumatoid arthritis, unspecified A E@ A PREGABALIN d05508A CDp M79.2 Neuralgia and neuritis, unspecified A E@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E@ A SEVELAMER d04363A C"0 N19 Unspecified kidney failure A E@ A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A ACETAMINOPHEN; CODEINE d03423A CDp G43 Migraine A Ep A LORATADINE d03050A CDp J01.9 J30.1 T78.40 Acute sinusitis, unspecified Allergic rhinitis due to pollen Allergy, unspecified A E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A CELECOXIB d04380A B M06.9 Rheumatoid arthritis, unspecified A E A CYCLOBENZAPRINE d00963A B M79.7 Fibromyalgia A E A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A D* Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A HYDROXYCHLOROQUINE d00817A A M06.9 Rheumatoid arthritis, unspecified A E A PREDNISONE d00350A B M06.9 Rheumatoid arthritis, unspecified A E A TOPIRAMATE d04115A B G43 Migraine A E A TRAMADOL d03826A CDp M06.9 Rheumatoid arthritis, unspecified A E A . . . E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction A` E A DIGOXIN d00210A C I50.9 Heart failure, unspecified A` E A METOPROLOL d00134A C I50.9 Heart failure, unspecified A` E A SPIRONOLACTONE d00373A C I50.9 Heart failure, unspecified A` E A VALSARTAN d04113A C I50.9 Heart failure, unspecified A` E A WARFARIN d00022A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A` E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C- R73 Elevated blood glucose level A@ E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A TRAZODONE d00395A Bz G47.0 Insomnia A@ E A . . . E A . . . E0 A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A E0 A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A E@ A . . . EP A . . . E` A MOUTH AND THROAT PRODUCTS - UNSPECIFIED c00146A A@ J02 Acute pharyngitis A Ep A DOXAZOSIN d00726A CDp N40 Enlarged prostate A Ep A FINASTERIDE d00563A C- R39.11 Hesitancy of micturition A E A . . . E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A BUDESONIDE d04276A CDp J45 Asthma A E A AMLODIPINE; BENAZEPRIL d03829A Ap I10 Essential (primary) hypertension AP E A ATENOLOL d00004A Ap I10 Essential (primary) hypertension AP E A HYDROXYZINE d00907A Ap F41.9 Anxiety disorder, unspecified AP E A TRAZODONE d00395A Ap G47.0 Insomnia AP E A VENLAFAXINE d03181A Ap F32.9 Major depressive disorder, single episode, unspecified AP E A ALBUTEROL d00749A D1 J45 Asthma Ap E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A GABAPENTIN d03182A C G25.81 Restless legs syndrome Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A B R73 Elevated blood glucose level Ap E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified Ap E A OLMESARTAN d04801A C I10 Essential (primary) hypertension Ap E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 E0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E@ A . . . EP A ALBUTEROL d00749A B J45 Asthma A EP A BUDESONIDE d04276A B J45 Asthma A E` A . . . Ep A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia Ap Ep A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia Ap Ep A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus Ap Ep A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus Ap Ep A LEVETIRACETAM d04499A B= G40 Epilepsy and recurrent seizures Ap Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap Ep A METOPROLOL d00134A C- I48.91 Unspecified atrial fibrillation Ap E A DABIGATRAN d07137A0 Cr I49.9 Cardiac arrhythmia, unspecified A` E A DIGOXIN d00210A0 C I49.9 Cardiac arrhythmia, unspecified A` E A FINASTERIDE d00563A0 C N40 Enlarged prostate A` E A FLECAINIDE d00234A0 C I49.9 Cardiac arrhythmia, unspecified A` E A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A VALSARTAN d04113A0 D I10 Essential (primary) hypertension A` E A . . . E A . . . E A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A E A OLOPATADINE OPHTHALMIC d04117A C H10.1 Acute atopic conjunctivitis A E A PIMECROLIMUS TOPICAL d04784A C- L40 Psoriasis A E A . . . E A CETIRIZINE d03827A C H10.1 R09.81 Acute atopic conjunctivitis Nasal congestion A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A IBANDRONATE d05357A C- M81 Osteoporosis without current pathological fracture AP E A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures AP E A PYRIDOSTIGMINE d00363A D)Y M62.81 Muscle weakness (generalized) AP E A . . . E A . . . E0 A ISOSORBIDE MONONITRATE d00269A B R07.9 Chest pain, unspecified A E0 A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` Ep A CALCIUM ACETATE d03689A Cr M81 Osteoporosis without current pathological fracture A` Ep A CLOPIDOGREL d04258A C I63.P Prevent stroke A` Ep A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A` Ep A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E A ALBUTEROL d00749A Ei J43 Emphysema A E A CLOBETASOL TOPICAL d01288A Ei L40 Psoriasis A E A CLOPIDOGREL d04258A C I77.9 Disorder of arteries and arterioles, unspecified A E A FINASTERIDE d00563A Cr R39.15 Urgency of urination A E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A Cr I95.9 Hypotension, unspecified A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E A OXYGEN a54115A Cr J43 Emphysema A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E A DRONEDARONE d07458A C Z79.P Prophylactic medication A@ E A OLMESARTAN d04801A C I10 Essential (primary) hypertension A@ E A TAMSULOSIN d04121A Dc N32.9 Bladder disorder, unspecified A@ E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C Z79.P Prophylactic medication AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A REPAGLINIDE d04267A C E11 Type 2 diabetes mellitus AP E A ZOLPIDEM d00910A B G47.0 Insomnia AP E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A ALBUTEROL d00749A D J45 Asthma A` E@ A ALBUTEROL d00749A D J45 Asthma A` E@ A ALPRAZOLAM d00168A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E@ A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A` E@ A HYDROCODONE d03075A C"0 T14.9 Unspecified injury A` E@ A MONTELUKAST d04289A D J45 Asthma A` EP A DESMOPRESSIN d00583A D R35.0 Frequency of micturition A0 EP A HYDROCORTISONE d00254A D E07.9 Disorder of thyroid, unspecified A0 EP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E` A . . . Ep A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A RIZATRIPTAN d04328A Dc G43 Migraine A E A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E0 A ALBUTEROL d00749A C J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A E0 A ALLOPURINOL d00023A C M1A Chronic gout A E0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E0 A DOCUSATE d01021A CDp K59.0 Constipation A E0 A FLUOXETINE d00236A CDp F41.9 F43.1 Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A E0 A INSULIN ISOPHANE; INSULIN REGULAR d04374A Cr E11 Type 2 diabetes mellitus A E0 A IPRATROPIUM d00265A C J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A E0 A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified A E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E0 A LORATADINE d03050A CDp T78.40 Allergy, unspecified A E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A E0 A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E0 A PRAZOSIN d00138A CDp F41.9 F43.1 Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A E0 A QUETIAPINE d04220A CDp F39 Unspecified mood [affective] disorder A E@ A . . . EP A . . . E` A MELOXICAM d04532A Bz M54.9 Dorsalgia, unspecified A@ E` A METHOCARBAMOL d00965A Bz M54.9 Dorsalgia, unspecified A@ E` A MIRTAZAPINE d04025A B G47.0 Insomnia A@ E` A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A@ Ep A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A AP I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A Cr M62.83 M79.1 Muscle spasm Myalgia AP E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E A MIRTAZAPINE d04025A Cr G47.0 Insomnia AP E A OMEPRAZOLE d00325A Cr 99999 AP E A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation AP E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B T14.9 Unspecified injury A0 E A CITALOPRAM d04332A Cr F32.9 M79.2 Major depressive disorder, single episode, unspecified Neuralgia and neuritis, unspecified A0 E A ZOLPIDEM d00910A C[@ G47.9 Sleep disorder, unspecified A0 E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E A CYCLOBENZAPRINE d00963A C M79.1 Myalgia A0 E A FENTANYL d00233A CDp M79.2 Neuralgia and neuritis, unspecified A0 E A . . . E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E` A CLOBAZAM d04557A C- G40 Epilepsy and recurrent seizures A Ep A AMLODIPINE; OLMESARTAN d06905A Cr I10 Essential (primary) hypertension A E A LIRAGLUTIDE d07466A C E11.P Prevent diabetes A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A NAPROXEN d00019A A H66.9 Otitis media, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A CELECOXIB d04380A C M19.9 Osteoarthritis, unspecified site A` E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A` E A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A D# Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A` E A METFORMIN d03807A C[@ R73.9 Hyperglycemia, unspecified A` E A RANITIDINE d00021A Dc K30 Functional dyspepsia A` E A . . . E A ALLOPURINOL d00023A C- M1A Chronic gout A E A DICLOFENAC d00848A C M10.9 Gout, unspecified A E A . . . E A . . . E A . . . E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E0 A ROSUVASTATIN d04851A B= E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A IBUPROFEN d00015A A R10.9 R50.9 Unspecified abdominal pain Fever, unspecified A Ep A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A DIGOXIN d00210A Cr I48.91 Unspecified atrial fibrillation AP E A PAROXETINE d03157A Cr F32.9 Major depressive disorder, single episode, unspecified AP E A PROPAFENONE d00358A Cr I48.91 Unspecified atrial fibrillation AP E A RIVAROXABAN d07356A C D75.9P Prevent blood clots AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A METFORMIN d03807A A E11.P Prevent diabetes A@ E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ E A . . . E0 A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A E@ A . . . EP A . . . E` A COLESEVELAM d04695A CDp R15 Fecal incontinence A0 E` A EZETIMIBE; SIMVASTATIN d05348A Cr E78.0 Pure hypercholesterolemia A0 E` A MIRABEGRON d07876A Ap N32.81 Overactive bladder A0 Ep A . . . E A . . . E A . . . E A OLMESARTAN d04801A Cr I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A DICYCLOMINE d00999A Cr K58 Irritable bowel syndrome A E A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A ALBUTEROL d00749A B J45 Asthma A0 E A BETAMETHASONE TOPICAL d03197A B L23 Allergic contact dermatitis A0 E A MOMETASONE TOPICAL d01300A B L23 Allergic contact dermatitis A0 E A . . . E A AMOXICILLIN d00088A B H66.9 Otitis media, unspecified A E0 A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL d00749A CDp J45 Asthma Ap Ep A ALLOPURINOL d00023A CDp M1A Chronic gout Ap Ep A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus Ap Ep A IBUPROFEN d00015A CDp M06.9 Rheumatoid arthritis, unspecified Ap Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap Ep A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension Ap Ep A OMEPRAZOLE d00325A CDp K25 Gastric ulcer Ap E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A CDp J30.1 Allergic rhinitis due to pollen AP E A GABAPENTIN d03182A CDp F41.9 Anxiety disorder, unspecified AP E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A LORATADINE d03050A D T78.40 Allergy, unspecified A E A MOMETASONE NASAL d04223A D J30.9 Allergic rhinitis, unspecified A E A AMITRIPTYLINE d00146A B G43 Migraine A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A DICLOFENAC d00848A B= R51 Headache A@ E A MONTELUKAST d04289A B[ J30.9 Allergic rhinitis, unspecified A@ E A . . . E A . . . E A ALENDRONATE d03849A0 Dc M81.P Prevent bone loss/osteoporosis A E A ASPIRIN d00170A0 Dc I21.P Prevent heart attack/myocardial infarction A E A CANDESARTAN d04322A0 Dc I10 Essential (primary) hypertension A E A CLOBETASOL TOPICAL d01288A0 Cr L40 Psoriasis A E A DONEPEZIL d04099A0 D G31.9 Degenerative disease of nervous system, unspecified A E A NIACIN d00314A0 Dc E78.0 Pure hypercholesterolemia A E A NIFEDIPINE d00051A0 Dc I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A0 Dc E78.0 Pure hypercholesterolemia A E A . . . E A ALBUTEROL; IPRATROPIUM d04066A C- 99999 A E A CARVEDILOL d03847A C- 99999 A E A CLOPIDOGREL d04258A C- 99999 A E A FLUOXETINE d00236A C- 99999 A E A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A E A LEVOTHYROXINE d00278A C- 99999 A E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E A PREDNISONE d00350A C- 99999 A E A SIMVASTATIN d00746A C- 99999 A E A TAMSULOSIN d04121A C- 99999 A E0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E0 A TELMISARTAN d04364A C- I10 Essential (primary) hypertension A0 E@ A AMITRIPTYLINE d00146A Cr N32.9 Bladder disorder, unspecified A E@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E@ A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E@ A OXYBUTYNIN d00328A Cr R35.0 Frequency of micturition A E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A TRAMADOL d03826A Cr M06.9 Rheumatoid arthritis, unspecified A E@ A TRAZODONE d00395A C G47.0 Insomnia A EP A . . . E` A . . . Ep A . . . E A . . . E A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction A` E A INDAPAMIDE d00260A CDp I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A` E A ALBUTEROL d00749A B J45 Asthma A E A . . . E A . . . E A AMLODIPINE d00689A B I21.P Prevent heart attack/myocardial infarction A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A BISOPROLOL d00709A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A C"0 I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A . . . E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C[@ E11.P Prevent diabetes A@ E A ROSUVASTATIN d04851A C[@ E78.0P Prevent high cholesterol A@ E A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CLOPIDOGREL d04258A C I63 Cerebral infarction Ap E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension Ap E A OXYBUTYNIN d00328A Cr N32.81 Overactive bladder Ap E A TRAVOPROST OPHTHALMIC d04753A B= H40 Glaucoma Ap E A VERAPAMIL d00048A C I10 Essential (primary) hypertension Ap E A . . . E A . . . E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EP A TAMSULOSIN d04121A Ap N20.0 Calculus of kidney A E` A DICLOFENAC d00848A A M25.56 Pain in knee A E` A HYDROCODONE d03075A AP M25.56 Pain in knee A Ep A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A Ep A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A IBUPROFEN d00015A A0 R50.9 Fever, unspecified A E A . . . E A . . . E A . . . E A FINASTERIDE d00563A CDp N40 Enlarged prostate AP E A FLUTICASONE NASAL d04283A CDp J30.1 Allergic rhinitis due to pollen AP E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D# I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension AP E A METFORMIN d03807A D R73 Elevated blood glucose level AP E A . . . E A . . . E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A NAPROXEN d00019A CDp M25.56 Pain in knee Ap E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A MELOXICAM d04532A C M79.1 Myalgia AP E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP E A . . . E A ALPRAZOLAM d00168A0 C- F41.9 Anxiety disorder, unspecified Ap E A CLOMIPRAMINE d00876A0 C- F42 Obsessive-compulsive disorder Ap E A GABAPENTIN d03182A0 Cr M79.2 Neuralgia and neuritis, unspecified Ap E A LITHIUM d00061A0 D# F31.9 Bipolar disorder, unspecified Ap E A MEDROXYPROGESTERONE d00284A0 Dc Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels Ap E A VENLAFAXINE d03181A0 CDp F32.9 Major depressive disorder, single episode, unspecified Ap E A ZOLPIDEM d00910A0 CDp G47.9 Sleep disorder, unspecified Ap E A . . . E A . . . E A AMOXICILLIN d00088A Ap J00 Acute nasopharyngitis [common cold] A E A MOXIFLOXACIN OPHTHALMIC d04860A Ap H57.8 Other specified disorders of eye and adnexa A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E@ A CETIRIZINE d03827A D T78.40 Allergy, unspecified A@ E@ A FAMOTIDINE d00141A B K30 Functional dyspepsia A@ E@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ EP A . . . E` A . . . Ep A ALBUTEROL d00749A D# J45 Asthma A0 Ep A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A0 Ep A RANITIDINE d00021A Cr K30 Functional dyspepsia A0 E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E A LORATADINE d03050A C- J00 Acute nasopharyngitis [common cold] AP E A LOSARTAN d03821A B I10 Essential (primary) hypertension AP E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E A WARFARIN d00022A Cr Z79.02 Long term (current) use of antithrombotics/antiplatelets AP E A . . . E A . . . E A . . . E A . . . E A . . . E A COLCHICINE d00150A D K12.0 Recurrent oral aphthae AP E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified AP E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension AP E A MELOXICAM d04532A C M54.9 Dorsalgia, unspecified AP E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 I51.9P Pure hyperglyceridemia Prevent heart disease AP E0 A . . . E@ A . . . EP A ALPRAZOLAM d00168A B[ F41.9 Anxiety disorder, unspecified A EP A DULOXETINE d05355A C M79.7 Fibromyalgia A EP A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EP A MELOXICAM d04532A Ap M79.7 Fibromyalgia A EP A OMEPRAZOLE d00325A C R12 Heartburn A EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EP A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A E` A . . . Ep A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A Ep A METOPROLOL d00134A C R07.9 Chest pain, unspecified A E A 99999 . . A E A . . . E A HYDROCORTISONE d00254A C- E27.9 Disorder of adrenal gland, unspecified A0 E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E A SOMATROPIN d00577A C- E34.3 Short stature due to endocrine disorder A0 E A DIPHENHYDRAMINE d00212A B L29.9 Pruritus, unspecified A@ E A QUETIAPINE d04220A B F31.9 Bipolar disorder, unspecified A@ E A RISPERIDONE d03180A B G47.9 Sleep disorder, unspecified A@ E A SERTRALINE d00880A B[ F32.9 Major depressive disorder, single episode, unspecified A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A ALLOPURINOL d00023A Bz M1A Chronic gout A0 E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A0 E A ARFORMOTEROL d05893A Cr J45 Asthma A E A BUDESONIDE d04276A Cr J45 Asthma A E A DIPHENHYDRAMINE d00212A C J30.9 Allergic rhinitis, unspecified A E A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified A E A MONTELUKAST d04289A Cr R07.89 Other chest pain A E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia A E A PREDNISONE d00350A C J45 Asthma A E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A E A SOLIFENACIN d05413A Cr R35.0 Frequency of micturition A E A THEOPHYLLINE d00142A C- J45 Asthma A E A TIOTROPIUM d04829A C- J45 Asthma A E A . . . E A ALBUTEROL d00749A DGJ J45 Asthma A E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A E A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A Ei L20.9 Atopic dermatitis, unspecified A E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E A FLUTICASONE NASAL d04283A Ei J30.9 Allergic rhinitis, unspecified A E A GLIPIZIDE; METFORMIN d04823A Bz E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A C"0 E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A C J30.9 J45 R07.89 Allergic rhinitis, unspecified Asthma Other chest pain A E A RANITIDINE d00021A A K30 Functional dyspepsia A E A CLOBETASOL TOPICAL d01288A B L20.9 Atopic dermatitis, unspecified Ap E A COLESTIPOL d00744A B K92.9 Disease of digestive system, unspecified Ap E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia Ap E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E A LEVOCETIRIZINE d05851A Cr J30.1 Allergic rhinitis due to pollen Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A MONTELUKAST d04289A C J45 Asthma Ap E A . . . E0 A EZETIMIBE; SIMVASTATIN d05348A Cr E78.0 Pure hypercholesterolemia A E0 A FENOFIBRIC ACID d07371A Cr E78.0 Pure hypercholesterolemia A E@ A ALBUTEROL d00749A CP J45 Asthma A EP A CARVEDILOL d03847A D I49.9 Cardiac arrhythmia, unspecified Ap EP A FUROSEMIDE d00070A C- I50.9 Heart failure, unspecified Ap EP A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease Ap EP A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified Ap EP A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia Ap EP A RAMIPRIL d00728A C- I10 Essential (primary) hypertension Ap EP A WARFARIN d00022A D# I26 Pulmonary embolism Ap E` A . . . Ep A HYDROMORPHONE d00255A C- M54.9 Dorsalgia, unspecified A E A . . . E A . . . E A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A ZOLPIDEM d00910A C[@ G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E0 A . . . E@ A . . . EP A ALBUTEROL d00749A C- J45 Asthma A EP A BACLOFEN d00967A CDp M62.83 Muscle spasm A EP A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A EP A CONJUGATED ESTROGENS d00541A C N95.2 Postmenopausal atrophic vaginitis A EP A ENALAPRIL d00013A CDp I10 Essential (primary) hypertension A EP A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A EP A OXAPROZIN d00853A C M19.9 Osteoarthritis, unspecified site A EP A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E` A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified AP E` A LORAZEPAM d00149A B[ R25.1 Tremor, unspecified AP E` A PRIMIDONE d00352A B R25.1 Tremor, unspecified AP E` A PROPRANOLOL d00032A B R25.1 Tremor, unspecified AP E` A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia AP Ep A LOVASTATIN d00280A D0z E78.0 Pure hypercholesterolemia A Ep A METOPROLOL d00134A D0z I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified Ap E A LANSOPRAZOLE d03828A D"8 K21 Gastro-esophageal reflux disease Ap E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A TOLTERODINE d04294A Dc N32.81 R32 Overactive bladder Unspecified urinary incontinence Ap E A . . . E A . . . E A . . . E A . . . E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ATENOLOL d00004A B= I10 Essential (primary) hypertension A Ep A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A E A . . . E A NAPROXEN d00019A B[ R51 Headache A E A VERAPAMIL d00048A B[ R51.P Prevent headache A E A ADALIMUMAB d04835A C- M06.9 Rheumatoid arthritis, unspecified A` E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` E A METHOTREXATE d00060A CDp M06.9 Rheumatoid arthritis, unspecified A` E A OMEPRAZOLE d00325A B K30 Functional dyspepsia A` E A PAROXETINE d03157A C- F41.9 Anxiety disorder, unspecified A` E A SULINDAC d00033A CDp M06.9 Rheumatoid arthritis, unspecified A` E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A B M1A Chronic gout AP E A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A . . . E A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A Bz R21 Rash and other nonspecific skin eruption A E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A C I51.9 Heart disease, unspecified A0 E` A ATENOLOL; CHLORTHALIDONE d03258A C I10 Essential (primary) hypertension A0 E` A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A0 Ep A . . . E A . . . E A . . . E A . . . E A ALISKIREN d06665A C I10 Essential (primary) hypertension A` E A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A` E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A` E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A TRIAMTERENE d00396A C I10 Essential (primary) hypertension A` E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A ESTRADIOL TOPICAL d04210A CDp N95.2 Postmenopausal atrophic vaginitis A E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A CDp E11 Type 2 diabetes mellitus A E A LATANOPROST OPHTHALMIC d04017A CDp H57.9 Unspecified disorder of eye and adnexa A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E A TRAMADOL d03826A C T14.9 Unspecified injury A0 E A METRONIDAZOLE d00108A A@ N76.0 Acute vaginitis A E A . . . E A ALBUTEROL d00749A C J45 Asthma A` E A ALBUTEROL d00749A C J45 Asthma A` E A BUDESONIDE d04276A Cr J45 Asthma A` E A ETHACRYNIC ACID d00649A C- H81.9 Unspecified disorder of vestibular function A` E A MOMETASONE d05262A C- R06.2 Wheezing A` E A MOMETASONE NASAL d04223A Cr J30.9 Allergic rhinitis, unspecified A` E0 A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A E@ A . . . EP A . . . E` A OPHTHALMIC ANTI-INFECTIVES - UNSPECIFIED c00163A A0 H10 Conjunctivitis A Ep A CONTRACEPTIVES - UNSPECIFIED c00102A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A0 E A . . . E A . . . E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified Ap E A OXYCODONE d00329A CDp M25.5 Pain in joint Ap E A OXYCODONE d00329A CDp M25.5 Pain in joint Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A WARFARIN d00022A C D75.9P Prevent blood clots Ap E A ZOLPIDEM d00910A C G47.0 Insomnia Ap E A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A . . . E@ A ATORVASTATIN d04105A C- 99999 A0 E@ A IMIPRAMINE d00259A C- R32 Unspecified urinary incontinence A0 E@ A LISINOPRIL d00732A C- 99999 A0 EP A . . . E` A ADALIMUMAB d04835A C M06.9 Rheumatoid arthritis, unspecified A E` A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A Ep A . . . E A ALBUTEROL d00749A D J45 Asthma A E A BECLOMETHASONE d00760A C J45 Asthma A E A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A@ E A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A@ E A LORATADINE d03050A B T78.40 Allergy, unspecified A@ E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A HYDROCODONE d03075A A T14.9 Unspecified injury A E A PREDNISONE d00350A B* S22 Fracture of rib(s), sternum and thoracic spine A E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A IBUPROFEN d00015A C- M06.9 M79.1 Rheumatoid arthritis, unspecified Myalgia A E@ A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . E A BUTALBITAL d03061A C- R52 Pain, unspecified A0 E A DULOXETINE d05355A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A RANITIDINE d00021A C- K25.P Prevent gastric ulcer A0 E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E A . . . E A AMITRIPTYLINE d00146A C[@ G47.0 Insomnia A E A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A CP J30.9 Allergic rhinitis, unspecified A0 E A INSULIN LISPRO d04373A C"0 E11 Type 2 diabetes mellitus A0 E A MONTELUKAST d04289A Cr J45 Asthma A0 E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A METFORMIN d03807A Bz N92.6 Irregular menstruation, unspecified A E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A Ap E78.0 Pure hypercholesterolemia A EP A CLOPIDOGREL d04258A Ap I63 Cerebral infarction A EP A DILTIAZEM d00045A A I10 Essential (primary) hypertension A EP A INSULIN ASPART d04697A A E11 Type 2 diabetes mellitus A EP A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A EP A LOSARTAN d03821A B I10 Essential (primary) hypertension A EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EP A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A E` A . . . Ep A . . . E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A ALLOPURINOL d00023A CDp M10.9 Gout, unspecified A` E A FINASTERIDE d00563A CDp N42.9 Disorder of prostate, unspecified A` E A FUROSEMIDE d00070A B[ J81 Pulmonary edema A` E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A` E A WARFARIN d00022A C[@ Z79.02 Long term (current) use of antithrombotics/antiplatelets A` E A . . . E A . . . E A . . . E A . . . E A GLIMEPIRIDE d03864A B= E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A0 E A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A0 E A DILTIAZEM d00045A C 99999 AP E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension AP E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP E A INSULIN GLARGINE d04538A Cr R73 Elevated blood glucose level A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A` E A SEVELAMER d04363A A Z99.2 Dependence on renal dialysis A` E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E A DIPHENHYDRAMINE d00212A C[@ L23 Allergic contact dermatitis A E A ENALAPRIL d00013A B I99.9 Unspecified disorder of circulatory system A E0 A . . . E@ A . . . EP A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A` EP A FENOFIBRATE d04286A C"0 E78.0 Pure hypercholesterolemia A` EP A ISOSORBIDE MONONITRATE d00269A C- E78.0 Pure hypercholesterolemia A` EP A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A` EP A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` EP A ROSUVASTATIN d04851A Cr E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A` E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E` A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E` A HYDROCODONE d03075A C M79.2 Neuralgia and neuritis, unspecified Ap E` A MELOXICAM d04532A B M19.9 Osteoarthritis, unspecified site Ap E` A NORTRIPTYLINE d00144A B= M79.2 Neuralgia and neuritis, unspecified Ap E` A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap Ep A . . . E A BACLOFEN d00967A C- M79.1 Myalgia A` E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A` E A OXCARBAZEPINE d04513A C G50.0 Trigeminal neuralgia A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E A SILDENAFIL d04299A C"0 N52.9 Male erectile dysfunction, unspecified A` E A VERAPAMIL d00048A C I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A Dc F41.9 G40 Anxiety disorder, unspecified Epilepsy and recurrent seizures A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C9 F90 Attention-deficit hyperactivity disorders A0 E A CITALOPRAM d04332A Cr F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A0 E A DILTIAZEM d00045A B R00.0 Tachycardia, unspecified A@ E A FLUTICASONE NASAL d04283A Bz J30.9 Allergic rhinitis, unspecified A@ E A MOMETASONE d05262A C- R06.02 Shortness of breath A@ E A OMEPRAZOLE d00325A B= K11.7 Disturbances of salivary secretion A@ E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- N92 Excessive, frequent and irregular menstruation A E A . . . E A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A FINASTERIDE d00563A C N40 Enlarged prostate A0 E@ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E@ A WARFARIN d00022A D* I48.91 Unspecified atrial fibrillation A0 EP A . . . E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 E` A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A B E78.1 Pure hyperglyceridemia A0 E` A SIMVASTATIN d00746A CDp E78.0P Prevent high cholesterol A0 Ep A . . . E A . . . E A RANITIDINE d00021A Bz K30 Functional dyspepsia A E A . . . E A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A@ E A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A MECLIZINE d00859A B= R42 Dizziness and giddiness A@ E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified Ap E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified Ap E A GABAPENTIN d03182A A F41.9 Anxiety disorder, unspecified Ap E A METOPROLOL d00134A D' I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A Cr R35.0 Frequency of micturition Ap E A . . . E A . . . E0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E0 A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E0 A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E0 A IMIPRAMINE d00259A C- N32.9 Bladder disorder, unspecified A E0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E0 A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E0 A NORETHINDRONE d00555A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E0 A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E0 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A ALBUTEROL d00749A C J45 Asthma A0 E` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp N92 Excessive, frequent and irregular menstruation A0 E` A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A0 Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A AMLODIPINE; OLMESARTAN d06905A Cr I10 Essential (primary) hypertension A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A POLYETHYLENE GLYCOL 3350 d05350A B N32.81 Overactive bladder A E A AMPHETAMINE d00803A B= F90 Attention-deficit hyperactivity disorders A E A BUPROPION d00181A Bz F90 Attention-deficit hyperactivity disorders A E A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified Ap E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A SERTRALINE d00880A C F39 Unspecified mood [affective] disorder Ap E A SUMATRIPTAN d03160A CDp G43 Migraine Ap E A CARVEDILOL d03847A C"0 I49.9 Cardiac arrhythmia, unspecified AP E A FUROSEMIDE d00070A C"0 E87.7 Fluid overload AP E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus AP E A ISOSORBIDE MONONITRATE d00269A C"0 I49.9 Cardiac arrhythmia, unspecified AP E A SOLIFENACIN d05413A B= N32.81 Overactive bladder AP E A . . . E A HYDROXYZINE d00907A C- L23 Allergic contact dermatitis A0 E A MINOCYCLINE d00110A C L70 Acne A0 E A MONTELUKAST d04289A C J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A0 E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified AP E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A VALSARTAN d04113A C I10 Essential (primary) hypertension AP E0 A . . . E@ A CYCLOBENZAPRINE d00963A A M54.9 Dorsalgia, unspecified A E@ A PREDNISONE d00350A A M51.9 Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder A EP A . . . E` A ASPIRIN d00170A B I21.P Prevent heart attack/myocardial infarction A E` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E` A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E` A DULOXETINE d05355A C M79.1 Myalgia A E` A GLIPIZIDE d00246A B[ E11 Type 2 diabetes mellitus A E` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A QUETIAPINE d04220A C F31.9 G47.0 Bipolar disorder, unspecified Insomnia A E` A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A0 E A OMEPRAZOLE d00325A C B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A0 E A OXYCODONE d00329A C R10.9 Unspecified abdominal pain A0 E A . . . E A ALLOPURINOL d00023A0 D% M1A Chronic gout A` E A ATORVASTATIN d04105A0 Ap E78.0 Pure hypercholesterolemia A` E A FUROSEMIDE d00070A0 C I51.9 Heart disease, unspecified A` E A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A0 C E87.6P Prevent hypokalemia A` E A SPIRONOLACTONE d00373A0 C I10 Essential (primary) hypertension A` E A CEFDINIR d04256A Ap H66.9 Otitis media, unspecified A E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A BUDESONIDE d04276A C J45 Asthma A E A . . . E A . . . E0 A . . . E@ A . . . EP A OXYCODONE d00329A A G89.18 Other acute postprocedural pain A E` A . . . Ep A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A DONEPEZIL d04099A B= G30.9 Alzheimer's disease, unspecified A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N94.6 Z79.3 Dysmenorrhea, unspecified Long term (current) use of hormonal contraceptives A E A MONTELUKAST d04289A C J45 Asthma A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified Ap Ep A ATENOLOL d00004A Cr I49.9 Cardiac arrhythmia, unspecified Ap Ep A CYCLOBENZAPRINE d00963A C[@ M54.9 Dorsalgia, unspecified Ap Ep A DOXAZOSIN d00726A Cr N40 Enlarged prostate Ap Ep A FINASTERIDE d00563A Cr N40 Enlarged prostate Ap Ep A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap Ep A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia Ap E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 E A ISOTRETINOIN d01245A B L70 Acne A0 E A LORATADINE d03050A C J30.2 Other seasonal allergic rhinitis A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B[ F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension AP E A ENALAPRIL d00013A C- 99999 AP E A GLIPIZIDE d00246A C"0 E11 Type 2 diabetes mellitus AP E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E 0 A CLONAZEPAM d00197A CDp F32.9 Major depressive disorder, single episode, unspecified A` E 0 A GABAPENTIN d03182A B F41.9 Anxiety disorder, unspecified A` E 0 A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A` E 0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E 0 A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A` E 0 A VILAZODONE d07740A C- F32.9 Major depressive disorder, single episode, unspecified A` E @ A . . . E P A . . . E ` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E ` A METOPROLOL d00134A C I10 Essential (primary) hypertension A E p A . . . E A . . . E A . . . E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A Ap H66.9 Otitis media, unspecified A0 E A FEXOFENADINE d04040A C9 T78.40 Allergy, unspecified A0 E A FLUTICASONE d01296A C- J45 Asthma A0 E A ACETAMINOPHEN; CODEINE d03423A B= M54.9 Dorsalgia, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUDESONIDE NASAL d03640A Cr J30.9 Allergic rhinitis, unspecified A E A DICYCLOMINE d00999A CDp K58 Irritable bowel syndrome A E A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A E A ESTRADIOL; NORETHINDRONE d04375A Dc Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A E A MELOXICAM d04532A CDp M19.9 Osteoarthritis, unspecified site A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A0 E A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A0 E A MONTELUKAST d04289A CDp J45 Asthma A0 E0 A 99999 . . A E@ A . . . EP A FAMOTIDINE d00141A C K30 Functional dyspepsia A EP A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A E` A . . . Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A` Ep A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A` Ep A METHOCARBAMOL d00965A C- M62.83 Muscle spasm A` Ep A MONTELUKAST d04289A C- J42 Unspecified chronic bronchitis A` Ep A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A` Ep A WARFARIN d00022A C- I26 Pulmonary embolism A` E A . . . E A . . . E A LANSOPRAZOLE d03828A D K30 Functional dyspepsia A E A IBUPROFEN d00015A C- M13 Other arthritis A E A FAMOTIDINE d00141A C K25.P Prevent gastric ulcer Ap E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia Ap E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A CDp E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C R12 Heartburn Ap E A . . . E A . . . E A . . . E A PHENYTOIN d00143A D ^ G40 Epilepsy and recurrent seizures A E A CLONIDINE d00044A B G47.0 Insomnia A0 E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A0 E A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A0 E A . . . E0 A . . . E@ A . . . EP A LISINOPRIL d00732A B 99999 A@ EP A METFORMIN d03807A A@ H57.9 Unspecified disorder of eye and adnexa A@ EP A NAPROXEN d00019A Ei 99999 A@ EP A PREDNISOLONE d00084A B H57.8 Other specified disorders of eye and adnexa A@ E` A . . . Ep A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A D T14.9 Unspecified injury A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A TRIAMTERENE d00396A Cr I10 Essential (primary) hypertension A E A 99999 A B 99999 A E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54.2 Cervicalgia A E A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension A E A FINASTERIDE d00563A B[ N39.4 Other specified urinary incontinence A E A FLUTICASONE d01296A Cr J45 Asthma A E A LORATADINE d03050A C[@ T78.40 Allergy, unspecified A E A TAMSULOSIN d04121A B[ R39.15 Urgency of urination A E A TIOTROPIUM d04829A C[@ J45 Asthma A E A ALBUTEROL d00749A Cr J45 Asthma A0 E A BUDESONIDE d04276A B J45 Asthma A0 E A PREDNISONE d00350A AP J40 J45 Bronchitis, not specified as acute or chronic Asthma A0 E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E A . . . E A ALBUTEROL d00749A D J45 Asthma A E A . . . E A 99999 . . A0 E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A0 E0 A ALBUTEROL d00749A Cr J45 Asthma A E0 A ALBUTEROL d00749A D J45 Asthma A E0 A ALBUTEROL; IPRATROPIUM d04066A D J45 Asthma A E0 A BENZONATATE d00796A D R05 Cough A E0 A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A E0 A FLUTICASONE; SALMETEROL d04611A D J45 Asthma A E0 A HYDROXYCHLOROQUINE d00817A C"0 M10.9 Gout, unspecified A E0 A MONTELUKAST d04289A D1 J45 Asthma A E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E0 A PREDNISONE d00350A D1 J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E0 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E@ A ALBUTEROL d00749A B J42 Unspecified chronic bronchitis A E@ A AMIODARONE d00002A Cr I49.9 Cardiac arrhythmia, unspecified A E@ A ATENOLOL d00004A C I10 Essential (primary) hypertension A E@ A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A E@ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E@ A FLUTICASONE; SALMETEROL d04611A C J42 Unspecified chronic bronchitis A E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A E@ A TOLTERODINE d04294A Dc N32.81 Overactive bladder A E@ A TORSEMIDE d03189A D# R60.9 Edema, unspecified A EP A . . . E` A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A@ E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E` A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A@ Ep A . . . E A CETIRIZINE; PSEUDOEPHEDRINE d04764A Dc T78.40 Allergy, unspecified A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A . . . E A CETIRIZINE d03827A B= T78.40 Allergy, unspecified A E A . . . E A . . . E A . . . E A HYDROXYZINE d00907A C R10.9 Unspecified abdominal pain A0 E A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A0 E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia AP E A FENOFIBRIC ACID d07371A C- E78.0 Pure hypercholesterolemia AP E A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified AP E A SPIRONOLACTONE d00373A CDp I51.7 Cardiomegaly AP E A . . . E A . . . E0 A ACETAMINOPHEN; CODEINE d03423A B[ T14.9 Unspecified injury A` E0 A ATENOLOL d00004A A I10 Essential (primary) hypertension A` E0 A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A` E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E0 A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus A` E0 A PAROXETINE d03157A Bz F32.9 Major depressive disorder, single episode, unspecified A` E@ A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A ALENDRONATE d03849A C 99999 A E@ A BUDESONIDE; FORMOTEROL d04795A B J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A EZETIMIBE d04824A C- E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A E@ A FUROSEMIDE d00070A Ei 99999 A E@ A IPRATROPIUM d00265A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A LISINOPRIL d00732A C- 99999 A E@ A METOPROLOL d00134A Ei 99999 A E@ A NITROGLYCERIN d00321A Ei R07.9 Chest pain, unspecified A E@ A OXYGEN a54115A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A SIMVASTATIN d00746A Ei 99999 A E@ A SPIRONOLACTONE d00373A Ei 99999 A E@ A TAMSULOSIN d04121A C[@ R33.9 Retention of urine, unspecified A EP A . . . E` A ACARBOSE d03846A B[ E11 Type 2 diabetes mellitus A` E` A ASPIRIN d00170A CDp D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A` E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A` E` A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A` E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E` A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A` Ep A . . . E A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified Ap E A ESTRADIOL d00537A C[@ Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels Ap E A IBUPROFEN d00015A C- M19.9 Osteoarthritis, unspecified site Ap E A LANSOPRAZOLE d03828A C- K21 Gastro-esophageal reflux disease Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified Ap E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A NAPROXEN d00019A C M54.9 Dorsalgia, unspecified A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A CDp J45 Asthma A E A TRIAMCINOLONE TOPICAL d03206A CDp L20.9 Atopic dermatitis, unspecified A E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A FLUTICASONE NASAL d04283A Cr T78.40 Allergy, unspecified A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A D* I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A LORATADINE d03050A C T78.40 Allergy, unspecified A E A LOSARTAN d03821A B I10 Essential (primary) hypertension A E A METOPROLOL d00134A B I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A B K30 Functional dyspepsia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A E A ALLOPURINOL d00023A CDp M1A Chronic gout A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATROPINE; DIPHENOXYLATE d03506A B[ K58 Irritable bowel syndrome A E A BACLOFEN d00967A C M54.9 Dorsalgia, unspecified A E A CLONAZEPAM d00197A C F32.9 Major depressive disorder, single episode, unspecified A E A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A E A PANCRELIPASE d01002A D K86.9 Disease of pancreas, unspecified A E A TIOTROPIUM d04829A Cr R06.2 Wheezing A E A ZOLPIDEM d00910A C G47.0 Insomnia A E0 A AMITRIPTYLINE d00146A C G43 G47.0 Migraine Insomnia A E0 A KETOCONAZOLE TOPICAL d03202A B B35.4 Tinea corporis A E@ A . . . EP A BISOPROLOL d00709A Ap I49.9 Cardiac arrhythmia, unspecified A EP A CONJUGATED ESTROGENS d00541A CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A EP A DILTIAZEM d00045A C I49.9 Cardiac arrhythmia, unspecified A EP A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A EP A ESCITALOPRAM d04812A C 99999 A EP A GABAPENTIN d03182A Ap M79.7 Fibromyalgia A EP A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified A EP A HYOSCYAMINE d00985A C R14.0 Abdominal distension (gaseous) A EP A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A EP A TRAMADOL d03826A B= M79.1 Myalgia A E` A ATENOLOL d00004A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E` A HYDROCHLOROTHIAZIDE d00253A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A0 K08.8 Other specified disorders of teeth and supporting structures A E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A ATENOLOL d00004A Dc I49.9 Cardiac arrhythmia, unspecified A0 E A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A 55555 A CDp I51.9 Heart disease, unspecified AP E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A C[@ I50.9 Heart failure, unspecified AP E A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots AP E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP E0 A RANITIDINE d00021A C[@ K30 Functional dyspepsia A E@ A . . . EP A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma AP E A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma AP E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified AP E A MONTELUKAST d04289A C- J45 Asthma AP E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A . . . E A ALFUZOSIN d04797A B N40 Enlarged prostate A E A INSULIN GLARGINE d04538A C E10 Type 1 diabetes mellitus A E A INSULIN LISPRO d04373A D= E10 Type 1 diabetes mellitus A E A LOSARTAN d03821A CDp E10.2 I50.9 Type 1 diabetes mellitus with kidney complications Heart failure, unspecified A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C- E78.1 Pure hyperglyceridemia A E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E0 A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A@ E0 A GLIPIZIDE d00246A B[ E11 Type 2 diabetes mellitus A@ E0 A LISINOPRIL d00732A Cr E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A@ E0 A METFORMIN; SITAGLIPTIN d06720A Cr E11 Type 2 diabetes mellitus A@ E@ A . . . EP A . . . E` A BUPROPION d00181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E` A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E` A MECLIZINE d00859A B T75.3 Motion sickness A0 Ep A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr R10.9 Unspecified abdominal pain AP E A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture AP E A DIAZEPAM d00148A Cr F41.9 M62.83 Anxiety disorder, unspecified Muscle spasm AP E A HYDROCHLOROTHIAZIDE d00253A D* N20.0P Prevent kidney stone AP E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E A . . . E A SERTRALINE d00880A B F90 Attention-deficit hyperactivity disorders A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A0 C I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A0 C[@ K21 Gastro-esophageal reflux disease A0 E A PRAVASTATIN d00348A0 C[@ I21.P Prevent heart attack/myocardial infarction A0 E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ALBUTEROL d00749A Ap J45 Asthma A0 EP A HOMATROPINE; HYDROCODONE d03340A Ap R05 Cough A0 EP A PREDNISONE d00350A Ap J42 Unspecified chronic bronchitis A0 E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C- J45 Asthma A0 E A CETIRIZINE d03827A C L29.9 Pruritus, unspecified A0 E A GEMFIBROZIL d00245A CDp E78.1 Pure hyperglyceridemia A0 E A . . . E A GLYBURIDE d00248A CDp E11 Type 2 diabetes mellitus A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 E A LIOTHYRONINE d00658A CDp E03.9 Hypothyroidism, unspecified A0 E A . . . E A . . . E A AZITHROMYCIN d00091A A@ J40 Bronchitis, not specified as acute or chronic A E A HYDROXYZINE d00907A C- L20.9 Atopic dermatitis, unspecified A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ E A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A@ E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ E A OXCARBAZEPINE d04513A CDp G40 Epilepsy and recurrent seizures A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E A IBANDRONATE d05357A C- M81 Osteoporosis without current pathological fracture A0 E A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A0 E A . . . E A CEPHALEXIN d00096A Ap N48.89 Other specified disorders of penis A E A OXYBUTYNIN d00328A A0 N48.89 Other specified disorders of penis A E A . . . E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus AP E A SAXAGLIPTIN d07467A C- E11 Type 2 diabetes mellitus AP E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A CDp J45 Asthma A E A . . . E 0 A . . . E @ A . . . E P A ASENAPINE d07473A Cr G47.0 Insomnia A` E P A CLONAZEPAM d00197A Cr G47.0 Insomnia A` E P A DULOXETINE d05355A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E P A MODAFINIL d04378A B G47.9 Sleep disorder, unspecified A` E P A OXCARBAZEPINE d04513A Cr F31.9 Bipolar disorder, unspecified A` E P A TRAZODONE d00395A Cr G47.0 Insomnia A` E ` Ap . . . E p A . . . E A . . . E A . . . E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A FLUTICASONE NASAL d04283A A R09.81 Nasal congestion A E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B K08.8 Other specified disorders of teeth and supporting structures A` E A AMOXICILLIN d00088A Cr K12.2 Cellulitis and abscess of mouth A` E A FAMOTIDINE d00141A B K25 Gastric ulcer A` E A IBUPROFEN d00015A C M25.52 Pain in elbow A` E A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A` E A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E 0 A FLUTICASONE NASAL d04283A B[ J30.9 Allergic rhinitis, unspecified A E @ A . . . E P A AMOXICILLIN d00088A A J02 Acute pharyngitis A E ` A . . . E p A ATENOLOL d00004A D I10 Essential (primary) hypertension A` E p A ENALAPRIL d00013A D 99999 A` E p A FUROSEMIDE d00070A D 99999 A` E p A ISOSORBIDE d00653A D 99999 A` E p A OMEPRAZOLE d00325A D K25 Gastric ulcer A` E p A PHENYTOIN d00143A D I49.9 Cardiac arrhythmia, unspecified A` E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A BRIMONIDINE OPHTHALMIC d04048A D* H40 Glaucoma A E A HYDROCODONE d03075A B M25.51 Pain in shoulder A E A . . . E A . . . E A MINOCYCLINE d00110A B L70 Acne A E A FLUTICASONE d01296A C J45 Asthma A E A . . . E A . . . E A . . . E A . . . E 0 A CETIRIZINE d03827A D T78.40 Allergy, unspecified A E 0 A CLONIDINE d00044A C I10 Essential (primary) hypertension A E 0 A DICYCLOMINE d00999A B= R10.83 Colic A E 0 A FINASTERIDE d00563A C- R39.11 Hesitancy of micturition A E 0 A NAPROXEN d00019A C M79.2 Neuralgia and neuritis, unspecified A E 0 A POVIDONE IODINE OPHTHALMIC d04205A D H40.P Prevent glaucoma A E 0 A QUINAPRIL d00365A CP I10 Essential (primary) hypertension A E 0 A TERAZOSIN d00386A C- N40 Enlarged prostate A E @ A . . . E P A EZETIMIBE; SIMVASTATIN d05348A Cr E78.0 Pure hypercholesterolemia AP E P A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E P A RANITIDINE BISMUTH CITRATE d04042A Cr K30 Functional dyspepsia AP E P A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified AP E P A SOLIFENACIN d05413A Cr N32.81 Overactive bladder AP E ` A . . . E p A . . . E A . . . E A . . . E A FLUTICASONE d01296A CDp J45 Asthma A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap N30 Cystitis A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A FELODIPINE d00231A Cr I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified Ap E A CYCLOSPORINE OPHTHALMIC d04836A0 B= H04.12 Dry eye syndrome Ap E A DEXLANSOPRAZOLE d07395A D* K21 Gastro-esophageal reflux disease Ap E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified Ap E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A D* I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A CARVEDILOL d03847A C N28.9 Disorder of kidney and ureter, unspecified Ap E P A DICLOFENAC TOPICAL d04722A B R52 Pain, unspecified Ap E P A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus Ap E P A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified Ap E P A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E P A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease Ap E P A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus Ap E ` A . . . E p A . . . E A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified AP E A DICLOFENAC d00848A Ap M79.64 Pain in hand and fingers AP E A FLUOXETINE d00236A Cr F41.9 Anxiety disorder, unspecified AP E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease AP E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 M79.1 M79.2 Dorsalgia, unspecified Myalgia Neuralgia and neuritis, unspecified B E A ALBUTEROL; IPRATROPIUM d04066A C J20.9 R06.2 Acute bronchitis, unspecified Wheezing B E A AMITRIPTYLINE d00146A C F32.9 G47.0 M79.7 Major depressive disorder, single episode, unspecified Insomnia Fibromyalgia B E A AMLODIPINE d00689A C I10 Essential (primary) hypertension B E A CITALOPRAM d04332A C[@ E11.4 F32.9 F41.9 Type 2 diabetes mellitus with neurological complications Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified B E A CLONIDINE d00044A B F41.9 I10 Anxiety disorder, unspecified Essential (primary) hypertension B E A DOMPERIDONE a59812A C K21 K31.84 R11.0 Gastro-esophageal reflux disease Gastroparesis Nausea B E A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level B E A LORAZEPAM d00149A C[@ F41.9 G47.0 Anxiety disorder, unspecified Insomnia B E A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level B E A MIRTAZAPINE d04025A C- F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia B E A MORPHINE d00308A C M54.9 M79.1 M79.2 Dorsalgia, unspecified Myalgia Neuralgia and neuritis, unspecified B E A NEBIVOLOL d05265A C I10 Essential (primary) hypertension B E A OLMESARTAN d04801A CDp E11.2 I10 Type 2 diabetes mellitus with kidney complications Essential (primary) hypertension B E A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn B E A PREGABALIN d05508A C F41.9 M79.2 M79.7 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified Fibromyalgia B E A SIMVASTATIN d00746A C E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia B E A TAMSULOSIN d04121A C R39.12 Poor urinary stream B E A THEOPHYLLINE d00142A Cr G47.30 J42 J45 Sleep apnea, unspecified Unspecified chronic bronchitis Asthma B E A TIZANIDINE d04102A C G47.0 M54.9 M79.1 Insomnia Dorsalgia, unspecified Myalgia B E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E A LOSARTAN d03821A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E0 A PAROXETINE d03157A A 77777 A E@ A ESTRADIOL d00537A B N95.1 Menopausal and female climacteric states A E@ A PROGESTERONE d00550A B N95.1 Menopausal and female climacteric states A EP A . . . E` A 99999 . . A Ep A . . . E A ACETAMINOPHEN; CODEINE d03423A B= M54.9 Dorsalgia, unspecified A` E A ALBUTEROL d00749A C J45 Asthma A` E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A` E A CAPECITABINE d04311A B C18 R91 Malignant neoplasm of colon Abnormal findings on diagnostic imaging of lung A` E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C"0 I10 Essential (primary) hypertension A` E A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A` E A . . . E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease B E A EZETIMIBE; SIMVASTATIN d05348A C E78.0 Pure hypercholesterolemia B E A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified B E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension B E A HYDROCODONE d03075A Cr M54.9 Dorsalgia, unspecified B E A IBUPROFEN d00015A Cr M54.9 Dorsalgia, unspecified B E A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified B E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified B E A LORAZEPAM d00149A Cr G40 Epilepsy and recurrent seizures B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A METOCLOPRAMIDE d00298A C R11.0 Nausea B E A METOPROLOL d00134A C I50.9 Heart failure, unspecified B E A OXYCODONE d00329A Cr M54.9 Dorsalgia, unspecified B E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus B E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia B E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus B E A . . . E A . . . E A ANTI-INFECTIVES - UNSPECIFIED c00001. . A E A TAMSULOSIN d04121A B R35.0 Frequency of micturition A E A LANSOPRAZOLE d03828A B[ K21 Gastro-esophageal reflux disease A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A E` A RANITIDINE d00021A C K30 Functional dyspepsia A Ep A . . . E A ATORVASTATIN d04105A Ei 99999 A` E A GABAPENTIN d03182A Ei E11.4 Type 2 diabetes mellitus with neurological complications A` E A LEVOTHYROXINE d00278A C[@ G83.9 Paralytic syndrome, unspecified A` E A PANTOPRAZOLE d04514A C[@ 99999 A` E A REPAGLINIDE d04267A C[@ E11 Type 2 diabetes mellitus A` E A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A` E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A0 M54.5 Low back pain A E A ORPHENADRINE d00966A A0 M54.9 Dorsalgia, unspecified A E A CARVEDILOL d03847A CP I49.9 Cardiac arrhythmia, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A C- I50.9 Heart failure, unspecified A0 E A WARFARIN d00022A CP I48.91 Unspecified atrial fibrillation A0 E A ALPRAZOLAM d00168A0 C- F41.9 Anxiety disorder, unspecified A E A BACLOFEN d00967A0 C[@ M54.9 M62.83 Dorsalgia, unspecified Muscle spasm A E A DIAZEPAM d00148A0 C[@ M62.83 Muscle spasm A E A GABAPENTIN d03182A0 C[@ M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A0 D I10 Essential (primary) hypertension A E A IBUPROFEN d00015A0 C[@ M79.673 Pain in unspecified foot A E A METHOCARBAMOL d00965A0 B M54.9 M79.606 Dorsalgia, unspecified Pain in leg, unspecified A E A MORPHINE d00308A0 C G89.18 Other acute postprocedural pain A E A OXYCODONE d00329A0 C[@ M54.9 Dorsalgia, unspecified A E A ALBUTEROL d00749A C[@ R06.2 Wheezing A@ E A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A@ E A LORATADINE d03050A C[@ T78.40 Allergy, unspecified A@ E A MONTELUKAST d04289A C[@ J30.9 Allergic rhinitis, unspecified A@ E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 Pain in joint A E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E A CLONAZEPAM d00197A D= 99999 A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GENTAMICIN OPHTHALMIC d03974A A H10 Conjunctivitis A E A IBUPROFEN d00015A D# R52 Pain, unspecified A E A METOCLOPRAMIDE d00298A C[@ R11.0 Nausea A E A PENICILLIN d00116A Ap K04.7 Periapical abscess without sinus A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E A ESOMEPRAZOLE d04749A B K21 Gastro-esophageal reflux disease A0 E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A0 E A SILDENAFIL d04299A C[@ N52.9 Male erectile dysfunction, unspecified A E A TRAZODONE d00395A C[@ M79.7 Fibromyalgia A E0 A . . . E@ A ALBUTEROL d00749A C J45 Asthma AP E@ A CLOPIDOGREL d04258A C R60.9 Edema, unspecified AP E@ A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots AP E@ A OLANZAPINE d04050A C F32.9 Major depressive disorder, single episode, unspecified AP E@ A OXYCODONE d00329A C G89.18 Other acute postprocedural pain AP EP A . . . E` A GATIFLOXACIN OPHTHALMIC d04857A B H10 Conjunctivitis A0 E` A INSULIN ISOPHANE; INSULIN REGULAR d04374A D* E11 Type 2 diabetes mellitus A0 E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ep A . . . E A FINASTERIDE d00563A B= N40 Enlarged prostate AP E A FOSINOPRIL d00242A C[@ I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP E A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus AP E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension AP E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A OXYCODONE d00329A C- N94.6 Dysmenorrhea, unspecified A E A . . . E A . . . E A . . . E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E0 A FLUTICASONE; SALMETEROL d04611A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A FINASTERIDE d00563A CDp N42.9 R39.9 Disorder of prostate, unspecified Unspecified symptoms and signs involving the genitourinary system AP E@ A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension AP E@ A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia AP E@ A TERAZOSIN d00386A CDp N42.9 R39.9 Disorder of prostate, unspecified Unspecified symptoms and signs involving the genitourinary system AP E@ A TRAMADOL d03826A B M13 Other arthritis AP EP A GLYBURIDE; METFORMIN d04703A C[@ E11 Type 2 diabetes mellitus AP EP A ISOSORBIDE MONONITRATE d00269A Bz I51.9 Heart disease, unspecified AP EP A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EP A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E` A . . . Ep A DEXLANSOPRAZOLE d07395A Bz K21 Gastro-esophageal reflux disease A0 Ep A IBUPROFEN d00015A B N42.9 Disorder of prostate, unspecified A0 Ep A TAMSULOSIN d04121A CDp N40 Enlarged prostate A0 E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A CDp I21.P Prevent heart attack/myocardial infarction A` E A GEMFIBROZIL d00245A C"0 I21.P Prevent heart attack/myocardial infarction A` E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E A . . . E A . . . E A ALBUTEROL d00749A B J20.9 Acute bronchitis, unspecified A@ E A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A@ E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A Cr E78.0P Prevent high cholesterol A@ E A . . . E A . . . E A AZITHROMYCIN d00091A AP J18.9 Pneumonia, unspecified organism A E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C R51 T14.9 Headache Unspecified injury A0 E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A0 E A RANITIDINE d00021A D K30 Functional dyspepsia A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ATENOLOL d00004A Dc I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A Ep A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ATENOLOL; CHLORTHALIDONE d03258A CP I10 Essential (primary) hypertension A E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A LACTULOSE d01024A CDp K59.0 Constipation A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A Cr M54.9 Dorsalgia, unspecified A E A TRAZODONE d00395A C G47.0 Insomnia A E A . . . E A CYCLOBENZAPRINE d00963A C T14.9 Unspecified injury AP E A HYDROCODONE d03075A C M54.9 Dorsalgia, unspecified AP E A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified AP E A MORPHINE d00308A C M54.9 Dorsalgia, unspecified AP E A TESTOSTERONE d00558A C E29.1 Testicular hypofunction AP E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A C I10 Essential (primary) hypertension A0 E A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A . . . E0 A ALLOPURINOL d00023A D@) M1A Chronic gout Ap E0 A AMLODIPINE d00689A D* I10 Essential (primary) hypertension Ap E0 A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E0 A LOSARTAN d03821A D* I10 Essential (primary) hypertension Ap E0 A METOPROLOL d00134A C R07.9 Chest pain, unspecified Ap E0 A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia Ap E0 A TRIAMCINOLONE NASAL d04233A Cr J01.9 Acute sinusitis, unspecified Ap E@ A . . . EP A . . . E` A ALBUTEROL d00749A C- J45 Asthma A E` A DIPHENHYDRAMINE d00212A C- G47.0 Insomnia A E` A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications A E` A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E` A INSULIN ISOPHANE; INSULIN REGULAR d04374A D7 E11 Type 2 diabetes mellitus A E` A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E` A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E` A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A Ep A . . . E A . . . E A . . . E A GLIMEPIRIDE d03864A C"0 R73 Elevated blood glucose level A0 E A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A FENOFIBRATE d04286A C- E78.1 Pure hyperglyceridemia A@ E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A PROGESTERONE d00550A CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A SEX HORMONES - UNSPECIFIED c00101A CDp N95.1 Menopausal and female climacteric states A E A . . . E A . . . E A TOBRAMYCIN OPHTHALMIC d03222A Ap H10 Conjunctivitis A E A BENZTROPINE d00175A0 B G20 Parkinson's disease A E A CARBIDOPA; LEVODOPA d03473A0 C G20 Parkinson's disease A E A DIAZEPAM d00148A0 B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A DIVALPROEX SODIUM d03833A0 B F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A E A FUROSEMIDE d00070A0 B[ I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A0 B[ K30 Functional dyspepsia A E A ONDANSETRON d00867A0 Bz R11 Nausea and vomiting A E A SERTRALINE d00880A0 A F31.9 Bipolar disorder, unspecified A E A TIZANIDINE d04102A0 B= M54.9 Dorsalgia, unspecified A E A TRAMADOL d03826A0 B= R10.9 Unspecified abdominal pain A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A@ E A IBUPROFEN d00015A Cr M79.1 Myalgia A@ E A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus A@ E A INSULIN REGULAR d04369A B E11 Type 2 diabetes mellitus A@ E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ASPIRIN d00170A C- D75.9P Prevent blood clots A Ep A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A Ep A LINAGLIPTIN d07767A B= E11.P Prevent diabetes A Ep A LOSARTAN d03821A C- I10 Essential (primary) hypertension A Ep A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Ep A NIACIN d00314A C- E78.0 Pure hypercholesterolemia A Ep A SIMVASTATIN d00746A C- E78.0P Prevent high cholesterol A Ep A TAMSULOSIN d04121A C- R32 Unspecified urinary incontinence A E A ERYTHROMYCIN d00046A B= K31.84 Gastroparesis A E A FUROSEMIDE d00070A B= 55555 A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A MUPIROCIN TOPICAL d01267A A T63.4 Toxic effect of venom of other arthropods A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A T63.4 Toxic effect of venom of other arthropods A E A . . . E A ALBUTEROL d00749A B J45 Asthma A E A ALBUTEROL d00749A B J45 Asthma A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A0 Ep A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A0 Ep A TAMSULOSIN d04121A C- N40 Enlarged prostate A0 E A ETONOGESTREL d04772A0 C ` Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A B I48.92 Unspecified atrial flutter A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E0 A ETHINYL ESTRADIOL; NORGESTREL d03241A D Z79.3 Long term (current) use of hormonal contraceptives A0 E0 A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease A0 E0 A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A0 E@ A ALBUTEROL d00749A Dc J45 Asthma AP E@ A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol AP E@ A FEXOFENADINE d04040A Dc J45 T78.40 Asthma Allergy, unspecified AP E@ A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension AP E@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP EP A AZITHROMYCIN d00091A C A69.2 Lyme disease A EP A RIFAMPIN d00047A C A44.9 Bartonellosis, unspecified A E` A CETIRIZINE d03827A B T78.40 Allergy, unspecified A Ep A . . . E A AMOXICILLIN; CLAVULANATE d00089A Ap J02 Acute pharyngitis A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A IRBESARTAN d04222A D I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E A VENLAFAXINE d03181A D F41.9 Anxiety disorder, unspecified A@ E A LOSARTAN d03821A B I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A B= J45 Asthma A E A CLONIDINE d00044A CDp G47.0 Insomnia A E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A FINASTERIDE d00563A0 C N40 Enlarged prostate AP E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus AP E A OLMESARTAN d04801A0 C I10 Essential (primary) hypertension AP E A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia AP E A TADALAFIL d04896A0 CDp N52.9 Male erectile dysfunction, unspecified AP E A . . . E A . . . E0 A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E0 A CILOSTAZOL d04382A C I70.2 Atherosclerosis of native arteries of extremities A E0 A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E0 A ESOMEPRAZOLE d04749A C K21 R12 Gastro-esophageal reflux disease Heartburn A E0 A FAMOTIDINE d00141A C I50.9 Heart failure, unspecified A E0 A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A E0 A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E0 A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E@ A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A0 E@ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 EP A . . . E` A CELECOXIB d04380A C M19.9 Osteoarthritis, unspecified site A E` A DULOXETINE d05355A C M25.5 Pain in joint A Ep A BUPROPION d00181A B F17.203 F41.9 Nicotine dependence unspecified, with withdrawal Anxiety disorder, unspecified A E A CLOPIDOGREL d04258A B= I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` E A MONTELUKAST d04289A C R06.9 Unspecified abnormalities of breathing A` E A MORPHINE d00308A B= M54.9 Dorsalgia, unspecified A` E A MORPHINE d00308A CDp M54.9 Dorsalgia, unspecified A` E A PREGABALIN d05508A CDp M62.83 Muscle spasm A` E A TIZANIDINE d04102A CDp M79.1 Myalgia A` E A ATROPINE; DIPHENOXYLATE d03506A B R19.7 Diarrhea, unspecified A` E A BUDESONIDE d04276A B R06.02 Shortness of breath A` E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A` E A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A` E A RANITIDINE d00021A B= K92.2 Gastrointestinal hemorrhage, unspecified A` E A TOLTERODINE d04294A C- N32.81 Overactive bladder A` E A . . . E A . . . E A . . . E A FLUTICASONE d01296A B[ J45 Asthma A E A . . . E A . . . E A ARIPIPRAZOLE d04825A C- F32.9 Major depressive disorder, single episode, unspecified A E A OLANZAPINE d04050A C- F20 Schizophrenia A E A . . . E A . . . E0 A ALLOPURINOL d00023A C M1A Chronic gout A0 E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E0 A METOPROLOL d00134A B I10 Essential (primary) hypertension A0 E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A` E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A` E A METOPROLOL d00134A B= I10 Essential (primary) hypertension A` E A OXYCODONE d00329A B= G89.18 R10.9 Other acute postprocedural pain Unspecified abdominal pain A` E A TRAZODONE d00395A B= G47.0 Insomnia A` E A . . . E A AMLODIPINE d00689A Ei 99999 A@ E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A OMEPRAZOLE d00325A Ei K30 Functional dyspepsia A@ E A POTASSIUM CHLORIDE d00345A Ei E87.6 Hypokalemia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ASPIRIN d00170A D D75.9P Prevent blood clots A E0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E0 A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A E0 A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D R60.9 Edema, unspecified A E0 A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction A E0 A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A E0 A VERAPAMIL d00048A D I51.9 Heart disease, unspecified A E@ A . . . EP A . . . E` A ONDANSETRON d00867A A R11.0 Nausea A Ep A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A0 Ep A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A0 Ep A LAMOTRIGINE d03809A C- F31.9 Bipolar disorder, unspecified A0 E A . . . E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E A . . . E A AMLODIPINE d00689A CP I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A ALBUTEROL d00749A C J45 Asthma Ap E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma Ap E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives Ap E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia Ap E A NAPROXEN d00019A A M79.1 Myalgia Ap E A PIOGLITAZONE d04442A CDp E11.P Prevent diabetes Ap E A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension Ap E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A0 E0 A . . . E@ A . . . EP A CLOPIDOGREL d04258A C D75.9P G45.9 Prevent blood clots Transient cerebral ischemic attack, unspecified A EP A DAPAGLIFLOZIN d07928A B= E11 Type 2 diabetes mellitus A EP A GLIMEPIRIDE d03864A C"0 E11 Type 2 diabetes mellitus A EP A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A EP A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EP A TELMISARTAN d04364A Cr I10 Essential (primary) hypertension A E` A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A METFORMIN d03807A B[ E11.P Prevent diabetes A@ E A ROSUVASTATIN d04851A B[ E78.1 Pure hyperglyceridemia A@ E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE d01296A C[@ J45 Asthma A E A 77777 . . A E A ALBUTEROL d00749A C- J45 Asthma A E A BECLOMETHASONE d00760A C- J45 Asthma A E0 A CETIRIZINE d03827A Ap J30.9 Allergic rhinitis, unspecified A E@ A . . . EP A . . . E` A BUDESONIDE; FORMOTEROL d04795A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A` E` A DULOXETINE d05355A C 99999 A` E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E` A METOPROLOL d00134A C I50.9 Heart failure, unspecified A` E` A PREDNISONE d00350A C 99999 A` E` A ZOLPIDEM d00910A C 99999 A` Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ep A CLOTRIMAZOLE TOPICAL d04395A B 55555 A E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A B[ M25.51 M54.2 M54.9 Pain in shoulder Cervicalgia Dorsalgia, unspecified A0 E A MELOXICAM d04532A B[ M25.51 M54.2 M54.9 Pain in shoulder Cervicalgia Dorsalgia, unspecified A0 E A METHYLPREDNISOLONE d00293A Ap R52 Pain, unspecified A0 E A . . . E A ALLOPURINOL d00023A C M1A Chronic gout A@ E A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E A GEMFIBROZIL d00245A CDp E78.0 Pure hypercholesterolemia A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A Dc K21 Gastro-esophageal reflux disease A@ E A EZETIMIBE; SIMVASTATIN d05348A D E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A@ E 0 A . . . E @ A . . . E P A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E P A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E P A RISEDRONATE d04300A Cr M81 Osteoporosis without current pathological fracture A@ E ` A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E p A . . . E A CETIRIZINE; PSEUDOEPHEDRINE d04764A Dc T78.40 Allergy, unspecified A0 E A OLOPATADINE NASAL d07132A C"0 R09.81 Nasal congestion A0 E A TRIAMCINOLONE NASAL d04233A Cr J30.9 Allergic rhinitis, unspecified A0 E A ALBUTEROL d00749A C J45 Asthma A E A FLUTICASONE d01296A C J45 Asthma A E A . . . E A . . . E A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified A E A BUPROPION d00181A Dc F32.9 Major depressive disorder, single episode, unspecified A E A CONJUGATED ESTROGENS d00541A D=O Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A C M54.9 Dorsalgia, unspecified A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr E87.7 I10 Fluid overload Essential (primary) hypertension A E A LEVOTHYROXINE d00278A DK E03.9 Hypothyroidism, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E A PRAVASTATIN d00348A C- I21.P Prevent heart attack/myocardial infarction A E A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified A0 E A RIVASTIGMINE d04537A A G30.9 Alzheimer's disease, unspecified A0 E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A0 E A . . . E 0 A . . . E @ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A0 E @ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E @ A MONTELUKAST d04289A C J45 Asthma A0 E P A 99999 . . A E ` A . . . E p A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A CORTICOTROPIN d00604A C[@ R80.9 Proteinuria, unspecified A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Cr 99999 A E A POTASSIUM CHLORIDE d00345A Cr 99999 A E A RAMIPRIL d00728A Cr R80.9 Proteinuria, unspecified A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A SOTALOL d00371A Cr I48.91 Unspecified atrial fibrillation A E A WARFARIN d00022A Cr D75.9P Prevent blood clots A E A . . . E A . . . E A ALBUTEROL d00749A C R06.02 Shortness of breath A E A ASPIRIN d00170A C D75.9P Prevent blood clots A E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A E A DIGOXIN d00210A C I48.91 Unspecified atrial fibrillation A E A GABAPENTIN d03182A C G47.9 Sleep disorder, unspecified A E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A E A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E A OXYCODONE d00329A C M25.51 Pain in shoulder A E A POTASSIUM CHLORIDE d00345A C R25.2P Prevent cramp and spasm A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ATROPINE; DIPHENOXYLATE d03506A C R19.7 Diarrhea, unspecified A E A ETANERCEPT d04365A C L40 Psoriasis A E A GABAPENTIN d03182A B= M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A OMEPRAZOLE d00325A Bz K21 Gastro-esophageal reflux disease A E A TEMAZEPAM d00384A C G47.9 Sleep disorder, unspecified A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A BENZONATATE d00796A C"0 R06.2 Wheezing AP E A CYCLOBENZAPRINE d00963A C ` M54.9 Dorsalgia, unspecified AP E A ESOMEPRAZOLE d04749A B K30 Functional dyspepsia AP E A ETODOLAC d00851A B M54.9 Dorsalgia, unspecified AP E A TIZANIDINE d04102A C"0 M54.9 Dorsalgia, unspecified AP E A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E A DOXYCYCLINE d00037A CDp L71 Rosacea A E A FLUNISOLIDE NASAL d04279A C- J30.9 Allergic rhinitis, unspecified A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A MIRTAZAPINE d04025A C- G47.0 Insomnia A E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E A TRAMADOL d03826A C- M79.1 Myalgia A E A VALSARTAN d04113A C- I21.P Prevent heart attack/myocardial infarction A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A . . . E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A VALACYCLOVIR d03838A C B00.1 Herpesviral vesicular dermatitis A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A0 E A LAMOTRIGINE d03809A D G40 Epilepsy and recurrent seizures A0 E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E 0 A . . . E @ A . . . E P A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E ` A . . . E p A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B= M79.1 Myalgia A E A ALBUTEROL d00749A B[ J45 Asthma A0 E A FEXOFENADINE d04040A C- T78.40 Allergy, unspecified A0 E A MONTELUKAST d04289A C- J45 Asthma A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A DIAZEPAM d00148A A0 M62.83 Muscle spasm A@ E A GABAPENTIN d03182A A0 M79.2 Neuralgia and neuritis, unspecified A@ E A OFLOXACIN OPHTHALMIC d03977A A` Z48.810 Encounter for surgical aftercare following surgery on the sense organs A@ E A PREDNISOLONE OPHTHALMIC d03221A A0 Z48.810 Encounter for surgical aftercare following surgery on the sense organs A@ E A . . . E A . . . E! A . . . E! A . . . E! A . . . E!0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C G43 Migraine AP E!0 A ACETAMINOPHEN; OXYCODONE d03431A Cr G43 Migraine AP E!0 A AMITRIPTYLINE d00146A A G47.0 Insomnia AP E!0 A PROMETHAZINE d00787A Cr R11 Nausea and vomiting AP E!0 A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified AP E!@ A . . . E!P A . . . E!` A . . . E!p A . . . E! A ATENOLOL d00004A CDp E05.9 Thyrotoxicosis, unspecified A E! A METHIMAZOLE d00290A CDp I10 Essential (primary) hypertension A E! A . . . E! A ATENOLOL d00004A D ^ I10 Essential (primary) hypertension AP E! A GLYBURIDE d00248A CDp E11 Type 2 diabetes mellitus AP E! A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E! A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E! A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E! A . . . E! A . . . E! A ALBUTEROL d00749A C J45 Asthma A E! A PREDNISONE d00350A C J45 Asthma A E! A OMEPRAZOLE d00325A B K30 Functional dyspepsia A E! A . . . E" A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified Ap E" A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Cr H40 Glaucoma Ap E" A DULOXETINE d05355A B[ F41.9 Anxiety disorder, unspecified Ap E" A LAMOTRIGINE d03809A A F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Ap E" A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma Ap E" A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified Ap E" A ZOLPIDEM d00910A C G47.0 Insomnia Ap E" A HYDROXYZINE d00907A C L20.9 Atopic dermatitis, unspecified A E" A TRIAMCINOLONE TOPICAL d03206A C"0 L20.9 Atopic dermatitis, unspecified A E" A . . . E"0 A . . . E"@ A CITALOPRAM d04332A B F41.9 Anxiety disorder, unspecified A0 E"@ A DONEPEZIL d04099A C[@ R41.3 Other amnesia A0 E"@ A PSEUDOEPHEDRINE d00769A C R09.89 Other specified symptoms and signs involving the circulatory and respiratory systems A0 E"P A . . . E"` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A0 E"` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E"` A RANITIDINE d00021A B= K30 Functional dyspepsia A0 E"p A . . . E" A AMIODARONE d00002A Dc I49.9 Cardiac arrhythmia, unspecified A E" A CARVEDILOL d03847A Dc I50.9 Heart failure, unspecified A E" A FUROSEMIDE d00070A Dc I50.9 Heart failure, unspecified A E" A LISINOPRIL d00732A Dc I50.9 Heart failure, unspecified A E" A METOLAZONE d00299A Dc I50.9 Heart failure, unspecified A E" A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia A E" A PRAVASTATIN d00348A Dc E78.0P Prevent high cholesterol A E" A SPIRONOLACTONE d00373A Dc I50.9 Heart failure, unspecified A E" A WARFARIN d00022A Dc D75.9P Prevent blood clots A E" A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia Ap E" A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension Ap E" A CLOPIDOGREL d04258A A D75.9P Prevent blood clots Ap E" A DIAZEPAM d00148A C F32.9 Major depressive disorder, single episode, unspecified Ap E" A PANTOPRAZOLE d04514A A K21 Gastro-esophageal reflux disease Ap E" A PROGESTERONE d00550A C 55555 Ap E" A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified Ap E" A . . . E" A ACETAMINOPHEN; CODEINE d03423A B[ T14.9 Unspecified injury A E" A . . . E" A . . . E" A . . . E" A . . . E# A . . . E# A . . . E# A . . . E#0 A . . . E#@ A . . . E#P A . . . E#` A . . . E#p A . . . E# A FLUOXETINE d00236A B 55555 A@ E# A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A@ E# A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ E# A TIOTROPIUM d04829A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A@ E# A . . . E# A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E# A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E# A LEVOTHYROXINE d00278A Ap E03.9 Hypothyroidism, unspecified A E# A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E# A OMEPRAZOLE d00325A C- K27 Peptic ulcer, site unspecified A E# A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E# A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus A E# A TRAMADOL d03826A C"0 M54.9 M79.1 M79.2 Dorsalgia, unspecified Myalgia Neuralgia and neuritis, unspecified A E# A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E# A . . . E# A . . . E# A TRAMADOL d03826A B[ M54.9 Dorsalgia, unspecified A E# A . . . E$ A . . . E$ A . . . E$ A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E$ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E$ A DOXAZOSIN d00726A C I10 Essential (primary) hypertension Ap E$ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E$ A MELOXICAM d04532A C M79.2 Neuralgia and neuritis, unspecified Ap E$ A METFORMIN d03807A C R73 Elevated blood glucose level Ap E$ A PENTOXIFYLLINE d00336A C[@ I70.2 Atherosclerosis of native arteries of extremities Ap E$0 A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP E$0 A LOSARTAN d03821A D* I10 Essential (primary) hypertension AP E$0 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension AP E$0 A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia AP E$0 A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified AP E$@ A . . . E$P A . . . E$` A . . . E$p A . . . E$ A ALBUTEROL d00749A B J45 Asthma A0 E$ A CETIRIZINE d03827A B= L30.9 Dermatitis, unspecified A0 E$ A FLUTICASONE d01296A B J45 Asthma A0 E$ A . . . E$ A BUSPIRONE d00182A C I51.9 Heart disease, unspecified Ap E$ A FUROSEMIDE d00070A C E87.7 Fluid overload Ap E$ A HYDROCHLOROTHIAZIDE d00253A C E87.7 Fluid overload Ap E$ A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E$ A OLMESARTAN d04801A C I10 Essential (primary) hypertension Ap E$ A POTASSIUM CHLORIDE d00345A C- 99999 Ap E$ A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified Ap E$ A . . . E$ A . . . E$ A . . . E$ A . . . E$ A . . . E% A . . . E% A . . . E% A . . . E%0 A . . . E%@ A HYDROCODONE d03075A B T14.9 Unspecified injury A E%@ A NAPROXEN d00019A B T14.9 Unspecified injury A E%P A . . . E%` A . . . E%p A HYDROCHLOROTHIAZIDE d00253A C- N28.9 Disorder of kidney and ureter, unspecified A0 E%p A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E%p A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A0 E% A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E% A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E% A OXCARBAZEPINE d04513A C[@ F31.9 Bipolar disorder, unspecified A0 E% A . . . E% A . . . E% A . . . E% A ACETAMINOPHEN; HYDROCODONE d03428A0 Bz M54.9 M79.606 Dorsalgia, unspecified Pain in leg, unspecified A E% A ATROPINE; DIPHENOXYLATE d03506A0 B R19.7 Diarrhea, unspecified A E% A CARISOPRODOL d00960A0 Bz M62.83 Muscle spasm A E% A CARVEDILOL d03847A0 B I50.9 Heart failure, unspecified A E% A FUROSEMIDE d00070A0 B R60.9 Edema, unspecified A E% A LISINOPRIL d00732A0 B I10 Essential (primary) hypertension A E% A LORAZEPAM d00149A0 Bz F41.9 Anxiety disorder, unspecified A E% A NITROFURANTOIN d00112A0 Ei N30 Cystitis A E% A PANTOPRAZOLE d04514A0 B K21 Gastro-esophageal reflux disease A E% A POTASSIUM CHLORIDE d00345A0 B E87.6 Hypokalemia A E% A PROCHLORPERAZINE d00355A0 B R11 Nausea and vomiting A E% A SUCRALFATE d00377A0 B[ K27 Peptic ulcer, site unspecified A E% A TRAZODONE d00395A0 B F41.9 Anxiety disorder, unspecified A E% A ZOLPIDEM d00910A0 Bz G47.9 Sleep disorder, unspecified A E% A . . . E% A . . . E% A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E% A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E& A . . . E& A DUTASTERIDE d04788A C N40 Enlarged prostate A0 E& A OMEPRAZOLE d00325A C K31.9P Prevent stomach problem A0 E& A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E& A . . . E&0 A . . . E&@ A . . . E&P A ANTI-INFECTIVES - UNSPECIFIED c00001. . A E&` A . . . E&p A CYCLOBENZAPRINE d00963A CDp M79.1 T14.9 Myalgia Unspecified injury A0 E&p A FLUCONAZOLE d00071A B B37.3 Candidiasis of vulva and vagina A0 E&p A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A0 E& A . . . E& A AMOXICILLIN; CLAVULANATE d00089A A@ H66.9 Otitis media, unspecified A E& A . . . E& A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E& A TRIAMTERENE d00396A C[@ I10 Essential (primary) hypertension A E& A PAROXETINE d03157A Cr F32.9 F41.0 F41.9 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A E& A ALBUTEROL d00749A D J43 Emphysema AP E& A ALBUTEROL; IPRATROPIUM d04066A C J43 Emphysema AP E& A FAMOTIDINE d00141A D K30 Functional dyspepsia AP E& A FLUTICASONE; SALMETEROL d04611A D J43 Emphysema AP E& A TIOTROPIUM d04829A D J43 Emphysema AP E& A . . . E& A . . . E' A IBUPROFEN d00015A C- R50.9 Fever, unspecified A E' A . . . E' A . . . E'0 A . . . E'@ A . . . E'P A . . . E'` A . . . E'p A . . . E' A . . . E' A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- Z79.3 Long term (current) use of hormonal contraceptives A E' A . . . E' A . . . E' A . . . E' A PENICILLIN V POTASSIUM d07730A B K04.7 Periapical abscess without sinus A E' A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A@ E' A NAPROXEN d00019A CDp M1A M54.2 Chronic gout Cervicalgia A@ E' A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E' A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E' A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E' A WARFARIN d00022A C- D75.9P Prevent blood clots A E( A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E( A IBUPROFEN d00015A Dc M79.1 Myalgia AP E( A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E( A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia AP E( A TRAZODONE d00395A D G47.0 Insomnia AP E( A WARFARIN d00022A D I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified AP E( A . . . E(0 A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A@ E(0 A EPLERENONE d04815A Cr I10 Essential (primary) hypertension A@ E(0 A METFORMIN d03807A Cr E11.P Prevent diabetes A@ E(0 A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E(@ A . . . E(P A . . . E(` A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A E(` A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E(p A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E( A . . . E( A . . . E( A GUAIFENESIN d00797A B* R09.3 Abnormal sputum A@ E( A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E( A OMEPRAZOLE d00325A B K30 Functional dyspepsia A@ E( A PREDNISONE d00350A B* J42 Unspecified chronic bronchitis A@ E( A AMITRIPTYLINE d00146A C F41.9 Anxiety disorder, unspecified A` E( A DONEPEZIL d04099A C- G25.81 Restless legs syndrome A` E( A FLUTICASONE NASAL d04283A C[@ J30.1 Allergic rhinitis due to pollen A` E( A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A` E( A GABAPENTIN d03182A C G25.81 Restless legs syndrome A` E( A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E( A . . . E( A . . . E( A . . . E( A . . . E) A . . . E) A BIMATOPROST OPHTHALMIC d04754A B[ H40 Glaucoma A E) A . . . E)0 A . . . E)@ A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction Ap E)@ A CETIRIZINE d03827A C- T78.40 Allergy, unspecified Ap E)@ A CILOSTAZOL d04382A C- I70.2 Atherosclerosis of native arteries of extremities Ap E)@ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap E)@ A ISOSORBIDE MONONITRATE d00269A C- I20.9 Angina pectoris, unspecified Ap E)@ A METOPROLOL d00134A C- I51.9 Heart disease, unspecified Ap E)@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E)P A . . . E)` A AMANTADINE d00086A D G20 Parkinson's disease A E)` A CARBIDOPA; ENTACAPONE; LEVODOPA d04877A CP G20 Parkinson's disease A E)` A CARBIDOPA; LEVODOPA d03473A CP G20 Parkinson's disease A E)` A CARBIDOPA; LEVODOPA d03473A CP G20 Parkinson's disease A E)` A CLONAZEPAM d00197A Cr T88.7 Unspecified adverse effect of drug or medicament A E)` A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A C G20 Z79.81 Parkinson's disease Long term (current) use of agents affecting estrogen receptors and estrogen levels A E)` A ONABOTULINUMTOXINA d07645A CP 55555 G20 Parkinson's disease A E)` A RASAGILINE d05612A Cr G20 Parkinson's disease A E)` A ROTIGOTINE d05848A B G20 Parkinson's disease A E)p A CELECOXIB d04380A Cr M13 Other arthritis AP E)p A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia AP E)p A OMEPRAZOLE d00325A B K30 Functional dyspepsia AP E)p A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia AP E)p A VALSARTAN d04113A Ei I10 Essential (primary) hypertension AP E) A . . . E) A . . . E) A . . . E) A . . . E) A ONDANSETRON d00867A B R11.0 Nausea A E) A CLINDAMYCIN TOPICAL d01241A C R21 Rash and other nonspecific skin eruption A E) A . . . E) A . . . E* A . . . E* A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E* A GLIMEPIRIDE d03864A Bz E11 Type 2 diabetes mellitus AP E* A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus AP E* A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified AP E* A RAMIPRIL d00728A C I21.P Prevent heart attack/myocardial infarction AP E* A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E* A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E* A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension A E* A LEVOTHYROXINE d00278A D& E03.9 Hypothyroidism, unspecified A E* A MELOXICAM d04532A Cr M13 Other arthritis A E* A OMEPRAZOLE d00325A CP K21 Gastro-esophageal reflux disease A E* A OXYBUTYNIN d00328A CDp R35.0 Frequency of micturition A E* A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E* A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A E*0 A . . . E*@ A . . . E*P A . . . E*` A . . . E*p A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture Ap E*p A ALLOPURINOL d00023A C M10.9 Gout, unspecified Ap E*p A AMLODIPINE; OLMESARTAN d06905A Cr I10 Essential (primary) hypertension Ap E*p A GEMFIBROZIL d00245A D= E78.0 Pure hypercholesterolemia Ap E*p A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus Ap E*p A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E*p A OMEPRAZOLE d00325A C- K30 Functional dyspepsia Ap E* A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E* A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E* A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E* A SEVELAMER d04363A C- E83.3 N19 Z99.2 Disorders of phosphorus metabolism and phosphatases Unspecified kidney failure Dependence on renal dialysis A@ E* A . . . E* A AZELASTINE OPHTHALMIC d04541A Cr H10.1 Acute atopic conjunctivitis A E* A DIAZEPAM d00148A C G40 Epilepsy and recurrent seizures A E* A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures A E* A HYDROCODONE d03075A C G40 Epilepsy and recurrent seizures A E* A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A E* A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E* A LORATADINE; PSEUDOEPHEDRINE d03818A Cr T78.40 Allergy, unspecified A E* A OMEPRAZOLE d00325A Cr R12 Heartburn A E* A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A E* A . . . E* A . . . E* A CYPROHEPTADINE d00790A A T78.40 Allergy, unspecified A E* A . . . E* A . . . E+ A CARBAMAZEPINE d00058A D G40 Epilepsy and recurrent seizures A@ E+ A LAMOTRIGINE d03809A Dc G40 Epilepsy and recurrent seizures A@ E+ A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A@ E+ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E+ A . . . E+ A . . . E+0 A LORAZEPAM d00149A Cr G47.0 Insomnia A@ E+0 A MIRTAZAPINE d04025A C- F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ E+0 A SENNA d01013A CDp K59.0 Constipation A@ E+0 A WARFARIN d00022A D D75.9P Prevent blood clots A@ E+@ A . . . E+P A GUANFACINE d00717A CDp F90 Attention-deficit hyperactivity disorders A E+P A QUETIAPINE d04220A CDp F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A E+` A MINOCYCLINE d00110A C- L03.90 Cellulitis, unspecified A E+p A . . . E+ A . . . E+ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E+ A FINASTERIDE d00563A C[@ N40 Enlarged prostate A0 E+ A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A0 E+ A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A0 E+ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E+ A RANITIDINE d00021A Ap K30 Functional dyspepsia A0 E+ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C- E78.1 Pure hyperglyceridemia A E+ A . . . E+ A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A E+ A . . . E+ A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension Ap E+ A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia Ap E+ A CARVEDILOL d03847A B I10 Essential (primary) hypertension Ap E+ A CONJUGATED ESTROGENS d00541A D; R51 Headache Ap E+ A FUROSEMIDE d00070A CP I51.9 Heart disease, unspecified Ap E+ A LEVOTHYROXINE d00278A D1 99999 Ap E+ A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified Ap E, A ANASTROZOLE d03873A C E29.1 Testicular hypofunction A0 E, A PANCRELIPASE d01002A C K86.9 Disease of pancreas, unspecified A0 E, A TESTOSTERONE d00558A C"@ E29.1 Testicular hypofunction A0 E, A . . . E, A . . . E,0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E,0 A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A0 E,0 A RANITIDINE d00021A Cr K30 Functional dyspepsia A0 E,@ A . . . E,P A PROGESTERONE d00550A C N95.1P Prevent menopause symptoms A E,` A IBUPROFEN d00015A C M19.9 M54.2 M54.9 Osteoarthritis, unspecified site Cervicalgia Dorsalgia, unspecified A0 E,` A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 E,` A SIMVASTATIN d00746A Ap E78.0 Pure hypercholesterolemia A0 E,p A ATENOLOL d00004A Cr I10 Essential (primary) hypertension AP E,p A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E,p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E,p A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E,p A TRIAMTERENE d00396A Cr I10 Essential (primary) hypertension AP E, A . . . E, A . . . E, A . . . E, A . . . E, A . . . E, A . . . E, A . . . E, A . . . E- A . . . E- A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A C J00 Acute nasopharyngitis [common cold] A E- A . . . E-0 A . . . E-@ A DESOGESTREL; ETHINYL ESTRADIOL d03782A D E28.9 Ovarian dysfunction, unspecified A E-@ A METFORMIN d03807A CDp E28.9 Ovarian dysfunction, unspecified A E-P A AMOXICILLIN d00088A C L70 Acne A0 E-P A DESLORATADINE; PSEUDOEPHEDRINE d05473A CDp T78.40 Allergy, unspecified A0 E-P A TOPIRAMATE d04115A C G43 Migraine A0 E-` A . . . E-p A . . . E- A ACETAMINOPHEN; CODEINE d03423A Dc T14.9 Unspecified injury A E- A . . . E- A . . . E- A . . . E- A CHLORHEXIDINE TOPICAL d01231A B K05.6 Periodontal disease, unspecified A@ E- A MIRTAZAPINE d04025A C"0 F32.9 Major depressive disorder, single episode, unspecified A@ E- A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A@ E- A ZOLPIDEM d00910A B G47.9 Sleep disorder, unspecified A@ E- A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E- A CARVEDILOL d03847A C I10 Essential (primary) hypertension AP E- A CLOPIDOGREL d04258A C 99999 AP E- A EZETIMIBE d04824A C I21.P Prevent heart attack/myocardial infarction AP E- A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E- A . . . E- A . . . E. A . . . E. A AMIODARONE d00002A C I51.9 Heart disease, unspecified A E. A ATENOLOL d00004A C I10 Essential (primary) hypertension A E. A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E. A DIGOXIN d00210A C I48.91 Unspecified atrial fibrillation A E. A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E. A FENOFIBRATE d04286A B= E03.9 Hypothyroidism, unspecified A E. A FINASTERIDE d00563A C N40 Enlarged prostate A E. A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A E. A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E. A MIRTAZAPINE d04025A C F32.9 Major depressive disorder, single episode, unspecified A E. A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E. A QUINIDINE d00020A C I48.91 Unspecified atrial fibrillation A E. A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E. A TIOTROPIUM d04829A C J44.9 R06.9 Chronic obstructive pulmonary disease, unspecified Unspecified abnormalities of breathing A E. A . . . E.0 A . . . E.@ A . . . E.P A BECLOMETHASONE d00760A C J45 Asthma A E.P A GRISEOFULVIN d00100A A B35.4 Tinea corporis A E.` A . . . E.p A . . . E. A . . . E. A AMPHETAMINE d00803A B F90 Attention-deficit hyperactivity disorders A E. A . . . E. A . . . E. A . . . E. A . . . E. A . . . E. A . . . E/ A . . . E/ A . . . E/ A . . . E/0 A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified A` E/0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E/0 A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A` E/0 A MONTELUKAST d04289A C J45 Asthma A` E/0 A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A` E/0 A WARFARIN d00022A C- D75.9P Prevent blood clots A` E/@ A ALPRAZOLAM d00168A CDp F32.9 Major depressive disorder, single episode, unspecified A E/@ A CLONIDINE d00044A CP 99999 A E/@ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E/@ A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A E/@ A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E/@ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E/@ A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified A E/@ A PAROXETINE d03157A Dc F32.9 Major depressive disorder, single episode, unspecified A E/@ A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E/@ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E/P A . . . E/` A . . . E/p A ALLOPURINOL d00023A D9 M1A Chronic gout A@ E/p A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E/p A GLIPIZIDE d00246A D R73 Elevated blood glucose level A@ E/p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E/ A . . . E/ A . . . E/ A . . . E/ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E/ A ATENOLOL d00004A C- I10 Essential (primary) hypertension AP E/ A ENALAPRIL d00013A C- I10 Essential (primary) hypertension AP E/ A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus AP E/ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E/ A . . . E/ A . . . E/ A . . . E/ A LEVOTHYROXINE d00278A0 Dc 99999 A@ E/ A LOSARTAN d03821A0 C"0 I10 Essential (primary) hypertension A@ E/ A PAROXETINE d03157A C Z79.P Prophylactic medication A@ E/ A TRIAMTERENE d00396A0 Ei I10 Essential (primary) hypertension A@ E0 A . . . E0 A . . . E0 A . . . E00 A . . . E0@ A . . . E0P A GLYBURIDE d00248A C"0 E11 Type 2 diabetes mellitus A E0P A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E0` A 55555 A C E11 Type 2 diabetes mellitus A E0` A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E0` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E0` A FUROSEMIDE d00070A B I10 N28.9 Essential (primary) hypertension Disorder of kidney and ureter, unspecified A E0` A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E0` A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E0` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E0` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E0p A . . . E0 A ALBUTEROL d00749A C- J45 Asthma A0 E0 A CETIRIZINE d03827A C- J30.9 Allergic rhinitis, unspecified A0 E0 A FORMOTEROL; MOMETASONE d07660A B[ J45 Asthma A0 E0 A IBUPROFEN d00015A CDp M54.9 Dorsalgia, unspecified A E0 A . . . E0 A . . . E0 A . . . E0 A . . . E0 A . . . E0 A . . . E1 A TRAZODONE d00395A Cr G47.0 Insomnia A E1 A . . . E1 A ALBUTEROL d00749A C J45 Asthma A E10 A . . . E1@ A LISINOPRIL d00732A B E11.2P Prevent diabetic kidney disease A E1P A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E1` A . . . E1p A . . . E1 A . . . E1 A . . . E1 A . . . E1 A . . . E1 A CANDESARTAN d04322A C[@ I10 Essential (primary) hypertension A E1 A . . . E1 A . . . E1 A AZITHROMYCIN d00091A AP J06.9 Acute upper respiratory infection, unspecified A E2 A BUDESONIDE d04276A Cr R06.2 Wheezing A E2 A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E2 A ERYTHROMYCIN d00046A C- A09 Infectious gastroenteritis and colitis, unspecified A E2 A LACOSAMIDE d07349A C G40 Epilepsy and recurrent seizures A E2 A LACTULOSE d01024A C[@ K59.0 Constipation A E2 A LANSOPRAZOLE d03828A C[@ K21 Gastro-esophageal reflux disease A E2 A LEVALBUTEROL d04427A Cr R06.2 Wheezing A E2 A MONTELUKAST d04289A Cr R06.2 Wheezing A E2 A NITROFURANTOIN d00112A CDp N39.9 Disorder of urinary system, unspecified A E2 A ONDANSETRON d00867A C- R11 Nausea and vomiting A E2 A POLYETHYLENE GLYCOL 3350 d05350A A K59.0 Constipation A E2 A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures A E2 A VALPROIC ACID d00083A C G40 Epilepsy and recurrent seizures A E2 A . . . E2 A . . . E20 A FINASTERIDE d00563A Cr N40 Enlarged prostate A E2@ A . . . E2P A . . . E2` A BUDESONIDE; FORMOTEROL d04795A B J44.9 Chronic obstructive pulmonary disease, unspecified A E2p A ACETAMINOPHEN; OXYCODONE d03431A C M54.9 Dorsalgia, unspecified A` E2p A CYCLOBENZAPRINE d00963A C M54.9 Dorsalgia, unspecified A` E2p A IBUPROFEN d00015A C N94.6 Dysmenorrhea, unspecified A` E2p A PREDNISONE d00350A C M25.5 M54.5 Pain in joint Low back pain A` E2p A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A` E2p A ZOLPIDEM d00910A C- G47.0 Insomnia A` E2 A . . . E2 A . . . E2 A ALBUTEROL d00749A C- R06.2 Wheezing A` E2 A CITALOPRAM d04332A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A` E2 A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A` E2 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E2 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A` E2 A TRAZODONE d00395A C F43.9 G47.9 Reaction to severe stress, unspecified Sleep disorder, unspecified A` E2 A . . . E2 A . . . E2 A . . . E2 A . . . E2 A . . . E3 A ATENOLOL d00004A D I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP E3 A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified AP E3 A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E3 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E3 A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP E3 A . . . E3 A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A E30 A . . . E3@ A . . . E3P A . . . E3` A FLUTICASONE d01296A C J45 Asthma A0 E3` A MOMETASONE NASAL d04223A B J30.9 Allergic rhinitis, unspecified A0 E3` A MONTELUKAST d04289A A J45 Asthma A0 E3p A . . . E3 A . . . E3 A TIZANIDINE d04102A A T14.9 Unspecified injury A E3 A . . . E3 A . . . E3 A ATENOLOL d00004A B[ I10 Essential (primary) hypertension A E3 A WARFARIN d00022A D D75.9P Prevent blood clots A E3 A . . . E3 A . . . E3 A . . . E4 A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A` E4 A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A` E4 A CYCLOBENZAPRINE d00963A B M54.9 Dorsalgia, unspecified A` E4 A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A` E4 A RISPERIDONE d03180A D F32.9 Major depressive disorder, single episode, unspecified A` E4 A TRAZODONE d00395A Ap G47.0 Insomnia A` E4 A . . . E4 A . . . E40 A . . . E4@ A . . . E4P A . . . E4` A . . . E4p A . . . E4 A . . . E4 A GLIPIZIDE d00246A B- N28.9 Disorder of kidney and ureter, unspecified A E4 A LISINOPRIL d00732A B- R73 Elevated blood glucose level A E4 A . . . E4 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E4 A AMOXICILLIN d00088A Ap A49.9P Prevent bacterial infection A E4 A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E4 A ATORVASTATIN d04105A C I10 Essential (primary) hypertension A E4 A CELECOXIB d04380A C- M13 Other arthritis A E4 A CILOSTAZOL d04382A CDp Z95.5 Presence of coronary angioplasty implant and graft A E4 A CILOSTAZOL d04382A CDp I70.2 Atherosclerosis of native arteries of extremities A E4 A CLOPIDOGREL d04258A Cr E78.0 Pure hypercholesterolemia A E4 A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A E4 A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A E4 A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension A E4 A SERTRALINE d00880A C T88.7 Unspecified adverse effect of drug or medicament A E4 A . . . E4 A . . . E4 A . . . E4 A CIMETIDINE d00140A B K30 Functional dyspepsia AP E4 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension AP E4 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E4 A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site AP E4 A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP E5 A LISINOPRIL d00732A C- N28.9 Disorder of kidney and ureter, unspecified A E5 A PHENTERMINE d00806A B[ E66 Overweight and obesity A E5 A . . . E5 A BUPROPION d00181A Dc F32.9 Major depressive disorder, single episode, unspecified A E5 A CONJUGATED ESTROGENS d00541A C N95.2 Postmenopausal atrophic vaginitis A E5 A CONJUGATED ESTROGENS d00541A D N95.1 Menopausal and female climacteric states A E5 A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A C- N95.1 Menopausal and female climacteric states A E5 A FLUCONAZOLE d00071A C B37.3 Candidiasis of vulva and vagina A E5 A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A E5 A GABAPENTIN d03182A A G40 Epilepsy and recurrent seizures A E5 A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E5 A LIOTHYRONINE d00658A C E03.9 Hypothyroidism, unspecified A E5 A NITROFURANTOIN d00112A D N39.0 Urinary tract infection, site not specified A E5 A SUMATRIPTAN d03160A Dc G43 Migraine A E5 A TIZANIDINE d04102A B M79.1 Myalgia A E5 A TRAZODONE d00395A D# G47.0 Insomnia A E50 A . . . E5@ A BROMOCRIPTINE d00178A C D35.2 Benign neoplasm of pituitary gland A` E5@ A LORATADINE d03050A C- T78.40 Allergy, unspecified A` E5@ A METFORMIN d03807A C- E88.81 Metabolic syndrome A` E5@ A PHENTERMINE d00806A C E66.3 Overweight A` E5@ A PREDNISONE d00350A C E27.40 Unspecified adrenocortical insufficiency A` E5@ A TRAZODONE d00395A B G47.0 Insomnia A` E5P A . . . E5` A . . . E5p A NAPROXEN d00019A CDp G43 Migraine A E5p A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E5 A . . . E5 A . . . E5 A . . . E5 A . . . E5 A . . . E5 A MEMANTINE d04899A CDp G30.9 Alzheimer's disease, unspecified AP E5 A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E5 A RISPERIDONE d03180A CDp F29 Unspecified psychosis not due to a substance or known physiological condition AP E5 A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified AP E5 A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia AP E5 A . . . E5 A . . . E6 A ACETAMINOPHEN; HYDROCODONE d03428A0 B M79.1 Myalgia A@ E6 A ALLOPURINOL d00023A0 Cr M10.9 Gout, unspecified A@ E6 A COLCHICINE d00150A0 B M1A Chronic gout A@ E6 A OXCARBAZEPINE d04513A0 Cr F39 Unspecified mood [affective] disorder A@ E6 A . . . E6 A . . . E60 A QUETIAPINE d04220A CDp F41.9 Anxiety disorder, unspecified A E6@ A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C L70 Z79.3 Acne Long term (current) use of hormonal contraceptives A E6P A . . . E6` A . . . E6p A ALBUTEROL d00749A D= J45 Asthma A E6 A . . . E6 A . . . E6 A OXYCODONE d00329A C- B02 Zoster [herpes zoster] A E6 A PREGABALIN d05508A C- B02 Zoster [herpes zoster] A E6 A . . . E6 A SIMVASTATIN d00746A D= E78.0 Pure hypercholesterolemia A E6 A . . . E6 A ALENDRONATE d03849A D M88 Osteitis deformans [Paget's disease of bone] A` E6 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E6 A FLUTICASONE; SALMETEROL d04611A B 55555 A` E6 A LORAZEPAM d00149A D* F41.9 Anxiety disorder, unspecified A` E6 A METOPROLOL d00134A B 99999 A` E6 A METOPROLOL d00134A B I51.9 Heart disease, unspecified A` E6 A OMEPRAZOLE d00325A C- K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A@ E6 A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A@ E6 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E6 A ZOLPIDEM d00910A C- G47.0 Insomnia A@ E7 A ALBUTEROL d00749A Cr J45 Asthma A E7 A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E7 A BENZTROPINE d00175A Cr G25.0 Essential tremor A E7 A HALOPERIDOL d00027A Cr F20 Schizophrenia A E7 A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified A E7 A PERPHENAZINE d00855A Cr F29 Unspecified psychosis not due to a substance or known physiological condition A E7 A SEVELAMER d04363A Cr E83.3 Disorders of phosphorus metabolism and phosphatases A E7 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E7 A TAMSULOSIN d04121A Cr R35.0 Frequency of micturition A E7 A VALPROIC ACID d00083A Cr F39 Unspecified mood [affective] disorder A E7 A ZOLPIDEM d00910A Cr G47.9 Sleep disorder, unspecified A E7 A FLUTICASONE d01296A C- J45 Asthma A E7 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE d03425A D G43 Migraine A@ E7 A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E7 A HYDROCHLOROTHIAZIDE d00253A A I10 Essential (primary) hypertension A@ E7 A NAPROXEN d00019A C N94.6 Dysmenorrhea, unspecified A@ E70 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E70 A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E7@ A . . . E7P A . . . E7` A ACETAMINOPHEN; HYDROCODONE d03428A A T14.9 Unspecified injury A E7` A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection A E7` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E7` A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A E7` A CLONAZEPAM d00197A C"0 G47.0 Insomnia A E7` A DIAZEPAM d00148A C M62.83 Muscle spasm A E7` A DICLOFENAC d00848A C- M13 Other arthritis A E7` A PROMETHAZINE d00787A A R11 Nausea and vomiting A E7` A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E7p A . . . E7 A AZELASTINE NASAL d04068A Cr J30.9 Allergic rhinitis, unspecified A E7 A CLOMIPRAMINE d00876A Cr F42 Obsessive-compulsive disorder A E7 A FLUTICASONE d01296A Cr J45 Asthma A E7 A LAMOTRIGINE d03809A C F31.9 Bipolar disorder, unspecified A E7 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E7 A LOXAPINE d00897A Cr F29 Unspecified psychosis not due to a substance or known physiological condition A E7 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E7 A ZOLPIDEM d00910A C G47.0 Insomnia A E7 A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified A E7 A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E7 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E7 A LOVASTATIN d00280A D* E78.0 Pure hypercholesterolemia A` E7 A METFORMIN d03807A C E66 Overweight and obesity A` E7 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E7 A POTASSIUM CHLORIDE d00345A D> E87.6P Prevent hypokalemia A` E7 A VENLAFAXINE d03181A CP F32.9 Major depressive disorder, single episode, unspecified A` E7 A . . . E7 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E7 A . . . E7 A . . . E7 A . . . E8 A CEPHALEXIN d00096A A@ N39.0 Urinary tract infection, site not specified A E8 A ONDANSETRON d00867A A@ R11 Nausea and vomiting A E8 A . . . E8 A . . . E80 A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E8@ A . . . E8P A . . . E8` A . . . E8p A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E8p A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E8p A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A0 E8 A . . . E8 A . . . E8 A . . . E8 A . . . E8 A . . . E8 A . . . E8 A . . . E8 A . . . E9 A . . . E9 A ALLOPURINOL d00023A C M1A Chronic gout A E9 A CLONIDINE d00044A B I10 Essential (primary) hypertension A E9 A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E9 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E9 A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A E9 A LORATADINE d03050A B T78.40 Allergy, unspecified A E9 A RIVAROXABAN d07356A B D75.9P Prevent blood clots A E9 A SPIRONOLACTONE d00373A B I50.9 Heart failure, unspecified A E9 A TORSEMIDE d03189A C R60.9 Edema, unspecified A E9 A . . . E90 A CITALOPRAM d04332A C[@ R45.86 Emotional lability A E90 A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E9@ A . . . E9P A . . . E9` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E9` A TRAMADOL d03826A C M19.9 Osteoarthritis, unspecified site A E9p A . . . E9 A ALPRAZOLAM d00168A B= M62.83 Muscle spasm A E9 A PRAMIPEXOLE d04145A CDp G25.81 Restless legs syndrome A E9 A . . . E9 A SERTRALINE d00880A B= F32.9 Major depressive disorder, single episode, unspecified A E9 A ASPIRIN d00170A D I63.P Prevent stroke A E9 A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A E9 A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E9 A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E9 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E9 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E9 A RAMIPRIL d00728A CDp E11.2 Type 2 diabetes mellitus with kidney complications A E9 A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E9 A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E9 A . . . E9 A ALBUTEROL d00749A C- J45 Asthma A E9 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ Z79.3 Long term (current) use of hormonal contraceptives A E9 A . . . E: A ALLOPURINOL d00023A C M1A Chronic gout A0 E: A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A0 E: A SIMVASTATIN d00746A Bz E78.0 Pure hypercholesterolemia A0 E: A . . . E: A BENAZEPRIL d00730A0 C I10 Essential (primary) hypertension A0 E: A CARVEDILOL d03847A0 C I48.91 Unspecified atrial fibrillation A0 E: A TOLTERODINE d04294A0 C N39.4 Other specified urinary incontinence A0 E:0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E:0 A PANTOPRAZOLE d04514A CDp K30 Functional dyspepsia A E:@ A . . . E:P A . . . E:` A . . . E:p A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E:p A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A E:p A ISOSORBIDE MONONITRATE d00269A CDp I51.9 Heart disease, unspecified A E:p A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E:p A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E:p A METOPROLOL d00134A C[@ I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E:p A NAPROXEN d00019A CDp M54.9 Dorsalgia, unspecified A E:p A NIACIN d00314A C[@ E78.1 Pure hyperglyceridemia A E:p A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E: A . . . E: A . . . E: A . . . E: A . . . E: A ESTRADIOL d00537A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A` E: A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A` E: A NADOLOL d00018A B I10 Essential (primary) hypertension A` E: A PROGESTERONE d00550A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A` E: A SERTRALINE d00880A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E: A THYROID DESICCATED d00655A C- E03.9 Hypothyroidism, unspecified A` E: A . . . E: A . . . E: A . . . E; A NIFEDIPINE d00051A B= I10 Essential (primary) hypertension A E; A GENTAMICIN OPHTHALMIC d03974A A S05 Injury of eye and orbit A E; A . . . E;0 A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A0 E;0 A PRAVASTATIN d00348A D I21.P Prevent heart attack/myocardial infarction A0 E;0 A QUINAPRIL d00365A D# I50.9 Heart failure, unspecified A0 E;@ A ALBUTEROL d00749A C J45 Asthma AP E;@ A BECLOMETHASONE d00760A C J45 Asthma AP E;@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives AP E;@ A IBUPROFEN d00015A B R51 Headache AP E;@ A MONTELUKAST d04289A B[ J45 Asthma AP E;P A . . . E;` A BUDESONIDE d04276A B J45 Asthma A E;` A LEVALBUTEROL d04427A B J45 Asthma A E;p A . . . E; A . . . E; A . . . E; A . . . E; A . . . E; A . . . E; A ACETAMINOPHEN; HYDROCODONE d03428A C M54.2 Cervicalgia A E; A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E; A . . . E; A . . . E< A . . . E< A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E< A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E< A LISINOPRIL d00732A C- I10 N19 Essential (primary) hypertension Unspecified kidney failure A0 E< A NITROFURANTOIN d00112A C- N39.0 Urinary tract infection, site not specified A0 E<0 A . . . E<@ A . . . E
A . . . E> A . . . E> A . . . E>0 A . . . E>@ A . . . E>P A . . . E>` A ALBUTEROL d00749A C- J45 Asthma A` E>` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E>` A ESCITALOPRAM d04812A B= F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A` E>` A LEVALBUTEROL d04427A C- J45 Asthma A` E>` A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` E>` A TAMSULOSIN d04121A Cr R39.15 Urgency of urination A` E>p A . . . E> A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A0 E> A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A0 E> A CLONIDINE d00044A B[ G47.9 Sleep disorder, unspecified A0 E> A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E> A CONJUGATED ESTROGENS d00541A C[@ N95.1 Menopausal and female climacteric states A` E> A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A` E> A GABAPENTIN d03182A C[@ M79.606 M79.673 Pain in leg, unspecified Pain in unspecified foot A` E> A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A` E> A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E> A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E> A . . . E> A ALBUTEROL d00749A CDp J45 Asthma A0 E> A AMPHETAMINE; DEXTROAMPHETAMINE d04035A D F90 Attention-deficit hyperactivity disorders A0 E> A FLUTICASONE; SALMETEROL d04611A B J45 Asthma A0 E> A . . . E> A . . . E> A . . . E? A . . . E? A . . . E? A ESTRADIOL; NORETHINDRONE d04375A Cr N95.1 Menopausal and female climacteric states A E?0 A . . . E?@ A . . . E?P A . . . E?` A FUROSEMIDE d00070A D I10 Essential (primary) hypertension A@ E?` A LABETALOL d00016A C I10 Essential (primary) hypertension A@ E?` A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E?` A ROSUVASTATIN d04851A B I21.P Prevent heart attack/myocardial infarction A@ E?p A . . . E? A . . . E? A CEFDINIR d04256A A0 H66.9 Otitis media, unspecified A E? A CLONIDINE d00044A B F90 Attention-deficit hyperactivity disorders A E? A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E? A . . . E? A ALPRAZOLAM d00168A Cr F43.9 Reaction to severe stress, unspecified A` E? A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E? A ATENOLOL d00004A D/ I10 Essential (primary) hypertension A` E? A CIMETIDINE d00140A C K30 Functional dyspepsia A` E? A OMEPRAZOLE d00325A B R42 Dizziness and giddiness A` E? A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E? A ERYTHROMYCIN d00046A C R11.1 Vomiting Ap E? A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease Ap E? A MIRTAZAPINE d04025A0 B# F41.9 Anxiety disorder, unspecified Ap E? A ONDANSETRON d00867A0 B# R11 Nausea and vomiting Ap E? A POLYETHYLENE GLYCOL 3350 d05350A0 B# K59.0 Constipation Ap E? A PROPRANOLOL d00032A0 B# R45.0 Nervousness Ap E? A SERTRALINE d00880A0 B# F41.9 Anxiety disorder, unspecified Ap E? A . . . E? A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E@ A . . . E@ A . . . E@ A . . . E@0 A . . . E@@ A . . . E@P A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A@ E@P A LISINOPRIL d00732A B# I10 Essential (primary) hypertension A@ E@P A LUBIPROSTONE d05736A C K58 K59.0 Irritable bowel syndrome Constipation A@ E@P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E@` A LISINOPRIL d00732A Ap I10 Essential (primary) hypertension A E@p A . . . E@ A . . . E@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E@ A ATORVASTATIN d04105A Bz I51.9 Heart disease, unspecified A@ E@ A CARVEDILOL d03847A Bz 99999 A@ E@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E@ A METFORMIN d03807A Bz R73 Elevated blood glucose level A@ E@ A . . . E@ A . . . E@ A . . . E@ A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E@ A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E@ A . . . EA A . . . EA A . . . EA A . . . EA0 A . . . EA@ A . . . EAP A . . . EA` A CLONIDINE d00044A C I10 Essential (primary) hypertension A EAp A . . . EA A . . . EA A . . . EA A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified Ap EA A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension Ap EA A ESOMEPRAZOLE d04749A C[@ K30 Functional dyspepsia Ap EA A FLECAINIDE d00234A C- I49.9 Cardiac arrhythmia, unspecified Ap EA A MELOXICAM d04532A B= M13 M79.7 Other arthritis Fibromyalgia Ap EA A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified Ap EA A VENLAFAXINE d03181A B F32.9 M79.7 Major depressive disorder, single episode, unspecified Fibromyalgia Ap EA A INTERFERON BETA-1A d04011A D G35 Multiple sclerosis A EA A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A EA A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A EA A . . . EA A . . . EA A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A EB A . . . EB A . . . EB A RALOXIFENE d04261A C M81 Osteoporosis without current pathological fracture A EB0 A . . . EB@ A . . . EBP A . . . EB` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N30 Cystitis A EBp A . . . EB A . . . EB A . . . EB A . . . EB A . . . EB A ALLOPURINOL d00023A CP M25.5 Pain in joint A@ EB A AMLODIPINE; BENAZEPRIL d03829A CP I10 Essential (primary) hypertension A@ EB A COLCHICINE d00150A CP E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A@ EB A LORATADINE d03050A C- T78.40 Allergy, unspecified A@ EB A . . . EB A . . . EB A . . . EC A BACLOFEN d00967A A@ M54.9 Dorsalgia, unspecified A EC A TRAMADOL d03826A A T14.9 Unspecified injury A EC A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A EC A . . . EC0 A DIGOXIN d00210A CP I48.91 Unspecified atrial fibrillation A EC0 A WARFARIN d00022A CP I48.91 Unspecified atrial fibrillation A EC@ A . . . ECP A . . . EC` A ALPRAZOLAM d00168A0 D F41.9 Anxiety disorder, unspecified A EC` A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A EC` A FUROSEMIDE d00070A0 D R60.9 Edema, unspecified A EC` A GEMFIBROZIL d00245A0 D ^ E78.0 Pure hypercholesterolemia A EC` A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus A EC` A HYDRALAZINE d00132A0 C I10 Essential (primary) hypertension A EC` A INSULIN ISOPHANE (NPH) d04370A0 C E11 Type 2 diabetes mellitus A EC` A LOSARTAN d03821A0 B= I10 Essential (primary) hypertension A EC` A METOPROLOL d00134A0 D I10 Essential (primary) hypertension A EC` A OMEPRAZOLE d00325A0 C[@ K27 Peptic ulcer, site unspecified A EC` A WARFARIN d00022A0 D ^ D75.9P Prevent blood clots A ECp A . . . EC A . . . EC A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EC A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EC A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A EC A MONTELUKAST d04289A Bz J45 Asthma A EC A AMOXICILLIN d00088A AP J02 Acute pharyngitis A0 EC A CEPHALEXIN d00096A AP J02 Acute pharyngitis A0 EC A PREDNISONE d00350A AP J02 Acute pharyngitis A0 EC A . . . EC A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C R51 Headache Ap EC A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap EC A ESTRADIOL d00537A B[ N95.1 Menopausal and female climacteric states Ap EC A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified Ap EC A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap EC A PROGESTERONE d00550A B[ N95.1 Menopausal and female climacteric states Ap EC A SERTRALINE d00880A C[@ F32.9 Major depressive disorder, single episode, unspecified Ap EC A . . . EC A . . . ED A IPRATROPIUM d00265A Ap J20.9 Acute bronchitis, unspecified A ED A . . . ED A . . . ED0 A . . . ED@ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A EDP A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A ED` A . . . EDp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EDp A PENTOSAN POLYSULFATE SODIUM d04052A C[@ N30.1 Interstitial cystitis (chronic) A ED A . . . ED A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP ED A CLOPIDOGREL d04258A C[@ I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction AP ED A ENALAPRIL d00013A C[@ I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP ED A ISOSORBIDE MONONITRATE d00269A C[@ I20.9 Angina pectoris, unspecified AP ED A METOPROLOL d00134A C[@ I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP ED A . . . ED A . . . ED A METFORMIN d03807A C R73.9 Hyperglycemia, unspecified A ED A . . . ED A . . . ED A . . . EE A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EE A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EE A CLONIDINE d00044A C I10 Essential (primary) hypertension A EE A DORZOLAMIDE OPHTHALMIC d03805A C H40 Glaucoma A EE A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A EE A ISOSORBIDE d00653A C R07.9 Chest pain, unspecified A EE A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A EE A METOPROLOL d00134A C I10 Essential (primary) hypertension A EE A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EE A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A EE A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A EE A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54.9 Dorsalgia, unspecified Ap EE A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture Ap EE A ATORVASTATIN d04105A Cr M81 Osteoporosis without current pathological fracture Ap EE A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified Ap EE A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified Ap EE A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap EE A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap EE A . . . EE0 A . . . EE@ A . . . EEP A . . . EE` A . . . EEp A . . . EE A . . . EE A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EE A BACLOFEN d00967A C M25.56 Pain in knee A EE A CLINDAMYCIN TOPICAL d01241A B[ L70 Acne A EE A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A EE A FUROSEMIDE d00070A C 99999 A EE A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EE A POTASSIUM CHLORIDE d00345A C I10 Essential (primary) hypertension A EE A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A EE A TRAMADOL d03826A B M25.56 Pain in knee A EE A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A EE A TRIAMCINOLONE TOPICAL d03206A B[ L70 Acne A EE A CELECOXIB d04380A B= G89.18 Other acute postprocedural pain A@ EE A HYDROXYZINE d00907A C L23 Allergic contact dermatitis A@ EE A NIFEDIPINE d00051A Ei I10 Essential (primary) hypertension A@ EE A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ EE A . . . EE A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A EE A DESONIDE TOPICAL d01290A B L20.9 Atopic dermatitis, unspecified A EE A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EE A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EE A . . . EF A CYCLOBENZAPRINE d00963A B[ M62.83 Muscle spasm A@ EF A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A@ EF A HYDROCODONE d03075A C T14.9 Unspecified injury A@ EF A LORATADINE d03050A B R09.81 Nasal congestion A@ EF A . . . EF A . . . EF0 A CARVEDILOL d03847A C I48.91 Unspecified atrial fibrillation A EF0 A DABIGATRAN d07137A CDp D75.9P Prevent blood clots A EF0 A DIGOXIN d00210A C I48.91 Unspecified atrial fibrillation A EF0 A ENALAPRIL d00013A Cr E11.2P Prevent diabetic kidney disease A EF0 A FUROSEMIDE d00070A Dc I50.9 Heart failure, unspecified A EF0 A METFORMIN d03807A C R73 Elevated blood glucose level A EF0 A MYCOPHENOLATE MOFETIL d03839A D 55555 A EF0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EF0 A SPIRONOLACTONE d00373A C E87.7 Fluid overload A EF@ A . . . EFP A . . . EF` A ACETAMINOPHEN; HYDROCODONE d03428A C M79.1 Myalgia Ap EF` A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap EF` A DILTIAZEM d00045A Cr I49.9 Cardiac arrhythmia, unspecified Ap EF` A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus Ap EF` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap EF` A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EF` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap EFp A ACETAMINOPHEN; HYDROCODONE d03428A0 B M54.9 Dorsalgia, unspecified A EFp A AMITRIPTYLINE d00146A0 C[@ G43 Migraine A EFp A AMLODIPINE; BENAZEPRIL d03829A0 C[@ I10 Essential (primary) hypertension A EFp A ATENOLOL d00004A0 Cr I10 Essential (primary) hypertension A EFp A CYCLOBENZAPRINE d00963A0 CDp R51 Headache A EFp A FLUOXETINE d00236A0 C F32.9 Major depressive disorder, single episode, unspecified A EFp A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A EFp A LOVASTATIN d00280A0 C- E78.0 Pure hypercholesterolemia A EFp A OMEPRAZOLE d00325A0 Cr K21 Gastro-esophageal reflux disease A EFp A POTASSIUM CHLORIDE d00345A0 CDp E87.6 Hypokalemia A EFp A TRAMADOL d03826A0 C M19.9 Osteoarthritis, unspecified site A EF A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A0 EF A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A0 EF A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EF A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 EF A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 EF A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EG A . . . EG A . . . EG A TAMOXIFEN d00381A CDp C50.P Prevent barest cancer A EG0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` EG0 A DIVALPROEX SODIUM d03833A Cr F39 Unspecified mood [affective] disorder A` EG0 A ISONIAZID d00101A Cr 99999 A` EG0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` EG0 A QUETIAPINE d04220A Cr F90 Attention-deficit hyperactivity disorders A` EG0 A RABEPRAZOLE d04448A Cr K21 Gastro-esophageal reflux disease A` EG@ A . . . EGP A . . . EG` A . . . EGp A . . . EG A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension Ap EG A ERYTHROMYCIN OPHTHALMIC d03973A Ap H57.8 Other specified disorders of eye and adnexa Ap EG A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap EG A LIDOCAINE TOPICAL d00683A C M79.2 Neuralgia and neuritis, unspecified Ap EG A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia Ap EG A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EG A PREDNISOLONE d00084A C- H57.8 Other specified disorders of eye and adnexa Ap EG A . . . EG A ELETRIPTAN d04849A C- G43 Migraine A EG A . . . EG A . . . EG A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr Z79.3 Long term (current) use of hormonal contraceptives A EG A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` EG A DOXAZOSIN d00726A C I10 Essential (primary) hypertension A` EG A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` EG A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A` EG A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A` EG A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A` EG A . . . EH A . . . EH A . . . EH A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ EH A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EH A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A@ EH A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EH0 A . . . EH@ A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots Ap EH@ A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension Ap EH@ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap EH@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap EH@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap EH@ A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap EH@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap EHP A ESOMEPRAZOLE d04749A Cr R12 Heartburn A0 EHP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A AP I10 Essential (primary) hypertension A0 EHP A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 EH` A . . . EHp A CELECOXIB d04380A Cr M79.1 Myalgia A EH A . . . EH A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A EH A . . . EH A . . . EH A . . . EH A FEXOFENADINE d04040A C- R09.81 Nasal congestion A0 EH A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 EH A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A0 EH A ALBUTEROL d00749A CP R06.9 Unspecified abnormalities of breathing A` EH A DONEPEZIL d04099A C- 99999 A` EH A FLUTICASONE; SALMETEROL d04611A C[@ R06.9 Unspecified abnormalities of breathing A` EH A ISOSORBIDE d00653A C I51.9 Heart disease, unspecified A` EH A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A` EH A TIOTROPIUM d04829A CP R06.9 Unspecified abnormalities of breathing A` EH A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A EI A . . . EI A . . . EI A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP EI A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP EI A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP EI A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures AP EI A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures AP EI0 A . . . EI@ A LORATADINE d03050A C T78.40 Allergy, unspecified A EIP A CARISOPRODOL d00960A Dc T14.9 Unspecified injury A EIP A LOSARTAN d03821A C I10 Essential (primary) hypertension A EIP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EIP A METOPROLOL d00134A C I10 Essential (primary) hypertension A EIP A MIRTAZAPINE d04025A Dc G47.9 Sleep disorder, unspecified A EIP A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A EIP A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A EIP A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A EI` A AMPHETAMINE d00803A C- F90 Attention-deficit hyperactivity disorders A EIp A . . . EI A IBUPROFEN d00015A Ap M94.0 Chondrocostal junction syndrome A EI A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia Ap EI A BUSPIRONE d00182A Cr F32.9 Major depressive disorder, single episode, unspecified Ap EI A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified Ap EI A DIVALPROEX SODIUM d03833A C- F32.9 Major depressive disorder, single episode, unspecified Ap EI A HALOPERIDOL d00027A Cr F91.9 Conduct disorder, unspecified Ap EI A LITHIUM d00061A C F31.9 Bipolar disorder, unspecified Ap EI A METFORMIN d03807A B E11 Type 2 diabetes mellitus Ap EI A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ EI A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- R53.83 Other fatigue A@ EI A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ EI A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ EI A . . . EI A . . . EI A . . . EI A ENALAPRIL d00013A C[@ I10 Essential (primary) hypertension A EI A ESTRADIOL d00537A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A EI A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A EI A NEBIVOLOL d05265A C R00.0 Tachycardia, unspecified A EI A OXYCODONE d00329A C- M25.56 Pain in knee A EI A PITAVASTATIN d07637A C E78.0 Pure hypercholesterolemia A EI A RANITIDINE d00021A C B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A EI A TEMAZEPAM d00384A C[@ G47.0 Insomnia A EI A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EJ A DESLORATADINE d04785A C T78.40 Allergy, unspecified A EJ A . . . EJ A . . . EJ0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` EJ0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EJ0 A ESOMEPRAZOLE d04749A C K46 Unspecified abdominal hernia A` EJ0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EJ0 A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A` EJ0 A NAPROXEN d00019A C T14.9 Unspecified injury A` EJ@ A . . . EJP A GLYBURIDE d00248A CDp E11 Type 2 diabetes mellitus A@ EJP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ EJP A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ EJP A METHADONE d00050A C[@ M25.51 Pain in shoulder A@ EJ` A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A` EJ` A CARBAMAZEPINE d00058A CDp F32.9 Major depressive disorder, single episode, unspecified A` EJ` A CLONAZEPAM d00197A CDp G47.9 Sleep disorder, unspecified A` EJ` A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia A` EJ` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` EJ` A TIZANIDINE d04102A C M62.83 Muscle spasm A` EJp A GLIPIZIDE d00246A C[@ R73 Elevated blood glucose level A` EJp A IBUPROFEN d00015A B T14.9 Unspecified injury A` EJp A LISINOPRIL d00732A C[@ I10.P Prevent hypertension A` EJp A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` EJp A SIMVASTATIN d00746A C[@ E78.0P Prevent high cholesterol A` EJp A TERAZOSIN d00386A B R39.15 Urgency of urination A` EJ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A` EJ A GLYBURIDE d00248A Dc E11 Type 2 diabetes mellitus A` EJ A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A` EJ A LISINOPRIL d00732A Cr I51.9 Heart disease, unspecified A` EJ A MONTELUKAST d04289A Cr J45 Asthma A` EJ A PIOGLITAZONE d04442A Dc E11 Type 2 diabetes mellitus A` EJ A . . . EJ A ACETAMINOPHEN; HYDROCODONE d03428A B T14.9 Unspecified injury A@ EJ A ACETAMINOPHEN; OXYCODONE d03431A B K08.8 Other specified disorders of teeth and supporting structures A@ EJ A AMOXICILLIN; CLAVULANATE d00089A B J02 Acute pharyngitis A@ EJ A SILVER SULFADIAZINE TOPICAL d01259A B T30.0 Burn of unspecified body region, unspecified degree A@ EJ A CLONIDINE d00044A C I10 Essential (primary) hypertension A EJ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EJ A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A EJ A . . . EJ A . . . EJ A . . . EK A . . . EK A ALBUTEROL d00749A C J45 R06.2 Asthma Wheezing A EK A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A EK A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A EK A DOMPERIDONE a59812A C- K92.9 Disease of digestive system, unspecified A EK A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A EK A LUBIPROSTONE d05736A C- K59.0 Constipation A EK A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A EK A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A EK A SUMATRIPTAN d03160A D"8 G43 Migraine A EK A VERAPAMIL d00048A D I10 Essential (primary) hypertension A EK A . . . EK0 A ALBUTEROL d00749A0 D J45 Asthma A@ EK0 A ALBUTEROL d00749A0 D1 J45 Asthma A@ EK0 A BUDESONIDE d04276A0 C J45 Asthma A@ EK0 A CYANOCOBALAMIN d00413A0 Cr E53.9 Vitamin B deficiency, unspecified A@ EK@ A . . . EKP A . . . EK` A . . . EKp A FOSINOPRIL; HYDROCHLOROTHIAZIDE d04539A D I10 Essential (primary) hypertension A EKp A LEVOTHYROXINE d00278A D* E04.1 Nontoxic single thyroid nodule A EK A . . . EK A . . . EK A AMLODIPINE d00689A D I10 Essential (primary) hypertension A EK A BISOPROLOL d00709A D I10 Essential (primary) hypertension A EK A . . . EK A . . . EK A BUSPIRONE d00182A A F32.9 Major depressive disorder, single episode, unspecified A@ EK A RISPERIDONE d03180A C- F39 G47.0 Unspecified mood [affective] disorder Insomnia A@ EK A TOPIRAMATE d04115A C- F50.9 Eating disorder, unspecified A@ EK A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A@ EK A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A EK A FORMOTEROL; MOMETASONE d07660A C J45 Asthma A EK A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C E28.2 Polycystic ovarian syndrome A EK A METFORMIN d03807A C R73 Elevated blood glucose level A EL A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EL A NORTRIPTYLINE d00144A A F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A0 EL A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A0 EL A TAMOXIFEN d00381A Cr C50.P Prevent barest cancer A EL A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A0 EL A RAMIPRIL d00728A Dc I10 Essential (primary) hypertension A0 EL A TRAVOPROST OPHTHALMIC d04753A B H40 Glaucoma A0 EL0 A . . . EL@ A . . . ELP A . . . EL` A . . . ELp A . . . EL A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease B EL A FENOFIBRATE d04286A Ei E78.0 Pure hypercholesterolemia B EL A FINASTERIDE d00563A Ei N40 Enlarged prostate B EL A FLUTICASONE; SALMETEROL d04611A0 C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma B EL A FUROSEMIDE d00070A0 Ei J98.9 Respiratory disorder, unspecified B EL A GLYBURIDE d00248A0 D E11 Type 2 diabetes mellitus B EL A INSULIN DETEMIR d05436A0 D E11 Type 2 diabetes mellitus B EL A IRBESARTAN d04222A0 Ei I10 Essential (primary) hypertension B EL A MONTELUKAST d04289A0 Ei J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma B EL A POTASSIUM CHLORIDE d00345A0 Ei E87.6 Hypokalemia B EL A PREDNISOLONE OPHTHALMIC d03221A0 Ap 99999 B EL A PREDNISONE d00350A0 C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma B EL A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia B EL A SERTRALINE d00880A0 C F39 Unspecified mood [affective] disorder B EL A TAMSULOSIN d04121A0 Ei N40 Enlarged prostate B EL A TRAZODONE d00395A0 Ei G47.9 Sleep disorder, unspecified B EL A WARFARIN d00022A0 Ei I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction B EL A . . . EL A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A EL A DIFLUPREDNATE OPHTHALMIC d07298A B* H11.3 Conjunctival hemorrhage A EL A DONEPEZIL d04099A B R41.3 Other amnesia A EL A EZETIMIBE; SIMVASTATIN d05348A Cr E78.0 Pure hypercholesterolemia A EL A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension A EL A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A EL A RALOXIFENE d04261A C[@ M81.P Prevent bone loss/osteoporosis A EL A VALSARTAN d04113A Cr I21.P Prevent heart attack/myocardial infarction A EL A . . . EL A PREDNISOLONE d00084A A R05 R11.1 Cough Vomiting A EL A . . . EL A . . . EL A . . . EM A . . . EM A . . . EM A . . . EM0 A . . . EM@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EMP A . . . EM` A . . . EMp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EMp A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A` EMp A HYDROCHLOROTHIAZIDE d00253A C I50.9 R60.9 Heart failure, unspecified Edema, unspecified A` EMp A LOSARTAN d03821A A I10 Essential (primary) hypertension A` EMp A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` EMp A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` EM A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap EM A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction Ap EM A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap EM A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EM A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction Ap EM A PANTOPRAZOLE d04514A CDp R12 Heartburn Ap EM A PRASUGREL d07409A C- Z95.5 Presence of coronary angioplasty implant and graft Ap EM A . . . EM A . . . EM A . . . EM A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EM A . . . EM A KETOROLAC d00273A C- G43 Migraine AP EM A LEVALBUTEROL d04427A C- J45 Asthma AP EM A MOMETASONE d05262A C- J45 Asthma AP EM A PHENYTOIN d00143A B G43 Migraine AP EM A SUMATRIPTAN d03160A B G43 Migraine AP EM A BISOPROLOL d00709A C I10 Essential (primary) hypertension A EM A DILTIAZEM d00045A CDp I49.9 Cardiac arrhythmia, unspecified A EM A DUTASTERIDE d04788A C N42.9 Disorder of prostate, unspecified A EM A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A EM A RIVAROXABAN d07356A B Z79.02 Long term (current) use of antithrombotics/antiplatelets A EM A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A EM A TIOTROPIUM d04829A C- J44.9 Chronic obstructive pulmonary disease, unspecified A EM A TORSEMIDE d03189A CDp I51.9 Heart disease, unspecified A EN A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A EN A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EN A . . . EN A ALBUTEROL d00749A Cr J45 Asthma A EN A FEXOFENADINE d04040A CDp T78.40 Allergy, unspecified A EN0 A . . . EN@ A . . . ENP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A ENP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EN` A LEVOTHYROXINE d00278A C C73 Malignant neoplasm of thyroid gland AP EN` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP EN` A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP EN` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease AP EN` A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP ENp A . . . EN A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 EN A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A0 EN A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A0 EN A . . . EN A . . . EN A . . . EN A CARISOPRODOL d00960A C- M62.83 Muscle spasm AP EN A ENALAPRIL d00013A B[ I10 Essential (primary) hypertension AP EN A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus AP EN A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP EN A TRAMADOL d03826A C- M79.7 Fibromyalgia AP EN A AMOXICILLIN d00088A Ap J20.9 Acute bronchitis, unspecified A EN A CHLORPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03370A Ap J09 Influenza due to certain identified influenza viruses A EN A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 EN A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 EN A PHENTERMINE d00806A C- 55555 A0 EN A . . . EO A CEFUROXIME d00056A AP J01.9 Acute sinusitis, unspecified A0 EO A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 EO A SPIRONOLACTONE d00373A C[@ L70 Acne A0 EO A AMLODIPINE d00689A B I10 Essential (primary) hypertension A EO A ALBUTEROL d00749A C J45 Asthma A EO0 A . . . EO@ A . . . EOP A . . . EO` A . . . EOp A NAPROXEN d00019A C M54.9 Dorsalgia, unspecified A EOp A RISEDRONATE d04300A C M81 Osteoporosis without current pathological fracture A EO A . . . EO A . . . EO A . . . EO A . . . EO A . . . EO A ACETAMINOPHEN; HYDROCODONE d03428A C R10.9 Unspecified abdominal pain AP EO A METOPROLOL d00134A D I10 Essential (primary) hypertension AP EO A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP EO A PHENOBARBITAL d00340A D9 G40 Epilepsy and recurrent seizures AP EO A WARFARIN d00022A D Z95.2 Presence of prosthetic heart valve AP EO A . . . EO A AMLODIPINE d00689A0 B I10 Essential (primary) hypertension A` EO A DABIGATRAN d07137A0 B I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A` EO A DICLOFENAC d00848A0 B M19.9 Osteoarthritis, unspecified site A` EO A OMEPRAZOLE d00325A0 B R12 Heartburn A` EO A QUETIAPINE d04220A0 C G31.9 Degenerative disease of nervous system, unspecified A` EO A ROSUVASTATIN d04851A0 B E78.0 Pure hypercholesterolemia A` EP A . . . EP A ALBUTEROL d00749A C- J45 Asthma A EP A ALBUTEROL d00749A CDp J45 Asthma A EP A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D= I10 Essential (primary) hypertension A EP0 A . . . EP@ A ALBUTEROL d00749A C- J45 Asthma A@ EP@ A BECLOMETHASONE d00760A C- J45 Asthma A@ EP@ A CEPHALEXIN d00096A A N48.29 Other inflammatory disorders of penis A@ EP@ A IBUPROFEN d00015A A M79.1 Myalgia A@ EPP A . . . EP` A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A EPp A . . . EP A . . . EP A DICLOFENAC d00848A C- M79.1 Myalgia A@ EP A HYDROCODONE d03075A CP M25.5 Pain in joint A@ EP A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ EP A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ EP A . . . EP A . . . EP A . . . EP A . . . EP A . . . EP A CARVEDILOL d03847A0 Cr I10 Essential (primary) hypertension A0 EP A INSULIN GLULISINE d05278A0 C- E11 Type 2 diabetes mellitus A0 EP A IPRATROPIUM NASAL d04235A0 CDp R09.89 Other specified symptoms and signs involving the circulatory and respiratory systems A0 EQ A ALBUTEROL d00749A C- J45 Asthma Ap EQ A ATOMOXETINE d04827A C- F90 Attention-deficit hyperactivity disorders Ap EQ A LORATADINE d03050A C- J30.9 J45 T78.40 Allergic rhinitis, unspecified Asthma Allergy, unspecified Ap EQ A METHYLPHENIDATE d00900A C- F32.9 F90 Major depressive disorder, single episode, unspecified Attention-deficit hyperactivity disorders Ap EQ A METHYLPHENIDATE d00900A C- F32.9 F90 Major depressive disorder, single episode, unspecified Attention-deficit hyperactivity disorders Ap EQ A QUETIAPINE d04220A C- F32.9 F90 Major depressive disorder, single episode, unspecified Attention-deficit hyperactivity disorders Ap EQ A RISPERIDONE d03180A C- F32.9 F90 Major depressive disorder, single episode, unspecified Attention-deficit hyperactivity disorders Ap EQ A . . . EQ A . . . EQ0 A . . . EQ@ A . . . EQP A AMLODIPINE; OLMESARTAN d06905A B I10 Essential (primary) hypertension A EQ` A . . . EQp A . . . EQ A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A CDp I10 Essential (primary) hypertension A EQ A . . . EQ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EQ A . . . EQ A . . . EQ A . . . EQ A ALBUTEROL d00749A C[@ J45 Asthma A EQ A AMLODIPINE d00689A0 Ei I10 Essential (primary) hypertension A EQ A AMMONIUM LACTATE TOPICAL d04049A0 Ei L85.3 Xerosis cutis A EQ A ASPIRIN; DIPYRIDAMOLE d04497A0 Ei I63.P Prevent stroke A EQ A ATORVASTATIN d04105A0 Ei E78.0 Pure hypercholesterolemia A EQ A DOCUSATE d01021A0 Ei K59.0 Constipation A EQ A FUROSEMIDE d00070A0 Ei R60.9 Edema, unspecified A EQ A HYDROCHLOROTHIAZIDE d00253A0 Ei I10 Essential (primary) hypertension A EQ A INSULIN ASPART d04697A0 Ei E11 Type 2 diabetes mellitus A EQ A INSULIN GLARGINE d04538A0 Ei E11 Type 2 diabetes mellitus A EQ A LINAGLIPTIN d07767A0 Ei E11 Type 2 diabetes mellitus A EQ A NITROGLYCERIN d00321A0 Ei R07.9 Chest pain, unspecified A EQ A OMEPRAZOLE d00325A0 Ei K21 Gastro-esophageal reflux disease A EQ A TAMSULOSIN d04121A0 Ei R35.0 Frequency of micturition A EQ A TERBINAFINE d04012A0 Ei B35.3 Tinea pedis A EQ A . . . ER A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction AP ER A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP ER A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP ER A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP ER A PIOGLITAZONE d04442A C[@ E11 Type 2 diabetes mellitus AP ER A . . . ER A AMLODIPINE; BENAZEPRIL d03829A C R00.2 Palpitations A ER A EXENATIDE d05529A Cr E11 Type 2 diabetes mellitus A ER A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A ER A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A ER A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A ER A METFORMIN d03807A C E11 Type 2 diabetes mellitus A ER A METOPROLOL d00134A B= R00.2 Palpitations A ER A RANITIDINE d00021A B K30 Functional dyspepsia A ER0 A . . . ER@ A . . . ERP A . . . ER` A . . . ERp A . . . ER A . . . ER A . . . ER A . . . ER A ALPRAZOLAM d00168A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A ER A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A ER A . . . ER A . . . ER A . . . ER A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP ER A CLONAZEPAM d00197A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia AP ER A DICLOFENAC TOPICAL d04722A B[ M19.9 Osteoarthritis, unspecified site AP ER A LAMOTRIGINE d03809A C F31.9 Bipolar disorder, unspecified AP ER A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified AP ES A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension A0 ES A ATORVASTATIN d04105A0 C- E78.0 Pure hypercholesterolemia A0 ES A LOSARTAN d03821A0 C- I10 Essential (primary) hypertension A0 ES A . . . ES A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A ES A POTASSIUM CITRATE d01423A Dc N20.0 Calculus of kidney A ES0 A . . . ES@ A . . . ESP A . . . ES` A . . . ESp A . . . ES A . . . ES A . . . ES A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap ES A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap ES A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap ES A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap ES A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap ES A OMEPRAZOLE d00325A C K27 Peptic ulcer, site unspecified Ap ES A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap ES A . . . ES A LOSARTAN d03821A B I10 Essential (primary) hypertension A ES A . . . ES A . . . ES A . . . ET A . . . ET A ACETAMINOPHEN; OXYCODONE d03431A B M79.2 Neuralgia and neuritis, unspecified A ET A DIPHENHYDRAMINE d00212A Ap J30.9 Allergic rhinitis, unspecified A ET A . . . ET0 A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A ET0 A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A ET@ A . . . ETP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Bz I10 Essential (primary) hypertension A ETP A OMEPRAZOLE d00325A Bz R12 Heartburn A ET` A . . . ETp A . . . ET A AMOXICILLIN d00088A A@ K08.4 Partial loss of teeth A ET A IBUPROFEN d00015A A K08.4 Partial loss of teeth A ET A . . . ET A 55555 A C D75.9P I63.P Prevent blood clots Prevent stroke AP ET A COLESEVELAM d04695A C E78.0 Pure hypercholesterolemia AP ET A ICOSAPENT d07891A C M25.5 Pain in joint AP ET A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP ET A LINAGLIPTIN; METFORMIN d07825A C R73 Elevated blood glucose level AP ET A CHLORHEXIDINE TOPICAL d01231A0 D* K05.6 Periodontal disease, unspecified AP ET A LEVOTHYROXINE d00278A0 DGJ E03.9 Hypothyroidism, unspecified AP ET A RANITIDINE d00021A Ei K30 Functional dyspepsia AP ET A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia AP ET A ZOLEDRONIC ACID d04708A0 CDp M85.80 Other specified disorders of bone density and structure, unspecified site AP ET A AZATHIOPRINE d00024A C M06.9 Rheumatoid arthritis, unspecified A` ET A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A` ET A HYDROCODONE d03075A CDp T14.9 Unspecified injury A` ET A IRBESARTAN d04222A CDp I10 Essential (primary) hypertension A` ET A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A` ET A METHOTREXATE d00060A Dc M06.9 Rheumatoid arthritis, unspecified A` ET A . . . ET A HYDROCODONE d03075A A S82.0 Fracture of patella A ET A . . . EU A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A0 EU A ATENOLOL d00004A D* I10 Essential (primary) hypertension A0 EU A TERAZOSIN d00386A D* I10 Essential (primary) hypertension A0 EU A ACETAMINOPHEN; HYDROCODONE d03428A0 B= M79.2 Neuralgia and neuritis, unspecified A EU A AMOXICILLIN d00088A0 B A49.9P Prevent bacterial infection A EU A CEPHALEXIN d00096A0 A L03.90 Cellulitis, unspecified A EU A DONEPEZIL d04099A0 B G30.9 Alzheimer's disease, unspecified A EU A HYDROXYZINE d00907A0 Ei L23 Allergic contact dermatitis A EU A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A EU A LOVASTATIN d00280A0 C E78.0 Pure hypercholesterolemia A EU A MEGESTROL d01348A0 B C61 Malignant neoplasm of prostate A EU A MEMANTINE d04899A0 B G30.9 Alzheimer's disease, unspecified A EU A DIGOXIN d00210A C I49.9 Cardiac arrhythmia, unspecified Ap EU A DILTIAZEM d00045A C I49.9 Cardiac arrhythmia, unspecified Ap EU A FAMOTIDINE d00141A Cr K21 Gastro-esophageal reflux disease Ap EU A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension Ap EU A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified Ap EU A METFORMIN d03807A D# E11 Type 2 diabetes mellitus Ap EU A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap EU0 A ESZOPICLONE d05421A D G47.9 Sleep disorder, unspecified A` EU0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A` EU0 A LUBIPROSTONE d05736A D 99999 A` EU0 A PRAMIPEXOLE d04145A D F98.4 Stereotyped movement disorders A` EU0 A PRIMIDONE d00352A D G40 Epilepsy and recurrent seizures A` EU0 A SERTRALINE d00880A D 99999 A` EU@ A ESTRADIOL d00537A C N95.1 Menopausal and female climacteric states A EU@ A SOTALOL d00371A D I48.91 Unspecified atrial fibrillation A EUP A 99999 . . A EUP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A EU` A . . . EUp A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A0 EUp A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma A0 EUp A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A0 EU A . . . EU A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A EU A MONTELUKAST d04289A CDp J45 Asthma A EU A AMOXICILLIN d00088A0 A H66.9 Otitis media, unspecified A EU A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A0 EU A CLONIDINE d00044A B I10 Essential (primary) hypertension A0 EU A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A0 EU A . . . EU A . . . EU A . . . EU A ALLOPURINOL d00023A Dc M1A Chronic gout A` EU A CARVEDILOL d03847A D# I50.9 Heart failure, unspecified A` EU A FUROSEMIDE d00070A C N18.9 Chronic kidney disease, unspecified A` EU A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` EU A NITROGLYCERIN d00321A D# R07.9 Chest pain, unspecified A` EU A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A` EV A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A EV A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A EV A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EV A DOXYCYCLINE d00037A Ap A69.2 Lyme disease A@ EV A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified A@ EV A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EV A CITALOPRAM d04332A B= F32.9 Major depressive disorder, single episode, unspecified A EV A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= Z79.3 Long term (current) use of hormonal contraceptives A EV0 A . . . EV@ A . . . EVP A . . . EV` A ALLOPURINOL d00023A Ei M1A Chronic gout A EV` A AMLODIPINE d00689A D I10 Essential (primary) hypertension A EV` A CALCIUM ACETATE d03689A A E58 Dietary calcium deficiency A EV` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A EV` A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A EV` A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A EV` A METOPROLOL d00134A D 99999 A EV` A OMEPRAZOLE d00325A Ei 99999 A EV` A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A EVp A . . . EV A DULOXETINE d05355A C F41.9 Anxiety disorder, unspecified A EV A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A EV A MONTELUKAST d04289A Bz H93.9 Unspecified disorder of ear A EV A . . . EV A . . . EV A . . . EV A . . . EV A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP EV A CARVEDILOL d03847A Bz I10 Essential (primary) hypertension AP EV A CINACALCET d05218A Bz E83.52 Hypercalcemia AP EV A LINAGLIPTIN d07767A Dc E11 Type 2 diabetes mellitus AP EV A WARFARIN d00022A Dc D75.9P Prevent blood clots AP EV A LABETALOL d00016A B I10 O13.9 Essential (primary) hypertension Gestational [pregnancy-induced] hypertension without significant proteinuria, unspecified trimester A EW A ALBUTEROL d00749A C J45 Asthma A EW A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EW A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A EW A BACLOFEN d00967A Cr M79.1 Myalgia A EW A CLOPIDOGREL d04258A C I48.91 Unspecified atrial fibrillation A EW A FORMOTEROL; MOMETASONE d07660A CDp J45 Asthma A EW A ONDANSETRON d00867A C- R42 Dizziness and giddiness A EW A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified A EW A . . . EW A . . . EW0 A FLUOXETINE d00236A Ap F41.9 Anxiety disorder, unspecified A EW@ A CLONAZEPAM d00197A B F32.9 Major depressive disorder, single episode, unspecified A@ EW@ A FENTANYL d00233A C M79.2 Neuralgia and neuritis, unspecified A@ EW@ A FLUOXETINE d00236A C- F41.9 Anxiety disorder, unspecified A@ EW@ A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A@ EWP A . . . EW` A . . . EWp A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A EW A . . . EW A AMLODIPINE d00689A CDp I20.9 Angina pectoris, unspecified Ap EW A ASPIRIN; DIPYRIDAMOLE d04497A C Z79.02 Long term (current) use of antithrombotics/antiplatelets Ap EW A HYDROCHLOROTHIAZIDE d00253A C 99999 Ap EW A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension Ap EW A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap EW A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified Ap EW A ZOLPIDEM d00910A C- G47.0 Insomnia Ap EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EW A ALLOPURINOL d00023A CDp M1A Chronic gout A0 EW A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A0 EW A RANITIDINE d00021A B K30 Functional dyspepsia A0 EX A . . . EX A . . . EX A . . . EX0 A LANSOPRAZOLE d03828A C K25.P Prevent gastric ulcer A EX@ A . . . EXP A . . . EX` A . . . EXp A . . . EX A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EX A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EX A . . . EX A . . . EX A ALBUTEROL d00749A C[@ J45 Asthma A EX A . . . EX A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap EX A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension Ap EX A GLYBURIDE d00248A D# E11 Type 2 diabetes mellitus Ap EX A LANSOPRAZOLE d03828A C K30 Functional dyspepsia Ap EX A METFORMIN d03807A D# E11 Type 2 diabetes mellitus Ap EX A METOPROLOL d00134A CDp I20.9 Angina pectoris, unspecified Ap EX A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia Ap EX A . . . EX A . . . EY A . . . EY A . . . EY A . . . EY0 A . . . EY@ A . . . EYP A . . . EY` A ESOMEPRAZOLE d04749A B= K30 Functional dyspepsia A EY` A RANITIDINE d00021A C- K27 R12 Peptic ulcer, site unspecified Heartburn A EYp A . . . EY A . . . EY A . . . EY A ACETAMINOPHEN; HYDROCODONE d03428A C M19.9 M54.9 M79.1 Osteoarthritis, unspecified site Dorsalgia, unspecified Myalgia B EY A ALBUTEROL d00749A C[@ J45 Asthma B EY A BENAZEPRIL d00730A C I10 Essential (primary) hypertension B EY A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma B EY A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified B EY A ECONAZOLE TOPICAL d01271A B[ R21 Rash and other nonspecific skin eruption B EY A EPINEPHRINE d00699A C- R06.2 Wheezing B EY A ESCITALOPRAM d04812A Cr F39 Unspecified mood [affective] disorder B EY A GABAPENTIN d03182A C G40 Epilepsy and recurrent seizures B EY A HYDROXYZINE d00907A Cr G47.0 Insomnia B EY A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified B EY A METFORMIN d03807A C E11 Type 2 diabetes mellitus B EY A PREDNISONE d00350A CP M06.9 Rheumatoid arthritis, unspecified B EY A PREGABALIN d05508A Cr M79.2 Neuralgia and neuritis, unspecified B EY A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia B EY A TIZANIDINE d04102A C M62.83 Muscle spasm B EY A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified B EY A . . . EY A . . . EY A . . . EY A . . . EY A 99999 . . A EY A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A B[ I10 Essential (primary) hypertension A EZ A . . . EZ A . . . EZ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ EZ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ EZ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ EZ A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A@ EZ0 A ALBUTEROL; IPRATROPIUM d04066A B[ J43 J45 Emphysema Asthma B EZ0 A ALBUTEROL; IPRATROPIUM d04066A Cr J45 Asthma B EZ0 A ATENOLOL d00004A C- I20.9 I49.9 Angina pectoris, unspecified Cardiac arrhythmia, unspecified B EZ0 A BIMATOPROST OPHTHALMIC d04754A B H40 Glaucoma B EZ0 A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma B EZ0 A CEPHALEXIN d00096A A L03.90 Cellulitis, unspecified B EZ0 A DIAZEPAM d00148A D F41.9 Anxiety disorder, unspecified B EZ0 A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia B EZ0 A FINASTERIDE d00563A C N40 Enlarged prostate B EZ0 A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified B EZ0 A GLIPIZIDE d00246A C R73 Elevated blood glucose level B EZ0 A HYDROMORPHONE d00255A B[ M54.9 Dorsalgia, unspecified B EZ0 A INSULIN d00262A C E11 Type 2 diabetes mellitus B EZ0 A LIRAGLUTIDE d07466A C- E11 Type 2 diabetes mellitus B EZ0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension B EZ0 A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia B EZ0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia B EZ0 A TIOTROPIUM d04829A C J45 Asthma B EZ0 A VERAPAMIL d00048A C- I10 Essential (primary) hypertension B EZ0 A WARFARIN d00022A C- D75.9P Prevent blood clots B EZ@ A . . . EZP A . . . EZ` A ALBUTEROL; IPRATROPIUM d04066A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A EZ` A CARVEDILOL d03847A B= I50.9 Heart failure, unspecified A EZ` A CHLORPROPAMIDE d00042A B E11 Type 2 diabetes mellitus A EZ` A DIFLUPREDNATE OPHTHALMIC d07298A B H02.84 Edema of eyelid A EZ` A FLUTICASONE; SALMETEROL d04611A Bz J44.9 Chronic obstructive pulmonary disease, unspecified A EZ` A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A EZ` A METFORMIN d03807A B E11 Type 2 diabetes mellitus A EZ` A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A EZ` A PEGINTERFERON ALFA-2A d04821A A B18.2 Chronic viral hepatitis C A EZ` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A EZ` A RIBAVIRIN d00085A AP B18.2 Chronic viral hepatitis C A EZ` A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A EZ` A VALSARTAN d04113A B I10 Essential (primary) hypertension A EZp A ATORVASTATIN d04105A B E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A EZ A . . . EZ A . . . EZ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EZ A PHENTERMINE d00806A D E66 Overweight and obesity A0 EZ A TOPIRAMATE d04115A C E66.9 G43 Obesity, unspecified Migraine A0 EZ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EZ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EZ A . . . EZ A . . . EZ A . . . EZ A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A0 EZ A HYDROCODONE d03075A C M54.9 Dorsalgia, unspecified A0 EZ A TRAZODONE d00395A C G47.9 M79.2 Sleep disorder, unspecified Neuralgia and neuritis, unspecified A0 E[ A . . . E[ A . . . E[ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E[ A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E[0 A . . . E[@ A HYDROCODONE d03075A C G89.4 Chronic pain syndrome Ap E[@ A IBUPROFEN d00015A C T14.9 Unspecified injury Ap E[@ A LAMOTRIGINE d03809A C F31.9 Bipolar disorder, unspecified Ap E[@ A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified Ap E[@ A SERTRALINE d00880A CDp F31.9 Bipolar disorder, unspecified Ap E[@ A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia Ap E[@ A TIZANIDINE d04102A B M79.1 Myalgia Ap E[P A PERMETHRIN TOPICAL d01279A Ap B86 Scabies A E[` A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E[` A ASPIRIN d00170A D I21.P Prevent heart attack/myocardial infarction Ap E[` A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E[` A BENAZEPRIL d00730A D I10 Essential (primary) hypertension Ap E[` A CLOPIDOGREL d04258A D D75.9P Prevent blood clots Ap E[` A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E[` A SILODOSIN d07354A C- N40 Enlarged prostate Ap E[p A . . . E[ A ATENOLOL; CHLORTHALIDONE d03258A Cr 99999 A E[ A CELECOXIB d04380A C M13 Other arthritis A E[ A . . . E[ A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E[ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E[ A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension Ap E[ A ATORVASTATIN d04105A0 A E78.0 Pure hypercholesterolemia Ap E[ A DULOXETINE d05355A C[@ F32.9 F43.1 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) Ap E[ A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension Ap E[ A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus Ap E[ A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus Ap E[ A NADOLOL d00018A Dc I49.9 Cardiac arrhythmia, unspecified Ap E[ A ALBUTEROL d00749A B[ J45 Asthma A@ E[ A ALBUTEROL d00749A Dc J45 Asthma A@ E[ A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A@ E[ A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ E[ A . . . E[ A . . . E[ A . . . E\ A . . . E\ A RANITIDINE d00021A A` K21 Gastro-esophageal reflux disease A E\ A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A E\0 A . . . E\@ A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E\@ A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A0 E\@ A LOVASTATIN d00280A D"8 E78.0 Pure hypercholesterolemia A0 E\P A . . . E\` A ALBUTEROL d00749A D3T J45 Asthma A E\p A . . . E\ A AMPHETAMINE d00803A C- F90 Attention-deficit hyperactivity disorders A E\ A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E\ A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E\ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E\ A . . . E\ A . . . E\ A ALBUTEROL d00749A A R05 Cough A E\ A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A D= N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A@ E\ A HYOSCYAMINE d00985A C R10.83 Colic A@ E\ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E\ A MOMETASONE NASAL d04223A B= J30.9 Allergic rhinitis, unspecified A@ E\ A ALLOPURINOL d00023A C[@ M1A Chronic gout A E\ A AMLODIPINE d00689A C R07.9 Chest pain, unspecified A E\ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E\ A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E\ A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A E\ A CYCLOBENZAPRINE d00963A C[@ M54.9 Dorsalgia, unspecified A E\ A ISOSORBIDE MONONITRATE d00269A B= I21.P Prevent heart attack/myocardial infarction A E\ A TAMSULOSIN d04121A C- N40 Enlarged prostate A E\ A . . . E] A . . . E] A . . . E] A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E] A GABAPENTIN d03182A CDp M54.9 Dorsalgia, unspecified A0 E] A LAMOTRIGINE d03809A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E]0 A . . . E]@ A . . . E]P A . . . E]` A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension A E]p A GABAPENTIN d03182A C M25.56 M79.2 Pain in knee Neuralgia and neuritis, unspecified A@ E]p A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E]p A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E]p A METFORMIN d03807A C- R73.9 Hyperglycemia, unspecified A@ E] A . . . E] A . . . E] A ALBUTEROL d00749A C- R06.02 Shortness of breath A E] A ALBUTEROL; IPRATROPIUM d04066A C- R06.9 Unspecified abnormalities of breathing A E] A FUROSEMIDE d00070A CDp I10 Essential (primary) hypertension A E] A GABAPENTIN d03182A CDp M25.5 Pain in joint A E] A LANSOPRAZOLE d03828A Cr K21 Gastro-esophageal reflux disease A E] A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E] A SPIRONOLACTONE d00373A C E87.6 Hypokalemia A E] A TERAZOSIN d00386A Cr N42.9 Disorder of prostate, unspecified A E] A TIOTROPIUM d04829A C- R06.9 Unspecified abnormalities of breathing A E] A TRAMADOL d03826A C M25.5 Pain in joint A E] A WARFARIN d00022A Dc Z79.02 Long term (current) use of antithrombotics/antiplatelets A E] A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A0 E] A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A0 E] A SIMVASTATIN d00746A D9 E78.0 Pure hypercholesterolemia A0 E] A . . . E] A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E] A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E] A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E] A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E] A . . . E] A . . . E^ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E^ A CYANOCOBALAMIN d00413A B= 55555 A E^ A FENOFIBRATE d04286A Cr 99999 A E^ A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E^ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E^ A NEBIVOLOL d05265A C I49.9 Cardiac arrhythmia, unspecified A E^ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E^ A TRAZODONE d00395A C"0 G47.0 Insomnia A E^ A VERAPAMIL d00048A Ei I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E^ A . . . E^ A . . . E^0 A ALBUTEROL d00749A B R06.9 Unspecified abnormalities of breathing A E^0 A ETHAMBUTOL d00068A B J18.9 Pneumonia, unspecified organism A E^@ A . . . E^P A BISOPROLOL d00709A C[@ I10 Essential (primary) hypertension A0 E^P A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified A0 E^P A OLMESARTAN d04801A Cr I10 Essential (primary) hypertension A0 E^` A . . . E^p A CEPHALEXIN d00096A B N12 Tubulo-interstitial nephritis, not specified as acute or chronic A E^p A TRAMADOL d03826A B M54.9 Dorsalgia, unspecified A E^ A DEXMETHYLPHENIDATE d04777A Bz F90 Attention-deficit hyperactivity disorders A E^ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E^ A . . . E^ A ATENOLOL d00004A C I10 Essential (primary) hypertension A E^ A COLCHICINE d00150A CDp M1A Chronic gout A E^ A DOCUSATE d01021A A K59.0 Constipation A E^ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E^ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E^ A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A E^ A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A E^ A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E^ A AMOXICILLIN d00088A Ap K02.7 Dental root caries A E^ A INSULIN GLULISINE d05278A C E11 Type 2 diabetes mellitus A E^ A . . . E^ A OXYCODONE d00329A Ap K58 Irritable bowel syndrome A E^ A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E_ A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A E_ A . . . E_ A BACLOFEN d00967A B= M62.83 Muscle spasm A@ E_ A CITALOPRAM d04332A A F39 Unspecified mood [affective] disorder A@ E_ A DICLOFENAC d00848A B= M54.9 Dorsalgia, unspecified A@ E_ A RANITIDINE d00021A C K30 Functional dyspepsia A@ E_0 A . . . E_@ A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A E_@ A ARIPIPRAZOLE d04825A C"0 F39 Unspecified mood [affective] disorder A E_P A . . . E_` A . . . E_p A . . . E_ A . . . E_ A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures A0 E_ A OXCARBAZEPINE d04513A C G40 Epilepsy and recurrent seizures A0 E_ A RISPERIDONE d03180A C- F91.9 Conduct disorder, unspecified A0 E_ A . . . E_ A . . . E_ A . . . E_ A HYDROCODONE d03075A A R52 T30.0 Pain, unspecified Burn of unspecified body region, unspecified degree A E_ A . . . E_ A AMLODIPINE; BENAZEPRIL d03829A B I10 Essential (primary) hypertension A E` A LOTEPREDNOL OPHTHALMIC d04292A Ap H10.1 Acute atopic conjunctivitis A E` A . . . E` A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A E`0 A . . . E`@ A . . . E`P A FINASTERIDE d00563A A@ L64 Androgenic alopecia A E`` A . . . E`p A . . . E` A . . . E` A . . . E` A . . . E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E` A . . . E` A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders AP E` A COLESEVELAM d04695A C9 E78.0 Pure hypercholesterolemia AP E` A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified AP E` A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia AP E` A ZOLPIDEM d00910A B G47.0 Insomnia AP E` A . . . E` A ACETAMINOPHEN; HYDROCODONE d03428A B M94.26 Chondromalacia, knee A0 E` A ESTRADIOL d00537A CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A0 E` A TRAMADOL d03826A C[@ M19.9 Osteoarthritis, unspecified site A0 Ea A ALLOPURINOL d00023A C[@ E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A0 Ea A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ea A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 Ea A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap Ea A DILTIAZEM d00045A C I10 Essential (primary) hypertension Ap Ea A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap Ea A LEVOTHYROXINE d00278A C E04.1 Nontoxic single thyroid nodule Ap Ea A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap Ea A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap Ea A TESTOSTERONE d00558A C E29.1 Testicular hypofunction Ap Ea A HYDROCODONE d03075A C T14.9 Unspecified injury A Ea0 A . . . Ea@ A 99999 . . A EaP A . . . Ea` A . . . Eap A . . . Ea A . . . Ea A . . . Ea A ACETAMINOPHEN; OXYCODONE d03431A B M54.9 Dorsalgia, unspecified A Ea A AMANTADINE d00086A C G20 Parkinson's disease A Ea A AMPHETAMINE d00803A CDp F90 Attention-deficit hyperactivity disorders A Ea A BENZTROPINE d00175A D G20 Parkinson's disease A Ea A CHLORPROMAZINE d00064A C[@ F20 Schizophrenia A Ea A HYDROXYZINE d00907A B[ G47.0 Insomnia A Ea A LISINOPRIL d00732A B I10 Essential (primary) hypertension A Ea A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A Ea A OLANZAPINE d04050A B F32.9 Major depressive disorder, single episode, unspecified A Ea A QUETIAPINE d04220A D F32.9 Major depressive disorder, single episode, unspecified A Ea A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A Ea A TAMSULOSIN d04121A C- R39.15 Urgency of urination A Ea A . . . Ea A AMLODIPINE d00689A A@ I10 Essential (primary) hypertension A Ea A . . . Ea A . . . Ea A CICLESONIDE NASAL d05899A Dc T78.40 Allergy, unspecified A@ Ea A DICLOFENAC d00848A C- M54.5 Low back pain A@ Ea A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A@ Ea A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A@ Eb A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A Eb A . . . Eb A . . . Eb0 A PROPRANOLOL d00032A C G43 Migraine A Eb@ A . . . EbP A . . . Eb` A . . . Ebp A . . . Eb A . . . Eb A . . . Eb A ARIPIPRAZOLE d04825A C F32.9 F91.9 Major depressive disorder, single episode, unspecified Conduct disorder, unspecified A0 Eb A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A0 Eb A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A0 Eb A . . . Eb A . . . Eb A NATALIZUMAB d05414A C[@ G35 Multiple sclerosis A Eb A ALBUTEROL d00749A CDp M79.7 R06.02 Fibromyalgia Shortness of breath A Eb A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A Eb A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A Eb A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A Eb A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A Eb A GABAPENTIN d03182A CDp M79.7 Fibromyalgia A Eb A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A Eb A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures A Eb A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A Eb A RISEDRONATE d04300A Cr M81 Osteoporosis without current pathological fracture A Eb A . . . Ec A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ec A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ N92 Excessive, frequent and irregular menstruation A Ec A . . . Ec0 A GABAPENTIN d03182A Cr G40 Epilepsy and recurrent seizures A Ec0 A GLYBURIDE; METFORMIN d04703A Cr E11 Type 2 diabetes mellitus A Ec0 A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A Ec0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A Ec0 A LORAZEPAM d00149A Cr G40 Epilepsy and recurrent seizures A Ec0 A PHENYTOIN d00143A Cr G40 Epilepsy and recurrent seizures A Ec0 A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A Ec0 A WARFARIN d00022A Cr D75.9P Prevent blood clots A Ec@ A . . . EcP A . . . Ec` A . . . Ecp A VALSARTAN d04113A C[@ I10 Essential (primary) hypertension A Ec A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ec A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A Ec A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension A` Ec A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` Ec A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma A` Ec A DORZOLAMIDE OPHTHALMIC d03805A Cr H40 Glaucoma A` Ec A DUTASTERIDE d04788A Cr R39.15 Urgency of urination A` Ec A TAMSULOSIN d04121A Cr R39.15 Urgency of urination A` Ec A . . . Ec A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ec A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A Ec A EZETIMIBE d04824A Dc E78.0 Pure hypercholesterolemia A Ec A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ec A METOPROLOL d00134A D I10 Essential (primary) hypertension A Ec A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A Ec A PENTOSAN POLYSULFATE SODIUM d04052A C N30.1 Interstitial cystitis (chronic) A Ec A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A Ec A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A Ec A SOTALOL d00371A C I48.91 Unspecified atrial fibrillation A Ec A WARFARIN d00022A Cr I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A Ec A . . . Ec A ESCITALOPRAM d04812A Bz F39 Unspecified mood [affective] disorder A Ec A . . . Ec A . . . Ed A . . . Ed A ENTECAVIR d05525A C B19.1 Unspecified viral hepatitis B A Ed A . . . Ed0 A . . . Ed@ A . . . EdP A . . . Ed` A . . . Edp A . . . Ed A ALLOPURINOL d00023A0 C- M1A Chronic gout Ap Ed A AMLODIPINE d00689A0 B[ I10 Essential (primary) hypertension Ap Ed A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia Ap Ed A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus Ap Ed A LOSARTAN d03821A0 CP I10 Essential (primary) hypertension Ap Ed A METOPROLOL d00134A0 B[ I10 Essential (primary) hypertension Ap Ed A TERAZOSIN d00386A0 C R35.0 Frequency of micturition Ap Ed A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A Ed A . . . Ed A . . . Ed A . . . Ed A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap Ed A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap Ed A DEXLANSOPRAZOLE d07395A C R12 Heartburn Ap Ed A FOSINOPRIL d00242A D I10 Essential (primary) hypertension Ap Ed A GABAPENTIN d03182A CDp E11.4 Type 2 diabetes mellitus with neurological complications Ap Ed A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus Ap Ed A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap Ed A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Ed A . . . Ee A ACETAMINOPHEN; HYDROCODONE d03428A C[@ M54.9 Dorsalgia, unspecified AP Ee A ADALIMUMAB d04835A C- M06.9 Rheumatoid arthritis, unspecified AP Ee A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension AP Ee A MELOXICAM d04532A C- M54.9 Dorsalgia, unspecified AP Ee A PREDNISONE d00350A C- M06.9 Rheumatoid arthritis, unspecified AP Ee A CLOPIDOGREL d04258A CDp I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 Ee A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 Ee A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A0 Ee A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A Ee0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 Ee0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 Ee0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ee@ A . . . EeP A ALBUTEROL d00749A CDp J45 Asthma A0 EeP A FORMOTEROL; MOMETASONE d07660A B[ J45 Asthma A0 EeP A MONTELUKAST d04289A C J45 Asthma A0 Ee` A . . . Eep A ALBUTEROL d00749A C J45 Asthma A0 Eep A FEXOFENADINE d04040A C T78.40 Allergy, unspecified A0 Eep A MONTELUKAST d04289A C J45 Asthma A0 Ee A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A Ee A . . . Ee A . . . Ee A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A@ Ee A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ Ee A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ Ee A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ Ee A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A Ee A OLMESARTAN d04801A C[@ I10 Essential (primary) hypertension A Ee A CAMPHOR TOPICAL d03712A C M54.9 Dorsalgia, unspecified A Ee A CYCLOBENZAPRINE d00963A D M79.1 Myalgia A Ee A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A Ee A HYDROCODONE d03075A D M54.9 Dorsalgia, unspecified A Ee A HYDROXYZINE d00907A D T75.3 Motion sickness A Ee A LOPERAMIDE d01025A D R19.7 Diarrhea, unspecified A Ee A METHOCARBAMOL d00965A D M62.83 Muscle spasm A Ee A NAPROXEN d00019A D T14.9 Unspecified injury A Ee A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A Ee A PANTOPRAZOLE d04514A D D49 Neoplasms of unspecified behavior A Ee A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A Ee A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A Ee A SODIUM CHLORIDE d00438A D R09.81 Nasal congestion A Ee A TRAMADOL d03826A D M54.9 Dorsalgia, unspecified A Ee A TRAZODONE d00395A D G47.0 Insomnia A Ee A PROPRANOLOL d00032A B[ G43 Migraine A Ee A SUMATRIPTAN d03160A Dc G43 Migraine A Ee A . . . Ef A . . . Ef A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 Ef A LORAZEPAM d00149A C G47.9 Sleep disorder, unspecified A0 Ef A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 Ef A . . . Ef0 A . . . Ef@ A . . . EfP A CIPROFLOXACIN d00011A C 99999 A0 EfP A MEMANTINE d04899A C G31.9 Degenerative disease of nervous system, unspecified A0 EfP A TRAZODONE d00395A C F29 Unspecified psychosis not due to a substance or known physiological condition A0 Ef` A . . . Efp A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A Ef A TAZAROTENE TOPICAL d04138A C- L55 Sunburn A Eg A . . . Eg A . . . Eg A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Eg0 A . . . Eg@ A DILTIAZEM d00045A Dc I10 Essential (primary) hypertension A Eg@ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A EgP A IBUPROFEN d00015A B= M25.53 Pain in wrist A EgP A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A Eg` A . . . Egp A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr L70 Z79.3 Acne Long term (current) use of hormonal contraceptives A Eg A . . . Eg A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A Eg A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A Eg A . . . Eg A . . . Eg A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP Eg A LISINOPRIL d00732A CDp I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP Eg A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP Eg A SIMVASTATIN d00746A CDp E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction AP Eg A ZOLPIDEM d00910A CDp F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified AP Eg A . . . Eg A CLOBETASOL TOPICAL d01288A C- L20.9 Atopic dermatitis, unspecified A Eg A ALBUTEROL d00749A C[@ J45 Asthma A0 Eg A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma A0 Eg A THYROID DESICCATED d00655A B= E03.9 Hypothyroidism, unspecified A0 Eh A . . . Eh A . . . Eh A DILTIAZEM d00045A C[@ I10 I73.0 Essential (primary) hypertension Raynaud's syndrome A@ Eh A ETANERCEPT d04365A Cr L40.5 Arthropathic psoriasis A@ Eh A LOSARTAN d03821A C I10 I73.0 Essential (primary) hypertension Raynaud's syndrome A@ Eh A METHOTREXATE d00060A C- L40 L40.5 Psoriasis Arthropathic psoriasis A@ Eh0 A . . . Eh@ A . . . EhP A . . . Eh` A . . . Ehp A . . . Eh A . . . Eh A . . . Eh A . . . Eh A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A Eh A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A Eh A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A Eh A CLOPIDOGREL d04258A Bz D75.9P Prevent blood clots A Eh A METOPROLOL d00134A Bz I10 Essential (primary) hypertension A Eh A NITROGLYCERIN d00321A Bz R07.9 Chest pain, unspecified A Eh A NORTRIPTYLINE d00144A C R51 Headache A Eh A PANTOPRAZOLE d04514A Bz K21 Gastro-esophageal reflux disease A Eh A . . . Eh A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A Eh A . . . Eh A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A` Eh A GLIMEPIRIDE d03864A B= E11 Type 2 diabetes mellitus A` Eh A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` Eh A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` Eh A NADOLOL d00018A B I10 Essential (primary) hypertension A` Eh A SAXAGLIPTIN d07467A B= E11 Type 2 diabetes mellitus A` Ei A . . . Ei A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A Ei A . . . Ei0 A . . . Ei@ A . . . EiP A . . . Ei` A . . . Eip A . . . Ei A . . . Ei A . . . Ei A . . . Ei A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Dc I10 Essential (primary) hypertension A Ei A . . . Ei A . . . Ei A . . . Ei A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Ej A . . . Ej A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Ej A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A@ Ej A POTASSIUM CITRATE d01423A A N20.0P Prevent kidney stone A@ Ej A RAMIPRIL d00728A B[ I10 Essential (primary) hypertension A@ Ej A . . . Ej0 A DULOXETINE d05355A B M79.7 Fibromyalgia A` Ej0 A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus A` Ej0 A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A` Ej0 A SPIRONOLACTONE d00373A C L70 Acne A` Ej0 A SULINDAC d00033A Cr L93 Lupus erythematosus A` Ej0 A ZOLPIDEM d00910A B F41.9 G47.0 Anxiety disorder, unspecified Insomnia A` Ej@ A . . . EjP A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap EjP A GLIPIZIDE d00246A D ^ E11 Type 2 diabetes mellitus Ap EjP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap EjP A METFORMIN d03807A D ^ E11 Type 2 diabetes mellitus Ap EjP A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap EjP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap EjP A QUINAPRIL d00365A C I10 Essential (primary) hypertension Ap Ej` A . . . Ejp A . . . Ej A ALBUTEROL d00749A C J45 Asthma A Ej A . . . Ej A . . . Ej A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A Ej A LEVALBUTEROL d04427A C J45 Asthma A Ej A . . . Ej A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ej A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A Ej A . . . Ej A . . . Ek A . . . Ek A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A Ek A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A Ek A . . . Ek0 A . . . Ek@ A . . . EkP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ EkP A CITALOPRAM d04332A Ap F32.9 Major depressive disorder, single episode, unspecified A@ EkP A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A@ EkP A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ Ek` A . . . Ekp A . . . Ek A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ Ek A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Ek A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A@ Ek A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ Ek A . . . Ek A GABAPENTIN d03182A B D49 Neoplasms of unspecified behavior A Ek A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension A Ek A LIDOCAINE TOPICAL d00683A B G89.3 Neoplasm related pain (acute) (chronic) A Ek A METOPROLOL d00134A B= I10 Essential (primary) hypertension A Ek A METOPROLOL d00134A B I10 Essential (primary) hypertension A Ek A OXYCODONE d00329A B G89.3 Neoplasm related pain (acute) (chronic) A Ek A OXYCODONE d00329A B G89.3 Neoplasm related pain (acute) (chronic) A Ek A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A Ek A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A Ek A . . . Ek A ESTRADIOL d00537A C- M81 N95.1 Osteoporosis without current pathological fracture Menopausal and female climacteric states A0 Ek A LEVOTHYROXINE d00278A D E07.9 Disorder of thyroid, unspecified A0 Ek A LORAZEPAM d00149A Dc F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A0 Ek A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A Ek A . . . Ek A . . . El A . . . El A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A@ El A LISINOPRIL d00732A C- E11.2 Type 2 diabetes mellitus with kidney complications A@ El A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ El A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A@ El A LEVALBUTEROL d04427A Cr J45 Asthma A El0 A ALBUTEROL d00749A B J45 Asthma A El0 A PREDNISONE d00350A A J45 Asthma A El@ A . . . ElP A CARVEDILOL d03847A CP I49.9 Cardiac arrhythmia, unspecified A0 ElP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 ElP A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A0 El` A . . . Elp A . . . El A . . . El A . . . El A . . . El A HYDROCODONE; IBUPROFEN d04225A B M54.2 Cervicalgia A El A . . . El A . . . El A . . . El A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A@ El A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A@ El A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus A@ El A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Em A 99999 . . A Em A . . . Em A . . . Em0 A . . . Em@ A . . . EmP A . . . Em` A . . . Emp A OXYCODONE d00329A CDp M54.9 Dorsalgia, unspecified A Em A FLUTICASONE NASAL d04283A Bz 99999 A Em A LISINOPRIL d00732A BZ I10 Essential (primary) hypertension A Em A AMITRIPTYLINE d00146A C 55555 A@ Em A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D* I10 Essential (primary) hypertension A@ Em A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A@ Em A VERAPAMIL d00048A C I49.9 Cardiac arrhythmia, unspecified A@ Em A . . . Em A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Em A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A Em A . . . Em A . . . Em A . . . Em A . . . En A . . . En A . . . En A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ En A NAPROXEN d00019A Cr T14.9 Unspecified injury A@ En A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A@ En A TRAZODONE d00395A Cr G47.0 Insomnia A@ En0 A . . . En@ A . . . EnP A . . . En` A . . . Enp A . . . En A . . . En A BUPROPION d00181A C- F17.203 Nicotine dependence unspecified, with withdrawal A0 En A FLUPHENAZINE d00237A D1 F20 Schizophrenia A0 En A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 En A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A En A DICLOFENAC d00848A B M79.1 Myalgia A En A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A En A LISINOPRIL d00732A C I10 Essential (primary) hypertension A En A METFORMIN d03807A C E11 Type 2 diabetes mellitus A En A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A En A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A En A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified A En A MONTELUKAST d04289A A R05 Cough A En A . . . En A ACETAMINOPHEN; HYDROCODONE d03428A0 C M54.9 Dorsalgia, unspecified Ap En A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus Ap En A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus Ap En A PAROXETINE d03157A0 C F41.9 Anxiety disorder, unspecified Ap En A SIMVASTATIN d00746A0 Cr E78.0 Pure hypercholesterolemia Ap En A TIZANIDINE d04102A0 C M54.9 Dorsalgia, unspecified Ap En A TRANDOLAPRIL d04008A0 Cr I10 Essential (primary) hypertension Ap En A . . . En A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 En A CETIRIZINE d03827A C T78.40 Allergy, unspecified A0 En A LEVOTHYROXINE d00278A DO E03.9 Hypothyroidism, unspecified A0 Eo A ALBUTEROL d00749A A J42 Unspecified chronic bronchitis A Eo A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A Eo A . . . Eo A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 T14.9 Dorsalgia, unspecified Unspecified injury A Eo A NORTRIPTYLINE d00144A Bz M79.2 Neuralgia and neuritis, unspecified A Eo0 A . . . Eo@ A . . . EoP A . . . Eo` A . . . Eop A . . . Eo A MELOXICAM d04532A B= M25.56 Pain in knee A Eo A . . . Eo A ALBUTEROL d00749A Cr J45 Asthma A Eo A CELECOXIB d04380A D M19.9 Osteoarthritis, unspecified site A Eo A FLUOXETINE d00236A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Eo A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A Eo A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A Eo A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D# I10 Essential (primary) hypertension A Eo A HYOSCYAMINE d00985A D K58 Irritable bowel syndrome A Eo A MONTELUKAST d04289A D# J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A Eo A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A Eo A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome A Eo A . . . Eo A . . . Eo A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eo A CLONIDINE d00044A C I10 Essential (primary) hypertension A Eo A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A Eo A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A Eo A METOPROLOL d00134A C I10 Essential (primary) hypertension A Eo A MINOXIDIL d00135A C I10 Essential (primary) hypertension A Eo A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A Eo A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A Eo A TERAZOSIN d00386A C I10 Essential (primary) hypertension A Eo A . . . Eo A . . . Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ep A CLONIDINE d00044A C- G47.0 Insomnia A Ep A FEXOFENADINE d04040A C T78.40 Allergy, unspecified A Ep0 A . . . Ep@ A . . . EpP A ACARBOSE d03846A C E11 Type 2 diabetes mellitus A EpP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EpP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EpP A DOXAZOSIN d00726A C R39.15 Urgency of urination A EpP A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A EpP A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus A EpP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EpP A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A EpP A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A Ep` A . . . Epp A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A0 Epp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 Epp A TRAZODONE d00395A C I51.9 Heart disease, unspecified A0 Ep A . . . Ep A CETIRIZINE d03827A B T78.40 Allergy, unspecified A Ep A NAPROXEN d00019A C- N94.6 R51 Dysmenorrhea, unspecified Headache A Ep A FLUTICASONE NASAL d04283A Bz J30.9 Allergic rhinitis, unspecified A Ep A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ep A . . . Ep A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma AP Ep A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma AP Ep A FINASTERIDE d00563A C N40 Enlarged prostate AP Ep A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma AP Ep A TERAZOSIN d00386A C[@ N40 Enlarged prostate AP Ep A . . . Ep A . . . Eq A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A Eq A AMLODIPINE d00689A B I10 Essential (primary) hypertension A Eq A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eq A CILOSTAZOL d04382A C[@ I70.2 Atherosclerosis of native arteries of extremities A Eq A DICLOFENAC d00848A Dc M19.9 Osteoarthritis, unspecified site A Eq A FUROSEMIDE d00070A C R60.9 Edema, unspecified A Eq A GABAPENTIN d03182A C[@ E11.4 Type 2 diabetes mellitus with neurological complications A Eq A IRBESARTAN d04222A Cr I10 Essential (primary) hypertension A Eq A LANSOPRAZOLE d03828A C M19.9 Osteoarthritis, unspecified site A Eq A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A Eq A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A Eq A . . . Eq A LISINOPRIL d00732A B= E11.2 Type 2 diabetes mellitus with kidney complications A Eq A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Eq0 A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A Eq@ A . . . EqP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EqP A DUTASTERIDE d04788A B N40 Enlarged prostate A@ EqP A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A@ EqP A TAMSULOSIN d04121A Cr N40 Enlarged prostate A@ Eq` A . . . Eqp A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 Dorsalgia, unspecified A@ Eqp A LEVOTHYROXINE d00278A Cr K44 Diaphragmatic hernia A@ Eqp A OMEPRAZOLE d00325A D K30 Functional dyspepsia A@ Eqp A ZOLPIDEM d00910A D G47.0 Insomnia A@ Eq A . . . Eq A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eq A . . . Eq A . . . Eq A . . . Eq A NORETHINDRONE d00555A A Z79.3 Long term (current) use of hormonal contraceptives A Eq A . . . Eq A . . . Er A ALBUTEROL d00749A CDp J20.9 Acute bronchitis, unspecified A Er A ALLOPURINOL d00023A C[@ M1A Chronic gout A Er A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Er A CARVEDILOL d03847A B~ I10 Essential (primary) hypertension A Er A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A Er A CYCLOBENZAPRINE d00963A Cr M79.1 Myalgia A Er A FESOTERODINE d07162A C R39.15 Urgency of urination A Er A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A Er A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Er A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A Er A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension A Er A NITROGLYCERIN d00321A C- R07.9 Chest pain, unspecified A Er A TAMSULOSIN d04121A C C61 Malignant neoplasm of prostate A Er A . . . Er A ALLOPURINOL d00023A D M1A Chronic gout A` Er A ATENOLOL d00004A D I49.9 Cardiac arrhythmia, unspecified A` Er A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A` Er A CLONAZEPAM d00197A B F32.9 Major depressive disorder, single episode, unspecified A` Er A FAMOTIDINE d00141A C K30 Functional dyspepsia A` Er A FENOFIBRIC ACID d07371A C[@ E78.1 Pure hyperglyceridemia A` Er0 A . . . Er@ A . . . ErP A . . . Er` A . . . Erp A CETIRIZINE d03827A C T78.40 Allergy, unspecified A Er A AMLODIPINE d00689A A I21.P Prevent heart attack/myocardial infarction A Er A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A Er A . . . Er A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Er A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ Er A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ Er A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ Er A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C L70 N92 Acne Excessive, frequent and irregular menstruation A Er A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Er A . . . Er A . . . Er A . . . Es A . . . Es A FEXOFENADINE d04040A C T78.40 Allergy, unspecified A@ Es A FLUOXETINE d00236A C F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A@ Es A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ Es A PANTOPRAZOLE d04514A A K21 Gastro-esophageal reflux disease A@ Es A . . . Es0 A AMOXICILLIN d00088A A@ K02.7 Dental root caries A Es@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EsP A . . . Es` A . . . Esp A . . . Es A ATENOLOL d00004A C R07.9 Chest pain, unspecified A0 Es A LANSOPRAZOLE d03828A B K30 Functional dyspepsia A0 Es A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 Es A . . . Es A . . . Es A . . . Es A . . . Es A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP Es A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP Es A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP Es A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP Es A QUINAPRIL d00365A C I10 Essential (primary) hypertension AP Es A . . . Es A . . . Et A . . . Et A . . . Et A . . . Et0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` Et0 A GABAPENTIN d03182A D E11.4 Type 2 diabetes mellitus with neurological complications A` Et0 A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A` Et0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` Et0 A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A` Et0 A QUINAPRIL d00365A CDp I10 Essential (primary) hypertension A` Et@ A . . . EtP A AMLODIPINE d00689A B I10 Essential (primary) hypertension A Et` A . . . Etp A . . . Et A ATENOLOL d00004A C I10 Essential (primary) hypertension A Et A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A Et A DICLOFENAC d00848A C M79.1 Myalgia A Et A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A Et A GALANTAMINE d04750A C- G31.84 Mild cognitive impairment, so stated A Et A MEMANTINE d04899A C- G31.84 Mild cognitive impairment, so stated A Et A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A Et A TOLTERODINE d04294A Cr N39.4 Other specified urinary incontinence A Et A . . . Et A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP Et A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia AP Et A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia AP Et A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP Et A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP Et A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] A Et A BECLOMETHASONE d00760A B[ J45 Asthma A Et A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Et A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ Et A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ Et A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A@ Et A . . . Et A . . . Eu A . . . Eu A . . . Eu A DIAZEPAM d00148A CP G40 Epilepsy and recurrent seizures A Eu0 A . . . Eu@ A . . . EuP A . . . Eu` A . . . Eup A . . . Eu A . . . Eu A ALFUZOSIN d04797A CDp N40 Enlarged prostate A0 Eu A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A0 Eu A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 Eu A . . . Eu A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A@ Eu A FLUTICASONE NASAL d04283A Bz J30.9 Allergic rhinitis, unspecified A@ Eu A MONTELUKAST d04289A B[ J30.9 Allergic rhinitis, unspecified A@ Eu A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A@ Eu A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A Eu A LORATADINE d03050A CDp T78.40 Allergy, unspecified A Eu A ALLOPURINOL d00023A Cr M1A Chronic gout A Eu A TAMSULOSIN d04121A Cr N40 Enlarged prostate A Eu A . . . Eu A . . . Ev A BUDESONIDE; FORMOTEROL d04795A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 Ev A TRAZODONE d00395A B= G47.0 Insomnia A0 Ev A VENLAFAXINE d03181A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 Ev A . . . Ev A CHLORTHALIDONE d00192A CDp R60.9 Edema, unspecified A0 Ev A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 Ev A METFORMIN d03807A Cr R73 Elevated blood glucose level A0 Ev0 A ACETAMINOPHEN; HYDROCODONE d03428A Cr M1A Chronic gout A Ev0 A INDOMETHACIN d00039A D# M1A Chronic gout A Ev@ A . . . EvP A CIMETIDINE d00140A C K30 Functional dyspepsia A Ev` A MOMETASONE d05262A C[@ J45 R05 R06.2 Asthma Cough Wheezing A Ev` A MONTELUKAST d04289A C[@ J45 R06.2 Asthma Wheezing A Evp A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C- N92 Excessive, frequent and irregular menstruation A0 Evp A PROPRANOLOL d00032A C G43.P Prevent migraine A0 Evp A SUMATRIPTAN d03160A C[@ G43 Migraine A0 Ev A . . . Ev A RIZATRIPTAN d04328A C G43 Migraine A Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A ALBUTEROL d00749A C- J45 Asthma A Ev A . . . Ew A . . . Ew A AMLODIPINE; BENAZEPRIL d03829A Dc I10 Essential (primary) hypertension A@ Ew A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Dc I10 Essential (primary) hypertension A@ Ew A DABIGATRAN d07137A C"0 D75.9P Prevent blood clots A@ Ew A SOTALOL d00371A C- I48.91 Unspecified atrial fibrillation A@ Ew A . . . Ew0 A . . . Ew@ A AMOXICILLIN d00088A A H66.9 J00 Otitis media, unspecified Acute nasopharyngitis [common cold] A EwP A . . . Ew` A BUPROPION d00181A A` F32.9 Major depressive disorder, single episode, unspecified A@ Ew` A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A@ Ew` A FAMOTIDINE d00141A D K25.P Prevent gastric ulcer A@ Ew` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ Ewp A . . . Ew A . . . Ew A . . . Ew A . . . Ew A . . . Ew A AMLODIPINE d00689A0 B I10 Essential (primary) hypertension A Ew A ASPIRIN; DIPYRIDAMOLE d04497A0 B I63 Cerebral infarction A Ew A BRIMONIDINE OPHTHALMIC d04048A0 C H40 Glaucoma A Ew A CLONIDINE d00044A0 B I10 Essential (primary) hypertension A Ew A FAMOTIDINE d00141A0 B K59.9 R12 Functional intestinal disorder, unspecified Heartburn A Ew A GLIPIZIDE d00246A0 B E11 Type 2 diabetes mellitus A Ew A LISINOPRIL d00732A0 B I10 Essential (primary) hypertension A Ew A PIOGLITAZONE d04442A0 B E11 Type 2 diabetes mellitus A Ew A ROSUVASTATIN d04851A0 B E78.0 Pure hypercholesterolemia A Ew A SITAGLIPTIN d05896A0 B E11 Type 2 diabetes mellitus A Ew A . . . Ew A ACETAMINOPHEN; HYDROCODONE d03428A B G89.18 Other acute postprocedural pain AP Ew A ALBUTEROL d00749A C J20.9 J45 R06.2 Acute bronchitis, unspecified Asthma Wheezing AP Ew A BETAMETHASONE TOPICAL d03197A C[@ L20.9 Atopic dermatitis, unspecified AP Ew A IBUPROFEN d00015A B G89.18 Other acute postprocedural pain AP Ew A TRIAMCINOLONE TOPICAL d03206A A L20.9 Atopic dermatitis, unspecified AP Ew A . . . Ex A GLIPIZIDE d00246A CP E11 Type 2 diabetes mellitus AP Ex A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP Ex A LISINOPRIL d00732A CP 99999 AP Ex A METFORMIN d03807A CP E11 Type 2 diabetes mellitus AP Ex A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia AP Ex A . . . Ex A . . . Ex0 A ALBUTEROL d00749A C J42 Unspecified chronic bronchitis A Ex@ A . . . ExP A . . . Ex` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ Ex` A OXYBUTYNIN d00328A D R35.0 Frequency of micturition A@ Ex` A SERTRALINE d00880A Cr N95.1 Menopausal and female climacteric states A@ Ex` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Exp A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A A B35.9 Dermatophytosis, unspecified A@ Exp A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A@ Exp A LISINOPRIL d00732A A I10 Essential (primary) hypertension A@ Exp A OMEPRAZOLE d00325A A K21 Gastro-esophageal reflux disease A@ Ex A . . . Ex A . . . Ex A . . . Ex A . . . Ex A . . . Ex A ESCITALOPRAM d04812A C G47.0 Insomnia A Ex A . . . Ex A ALBUTEROL d00749A C"0 J45 Asthma A Ex A MONTELUKAST d04289A C J45 Asthma A Ey A . . . Ey A IBUPROFEN d00015A A K08.4 Partial loss of teeth A Ey A PENICILLIN V POTASSIUM d07730A A K08.4 Partial loss of teeth A Ey A ASPIRIN d00170A Cr D75.9P Prevent blood clots A@ Ey A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ Ey A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A@ Ey A LISINOPRIL d00732A Cr I50.9 Heart failure, unspecified A@ Ey0 A . . . Ey@ A ALENDRONATE d03849A Dc M85.80 Other specified disorders of bone density and structure, unspecified site Ap Ey@ A ETODOLAC d00851A C M19.9 Osteoarthritis, unspecified site Ap Ey@ A FUROSEMIDE d00070A B R60.9 Edema, unspecified Ap Ey@ A LOSARTAN d03821A CP I10 Essential (primary) hypertension Ap Ey@ A NYSTATIN TOPICAL d04399A C B37.0 Candidal stomatitis Ap Ey@ A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease Ap Ey@ A SUCRALFATE d00377A C K92.2 Gastrointestinal hemorrhage, unspecified Ap EyP A . . . Ey` A . . . Eyp A . . . Ey A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A Ey A . . . Ey A . . . Ey A . . . Ey A . . . Ey A ESTROGENS - UNSPECIFIED c00183. . AP Ey A LITHIUM d00061A C- F39 F41.0 Unspecified mood [affective] disorder Panic disorder [episodic paroxysmal anxiety] without agoraphobia AP Ey A PANTOPRAZOLE d04514A Dc F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia AP Ey A SERTRALINE d00880A Dc F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia AP Ey A ZIPRASIDONE d04747A Dc F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia AP Ey A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension A0 Ey A METFORMIN d03807A C E28.2 E88.81 Polycystic ovarian syndrome Metabolic syndrome A0 Ey A METOPROLOL d00134A B= R07.9 Chest pain, unspecified A0 Ey A . . . Ez A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP Ez A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus AP Ez A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP Ez A NAPROXEN d00019A C M06.9 M54.9 Rheumatoid arthritis, unspecified Dorsalgia, unspecified AP Ez A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease AP Ez A . . . Ez A ACETAMINOPHEN; HYDROCODONE d03428A CDp M19.9 Osteoarthritis, unspecified site A@ Ez A ALBUTEROL d00749A C- J45 Asthma A@ Ez A ALBUTEROL d00749A C J45 Asthma A@ Ez A DESVENLAFAXINE d07113A C F32.9 R52 Major depressive disorder, single episode, unspecified Pain, unspecified A@ Ez0 A . . . Ez@ A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A EzP A . . . Ez` A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A@ Ez` A DICYCLOMINE d00999A C- K58 Irritable bowel syndrome A@ Ez` A HYDROCODONE; IBUPROFEN d04225A C M79.2 Neuralgia and neuritis, unspecified A@ Ez` A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A@ Ezp A . . . Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A ATOMOXETINE d04827A B F90 Attention-deficit hyperactivity disorders A@ Ez A CLONIDINE d00044A C- G47.0 Insomnia A@ Ez A CYPROHEPTADINE d00790A B G47.0 Insomnia A@ Ez A RISPERIDONE d03180A C F91.9 Conduct disorder, unspecified A@ E{ A . . . E{ A . . . E{ A . . . E{0 A ETANERCEPT d04365A CDp L40 L40.5 M06.9 Psoriasis Arthropathic psoriasis Rheumatoid arthritis, unspecified A@ E{0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E{0 A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A@ E{0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E{@ A . . . E{P A . . . E{` A . . . E{p A . . . E{ A ACETAMINOPHEN; HYDROCODONE d03428A C- 99999 A E{ A ALPRAZOLAM d00168A C- 99999 A E{ A ATORVASTATIN d04105A C- 99999 A E{ A GLYBURIDE d00248A C- 99999 A E{ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E{ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E{ A SERTRALINE d00880A C- 99999 A E{ A THEOPHYLLINE d00142A C- J45 Asthma A E{ A . . . E{ A . . . E{ A . . . E{ A . . . E{ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E{ A MODAFINIL d04378A C- G47.41 Narcolepsy A E{ A . . . E{ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E| A . . . E| A . . . E| A . . . E|0 A . . . E|@ A AMLODIPINE d00689A C 99999 A E|@ A ATORVASTATIN d04105A0 C 99999 A E|@ A CLOPIDOGREL d04258A0 C 99999 A E|@ A ESOMEPRAZOLE d04749A0 C K21 Gastro-esophageal reflux disease A E|@ A FUROSEMIDE d00070A0 C 99999 A E|@ A GLIPIZIDE d00246A0 C 99999 A E|@ A INSULIN ASPART d04697A0 C 99999 A E|@ A INSULIN GLARGINE d04538A0 C 99999 A E|@ A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E|@ A METFORMIN d03807A0 C 99999 A E|@ A METOPROLOL d00134A0 C 99999 A E|@ A NITROGLYCERIN d00321A0 C 99999 A E|P A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A0 E|P A METFORMIN d03807A C N83.2 Other and unspecified ovarian cysts A0 E|P A PROMETHAZINE d00787A Ap R11.0 Nausea A0 E|` A AMIODARONE d00002A CDp I10 Essential (primary) hypertension Ap E|` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap E|` A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified Ap E|` A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E|` A POTASSIUM CHLORIDE d00345A CDp E87.6P Prevent hypokalemia Ap E|` A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia Ap E|` A WARFARIN d00022A CDp Z79.02 Long term (current) use of antithrombotics/antiplatelets Ap E|p A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E|p A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E| A FLUTICASONE NASAL d04283A Dc J30.9 Allergic rhinitis, unspecified A E| A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A E| A . . . E| A . . . E| A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A0 E| A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A0 E| A QUETIAPINE d04220A B F31.9 F41.9 Bipolar disorder, unspecified Anxiety disorder, unspecified A0 E| A . . . E| A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E| A IBUPROFEN d00015A B N94.6 Dysmenorrhea, unspecified A E| A . . . E} A ALBUTEROL d00749A B J45 Asthma A E} A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A E} A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E} A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E} A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E} A . . . E}0 A . . . E}@ A . . . E}P A . . . E}` A . . . E}p A . . . E} A ACETAMINOPHEN; HYDROCODONE d03428A Cr G89.18 M54.2 M54.9 Other acute postprocedural pain Cervicalgia Dorsalgia, unspecified A0 E} A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E} A EMTRICITABINE; RILPIVIRINE; TENOFOVIR d07796A C B20 Human immunodeficiency virus [HIV] disease A0 E} A MESALAMINE d01031A C K51 Ulcerative colitis A E} A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E} A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A0 E} A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E} A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E} A . . . E} A . . . E} A . . . E} A DIVALPROEX SODIUM d03833A C F31.9 Bipolar disorder, unspecified A E} A GABAPENTIN d03182A C G40 Epilepsy and recurrent seizures A E} A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E} A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E} A METOPROLOL d00134A C I20.9 Angina pectoris, unspecified A E} A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E} A PRAZOSIN d00138A C I10 Essential (primary) hypertension A E} A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E} A ZIPRASIDONE d04747A C F31.9 Bipolar disorder, unspecified A E} A . . . E~ A BETAXOLOL OPHTHALMIC d04038A0 D H40 Glaucoma A E~ A FLUNISOLIDE NASAL d04279A0 Cr J30.9 Allergic rhinitis, unspecified A E~ A ISOSORBIDE MONONITRATE d00269A0 Cr R07.9 Chest pain, unspecified A E~ A LISINOPRIL d00732A0 Cr I10 Essential (primary) hypertension A E~ A LOVASTATIN d00280A0 Cr E78.0 Pure hypercholesterolemia A E~ A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A E~ A OMEPRAZOLE d00325A0 C[@ K30 Functional dyspepsia A E~ A RIVAROXABAN d07356A0 C D75.9P Prevent blood clots A E~ A SERTRALINE d00880A0 CDp F41.9 Anxiety disorder, unspecified A E~ A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E~ A . . . E~0 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C N94.3 Premenstrual tension syndrome A E~@ A . . . E~P A . . . E~` A . . . E~p A CLOBETASOL TOPICAL d01288A C- L40 Psoriasis A@ E~p A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A@ E~p A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A@ E~p A HOMATROPINE; HYDROCODONE d03340A A0 J00 Acute nasopharyngitis [common cold] A@ E~ A . . . E~ A CELECOXIB d04380A B M54.9 Dorsalgia, unspecified Ap E~ A DICLOFENAC d00848A B M19.9 Osteoarthritis, unspecified site Ap E~ A ESOMEPRAZOLE d04749A D* K30 Functional dyspepsia Ap E~ A GABAPENTIN d03182A C G25.81 Restless legs syndrome Ap E~ A HYDROCODONE d03075A Cr M54.9 Dorsalgia, unspecified Ap E~ A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified Ap E~ A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia Ap E~ A TOPIRAMATE d04115A C G43 Migraine A E~ A . . . E~ A . . . E~ A . . . E~ A ACETAMINOPHEN; HYDROCODONE d03428A B= M54.9 Dorsalgia, unspecified AP E~ A IBUPROFEN d00015A D M54.9 Dorsalgia, unspecified AP E~ A LORATADINE d03050A C T78.40 Allergy, unspecified AP E~ A SIMVASTATIN; SITAGLIPTIN d07805A C[@ E78.0 Pure hypercholesterolemia AP E~ A TOLTERODINE d04294A D N32.81 Overactive bladder AP E~ A . . . E A ALBUTEROL d00749A Cr J45 Asthma A0 E A BECLOMETHASONE d00760A C- J45 Asthma A0 E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A0 E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E A . . . E0 A ANTI-INFECTIVES - UNSPECIFIED c00001A A0 R21 Rash and other nonspecific skin eruption A E0 A HYDROCORTISONE TOPICAL d03205A A R21 Rash and other nonspecific skin eruption A E@ A . . . EP A . . . E` A . . . Ep A . . . E A DICYCLOMINE d00999A AP K21 Gastro-esophageal reflux disease AP E A HYDROXYZINE d00907A C J30.9 L23 T78.40 Allergic rhinitis, unspecified Allergic contact dermatitis Allergy, unspecified AP E A NABUMETONE d00310A AP M13 Other arthritis AP E A PIMECROLIMUS TOPICAL d04784A Ap L20.9 L50 Atopic dermatitis, unspecified Urticaria AP E A RANITIDINE d00021A AP K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A@ E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension A@ E A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified A@ E A . . . E A LORATADINE; PSEUDOEPHEDRINE d03818A B[ T78.40 Allergy, unspecified A E A . . . E0 A GRISEOFULVIN d00100A B B35.4 Tinea corporis A E@ A . . . EP A . . . E` A ALBUTEROL d00749A D9 J45 Asthma AP E` A DILTIAZEM d00045A B= I10 Essential (primary) hypertension AP E` A EZETIMIBE d04824A B= E78.0 Pure hypercholesterolemia AP E` A FLUTICASONE; SALMETEROL d04611A0 Bz J45 Asthma AP E` A WARFARIN d00022A B[ D75.9P Prevent blood clots AP Ep A . . . E A AMOXICILLIN d00088A A 99999 A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A E A TRIAMTERENE d00396A C I10 Essential (primary) hypertension A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C[@ G43 Migraine AP E A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified AP E A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified AP E A MORPHINE d00308A C M25.56 M54.9 M79.2 Pain in knee Dorsalgia, unspecified Neuralgia and neuritis, unspecified AP E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A ATORVASTATIN d04105A C 99999 A0 E A ROSUVASTATIN d04851A C 99999 A0 E A SITAGLIPTIN d05896A C I10 Essential (primary) hypertension A0 E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54.9 Dorsalgia, unspecified A` E A LABETALOL d00016A D9 I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A` E A TOLTERODINE d04294A C R39.15 Urgency of urination A` E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E0 A BACLOFEN d00967A D M62.83 Muscle spasm A E0 A TERAZOSIN d00386A B R39.12 Poor urinary stream A E@ A ENALAPRIL d00013A C I42.9 Cardiomyopathy, unspecified A EP A . . . E` A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E` A LISINOPRIL d00732A D1 I10 Essential (primary) hypertension A Ep A . . . E A ASENAPINE d07473A C- F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A@ E A CLONAZEPAM d00197A B[ F41.9 R45.1 Anxiety disorder, unspecified Restlessness and agitation A@ E A LITHIUM d00061A C- F31.9 F39 F90 Bipolar disorder, unspecified Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders A@ E A TOPIRAMATE d04115A C F31.9 Bipolar disorder, unspecified A@ E A AZELASTINE NASAL d04068A C[@ J30.9 Allergic rhinitis, unspecified A E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ALBUTEROL d00749A C R07.89 Other chest pain A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A AMLODIPINE; OLMESARTAN d06905A B[ I10 Essential (primary) hypertension A E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A CDp H40 Glaucoma A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TRAVOPROST OPHTHALMIC d04753A CDp H40 Glaucoma A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E0 A . . . E@ A . . . EP A . . . E` A CETIRIZINE d03827A B T78.40 Allergy, unspecified A0 E` A FLUTICASONE NASAL d04283A B T78.40 Allergy, unspecified A0 E` A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A0 Ep A . . . E A AMITRIPTYLINE d00146A CDp G43 Migraine A E A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A AMOXICILLIN d00088A A A49.9 Bacterial infection, unspecified A E A . . . E A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A` E A GABAPENTIN d03182A B= R25.2 Cramp and spasm A` E A GLYBURIDE; METFORMIN d04703A D E11 Type 2 diabetes mellitus A` E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A CHLORTHALIDONE d00192A Cr R60.9 Edema, unspecified A` E A MELOXICAM d04532A C M13 M54.9 Other arthritis Dorsalgia, unspecified A` E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A` E A NABUMETONE d00310A C M06.9 Rheumatoid arthritis, unspecified A` E A TRAMADOL d03826A C- M13 Other arthritis A` E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A C- I10 Essential (primary) hypertension A@ E A ESCITALOPRAM d04812A Cr F41.9 Anxiety disorder, unspecified A@ E A METFORMIN d03807A Dc R73.9 Hyperglycemia, unspecified A@ E A CARVEDILOL d03847A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A FORMOTEROL d04572A CDp J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A FUROSEMIDE d00070A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A HYDROCORTISONE d00254A CDp E27.1 Primary adrenocortical insufficiency A E A LOSARTAN d03821A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A METOCLOPRAMIDE d00298A C- K21 Gastro-esophageal reflux disease A E A MOMETASONE d05262A CDp J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A NAPROXEN d00019A C[@ M25.51 M25.56 M54.9 Pain in shoulder Pain in knee Dorsalgia, unspecified A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A TEMAZEPAM d00384A C G47.0 Insomnia A E A TIOTROPIUM d04829A CDp J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A . . . E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E A FEXOFENADINE d04040A C T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A AMOXICILLIN d00088A A L02.92 Furuncle, unspecified A E A TRIAMCINOLONE TOPICAL d03206A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E0 A MINOCYCLINE d00110A C L03.90 Cellulitis, unspecified A E@ A . . . EP A . . . E` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A Ep A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia A@ E A RALOXIFENE d04261A CDp M85.80 Other specified disorders of bone density and structure, unspecified site A@ E A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A@ E A ACETAMINOPHEN; HYDROCODONE d03428A B= M54.9 Dorsalgia, unspecified Ap E A AMLODIPINE d00689A B I20.9 Angina pectoris, unspecified Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A METAXALONE d00964A B= M54.9 Dorsalgia, unspecified Ap E A METOPROLOL d00134A B I10 Essential (primary) hypertension Ap E A PANTOPRAZOLE d04514A B K21 K30 Gastro-esophageal reflux disease Functional dyspepsia Ap E A RANITIDINE d00021A B K27 Peptic ulcer, site unspecified Ap E A . . . E A . . . E A . . . E A CAPTOPRIL d00006A C I10 Essential (primary) hypertension A E A GLYBURIDE; METFORMIN d04703A C E11 Type 2 diabetes mellitus A E A IBUPROFEN d00015A Cr M79.1 Myalgia A E A BUDESONIDE d04276A C- K91.2 Postsurgical malabsorption, not elsewhere classified A` E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A` E A METRONIDAZOLE d00108A CDp K91.2 Postsurgical malabsorption, not elsewhere classified A` E A MONTELUKAST d04289A B= K21 Gastro-esophageal reflux disease A` E A MULTIVITAMIN d03140A Ap E56.9 K91.2 Vitamin deficiency, unspecified Postsurgical malabsorption, not elsewhere classified A` E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C- K91.2 Postsurgical malabsorption, not elsewhere classified A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ALLOPURINOL d00023A C M25.5 Pain in joint AP E A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A CLINDAMYCIN d00043A B A49.9P Prevent bacterial infection A E A HYDROCODONE d03075A B K08.8 Other specified disorders of teeth and supporting structures A E0 A . . . E@ A . . . EP A . . . E` A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A` E` A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A` E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E` A OMEPRAZOLE d00325A C K27 Peptic ulcer, site unspecified A` E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ep A . . . E A BENZONATATE d00796A B= J42 Unspecified chronic bronchitis A E A EXEMESTANE d04461A C- C50 Malignant neoplasm of breast A E A FUROSEMIDE d00070A B= R60.9 Edema, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E A TRAMADOL d03826A Cr M25.56 Pain in knee A E A VENLAFAXINE d03181A B N95.1 Menopausal and female climacteric states A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E A GLIMEPIRIDE d03864A B= E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E A SAXAGLIPTIN d07467A B= E11 Type 2 diabetes mellitus AP E A . . . E A CETIRIZINE d03827A D9 T78.40 Allergy, unspecified A` E A FUROSEMIDE d00070A C[@ K76.9 R60.9 Liver disease, unspecified Edema, unspecified A` E A LEVOTHYROXINE d00278A D@) E03.9 Hypothyroidism, unspecified A` E A METHYCLOTHIAZIDE d00643A Cr R60.9 Edema, unspecified A` E A METOCLOPRAMIDE d00298A B K30 Functional dyspepsia A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A BETHANECHOL d01427A C R33.9 Retention of urine, unspecified Ap E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction Ap E A DEXLANSOPRAZOLE d07395A C K30 Functional dyspepsia Ap E A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction Ap E A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction Ap E A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified Ap E0 A . . . E@ A ALBUTEROL d00749A B J42 J45 Unspecified chronic bronchitis Asthma AP E@ A ATENOLOL d00004A C- I10 Essential (primary) hypertension AP E@ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E@ A FORMOTEROL; MOMETASONE d07660A B J42 J45 Unspecified chronic bronchitis Asthma AP E@ A METFORMIN d03807A B R73.9 Hyperglycemia, unspecified AP EP A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A E` A AFLIBERCEPT OPHTHALMIC d07815A Cr H35.30 Unspecified macular degeneration (age-related) A@ E` A BUPROPION d00181A CP F32.9 Major depressive disorder, single episode, unspecified A@ E` A CELECOXIB d04380A C M19.9 Osteoarthritis, unspecified site A@ E` A DENOSUMAB d07640A C M81 Osteoporosis without current pathological fracture A@ Ep A . . . E A AMOXICILLIN d00088A A J42 Unspecified chronic bronchitis A E A . . . E A CLONAZEPAM d00197A B F41.9 Anxiety disorder, unspecified A E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROCODONE d03075A B K08.8 Other specified disorders of teeth and supporting structures A0 E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A ALBUTEROL d00749A C J45 Asthma A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ATROPINE; DIPHENOXYLATE d03506A C R19.7 Diarrhea, unspecified A E A BECLOMETHASONE d00760A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A CYCLOSPORINE OPHTHALMIC d04836A C- H04.12 Dry eye syndrome A E A GABAPENTIN d03182A C G25.81 M79.2 Restless legs syndrome Neuralgia and neuritis, unspecified A E A GABAPENTIN d03182A C- M79.7 Fibromyalgia A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E A METFORMIN; SAXAGLIPTIN d07709A C"0 E11 Type 2 diabetes mellitus A E A MIRTAZAPINE d04025A C- G25.81 G47.0 Restless legs syndrome Insomnia A E A TOPIRAMATE d04115A C- F41.9 Anxiety disorder, unspecified A E A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E A DILTIAZEM d00045A C R00.0 Tachycardia, unspecified A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A C I21.P Prevent heart attack/myocardial infarction A E A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A E A . . . E0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E@ A . . . EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N92 N94.6 Excessive, frequent and irregular menstruation Dysmenorrhea, unspecified A E` A . . . Ep A FLUTICASONE NASAL d04283A B[ J30.9 Allergic rhinitis, unspecified A E A . . . E A METOPROLOL d00134A0 CP I10 Essential (primary) hypertension A@ E A NIACIN d00314A CP I21.P Prevent heart attack/myocardial infarction A@ E A PRAVASTATIN d00348A CP E78.0 Pure hypercholesterolemia A@ E A RAMIPRIL d00728A CP I51.9P Prevent heart disease A@ E A . . . E A CARVEDILOL d03847A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A0 E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A0 E A PROMETHAZINE d00787A C R11 Nausea and vomiting A0 E A BECLOMETHASONE d00760A C R06.9 Unspecified abnormalities of breathing A E A BUDESONIDE; FORMOTEROL d04795A B= R06.9 Unspecified abnormalities of breathing A E A FENOFIBRATE d04286A B R00.2 Palpitations A E A FUROSEMIDE d00070A Ap R60.9 Edema, unspecified A E A GABAPENTIN d03182A B G25.81 Restless legs syndrome A E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E A LORATADINE d03050A C T78.40 Allergy, unspecified A E A MONTELUKAST d04289A B= R06.9 Unspecified abnormalities of breathing A E A OLMESARTAN d04801A Ap I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A TIOTROPIUM d04829A B= R06.9 Unspecified abnormalities of breathing A E A . . . E A ACYCLOVIR d00001A C Z48.29 Encounter for aftercare following bone marrow transplant A E A OMEPRAZOLE d00325A C Z48.29 Encounter for aftercare following bone marrow transplant A E A . . . E A AMOXICILLIN d00088A A@ H66.9 Otitis media, unspecified A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A . . . E0 A . . . E@ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E@ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E@ A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension AP E@ A NORTRIPTYLINE d00144A CDp R52 Pain, unspecified AP E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54.2 M79.1 Cervicalgia Myalgia A E A CARISOPRODOL d00960A CDp M54.2 M79.1 Cervicalgia Myalgia A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A C- M13 Other arthritis A Ep A BACLOFEN d00967A C- M62.83 Muscle spasm A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE d00253A CDp 99999 A@ E A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A THYROID DESICCATED d00655A B E03.9 Hypothyroidism, unspecified A0 E A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A B= E78.0P Prevent high cholesterol A E A BUPROPION d00181A D F41.9 Anxiety disorder, unspecified A E A FUROSEMIDE d00070A D6. R60.9 Edema, unspecified A E A HYDROCODONE d03075A B T14.9 Unspecified injury A E A IBUPROFEN d00015A C T14.9 Unspecified injury A E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A ACYCLOVIR d00001A Cr B00.1 Herpesviral vesicular dermatitis AP E A ATORVASTATIN d04105A C E78.1 I21.P Pure hyperglyceridemia Prevent heart attack/myocardial infarction AP E A METHAZOLAMIDE d00640A C H40 Glaucoma AP E A TOLTERODINE d04294A C[@ R32 Unspecified urinary incontinence AP E A WARFARIN d00022A C I48.91 Unspecified atrial fibrillation AP E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E` A . . . Ep A LEVOTHYROXINE d00278A Cr E04.1 Nontoxic single thyroid nodule A Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A@ E A CLONIDINE d00044A D I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E A . . . E A CANDESARTAN d04322A Cr I10 Essential (primary) hypertension A@ E A FLUTICASONE NASAL d04283A B= H93.9 Unspecified disorder of ear A@ E A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A@ E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A@ E A . . . E A ETANERCEPT d04365A C L40.5 Arthropathic psoriasis A0 E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A E A . . . E A . . . E A METHADONE d00050A C1` F11.2 Opioid dependence A E A . . . E0 A . . . E@ A . . . EP A CELECOXIB d04380A C- M54.9 M79.1 Dorsalgia, unspecified Myalgia A EP A CITALOPRAM d04332A0 C F43.1 Post-traumatic stress disorder (PTSD) A EP A CYCLOBENZAPRINE d00963A0 C M62.83 Muscle spasm A EP A GABAPENTIN d03182A0 C F43.1 Post-traumatic stress disorder (PTSD) A EP A HYDROCODONE d03075A B M79.2 Neuralgia and neuritis, unspecified A EP A KETOCONAZOLE TOPICAL d03202A0 C B35.9 Dermatophytosis, unspecified A EP A LORATADINE d03050A0 C H10.1 L23 Acute atopic conjunctivitis Allergic contact dermatitis A EP A NAPROXEN d00019A0 C M79.2 Neuralgia and neuritis, unspecified A EP A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A EP A RANITIDINE d00021A0 C K21 Gastro-esophageal reflux disease A EP A TERAZOSIN d00386A0 CDp N40 Enlarged prostate A EP A TRIAMCINOLONE d00620A0 CDp K52.9 Noninfective gastroenteritis and colitis, unspecified A E` A . . . Ep A PREDNISOLONE d00084A A0 J42 Unspecified chronic bronchitis A E A LISINOPRIL d00732A B 99999 A E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ACYCLOVIR d00001A C B00.1 Herpesviral vesicular dermatitis A E A . . . E A . . . E0 A ETHINYL ESTRADIOL; ETONOGESTREL d04773A CDp N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E0 A NAPROXEN d00019A A0 M79.1 Myalgia A E@ A CETIRIZINE d03827A B= T78.40 Allergy, unspecified A E@ A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A EP A FLUOXETINE d00236A C- F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A E` A . . . Ep A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A CDp I10 Essential (primary) hypertension A E A . . . E A HYDROCHLOROTHIAZIDE d00253A D=O I10 Essential (primary) hypertension A0 E A POTASSIUM CHLORIDE d00345A D9 E87.6 Hypokalemia A0 E A VERAPAMIL d00048A C I49.9 Cardiac arrhythmia, unspecified A0 E A . . . E A . . . E A . . . E0 A ACETAMINOPHEN; CODEINE d03423A A K04.7 Periapical abscess without sinus A` E0 A GLIPIZIDE d00246A Bz E88.81 Metabolic syndrome A` E0 A IBUPROFEN d00015A A0 M54.9 Dorsalgia, unspecified A` E0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E0 A METFORMIN d03807A CDp R73 Elevated blood glucose level A` E0 A SITAGLIPTIN d05896A C R73 Elevated blood glucose level A` E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 Ep A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A0 Ep A ATENOLOL; CHLORTHALIDONE d03258A B[ I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A BZ I10 Essential (primary) hypertension A E A METOPROLOL d00134A BZ I48.91 Unspecified atrial fibrillation A E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A@ E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A@ E A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A@ E A VALSARTAN d04113A C- I50.9 Heart failure, unspecified A@ E A CEFUROXIME d00056A A J01.9 Acute sinusitis, unspecified A E A CODEINE; GUAIFENESIN d03393A A J01.9 Acute sinusitis, unspecified A E A EXEMESTANE d04461A C C50 Malignant neoplasm of breast A E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A AMOXICILLIN d00088A A H10 H66.9 Conjunctivitis Otitis media, unspecified A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E0 A . . . E@ A ISOSORBIDE MONONITRATE d00269A D* I20.9 Angina pectoris, unspecified AP E@ A LANSOPRAZOLE d03828A C K29.70 K30 Gastritis, unspecified, without bleeding Functional dyspepsia AP E@ A LISINOPRIL d00732A D* I10 Essential (primary) hypertension AP E@ A NITROGLYCERIN d00321A D* R07.9 Chest pain, unspecified AP E@ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia AP EP A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A C R05 Cough A E` A . . . Ep A . . . E A RANITIDINE d00021A B= K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal Ap E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified Ap E A IBUPROFEN d00015A B J09 Influenza due to certain identified influenza viruses Ap E A MECLIZINE d00859A B J09 Influenza due to certain identified influenza viruses Ap E A MIRTAZAPINE d04025A C G47.0 Insomnia Ap E A PROCHLORPERAZINE d00355A B R11 Nausea and vomiting Ap E A TRAZODONE d00395A C G47.0 Insomnia Ap E A . . . E A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A DILTIAZEM d00045A Cr I47.1 Supraventricular tachycardia AP E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension AP E A MOMETASONE d05262A C[@ J45 Asthma AP E A MOMETASONE NASAL d04223A Cr J30.9 Allergic rhinitis, unspecified AP E A RISEDRONATE d04300A C M85.80 Other specified disorders of bone density and structure, unspecified site AP E A . . . E A ALENDRONATE d03849A B M85.80 Other specified disorders of bone density and structure, unspecified site A@ E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E0 A NIACIN d00314A C E78.0 Pure hypercholesterolemia A0 E0 A SOLIFENACIN d05413A Dc N32.81 Overactive bladder A0 E@ A CYCLOBENZAPRINE d00963A A M54.9 Dorsalgia, unspecified A E@ A NAPROXEN d00019A A M54.9 Dorsalgia, unspecified A EP A . . . E` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Ep A . . . E A . . . E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E A ZOLPIDEM d00910A B= G47.0 Insomnia A E A . . . E A CITALOPRAM d04332A BF F41.9 Anxiety disorder, unspecified A E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A C- I10 Essential (primary) hypertension A E A . . . E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E0 A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma A` E0 A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A` E0 A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus A` E0 A LOSARTAN d03821A D I10 Essential (primary) hypertension A` E0 A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia A` E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E@ A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A0 E@ A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A0 EP A . . . E` A ONDANSETRON d00867A Ap R11 Nausea and vomiting A Ep A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified AP Ep A CLONAZEPAM d00197A CDp F32.9 Major depressive disorder, single episode, unspecified AP Ep A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP Ep A LORAZEPAM d00149A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified AP Ep A ZOLPIDEM d00910A CDp G47.9 Sleep disorder, unspecified AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A B I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A D E10 Type 1 diabetes mellitus A E A LEVOTHYROXINE d00278A CDp E04.1 Nontoxic single thyroid nodule A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A C M79.1 Myalgia A E A METFORMIN d03807A B[ E10 Type 1 diabetes mellitus A E A VALACYCLOVIR d03838A B= B02 Zoster [herpes zoster] A E A ACETAMINOPHEN; HYDROCODONE d03428A B M79.1 Myalgia A0 E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E A ACETAMINOPHEN; OXYCODONE d03431A C R52 Pain, unspecified A E A ALPRAZOLAM d00168A Cr F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A B= M62.83 Muscle spasm A E A ESTRADIOL d00537A D Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A D G40 Epilepsy and recurrent seizures A E A MILNACIPRAN d06635A C M79.7 Fibromyalgia A E A MIRTAZAPINE d04025A C G47.9 Sleep disorder, unspecified A E A PRAZOSIN d00138A C G47.0 Insomnia A E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures A E A VALACYCLOVIR d03838A C B00.9 Herpesviral infection, unspecified A E A CLOPIDOGREL d04258A C- Z79.02 Long term (current) use of antithrombotics/antiplatelets A E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B[ I10 Essential (primary) hypertension A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots Ap E A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia Ap E A FLUTICASONE NASAL d04283A C J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion Ap E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension Ap E A LOTEPREDNOL OPHTHALMIC d04292A C- H57.8 H57.9 Other specified disorders of eye and adnexa Unspecified disorder of eye and adnexa Ap E A METOPROLOL d00134A C I51.9 Heart disease, unspecified Ap E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 M79.2 T14.9 Dorsalgia, unspecified Neuralgia and neuritis, unspecified Unspecified injury A E A BUPRENORPHINE d00840A B[ M54.9 Dorsalgia, unspecified A E A DOXYCYCLINE d00037A C L71 Rosacea A0 E A QUINAPRIL d00365A C I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A0 E A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia B E A BUDESONIDE; FORMOTEROL d04795A D J44.9 Chronic obstructive pulmonary disease, unspecified B E A DRONEDARONE d07458A C I51.9 Heart disease, unspecified B E A FENOFIBRATE d04286A D E78.0 Pure hypercholesterolemia B E A FINASTERIDE d00563A C N28.9 Disorder of kidney and ureter, unspecified B E A FUROSEMIDE d00070A CDp N39.9 Disorder of urinary system, unspecified B E A GABAPENTIN d03182A D M54.9 Dorsalgia, unspecified B E A ISOSORBIDE MONONITRATE d00269A Dc I51.9 Heart disease, unspecified B E A LISINOPRIL d00732A Dc I51.9 Heart disease, unspecified B E A METOCLOPRAMIDE d00298A C R10.9 Unspecified abdominal pain B E A OMEPRAZOLE d00325A D K30 Functional dyspepsia B E A OXYCODONE d00329A D R52 Pain, unspecified B E A OXYCODONE d00329A D R52 Pain, unspecified B E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia B E A SERTRALINE d00880A C- I51.9 Heart disease, unspecified B E A TAMSULOSIN d04121A C N28.9 Disorder of kidney and ureter, unspecified B E A TESTOSTERONE d00558A D E29.1 Testicular hypofunction B E A TIOTROPIUM d04829A D J44.9 Chronic obstructive pulmonary disease, unspecified B E A WARFARIN d00022A Dc Z79.02 Long term (current) use of antithrombotics/antiplatelets B E A . . . E0 A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A0 E0 A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified A0 E0 A QUETIAPINE d04220A CDp G47.9 Sleep disorder, unspecified A0 E@ A . . . EP A ACETAMINOPHEN; CODEINE d03423A Bz M79.1 Myalgia A EP A AMLODIPINE d00689A B I10 Essential (primary) hypertension A EP A COLCHICINE d00150A B[ 99999 A EP A GABAPENTIN d03182A B[ E11.4 Type 2 diabetes mellitus with neurological complications A EP A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A EP A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A EP A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A EP A PREDNISONE d00350A C E06.9 Thyroiditis, unspecified A EP A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EP A SAXAGLIPTIN d07467A B E11 Type 2 diabetes mellitus A E` A . . . Ep A DIAZEPAM d00148A Ap F41.9 Anxiety disorder, unspecified A E A ASPIRIN d00170A C- I21.P Prevent heart attack/myocardial infarction Ap E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension Ap E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E A LINAGLIPTIN d07767A B[ E11 Type 2 diabetes mellitus Ap E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C[@ R12 Heartburn Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A Dc I10 Essential (primary) hypertension A E A . . . E A CARBAMAZEPINE d00058A D G40 Epilepsy and recurrent seizures A E A VALPROIC ACID d00083A D G40 Epilepsy and recurrent seizures A E0 A . . . E@ A ALBUTEROL d00749A B J45 Asthma B E@ A BACITRACIN TOPICAL d03756A B L98.9 Disorder of the skin and subcutaneous tissue, unspecified B E@ A CEPHALEXIN d00096A A0 J42 Unspecified chronic bronchitis B E@ A CILOSTAZOL d04382A Cr L97 Non-pressure chronic ulcer of lower limb, not elsewhere classified B E@ A CLONAZEPAM d00197A C"0 G47.9 Sleep disorder, unspecified B E@ A COLLAGENASE TOPICAL d01315A B[ L03.90 Cellulitis, unspecified B E@ A DICLOFENAC d00848A Dc M13 Other arthritis B E@ A ENOXAPARIN d03041A A0 I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified B E@ A HYDROCHLOROTHIAZIDE d00253A A0 N28.9 Disorder of kidney and ureter, unspecified B E@ A LANSOPRAZOLE d03828A CDp K31.9 Disease of stomach and duodenum, unspecified B E@ A MUPIROCIN TOPICAL d01267A B= L03.90 Cellulitis, unspecified B E@ A PROPRANOLOL d00032A Cr I10 Essential (primary) hypertension B E@ A ROPINIROLE d04215A Cr G25.0 Essential tremor B E@ A TAMSULOSIN d04121A D ^ N40 Enlarged prostate B E@ A TOLTERODINE d04294A Cr 99999 B E@ A WARFARIN d00022A A0 D75.9P Prevent blood clots B EP A . . . E` A . . . Ep A . . . E A HYDROCODONE d03075A B M19.9 Osteoarthritis, unspecified site A E A . . . E A . . . E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A E A SERTRALINE d00880A D F41.9 Anxiety disorder, unspecified A E A ZOLPIDEM d00910A D G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE; VALSARTAN d06662A D I10 Essential (primary) hypertension A` E0 A ESOMEPRAZOLE d04749A D R12 Heartburn A` E0 A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A` E0 A FUROSEMIDE d00070A D R60.9 Edema, unspecified A` E0 A METOPROLOL d00134A D I10 Essential (primary) hypertension A` E0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` E@ A . . . EP A DEXLANSOPRAZOLE d07395A C[@ K27 Peptic ulcer, site unspecified A E` A . . . Ep A . . . E A . . . E A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A0 E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis AP E A ESTRADIOL; NORETHINDRONE d04375A C[@ Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels AP E A FENOFIBRATE d04286A C"0 E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A LAMOTRIGINE d03809A C[@ G40 Epilepsy and recurrent seizures AP E A POLYETHYLENE GLYCOL 3350 d05350A D K59.0 Constipation AP E A PROPRANOLOL d00032A Cr R45.4 Irritability and anger AP E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures AP E A TRAZODONE d00395A CP G47.0 Insomnia AP E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified Ap E A DICYCLOMINE d00999A C- R10.83 Colic Ap E A DULOXETINE d05355A C[@ M79.7 Fibromyalgia Ap E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease Ap E A ETANERCEPT d04365A C L40 Psoriasis Ap E A NAPROXEN d00019A C- M54.2 Cervicalgia Ap E A PREGABALIN d05508A C[@ M79.7 Fibromyalgia Ap E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A FUROSEMIDE d00070A D* I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A@ E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- N92 Excessive, frequent and irregular menstruation A E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A E0 A ALBUTEROL d00749A Ei J45 Asthma A0 E0 A BUDESONIDE d04276A C[@ J45 Asthma A0 E0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E@ A . . . EP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E` A . . . Ep A ACYCLOVIR d00001A C B02 Zoster [herpes zoster] A Ep A AMLODIPINE; OLMESARTAN d06905A C- I10 Essential (primary) hypertension A Ep A CELECOXIB d04380A CDp M19.9 Osteoarthritis, unspecified site A Ep A CLOPIDOGREL d04258A C 99999 A Ep A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A Ep A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A Ep A METFORMIN; PIOGLITAZONE d05635A C[@ E11 Type 2 diabetes mellitus A Ep A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A Ep A NEBIVOLOL d05265A CDp I50.9 Heart failure, unspecified A Ep A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A0 E A ALBUTEROL d00749A C J45 Asthma A@ E A ALBUTEROL d00749A C J45 Asthma A@ E A BUDESONIDE d04276A C J45 Asthma A@ E A TRIAMCINOLONE TOPICAL d03206A C[@ L20.9 Atopic dermatitis, unspecified A@ E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension AP Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ep A NAPROXEN d00019A B= M79.7 Fibromyalgia AP Ep A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified AP Ep A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ALENDRONATE d03849A0 C M81 Osteoporosis without current pathological fracture AP E A MELOXICAM d04532A0 C M79.1 Myalgia AP E A MONTELUKAST d04289A0 C R06.2 Wheezing AP E A OMEPRAZOLE d00325A0 C 99999 AP E A PREDNISONE d00350A0 C 99999 AP E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C[@ I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E A PREGABALIN d05508A B[ M25.51 M25.56 Pain in shoulder Pain in knee A@ E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A M54.9 Dorsalgia, unspecified AP E A CYCLOBENZAPRINE d00963A B= M54.9 Dorsalgia, unspecified AP E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified AP E A METOPROLOL d00134A C I50.9 Heart failure, unspecified AP E A PREDNISONE d00350A D M06.9 Rheumatoid arthritis, unspecified AP E A ALBUTEROL d00749A D= J45 Asthma A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A BISACODYL d01015A C- K59.0 Constipation A` E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A` E A MONTELUKAST d04289A C[@ J45 Asthma A` E A ZOLPIDEM d00910A C G47.0 Insomnia A` E A ACETAMINOPHEN; HYDROCODONE d03428A0 D M54.9 Dorsalgia, unspecified A E A BENZONATATE d00796A0 C J42 Unspecified chronic bronchitis A E A FLUTICASONE; SALMETEROL d04611A0 C[@ J45 Asthma A E A GABAPENTIN d03182A0 Cr M79.2 Neuralgia and neuritis, unspecified A E A LANSOPRAZOLE d03828A0 C K21 Gastro-esophageal reflux disease A E A ORPHENADRINE d00966A0 C- M54.9 Dorsalgia, unspecified A E A SPIRONOLACTONE d00373A0 C I10 Essential (primary) hypertension A E A TIOTROPIUM d04829A0 CDp J45 Asthma A E A . . . E A . . . E A . . . E0 A . . . E@ A DICLOFENAC d00848A D= M19.9 Osteoarthritis, unspecified site Ap E@ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease Ap E@ A HYDROXYCHLOROQUINE d00817A CDp M06.9 Rheumatoid arthritis, unspecified Ap E@ A LEFLUNOMIDE d04349A CDp M06.9 Rheumatoid arthritis, unspecified Ap E@ A METHOTREXATE d00060A C9 M06.9 Rheumatoid arthritis, unspecified Ap E@ A METHYLPREDNISOLONE d00293A B K13.79 S81.80 Other lesions of oral mucosa Unspecified open wound of lower leg Ap E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap EP A . . . E` A FORMOTEROL; MOMETASONE d07660A CDp J45 Asthma A Ep A . . . E A . . . E A . . . E A ALBUTEROL d00749A CP J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A0 E A FLUTICASONE; SALMETEROL d04611A CP J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A0 E A . . . E A PREDNISONE d00350A AP M19.9 Osteoarthritis, unspecified site A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C T14.9 Unspecified injury A E A ALBUTEROL d00749A C- J20.9 J44.9 J45 Acute bronchitis, unspecified Chronic obstructive pulmonary disease, unspecified Asthma A E A BUPROPION d00181A C F17.203 Nicotine dependence unspecified, with withdrawal A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A DOXEPIN d00217A C[@ G47.0 Insomnia A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A D6. E03.9 Hypothyroidism, unspecified A E A MOMETASONE d05262A C- J20.9 J44.9 J45 Acute bronchitis, unspecified Chronic obstructive pulmonary disease, unspecified Asthma A E A MORPHINE d00308A C G89.4 Chronic pain syndrome A E A TIOTROPIUM d04829A C"0 J20.9 J44.9 J45 Acute bronchitis, unspecified Chronic obstructive pulmonary disease, unspecified Asthma A E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A MEGESTROL d01348A C R63.0 Anorexia Ap E A ONDANSETRON d00867A C R11 Nausea and vomiting Ap E A SEVELAMER d04363A C E83.3 Disorders of phosphorus metabolism and phosphatases Ap E A . . . E0 A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A@ E A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A@ E A BECLOMETHASONE d00760A C"0 J45 Asthma A@ E A CODEINE; GUAIFENESIN d03393A AP J20.9 Acute bronchitis, unspecified A@ E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A0 E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A0 E A ONDANSETRON d00867A B R11.0 Nausea A0 E A ALLOPURINOL d00023A Dc M1A Chronic gout Ap E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia Ap E A NITROFURANTOIN d00112A C[@ A49.9P Prevent bacterial infection Ap E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension Ap E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia Ap E A ZOLPIDEM d00910A C[@ G47.0 Insomnia Ap E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified A E0 A . . . E@ A BUPROPION d00181A C"0 F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E@ A INSULIN ASPART d04697A Dc E10 Type 1 diabetes mellitus A0 E@ A METFORMIN d03807A C E10 Type 1 diabetes mellitus A0 EP A . . . E` A . . . Ep A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A0 Ep A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E A . . . E A LAMOTRIGINE d03809A B 99999 A` E A LOSARTAN d03821A B 99999 A` E A OLANZAPINE d04050A B F31.9 Bipolar disorder, unspecified A` E A OMEPRAZOLE d00325A B 99999 A` E A SERTRALINE d00880A B 99999 A` E A TAMSULOSIN d04121A B 99999 A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A LEVOTHYROXINE d00278A D> E03.9 Hypothyroidism, unspecified A Ep A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A Ep A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ALBUTEROL d00749A B R06.02 Shortness of breath A0 E A BISOPROLOL d00709A C- I10 Essential (primary) hypertension A0 E A MONTELUKAST d04289A Cr J45 Asthma A0 E A AMLODIPINE d00689A Cr 99999 A E A CITALOPRAM d04332A0 C F32.9 Major depressive disorder, single episode, unspecified A E A DIVALPROEX SODIUM d03833A B= G43 Migraine A E A HYDROXYZINE d00907A C G47.9 Sleep disorder, unspecified A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A PROMETHAZINE d00787A0 Cr K30 Functional dyspepsia A E A SUMATRIPTAN d03160A0 D G43 Migraine A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C[@ I21.P Prevent heart attack/myocardial infarction A E A SERTRALINE d00880A B= F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E A PHENYTOIN d00143A D ^ G40 Epilepsy and recurrent seizures A E A . . . E0 A PENICILLIN V POTASSIUM d07730A A A49.9 Bacterial infection, unspecified A E@ A . . . EP A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified AP EP A LEVOCETIRIZINE d05851A B T78.40 Allergy, unspecified AP EP A MELOXICAM d04532A B M25.56 Pain in knee AP EP A MINOCYCLINE d00110A B L70 Acne AP EP A MONTELUKAST d04289A C- J45 Asthma AP E` A . . . Ep A CETIRIZINE d03827A C T78.40 Allergy, unspecified A Ep A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A LORATADINE d03050A Ap T78.40 Allergy, unspecified A E A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia AP E A TADALAFIL d04896A Cr N52.9 Male erectile dysfunction, unspecified AP E A VALSARTAN d04113A C E11.2 Type 2 diabetes mellitus with kidney complications AP E A . . . E A . . . E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A 99999 . . A Ep A . . . E A ALBUTEROL d00749A CDp J45 Asthma AP E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP E A NAPROXEN d00019A C- M25.51 Pain in shoulder AP E A POTASSIUM CHLORIDE d00345A C- I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D/ E03.9 Hypothyroidism, unspecified A E A SIMVASTATIN d00746A Ap E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A E A ENOXAPARIN d03041A B I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A WARFARIN d00022A C- D75.9P Prevent blood clots A E A . . . E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E@ A AGOMELATINE h00035A B 55555 A EP A . . . E` A CETIRIZINE d03827A C"0 H10.1 J30.9 Acute atopic conjunctivitis Allergic rhinitis, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap E A CIPROFLOXACIN d00011A C N30 Cystitis Ap E A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified Ap E A POTASSIUM CITRATE d01423A B N20.0 Calculus of kidney Ap E A SOLIFENACIN d05413A C R35.0 Frequency of micturition Ap E A TAMSULOSIN d04121A B N20.0 Calculus of kidney Ap E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A B J45 Asthma A E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E A WARFARIN d00022A C- Z79.02 Long term (current) use of antithrombotics/antiplatelets A E A . . . E0 A . . . E@ A ALBUTEROL d00749A C- J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E@ A FLUTICASONE; SALMETEROL d04611A C- J43 J44.9 J45 Emphysema Chronic obstructive pulmonary disease, unspecified Asthma A@ E@ A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ E@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ EP A . . . E` A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A` E` A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D I10 Essential (primary) hypertension A` E` A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A` E` A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` E` A PROPRANOLOL d00032A CDp R25.1 Tremor, unspecified A` E` A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A` Ep A . . . E A CARVEDILOL d03847A Cr I49.9 Cardiac arrhythmia, unspecified A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ E A SPIRONOLACTONE d00373A C- I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A Ei 99999 A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A RISPERIDONE d03180A C"0 F32.9 Major depressive disorder, single episode, unspecified A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A FLURAZEPAM d00238A C G47.0 Insomnia A E A ZIPRASIDONE d04747A C F29 F31.9 Unspecified psychosis not due to a substance or known physiological condition Bipolar disorder, unspecified A E A . . . E A . . . E A BUPROPION d00181A CDp R45.86 Emotional lability AP E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives AP E A FLUOXETINE d00236A CDp R45.86 Emotional lability AP E A METHYLPHENIDATE d00900A CDp R45.86 Emotional lability AP E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A CDp L03.90 Cellulitis, unspecified AP E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified Ap E A CYCLOBENZAPRINE d00963A CP M62.83 Muscle spasm Ap E A NAPROXEN d00019A Cr M54.9 Dorsalgia, unspecified Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified Ap E A PRAZOSIN d00138A C F43.1 Post-traumatic stress disorder (PTSD) Ap E A VALACYCLOVIR d03838A Cr B02 Zoster [herpes zoster] Ap E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A ALBUTEROL d00749A C J45 Asthma A Ep A . . . E A . . . E A ALPRAZOLAM d00168A B G47.0 Insomnia A` E A ATENOLOL d00004A0 C- I10 Essential (primary) hypertension A` E A FUROSEMIDE d00070A0 C R60.9 Edema, unspecified A` E A LOVASTATIN d00280A0 C E78.0 Pure hypercholesterolemia A` E A MIRTAZAPINE d04025A Ap F32.9 Major depressive disorder, single episode, unspecified A` E A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia A` E A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTREL d03241A CP Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A Ap I10 Essential (primary) hypertension A E0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E0 A BRIMONIDINE OPHTHALMIC d04048A B H40 Glaucoma A E0 A DORZOLAMIDE OPHTHALMIC d03805A B[ H40 Glaucoma A E0 A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E0 A LEVOTHYROXINE d00278A C[@ C73 Malignant neoplasm of thyroid gland A E0 A LISINOPRIL d00732A Ap I10 Essential (primary) hypertension A E0 A METOPROLOL d00134A D I10 Essential (primary) hypertension A E0 A TIMOLOL OPHTHALMIC d04037A B[ H40 Glaucoma A E@ A . . . EP A LORATADINE; PSEUDOEPHEDRINE d03818A D* T78.40 Allergy, unspecified A EP A MONTELUKAST d04289A C T78.40 Allergy, unspecified A E` A . . . Ep A . . . E A CYCLOSPORINE OPHTHALMIC d04836A C H04.12 Dry eye syndrome A E A . . . E A CYCLOSPORINE OPHTHALMIC d04836A C H04.12 Dry eye syndrome A@ E A LEVOTHYROXINE d00278A D,3 E03.9 Hypothyroidism, unspecified A@ E A TAMOXIFEN d00381A C[@ C50 Malignant neoplasm of breast A@ E A VENLAFAXINE d03181A C[@ N95.1 Menopausal and female climacteric states A@ E A . . . E A . . . E A ALBUTEROL d00749A C J45.P Prevent asthma A E A MONTELUKAST d04289A CDp J45 Asthma A E A CITALOPRAM d04332A B G47.9 Sleep disorder, unspecified A@ E A FENOFIBRATE d04286A C- E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E A RANITIDINE d00021A C K30 Functional dyspepsia A@ E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A C"0 99999 A` E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A` E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A` E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A CLONIDINE d00044A C- I10 Essential (primary) hypertension A0 E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A . . . E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A E A OLMESARTAN d04801A Cr I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K27 Peptic ulcer, site unspecified A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A0 E A IBUPROFEN d00015A A K08.4 Partial loss of teeth A0 E A PENICILLIN d00116A A K08.4 Partial loss of teeth A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A DEXTROAMPHETAMINE d00804A Cr F90 Attention-deficit hyperactivity disorders A E A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension A E0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E0 A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E0 A METFORMIN d03807A C R73.9 Hyperglycemia, unspecified A@ E0 A ZOLPIDEM d00910A Cr G47.0 Insomnia A@ E@ A . . . EP A . . . E` A ENALAPRIL d00013A C I10 Essential (primary) hypertension A Ep A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A BISOPROLOL d00709A C I10 Essential (primary) hypertension A@ E A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A@ E A VALSARTAN d04113A BF I10 Essential (primary) hypertension A@ E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A@ E A RANITIDINE d00021A Cr K30 Functional dyspepsia A@ E A FLUTICASONE d01296A C[@ J45 Asthma A E A MONTELUKAST d04289A C[@ J45 T78.40 Asthma Allergy, unspecified A E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A PAROXETINE d03157A Dc F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A0 E A DAPSONE TOPICAL d05543A C L70 Acne A E A . . . E A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A IBUPROFEN d00015A Ap J02 Acute pharyngitis A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension AP E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E0 A CYCLOBENZAPRINE d00963A A M79.1 Myalgia A E@ A . . . EP A . . . E` A . . . Ep A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A CHLOROQUINE d00035A B[ M06.9 Rheumatoid arthritis, unspecified A E A DEFLAZACORT a71066A B[ 55555 A E A . . . E A . . . E A . . . E A . . . E A . . . E A AZELASTINE; FLUTICASONE NASAL d07868A B= J01.9 T78.40 Acute sinusitis, unspecified Allergy, unspecified A E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A E A CARISOPRODOL d00960A C- M79.1 Myalgia A E A CLONIDINE d00044A B F41.9 Anxiety disorder, unspecified A E A IBUPROFEN d00015A Cr M54.9 Dorsalgia, unspecified A E A LIDOCAINE TOPICAL d00683A C R52 Pain, unspecified A E A MONTELUKAST d04289A C ` R06.2 Wheezing A E A PREGABALIN d05508A Cr F41.9 Anxiety disorder, unspecified A E A TRAZODONE d00395A C- F32.9 Major depressive disorder, single episode, unspecified A E A VALACYCLOVIR d03838A Cr B00.1 Herpesviral vesicular dermatitis A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A Ep A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia Ap E A GLIPIZIDE d00246A B= E11 Type 2 diabetes mellitus Ap E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C- E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E A ALLOPURINOL d00023A0 Ap M1A Chronic gout Ap E A LEVOTHYROXINE d00278A0 Ap E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A0 Dc K21 Gastro-esophageal reflux disease Ap E A PAROXETINE d03157A0 C[@ F41.9 Anxiety disorder, unspecified Ap E A ROSUVASTATIN d04851A0 Ap E78.0 Pure hypercholesterolemia Ap E A TRAMADOL d03826A0 B T14.9 Unspecified injury Ap E A . . . E A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A E A . . . E A DILTIAZEM d00045A D* I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E0 A . . . E@ A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A EP A . . . E` A . . . Ep A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D Z79.3 Long term (current) use of hormonal contraceptives A E A SERTRALINE d00880A Cr F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A ESCITALOPRAM d04812A C"0 F41.9 Anxiety disorder, unspecified A E A IBUPROFEN d00015A A S62.6 Fracture of other and unspecified finger(s) A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A FINASTERIDE d00563A CDp L64 Androgenic alopecia A EP A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E` A . . . Ep A . . . E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A PRAVASTATIN d00348A C E78.1 Pure hyperglyceridemia A E A . . . E A . . . E A DOXYCYCLINE d00037A A K08.4 Partial loss of teeth A0 E A HYDROCODONE d03075A A M79.2 Neuralgia and neuritis, unspecified A0 E A IBUPROFEN d00015A A M79.2 Neuralgia and neuritis, unspecified A0 E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A AP L01.0 Impetigo A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B[ I10 Essential (primary) hypertension A0 E@ A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A0 E@ A TRAMADOL d03826A Dc M79.2 Neuralgia and neuritis, unspecified A0 EP A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` EP A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A` EP A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A` EP A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A` EP A TRAMADOL d03826A C- M54.9 Dorsalgia, unspecified A` EP A VALSARTAN d04113A C I10 Essential (primary) hypertension A` E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A D"8 R52 Pain, unspecified A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A Cr M79.7 Fibromyalgia A E A FUROSEMIDE d00070A Ei 99999 A E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A E A NORTRIPTYLINE d00144A C- M79.2 Neuralgia and neuritis, unspecified A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A C- 99999 A E A POTASSIUM CHLORIDE d00345A Ei 99999 A E A PRAMIPEXOLE d04145A C[@ G25.81 Restless legs syndrome A E A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified A E A VENLAFAXINE d03181A C- G47.9 Sleep disorder, unspecified A E A ZOLPIDEM d00910A C- G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A ATENOLOL d00004A D6. I10 Essential (primary) hypertension A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A AMOXICILLIN d00088A Ap K08.4 Partial loss of teeth A E0 A 99999 . . A@ E0 A INSULIN d00262A C E11 Type 2 diabetes mellitus A@ E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E@ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E@ A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A EP A . . . E` A LEVOTHYROXINE d00278A Dc C73 Malignant neoplasm of thyroid gland A Ep A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C- N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A HYDROCODONE d03075A A` K08.8 Other specified disorders of teeth and supporting structures A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A TIZANIDINE d04102A A M62.83 M79.1 Muscle spasm Myalgia A E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A0 E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Cr E78.1 Pure hyperglyceridemia A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A . . . E A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ALBUTEROL d00749A B J45 Asthma A E@ A FLUTICASONE d01296A B= J45 Asthma A EP A . . . E` A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A Ep A . . . E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified A0 E A LEVOCETIRIZINE d05851A C[@ T78.40 Allergy, unspecified A0 E A LISDEXAMFETAMINE d06663A C ` F90 Attention-deficit hyperactivity disorders A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE; OLMESARTAN d06905A C I10 Essential (primary) hypertension A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; CODEINE d03423A D M54.9 Dorsalgia, unspecified A E` A ALBUTEROL d00749A C J45 Asthma A@ E` A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E` A BECLOMETHASONE d00760A C- J45 Asthma A@ E` A PREDNISONE d00350A Cr J45 Asthma A@ Ep A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A D4 55555 A E A ALPRAZOLAM d00168A D G47.9 Sleep disorder, unspecified A E A . . . E A . . . E A CETIRIZINE d03827A B T78.40 Allergy, unspecified AP E A CYCLOBENZAPRINE d00963A A M62.83 Muscle spasm AP E A GABAPENTIN d03182A B= F32.9 Major depressive disorder, single episode, unspecified AP E A MELOXICAM d04532A C R10.9 Unspecified abdominal pain AP E A PHENTERMINE d00806A B E66.9 Obesity, unspecified AP E A HORMONES/HORMONE MODIFIERS - UNSPECIFIED c00097A C 55555 A E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A DIAZEPAM d00148A Dc F41.9 Anxiety disorder, unspecified A E A FLUOXETINE d00236A Ap F32.9 Major depressive disorder, single episode, unspecified A E A FLUTICASONE NASAL d04283A C R09.82 Postnasal drip A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A MORPHINE d00308A Dc M54.9 Dorsalgia, unspecified A E A OLOPATADINE NASAL d07132A C R09.89 Other specified symptoms and signs involving the circulatory and respiratory systems A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E A TAMSULOSIN d04121A B R35.0 Frequency of micturition A E A TIZANIDINE d04102A Dc M62.83 Muscle spasm A E A ZOLPIDEM d00910A BF G47.9 Sleep disorder, unspecified A E0 A CLONAZEPAM d00197A B= G47.9 Sleep disorder, unspecified A E0 A MELOXICAM d04532A B= T14.9 Unspecified injury A E@ A . . . EP A LISINOPRIL d00732A B= E11.2P Prevent diabetic kidney disease A0 EP A PENTOXIFYLLINE d00336A B= I70.2 Atherosclerosis of native arteries of extremities A0 EP A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A0 E` A . . . Ep A . . . E A . . . E A . . . E A AMLODIPINE d00689A DGJ I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified A0 E A ISOSORBIDE MONONITRATE d00269A DGJ I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified A0 E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A . . . E0 A ALISKIREN; HYDROCHLOROTHIAZIDE d07077A D I10 Essential (primary) hypertension A@ E0 A CARVEDILOL d03847A D I10 Essential (primary) hypertension A@ E0 A POTASSIUM CHLORIDE d00345A B E87.6P Prevent hypokalemia A@ E0 A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A@ E@ A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension A@ E@ A LANSOPRAZOLE d03828A CDp K25 Gastric ulcer A@ E@ A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E@ A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified A@ EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap EP A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap EP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension Ap EP A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia Ap EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EP A TERAZOSIN d00386A C I10 Essential (primary) hypertension Ap E` A ALENDRONATE d03849A Ei M81 Osteoporosis without current pathological fracture A E` A ALLOPURINOL d00023A D N20.0 Calculus of kidney A E` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E` A FUROSEMIDE d00070A Ei I10 Essential (primary) hypertension A E` A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E` A MELOXICAM d04532A0 Bz M25.56 Pain in knee A E` A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E` A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E` A VALSARTAN d04113A Ei I10 Essential (primary) hypertension A Ep A . . . E A ALBUTEROL d00749A C J45 Asthma A0 E A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A0 E A MONTELUKAST d04289A C J45 Asthma A0 E A ACETAMINOPHEN; HYDROCODONE d03428A0 B= R52 Pain, unspecified A E A BUSPIRONE d00182A0 C[@ F41.9 Anxiety disorder, unspecified A E A CLONAZEPAM d00197A0 C[@ F41.9 Anxiety disorder, unspecified A E A CONJUGATED ESTROGENS TOPICAL d04396A0 B= Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A GEMFIBROZIL d00245A0 C[@ E78.0 Pure hypercholesterolemia A E A INSULIN ASPART d04697A0 B E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A0 Ap E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A0 B[ R80.9 Proteinuria, unspecified A E A MECLIZINE d00859A0 C- R42 Dizziness and giddiness A E A METFORMIN; SITAGLIPTIN d06720A0 Cr E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A0 C[@ E78.0 Pure hypercholesterolemia A E A PROMETHAZINE d00787A0 B= R11 Nausea and vomiting A E A . . . E A . . . E A . . . E A CETIRIZINE d03827A Bz R09.81 Nasal congestion A E A TRIAMCINOLONE TOPICAL d03206A A@ L85.3 Xerosis cutis A E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A MONTELUKAST d04289A B J45 Asthma A E A . . . E A . . . E A . . . E0 A TOPIRAMATE d04115A C G43 Migraine A E@ A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A EP A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia Ap EP A DIVALPROEX SODIUM d03833A C[@ G47.9 Sleep disorder, unspecified Ap EP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap EP A MIRTAZAPINE d04025A C[@ G47.9 Sleep disorder, unspecified Ap EP A SERTRALINE d00880A C[@ F39 Unspecified mood [affective] disorder Ap EP A TOPIRAMATE d04115A C[@ G47.0 Insomnia Ap EP A ZIPRASIDONE d04747A C[@ G47.9 Sleep disorder, unspecified Ap E` A . . . Ep A . . . E A . . . E A . . . E A ESTRADIOL TOPICAL d04210A C[@ N95.2 Postmenopausal atrophic vaginitis A E A . . . E A . . . E A AMOXICILLIN d00088A AP K57 Diverticular disease of intestine A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A IBUPROFEN d00015A B[ M25.55 Pain in hip A E A . . . E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A . . . E0 A . . . E@ A . . . EP A CETIRIZINE d03827A C T78.40 Allergy, unspecified Ap EP A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified Ap EP A GUANFACINE d00717A CDp G47.0 Insomnia Ap EP A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders Ap EP A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders Ap EP A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified Ap EP A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E` A . . . Ep A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A Ep A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A NIACIN d00314A B E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified AP E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease AP E A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension AP E A METAXALONE d00964A Cr M62.83 M79.1 T14.9 Muscle spasm Myalgia Unspecified injury A@ E A NABUMETONE d00310A C M54.9 M79.1 Dorsalgia, unspecified Myalgia A@ E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E A TESTOSTERONE d00558A A E29.1 Testicular hypofunction A@ E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E A ATENOLOL d00004A C- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A` E A FAMOTIDINE d00141A C[@ K21 Gastro-esophageal reflux disease A` E A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A` E A . . . E A . . . E A . . . E A CARVEDILOL d03847A Ei I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A PIOGLITAZONE d04442A Ei E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia Ap E A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus Ap E A SOLIFENACIN d05413A C- R35.0 Frequency of micturition Ap E A VALSARTAN d04113A Ei I10 Essential (primary) hypertension Ap E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A B M54.9 Dorsalgia, unspecified A E@ A ONDANSETRON d00867A B R11 Nausea and vomiting A EP A . . . E` A . . . Ep A AMLODIPINE d00689A C I99.9 Unspecified disorder of circulatory system AP Ep A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia AP Ep A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP Ep A NIACIN d00314A Cr E78.0 Pure hypercholesterolemia AP Ep A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia AP E A 99999 . . A E A ACETAMINOPHEN; HYDROCODONE d03428A B R52 Pain, unspecified A E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Cr 99999 A E A CYCLOBENZAPRINE d00963A Bz 55555 A E A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia A E A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A PAROXETINE d03157A CDp 99999 A E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E A TRAMADOL d03826A Cr E07.9 Disorder of thyroid, unspecified A E A GEMFIBROZIL d00245A CDp K76.0 Fatty (change of) liver, not elsewhere classified AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension AP E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A VERAPAMIL d00048A C I10 Essential (primary) hypertension AP E A . . . E A . . . E A . . . E A . . . E A . . . E A BECLOMETHASONE d00760A C J45 R06.2 Asthma Wheezing A E A . . . E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; CODEINE d03423A C M54.9 Dorsalgia, unspecified A EP A ALBUTEROL d00749A C J45 Asthma A EP A CYPROHEPTADINE d00790A B E56.9P Prevent vitamin deficiency A EP A DIGOXIN d00210A C I50.9 Heart failure, unspecified A EP A DULOXETINE d05355A C F41.9 Anxiety disorder, unspecified A EP A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified A EP A GABAPENTIN d03182A C F41.9 Anxiety disorder, unspecified A EP A HYDROXYZINE d00907A C- T78.40 Allergy, unspecified A EP A INDOMETHACIN d00039A C M13 Other arthritis A EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A EP A TEMAZEPAM d00384A B G47.0 Insomnia A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A` E A CLONIDINE d00044A C F90 Attention-deficit hyperactivity disorders A` E A CLONIDINE d00044A C G47.0 Insomnia A` E A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures A` E A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures A` E A RISPERIDONE d03180A C F95.9 Tic disorder, unspecified A` E A . . . E A MONTELUKAST d04289A B= J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A INSULIN LISPRO d04373A C- R73 Elevated blood glucose level A0 E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ARIPIPRAZOLE d04825A CDp F99 Mental disorder, not otherwise specified AP E A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia AP E A DABIGATRAN d07137A CDp D75.9P Prevent blood clots AP E A FLUOXETINE d00236A CP F99 Mental disorder, not otherwise specified AP E A TRAZODONE d00395A D G47.0 Insomnia AP E A . . . E A . . . E A . . . E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A ACETAMINOPHEN; OXYCODONE d03431A Cr M54.9 Dorsalgia, unspecified A@ E A IPRATROPIUM d00265A C- J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A TEMAZEPAM d00384A Cr G47.9 Sleep disorder, unspecified A@ E A . . . E0 A LISINOPRIL d00732A Ap I10 Essential (primary) hypertension A E@ A ALBUTEROL d00749A B= J20.9 Acute bronchitis, unspecified A EP A IBUPROFEN d00015A A K02.7 K08.8 Dental root caries Other specified disorders of teeth and supporting structures A EP A PENICILLIN d00116A A K04.7P Prevent tooth infection A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B[ T14.9 Unspecified injury A E A ALENDRONATE d03849A Bz M81 Osteoporosis without current pathological fracture A E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A E A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A E A LORATADINE d03050A C T78.40 Allergy, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A FLUOXETINE d00236A C"0 F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ARIPIPRAZOLE d04825A Ei 99999 A E A BENZTROPINE d00175A B T88.7 Unspecified adverse effect of drug or medicament A E A DIAZEPAM d00148A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A E A FEXOFENADINE d04040A0 B R09.81 Nasal congestion A E A HYDROCODONE d03075A0 A G43 Migraine A E A IBUPROFEN d00015A C[@ G43 N94.6 T14.9 Migraine Dysmenorrhea, unspecified Unspecified injury A E A PAROXETINE d03157A CDp F32.9 Major depressive disorder, single episode, unspecified A E A PRAZOSIN d00138A0 B[ K30 Functional dyspepsia A E A PROPRANOLOL d00032A Ei 99999 A E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A NAPROXEN d00019A C M79.1 Myalgia A@ E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A@ E A TERAZOSIN d00386A B N40 Enlarged prostate A@ E A . . . E0 A . . . E@ A 99999 . . A E@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E A FLUTICASONE d01296A C- J45 Asthma A E A . . . E A . . . E A AMLODIPINE d00689A C I73.0 Raynaud's syndrome A0 E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A CHOLESTYRAMINE d00193A Cr E78.0 Pure hypercholesterolemia A E@ A LETROZOLE d04156A Cr C50 Malignant neoplasm of breast A EP A . . . E` A FUROSEMIDE d00070A C- I10 Essential (primary) hypertension A@ E` A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ E` A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A@ E` A WARFARIN d00022A C- I10 Essential (primary) hypertension A@ Ep A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A VERAPAMIL d00048A C I10 Essential (primary) hypertension A E A AMITRIPTYLINE d00146A CDp G47.0 Insomnia A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A E A . . . E A . . . E A ALLOPURINOL d00023A C M1A Chronic gout A@ E A MELOXICAM d04532A CDp M25.56 M79.1 T14.9 Pain in knee Myalgia Unspecified injury A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E0 A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E A IBUPROFEN d00015A B[ M54.9 Dorsalgia, unspecified A E A . . . E A . . . E A ATENOLOL d00004A D* I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A@ E A NIFEDIPINE d00051A D* I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A D# E78.0 Pure hypercholesterolemia A@ E A . . . E A DOXYCYCLINE d00037A A N39.0 Urinary tract infection, site not specified A E A PROMETHAZINE d00787A A R11 Nausea and vomiting A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E@ A ALPRAZOLAM d00168A D F42 Obsessive-compulsive disorder A E@ A FENOFIBRATE d04286A Ei E78.0 Pure hypercholesterolemia A E@ A FLUOXETINE d00236A D F42 Obsessive-compulsive disorder A E@ A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E@ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E@ A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A EP A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A EP A ZOLPIDEM d00910A Cr G47.0 Insomnia A E` A AZATHIOPRINE d00024A D* T86.9P Prevent transplanted organ and tissue rejection A` E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E` A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A` E` A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E` A PREDNISONE d00350A D* T86.9P Prevent transplanted organ and tissue rejection A` E` A WARFARIN d00022A Dc I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A CDp I10 Essential (primary) hypertension Ap E A DIGOXIN d00210A CDp I49.9 Cardiac arrhythmia, unspecified Ap E A DOXAZOSIN d00726A CDp R00.9 Unspecified abnormalities of heart beat Ap E A EZETIMIBE; SIMVASTATIN d05348A CDp E78.0 Pure hypercholesterolemia Ap E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified Ap E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A VENLAFAXINE d03181A B F41.9 Anxiety disorder, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C[@ R73.9 Hyperglycemia, unspecified A@ E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr T14.9 Unspecified injury A E A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E A BACLOFEN d00967A Cr M62.83 Muscle spasm A E A BUDESONIDE d04276A Cr J45 Asthma A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A LORATADINE d03050A Cr R09.81 Nasal congestion A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A Cr J45 Asthma A E A OMEPRAZOLE d00325A Cr B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E A QUETIAPINE d04220A Cr G47.9 Sleep disorder, unspecified A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A Cr M79.2 M79.673 Neuralgia and neuritis, unspecified Pain in unspecified foot A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C[@ R51 Headache A E A ACETAMINOPHEN; HYDROCODONE d03428A B R51 Headache A E A ATOMOXETINE d04827A C[@ F90 Attention-deficit hyperactivity disorders AP E A HYDROXYZINE d00907A C[@ F41.9 Anxiety disorder, unspecified AP E A ILOPERIDONE d07441A C[@ F20 Schizophrenia AP E A MIRTAZAPINE d04025A C[@ G47.9 Sleep disorder, unspecified AP E A SERTRALINE d00880A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A CLARITHROMYCIN d00097A A J18.9 Pneumonia, unspecified organism A E A . . . E A . . . E A DIVALPROEX SODIUM d03833A A F32.9 Major depressive disorder, single episode, unspecified A` E A DIVALPROEX SODIUM d03833A C[@ G40 Epilepsy and recurrent seizures A` E A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E A LAMOTRIGINE d03809A C[@ F32.9 G40 Major depressive disorder, single episode, unspecified Epilepsy and recurrent seizures A` E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A` E A QUETIAPINE d04220A C[@ G47.0 Insomnia A` E A . . . E A . . . E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E0 A BISOPROLOL d00709A B= I10 Essential (primary) hypertension AP E0 A BUPRENORPHINE d00840A B R52 Pain, unspecified AP E0 A CLONAZEPAM d00197A B= G47.9 Sleep disorder, unspecified AP E0 A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified AP E0 A LAMOTRIGINE d03809A C F39 Unspecified mood [affective] disorder AP E@ A . . . EP A ESOMEPRAZOLE d04749A B K21 Gastro-esophageal reflux disease A E` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A Ep A ALBUTEROL d00749A C J43 Emphysema A Ep A ALBUTEROL d00749A D J43 Emphysema A Ep A BUDESONIDE; FORMOTEROL d04795A B[ J43 Emphysema A Ep A CIPROFLOXACIN d00011A B J18.9 Pneumonia, unspecified organism A Ep A DOXYCYCLINE d00037A B J18.9 Pneumonia, unspecified organism A Ep A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A Ep A PREDNISONE d00350A B* J43 Emphysema A Ep A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B J18.9 Pneumonia, unspecified organism A Ep A THEOPHYLLINE d00142A C J43 Emphysema A E A . . . E A AZITHROMYCIN d00091A C A49.9 Bacterial infection, unspecified A E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A TOPIRAMATE d04115A C ` G43 Migraine A E A . . . E A . . . E A ALENDRONATE d03849A B[ M81.P Prevent bone loss/osteoporosis Ap E A ALPRAZOLAM d00168A CDp R45.0 Nervousness Ap E A AMLODIPINE d00689A B I10 Essential (primary) hypertension Ap E A INDAPAMIDE d00260A C- I10 Essential (primary) hypertension Ap E A PREDNISONE d00350A C M31.6 Other giant cell arteritis Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A ZOLPIDEM d00910A CDp G47.9 Sleep disorder, unspecified Ap E A . . . E A . . . E A . . . E A . . . E0 A TRETINOIN TOPICAL d01244A C L57.8 L70 Other skin changes due to chronic exposure to nonionizing radiation Acne A E@ A . . . EP A . . . E` A ACETAMINOPHEN; HYDROCODONE d03428A C T14.9 Unspecified injury A E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E` A EXEMESTANE d04461A Cr C50 Malignant neoplasm of breast A E` A GABAPENTIN d03182A C- I72.9P Prevent aneurysm A E` A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Dc I10 Essential (primary) hypertension A E` A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A E` A PAROXETINE d03157A C[@ F41.9 Anxiety disorder, unspecified A E` A PREDNISONE d00350A B[ M19.90 Unspecified osteoarthritis, unspecified site A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A . . . E A . . . E A RANITIDINE d00021A C K30 Functional dyspepsia A E0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E0 A METFORMIN d03807A C R73 Elevated blood glucose level A@ E0 A SITAGLIPTIN d05896A B R73 Elevated blood glucose level A@ E@ A ALBUTEROL; IPRATROPIUM d04066A Cr J42 J44.9 J45 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified Asthma Ap E@ A BENZTROPINE d00175A D G25.0 Essential tremor Ap E@ A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified Ap E@ A CLOZAPINE d00199A D F20 Schizophrenia Ap E@ A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease Ap E@ A FLUVOXAMINE d03804A CDp F31.9 F41.0 F42 Bipolar disorder, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia Obsessive-compulsive disorder Ap E@ A LORATADINE d03050A CDp T78.40 Allergy, unspecified Ap EP A . . . E` A DILTIAZEM d00045A C- I48.91 Unspecified atrial fibrillation A0 E` A ESTRADIOL d00537A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A0 E` A LORAZEPAM d00149A Cr G47.0 Insomnia A0 Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A DOXYCYCLINE d00037A B L70 Acne A E A . . . E A ALPRAZOLAM d00168A C G47.0 Insomnia A E A AMLODIPINE; VALSARTAN d06662A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E A DOXEPIN d00217A C G47.0 Insomnia A E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A E A INSULIN d00262A D E11 Type 2 diabetes mellitus A E A LORATADINE d03050A C- J30.9 Allergic rhinitis, unspecified A E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A E0 A ACETAMINOPHEN; OXYCODONE d03431A A R10.9 Unspecified abdominal pain A E@ A . . . EP A . . . E` A AMLODIPINE; BENAZEPRIL d03829A Ei I10 Essential (primary) hypertension A@ E` A LORATADINE d03050A Ei J45 T78.40 Asthma Allergy, unspecified A@ E` A MONTELUKAST d04289A Ei R06.9 Unspecified abnormalities of breathing A@ E` A RISPERIDONE d03180A Ei F91.9 Conduct disorder, unspecified A@ Ep A . . . E A ATENOLOL d00004A Ei 99999 A E A DICLOFENAC d00848A Ei 99999 A E A DONEPEZIL d04099A Ei 99999 A E A ESCITALOPRAM d04812A Ei 99999 A E A HYDROCHLOROTHIAZIDE d00253A Ei 99999 A E A MELOXICAM d04532A Ei 99999 A E A MEMANTINE d04899A Ei F32.9 Major depressive disorder, single episode, unspecified A E A NIFEDIPINE d00051A C 99999 A E A PRAVASTATIN d00348A Ei 99999 A E A RALOXIFENE d04261A Ei 99999 A E A TRAMADOL d03826A Ei 99999 A E A VALSARTAN d04113A Ei 99999 A E A FAMOTIDINE d00141A C- K21 K25 Gastro-esophageal reflux disease Gastric ulcer A` E A HYDROCODONE d03075A C- T14.9 Unspecified injury A` E A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A` E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A` E A METHYLPHENIDATE d00900A B# F90 Attention-deficit hyperactivity disorders A` E A MIRTAZAPINE d04025A C F32.9 Major depressive disorder, single episode, unspecified A` E A CLINDAMYCIN d00043A A K04.7 Periapical abscess without sinus A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E0 A . . . E@ A 99999 . . A` E@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E@ A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A` E@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E@ A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` E@ A PIOGLITAZONE d04442A Cr E11 Type 2 diabetes mellitus A` EP A ATENOLOL d00004A C"0 I10 Essential (primary) hypertension A EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C"0 I10 Essential (primary) hypertension A E` A FLUTICASONE TOPICAL d04284A CDp L20.9 Atopic dermatitis, unspecified A@ E` A MONTELUKAST d04289A C"0 J30.9 Allergic rhinitis, unspecified A@ E` A OLOPATADINE NASAL d07132A C"0 J30.9 Allergic rhinitis, unspecified A@ E` A OLOPATADINE OPHTHALMIC d04117A C"0 H10.1 Acute atopic conjunctivitis A@ Ep A . . . E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A C M79.1 Myalgia A E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A0 E A LEVOTHYROXINE d00278A C E04.9 Nontoxic goiter, unspecified A0 E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP E A BRIMONIDINE OPHTHALMIC d04048A C"0 H40 Glaucoma AP E A DORZOLAMIDE OPHTHALMIC d03805A C"0 H40 Glaucoma AP E A GABAPENTIN d03182A Ap M79.2 Neuralgia and neuritis, unspecified AP E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E0 A HYDROCHLOROTHIAZIDE d00253A C 99999 A@ E0 A LISINOPRIL d00732A C 99999 A@ E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E0 A PRAVASTATIN d00348A C I10 Essential (primary) hypertension A@ E@ A CLARITHROMYCIN d00097A A J18.9 Pneumonia, unspecified organism A@ E@ A IBUPROFEN d00015A Ap R60.9 Edema, unspecified A@ E@ A MOMETASONE d05262A A J45 R05 Asthma Cough A@ E@ A PROMETHAZINE d00787A A R05 Cough A@ EP A . . . E` A AMLODIPINE d00689A0 C R80.9 Proteinuria, unspecified A@ E` A DILTIAZEM d00045A0 D' I10 Essential (primary) hypertension A@ E` A SPIRONOLACTONE d00373A0 D R60.9 Edema, unspecified A@ E` A WARFARIN d00022A0 D' I48.91 Unspecified atrial fibrillation A@ Ep A . . . E A . . . E A AMOXICILLIN d00088A Ap H10 Conjunctivitis A E A ACETAMINOPHEN; HYDROCODONE d03428A B N20.0 Calculus of kidney AP E A CLONAZEPAM d00197A B* F41.9 Anxiety disorder, unspecified AP E A FAMOTIDINE d00141A B K25 Gastric ulcer AP E A ONDANSETRON d00867A B R11 Nausea and vomiting AP E A PROPRANOLOL d00032A B* F41.9 R07.9 Anxiety disorder, unspecified Chest pain, unspecified AP E A . . . E A . . . E A . . . E A CLONIDINE d00044A C G47.0 Insomnia A0 E A GUANFACINE d00717A B F91.9 Conduct disorder, unspecified A0 E A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A0 E A ACYCLOVIR d00001A Cr B02 Zoster [herpes zoster] A E A ALBUTEROL d00749A C[@ J43 J45 Emphysema Asthma A E A ALBUTEROL d00749A Ei J20.9 Acute bronchitis, unspecified A E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E A FLUTICASONE; SALMETEROL d04611A Ei J43 J45 Emphysema Asthma A E A HYDROCHLOROTHIAZIDE d00253A B= K76.9 Liver disease, unspecified A E A LORAZEPAM d00149A Ei 99999 A E A OXYCODONE d00329A A0 T14.9 Unspecified injury A E A PROMETHAZINE d00787A C- R11 Nausea and vomiting A E A VALSARTAN d04113A D I21.P Prevent heart attack/myocardial infarction A E A . . . E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A` E@ A CELECOXIB d04380A C- M13 Other arthritis A` E@ A DULOXETINE d05355A C[@ M54.9 Dorsalgia, unspecified A` E@ A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A` E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E@ A PRAVASTATIN d00348A Dc E78.0P Prevent high cholesterol A` EP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EP A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A EP A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A EP A FINASTERIDE d00563A C N40 Enlarged prostate A EP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EP A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A EP A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A EP A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A EP A TERAZOSIN d00386A C- N40 Enlarged prostate A E` A ALBUTEROL d00749A Cr J45 Asthma A@ E` A ALBUTEROL d00749A C J45 Asthma A@ E` A FLUTICASONE NASAL d04283A C J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A@ E` A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A@ Ep A ALBUTEROL d00749A B J45 Asthma A E A ALBUTEROL d00749A Cr J45 Asthma A0 E A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A0 E A TIOTROPIUM d04829A Cr J45 Asthma A0 E A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus Ap E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A TERAZOSIN d00386A C N40 Enlarged prostate Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A ACETAMINOPHEN; HYDROCODONE d03428A C R10.9 Unspecified abdominal pain A E A FUROSEMIDE d00070A A R60.9 Edema, unspecified A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A MIRTAZAPINE d04025A C F41.9 Anxiety disorder, unspecified A E A PREDNISONE d00350A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B N30 Cystitis A E A WARFARIN d00022A A D75.9P Prevent blood clots A E A . . . E A . . . E A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A0 E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E0 A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A RANITIDINE d00021A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A ACETAMINOPHEN; HYDROCODONE d03428A C[@ M79.2 Neuralgia and neuritis, unspecified A E A ALBUTEROL d00749A Cr J45 Asthma A0 E A AMOXICILLIN; CLAVULANATE d00089A A@ J01.9 Acute sinusitis, unspecified A0 E A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A0 E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A D G47.0 R25.1 R45.0 Insomnia Tremor, unspecified Nervousness A@ E A CHLORPROMAZINE d00064A D F20 R44.0 Schizophrenia Auditory hallucinations A@ E A GABAPENTIN d03182A B G43 Migraine A@ E A OLANZAPINE d04050A B F41.9 Anxiety disorder, unspecified A@ E A . . . E A . . . E0 A . . . E@ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EP A ADAPALENE; BENZOYL PEROXIDE TOPICAL d07382A B[ L70 Acne A E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A@ E` A CLONIDINE d00044A C- G47.0 Insomnia A@ E` A DIPHENHYDRAMINE d00212A CDp G47.0 Insomnia A@ E` A RISPERIDONE d03180A C[@ F90 Attention-deficit hyperactivity disorders A@ Ep A . . . E A CINACALCET d05218A C E83.52 Hypercalcemia A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A E A DOCUSATE d01021A C K59.0 Constipation A E A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A E A MYCOPHENOLIC ACID d05217A C T86.9P Prevent transplanted organ and tissue rejection A E A NEBIVOLOL d05265A C I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A E A PREDNISONE d00350A C T86.9P Prevent transplanted organ and tissue rejection A E A TACROLIMUS d03752A C T86.9P Prevent transplanted organ and tissue rejection A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A . . . E A CARVEDILOL d03847A Ei 99999 A E A CITALOPRAM d04332A Ei 99999 A E A DIGOXIN d00210A Ei 99999 A E A FUROSEMIDE d00070A Ei 99999 A E A INSULIN GLARGINE d04538A Ei E11 Type 2 diabetes mellitus A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A OMEPRAZOLE d00325A Ei 99999 A E A WARFARIN d00022A Ei 99999 A E A . . . E A 77777 . . A E A . . . E A CAPTOPRIL; HYDROCHLOROTHIAZIDE d03566A Dc I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A CARVEDILOL d03847A Cr I48.91 Unspecified atrial fibrillation A E A COLCHICINE d00150A C[@ M1A Chronic gout A E A DOFETILIDE d04459A Dc I48.91 Unspecified atrial fibrillation A E A DUTASTERIDE; TAMSULOSIN d07634A CDp N40 Enlarged prostate A E A EZETIMIBE d04824A Dc E78.0 Pure hypercholesterolemia A E A FENOFIBRATE d04286A C I21.P Prevent heart attack/myocardial infarction A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E A MIRTAZAPINE d04025A CDp F41.9 Anxiety disorder, unspecified A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E A WARFARIN d00022A D Z95.2 Presence of prosthetic heart valve A E A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A@ E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A C- I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A D% E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C- 99999 A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A AMLODIPINE; BENAZEPRIL d03829A0 C I10 Essential (primary) hypertension A E A CARISOPRODOL d00960A0 C M79.1 Myalgia A E A CELECOXIB d04380A0 C M19.9 Osteoarthritis, unspecified site A E A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A0 C E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A0 C M19.9 Osteoarthritis, unspecified site A E A ZOLPIDEM d00910A0 C G47.0 Insomnia A E A . . . E A . . . E A MONTELUKAST d04289A C- J45 Asthma A E A CARVEDILOL d03847A C 99999 AP E A CLOPIDOGREL d04258A Ei 99999 AP E A LORATADINE d03050A C 99999 AP E A POTASSIUM CHLORIDE d00345A Ei 99999 AP E A ROSUVASTATIN d04851A C- 99999 AP E0 A . . . E@ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E@ A LOSARTAN d03821A B[ I10 Essential (primary) hypertension A0 EP A . . . E` A . . . Ep A AMOXICILLIN d00088A Ap R09.81 Nasal congestion A` Ep A CETIRIZINE d03827A B T78.40 Allergy, unspecified A` Ep A CITALOPRAM d04332A C F42 Obsessive-compulsive disorder A` Ep A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A` Ep A PHENTERMINE d00806A C9 E66.9 Obesity, unspecified A` Ep A TOPIRAMATE d04115A C G43 Migraine A` E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C R35.0 Frequency of micturition A E A . . . E A . . . E A . . . E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E@ A . . . EP A BUPROPION d00181A Bz F32.9 Major depressive disorder, single episode, unspecified A EP A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A E` A . . . Ep A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE d01296A C"0 J45 Asthma A E A . . . E A ALBUTEROL d00749A CDp R06.2 Wheezing A E A AMLODIPINE; VALSARTAN d06662A C[@ I10 Essential (primary) hypertension Ap E A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension Ap E A CONJUGATED ESTROGENS d00541A C[@ N95.1 Menopausal and female climacteric states Ap E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A D# I10 Essential (primary) hypertension Ap E A FENOFIBRIC ACID d07371A C[@ E78.0 Pure hypercholesterolemia Ap E A LANSOPRAZOLE d03828A Dc K21 Gastro-esophageal reflux disease Ap E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia Ap E A CITALOPRAM d04332A D F41.9 Anxiety disorder, unspecified A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A Ep A . . . E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A METFORMIN d03807A CDp E28.2 Polycystic ovarian syndrome A E° A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E° A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A PREDNISONE d00350A C ` M35.3 Polymyalgia rheumatica A E A . . . E A LOVASTATIN d00280A B E78.0 Pure hypercholesterolemia A E A RANITIDINE d00021A C[@ K30 Functional dyspepsia A E A AMLODIPINE; OLMESARTAN d06905A C I10 Essential (primary) hypertension A0 E A DOXAZOSIN d00726A C I10 Essential (primary) hypertension A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E0 A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E@ A . . . EP A . . . E` A . . . Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EÀ A . . . EÐ A CEFPROZIL d00073A C- H66.9 Otitis media, unspecified A Eà A . . . Eð A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A Eð A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A Eð A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Eð A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eð A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A Eð A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Eð A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A Eð A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E A . . . E A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A E A ALBUTEROL d00749A C- J45 Asthma A E A FLUTICASONE d01296A Bz J45 Asthma A E A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A@ E A METFORMIN d03807A C- R73.9 Hyperglycemia, unspecified A@ E A TAMSULOSIN d04121A C- I10 Essential (primary) hypertension A@ E A . . . E A . . . E0 A . . . E@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A EP A . . . E` A . . . Ep A . . . EĀ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F32.9 Major depressive disorder, single episode, unspecified A EĐ A . . . EĠ A AZITHROMYCIN d00091A C9 J01.9 Acute sinusitis, unspecified A Eİ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A NYSTATIN d01233A Ap B37.0 Candidal stomatitis A E0 A . . . E@ A ALPRAZOLAM d00168A CDp G47.9 Sleep disorder, unspecified A@ E@ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A@ E@ A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A@ E@ A ZOLPIDEM d00910A CDp G47.0 Insomnia A@ EP A AMOXICILLIN d00088A A N73.9 Female pelvic inflammatory disease, unspecified A EP A PROMETHAZINE d00787A A R11 Nausea and vomiting A E` A CLINDAMYCIN d00043A Ap K08.4 Partial loss of teeth A E` A HYDROCODONE d03075A Ap K08.8 Other specified disorders of teeth and supporting structures A Ep A . . . Eŀ A . . . EŐ A . . . EŠ A . . . EŰ A DILTIAZEM d00045A C I48.91 Unspecified atrial fibrillation A EŰ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A EŰ A ESTRONE d00534A D1 Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A EŰ A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A EŰ A METOPROLOL d00134A C I10 Essential (primary) hypertension A EŰ A OMEPRAZOLE d00325A Ei K30 Functional dyspepsia A EŰ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A EŰ A RIVAROXABAN d07356A DGJ I48.91 Unspecified atrial fibrillation A E A ALENDRONATE d03849A CP M81 Osteoporosis without current pathological fracture A E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eƀ A . . . EƐ A . . . EƠ A . . . Eư A . . . E A . . . E A . . . E A ONDANSETRON d00867A A0 R11 Nausea and vomiting A E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A DOCUSATE d01021A C- K59.0 Constipation A E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A TRAMADOL d03826A C M13 M79.1 Other arthritis Myalgia A E A . . . E0 A IBUPROFEN d00015A D M54.9 Dorsalgia, unspecified AP E0 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified AP E0 A PAROXETINE d03157A B= F41.9 Anxiety disorder, unspecified AP E0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E0 A TRIAMTERENE d00396A D I10 Essential (primary) hypertension AP E@ A OXYCODONE d00329A CDp M87.9 Osteonecrosis, unspecified A EP A . . . E` A . . . Ep A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B[ Z79.3 Long term (current) use of hormonal contraceptives A Eǀ A . . . Eǐ A . . . EǠ A . . . Eǰ A LEVOCETIRIZINE d05851A B= T78.40 Allergy, unspecified A Eǰ A MONTELUKAST d04289A B J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A BECLOMETHASONE d00760A C[@ J45 Asthma A0 E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A0 E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E0 A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E@ A . . . EP A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E` A ALLOPURINOL d00023A CDp M1A Chronic gout A@ E` A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A@ E` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E` A TAMSULOSIN d04121A B= N40 Enlarged prostate A@ Ep A . . . EȀ A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A EȀ A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Dc I10 Essential (primary) hypertension A EȐ A . . . EȠ A . . . EȰ A . . . E A 77777 . . A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92.6 Irregular menstruation, unspecified A E@ A . . . EP A . . . E` A . . . Ep A . . . Eɀ A . . . Eɐ A . . . Eɠ A . . . Eɰ A . . . E A LANSOPRAZOLE d03828A B K21 Gastro-esophageal reflux disease A E A SULFAMETHOXAZOLE d00119A Ap N30 Cystitis A E A . . . E A INSULIN d00262A Cr E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E A TRAZODONE d00395A CDp G47.0 Insomnia AP E A . . . E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALLOPURINOL d00023A D M1A Chronic gout AP Ep A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified AP Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP Ep A METOPROLOL d00134A D I10 Essential (primary) hypertension AP Ep A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP Eʀ A . . . Eʐ A . . . Eʠ A . . . Eʰ A . . . E A ATENOLOL d00004A C- I10 Essential (primary) hypertension A E A CLONAZEPAM d00197A B F32.9 Major depressive disorder, single episode, unspecified AP E A GABAPENTIN d03182A B R20.2 Paresthesia of skin AP E A LORATADINE d03050A B T78.40 Allergy, unspecified AP E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease AP E A PAROXETINE d03157A B F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A A Z79.3 Long term (current) use of hormonal contraceptives A E0 A . . . E@ A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A B= L81.9 Disorder of pigmentation, unspecified A EP A AZITHROMYCIN d00091A AP H66.9 Otitis media, unspecified A E` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E` A LOSARTAN d03821A B= I10 Essential (primary) hypertension A Ep A LOSARTAN d03821A Cr I21.P Prevent heart attack/myocardial infarction A@ Ep A MIRABEGRON d07876A A N42.9 Disorder of prostate, unspecified A@ Ep A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ Ep A WARFARIN d00022A Bz I26 I80.3 Pulmonary embolism Phlebitis and thrombophlebitis of lower extremities, unspecified A@ Eˀ A . . . Eː A . . . Eˠ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eˠ A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E˰ A . . . E A . . . E A . . . E A PENICILLIN V POTASSIUM d07730A Ap K04.7P Prevent tooth infection A E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A . . . E A . . . E0 A ALBUTEROL d00749A C J45 Asthma A E0 A BECLOMETHASONE d00760A C[@ J45 Asthma A E@ A . . . EP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 EP A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 EP A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A0 E` A DIPHENHYDRAMINE d00212A A T63.4 Toxic effect of venom of other arthropods A Ep A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A@ Ep A DIVALPROEX SODIUM d03833A C F31.9 F41.9 G40 Bipolar disorder, unspecified Anxiety disorder, unspecified Epilepsy and recurrent seizures A@ Ep A QUETIAPINE d04220A C F29 Unspecified psychosis not due to a substance or known physiological condition A@ Ep A WARFARIN d00022A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A@ È A . . . E̐ A . . . E̠ A . . . Ḛ A . . . E A APIXABAN d07804A B I48.91 Unspecified atrial fibrillation A E A CLOPIDOGREL d04258A CDp E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A ISOSORBIDE MONONITRATE d00269A C& I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A E A NITROGLYCERIN d00321A C I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A SIMVASTATIN d00746A C E78.0P I63.P Prevent high cholesterol Prevent stroke A E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C[@ I10 Essential (primary) hypertension A E A DESVENLAFAXINE d07113A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E0 A NAPROXEN d00019A B[ T14.9 Unspecified injury A E@ A . . . EP A ACETAMINOPHEN; BUTALBITAL d03456A C R51 Headache A EP A AMLODIPINE; BENAZEPRIL d03829A CDp I10 Essential (primary) hypertension A EP A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A EP A MELOXICAM d04532A C- A08.4 Viral intestinal infection, unspecified A EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EP A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A EP A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A EP A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A EP A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C A49.9 Bacterial infection, unspecified A EP A TOLTERODINE d04294A C- N32.81 Overactive bladder A E` A AZELAIC ACID TOPICAL d03848A B[ L71 Rosacea A E` A LOTEPREDNOL OPHTHALMIC d04292A A0 H00.1 Chalazion A Ep A CAPTOPRIL d00006A D I10 Essential (primary) hypertension AP Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Ep A PANTOPRAZOLE d04514A B[ K92.2 Gastrointestinal hemorrhage, unspecified AP Ep A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified AP Ep A VERAPAMIL d00048A D* I49.9 Cardiac arrhythmia, unspecified AP È A . . . E͐ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E͐ A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E͐ A GABAPENTIN d03182A Cr B02 Zoster [herpes zoster] A@ E͐ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E͠ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E͠ A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A EͰ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A FOSINOPRIL d00242A Cr I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A E0 A . . . E@ A FLUOXETINE d00236A B F31.9 Bipolar disorder, unspecified A0 E@ A QUETIAPINE d04220A B F32.9 Major depressive disorder, single episode, unspecified A0 E@ A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified A0 EP A . . . E` A . . . Ep A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A . . . Eΐ A . . . EΠ A . . . Eΰ A . . . E A . . . E A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A@ E A CLOBAZAM d04557A C G40 Epilepsy and recurrent seizures A@ E A LACOSAMIDE d07349A C"0 G40 Epilepsy and recurrent seizures A@ E A LAMOTRIGINE d03809A C[@ G40 Epilepsy and recurrent seizures A@ E A FUROSEMIDE d00070A0 CDp I10 I50.9 N18.9 Essential (primary) hypertension Heart failure, unspecified Chronic kidney disease, unspecified A0 E A METOPROLOL d00134A0 B I48.91 Unspecified atrial fibrillation A0 E A PROPAFENONE d00358A0 B I48.91 Unspecified atrial fibrillation A0 E A . . . E A . . . E A TETRACYCLINE d00041A Bz L70 Acne A E A . . . E0 A . . . E@ A . . . EP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Ep A ALBUTEROL d00749A B[ J20.9 Acute bronchitis, unspecified Ap Ep A BENZONATATE d00796A B[ J45 Asthma Ap Ep A CARVEDILOL d03847A B[ I10 Essential (primary) hypertension Ap Ep A DILTIAZEM d00045A B[ I10 Essential (primary) hypertension Ap Ep A GLIPIZIDE d00246A B[ E11 Type 2 diabetes mellitus Ap Ep A LOSARTAN d03821A B[ I10 Essential (primary) hypertension Ap Ep A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia Ap Eπ A ALLOPURINOL d00023A B M1A Chronic gout A Eπ A INDOMETHACIN d00039A B M1A Chronic gout A Eϐ A ALBUTEROL d00749A C- J45 Asthma A0 Eϐ A BUDESONIDE d04276A C- J45 Asthma A0 Eϐ A PREDNISOLONE d00084A A J45 Asthma A0 EϠ A . . . Eϰ A ACETAMINOPHEN; HYDROCODONE d03428A C[@ M54.2 M54.9 M79.1 Cervicalgia Dorsalgia, unspecified Myalgia A` Eϰ A DICYCLOMINE d00999A B[ K58 Irritable bowel syndrome A` Eϰ A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A` Eϰ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` Eϰ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` Eϰ A VERAPAMIL d00048A C I10 Essential (primary) hypertension A` E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A BENAZEPRIL d00730A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A BUPROPION d00181A CDp F31.9 Bipolar disorder, unspecified A E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E A DEXTROMETHORPHAN; GUAIFENESIN; PHENYLEPHRINE d03408A Ap R09.81 Nasal congestion AP E A FAMOTIDINE d00141A C[@ K21 Gastro-esophageal reflux disease AP E A LORATADINE d03050A CDp J30.9 Allergic rhinitis, unspecified AP E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . EЀ A . . . EА A . . . EР A . . . Eа A ALISKIREN d06665A C I10 Essential (primary) hypertension A` Eа A AMLODIPINE; BENAZEPRIL d03829A Dc I10 Essential (primary) hypertension A` Eа A ATORVASTATIN d04105A Ei 99999 A` Eа A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` Eа A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A` Eа A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A` E A . . . E A . . . E A ALLOPURINOL d00023A C[@ M10.9 Gout, unspecified A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A BUMETANIDE d00179A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A C I63 Cerebral infarction A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A CDp R12 Heartburn A E A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A E A RIVAROXABAN d07356A C I63 Cerebral infarction A E A . . . E A CARBETAPENTANE; CHLORPHENIRAMINE d04770A A T78.40 Allergy, unspecified A E A MINOCYCLINE d00110A B L70 Acne A E A . . . E A . . . E0 A . . . E@ A . . . EP A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E` A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E` A METFORMIN d03807A C[@ E28.2 Polycystic ovarian syndrome A0 Ep A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A0 Ep A LISINOPRIL d00732A C E78.0 Pure hypercholesterolemia A0 Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Eр A . . . Eѐ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EѠ A . . . EѰ A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension AP EѰ A CINACALCET d05218A0 Bz N19 Z99.2 Unspecified kidney failure Dependence on renal dialysis AP EѰ A HYDRALAZINE d00132A0 C I10 Essential (primary) hypertension AP EѰ A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia AP EѰ A PRAVASTATIN d00348A0 C E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A CP I10 Essential (primary) hypertension A0 E0 A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A0 E0 A TOPIRAMATE d04115A C G43 Migraine A0 E@ A . . . EP A . . . E` A . . . Ep A . . . EҀ A . . . EҐ A . . . EҠ A . . . EҰ A . . . E A . . . E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified AP E A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCODONE d03075A Ap M79.2 Neuralgia and neuritis, unspecified A0 E@ A LEVOTHYROXINE d00278A B$ E03.9 Hypothyroidism, unspecified A0 E@ A NAPROXEN d00019A Ap M54.2 Cervicalgia A0 EP A . . . E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E` A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A0 E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 Ep A FINASTERIDE d00563A C L64 Androgenic alopecia A EӀ A . . . EӐ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EӠ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 EӠ A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A0 EӠ A LORATADINE d03050A Cr T78.40 Allergy, unspecified A0 EӰ A . . . E A ACETAMINOPHEN; OXYCODONE d03431A A T14.9 Unspecified injury A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CP Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E0 A . . . E@ A . . . EP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 EP A MELOXICAM d04532A B M06.9 Rheumatoid arthritis, unspecified A0 EP A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E` A . . . Ep A . . . EԀ A . . . EԐ A ALLOPURINOL d00023A C[@ M1A Chronic gout A EԠ A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A@ EԠ A AMLODIPINE d00689A D= I10 Essential (primary) hypertension A@ EԠ A METOPROLOL d00134A D= 99999 A@ EԠ A OMEPRAZOLE d00325A D= K21 Gastro-esophageal reflux disease A@ E A . . . E A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A C M81 Osteoporosis without current pathological fracture A` E A ESTRADIOL d00537A C N95.1 Menopausal and female climacteric states A` E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A` E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A` E A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A` E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A` E A . . . E A . . . E A ATAZANAVIR d04882A C B20 Human immunodeficiency virus [HIV] disease A E A DOXYCYCLINE d00037A A 55555 A E A EMTRICITABINE; TENOFOVIR d05352A C B20 Human immunodeficiency virus [HIV] disease A E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A MELOXICAM d04532A C R09.81 Nasal congestion A E A MIRTAZAPINE d04025A C- F32.9 Major depressive disorder, single episode, unspecified A E A NAPROXEN d00019A B= M79.2 Neuralgia and neuritis, unspecified A E A RITONAVIR d03984A C B20 Human immunodeficiency virus [HIV] disease A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A FENOFIBRATE d04286A B[ E78.0 Pure hypercholesterolemia A E` A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C Z79.3 Long term (current) use of hormonal contraceptives A E` A METFORMIN d03807A C R73.9 Hyperglycemia, unspecified A Ep A . . . EՀ A . . . EՐ A . . . Eՠ A . . . Eհ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A Eհ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A AZITHROMYCIN d00091A AP J42 Unspecified chronic bronchitis AP E A BUDESONIDE; FORMOTEROL d04795A B J20.9 Acute bronchitis, unspecified AP E A CYCLOBENZAPRINE d00963A B T14.9 Unspecified injury AP E A DEXLANSOPRAZOLE d07395A B K21 Gastro-esophageal reflux disease AP E A NAPROXEN d00019A B T14.9 Unspecified injury AP E A . . . E A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders A0 E A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A0 E A TOPIRAMATE d04115A C G43 Migraine A0 E A . . . E A . . . E A CLOBETASOL TOPICAL d01288A B[ L20.9 Atopic dermatitis, unspecified A E A MONTELUKAST d04289A CDp J45 Asthma A E A . . . E0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A DGJ G43 Migraine Ap E0 A ALPRAZOLAM d00168A C- G47.9 Sleep disorder, unspecified Ap E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E0 A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap E0 A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma Ap E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E0 A WARFARIN d00022A C I63 Cerebral infarction Ap E@ A . . . EP A . . . E` A . . . Ep A . . . Eր A BETAXOLOL d00176A DA I10 Essential (primary) hypertension A@ Eր A LORAZEPAM d00149A DE F41.9 Anxiety disorder, unspecified A@ Eր A MELOXICAM d04532A D M06.9 Rheumatoid arthritis, unspecified A@ Eր A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A@ E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma A0 E֠ A . . . Eְ A AMLODIPINE d00689A Cr E78.0 Pure hypercholesterolemia A@ Eְ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Eְ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ Eְ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E A METHADONE d00050A C F11.23 Opioid dependence with withdrawal A E A DEXMETHYLPHENIDATE d04777A A F90 F91.3 Attention-deficit hyperactivity disorders Oppositional defiant disorder A E A FLUOXETINE d00236A B F90 Attention-deficit hyperactivity disorders A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap A49.9 Bacterial infection, unspecified A E0 A WARFARIN d00022A Cr D75.9P Prevent blood clots A E@ A . . . EP A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A EP A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E` A . . . Ep A CEFDINIR d04256A A J01.9 Acute sinusitis, unspecified A E׀ A . . . Eא A . . . Eנ A . . . Eװ A METFORMIN d03807A C[@ E11.P Prevent diabetes A E A . . . E A CEPHALEXIN d00096A A N48.29 Other inflammatory disorders of penis A E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A0 E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A0 E A MONTELUKAST d04289A CDp J45 Asthma A0 E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A D I10 Essential (primary) hypertension A@ E A VENLAFAXINE d03181A Dc N95.1 Menopausal and female climacteric states A@ E A ZOLPIDEM d00910A B= G47.0 Insomnia A@ E0 A . . . E@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E@ A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A EP A DILTIAZEM d00045A D0z I10 Essential (primary) hypertension A@ EP A ESTRADIOL d00537A C[@ M81 Osteoporosis without current pathological fracture A@ EP A PROGESTERONE TOPICAL d04213A C[@ N95.1 Menopausal and female climacteric states A@ EP A RAMIPRIL d00728A D0z I10 Essential (primary) hypertension A@ E` A . . . Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A Ep A CLONAZEPAM d00197A B F41.9 Anxiety disorder, unspecified A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A Eؐ A . . . Eؠ A . . . Eذ A HYDROQUINONE TOPICAL d01319A A L81.9 Disorder of pigmentation, unspecified A E A PITAVASTATIN d07637A Bz E78.0 Pure hypercholesterolemia A E A BECLOMETHASONE d00760A C J45 Asthma A E A FLUTICASONE; SALMETEROL d04611A AP J45 Asthma A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E A FLUOXETINE d00236A C- F42 Obsessive-compulsive disorder A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A C R12 Heartburn A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A D I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 E A . . . E A 55555 A B M25.56 Pain in knee A0 E A AMOXICILLIN d00088A A K08.8 Other specified disorders of teeth and supporting structures A0 E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A0 E0 A . . . E@ A . . . EP A . . . E` A ALBUTEROL; IPRATROPIUM d04066A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E` A BISOPROLOL d00709A C I10 Essential (primary) hypertension Ap E` A DIGOXIN d00210A D I50.9 Heart failure, unspecified Ap E` A MORPHINE d00308A B= M54.2 Cervicalgia Ap E` A OXYCODONE d00329A CDp M54.2 Cervicalgia Ap E` A SPIRONOLACTONE d00373A D I50.9 Heart failure, unspecified Ap E` A WARFARIN d00022A D I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified Ap Ep A . . . Eـ A DOXYCYCLINE d00037A B N73.9 Female pelvic inflammatory disease, unspecified A Eِ A . . . E٠ A ACETAMINOPHEN; HYDROCODONE d03428A C- T14.9 Unspecified injury Ap E٠ A ALBUTEROL d00749A CDp R06.9 Unspecified abnormalities of breathing Ap E٠ A ALPRAZOLAM d00168A C- G47.9 Sleep disorder, unspecified Ap E٠ A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction Ap E٠ A FAMOTIDINE d00141A C- I10 Essential (primary) hypertension Ap E٠ A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia Ap E٠ A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified Ap Eٰ A LORATADINE d03050A B T78.40 Allergy, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eڀ A . . . Eڐ A . . . Eڠ A . . . Eڰ A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified AP E A HALCINONIDE TOPICAL d01297A C"0 R21 Rash and other nonspecific skin eruption AP E A IBUPROFEN d00015A C M19.9 M54.9 Osteoarthritis, unspecified site Dorsalgia, unspecified AP E A . . . E0 A . . . E@ A ALLOPURINOL d00023A A M1A Chronic gout AP E@ A ENALAPRIL d00013A C- I10 Essential (primary) hypertension AP E@ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E@ A MELOXICAM d04532A B[ M25.56 Pain in knee AP E@ A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified AP EP A . . . E` A . . . Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A A F90 Attention-deficit hyperactivity disorders A Eۀ A . . . Eې A . . . E۠ A . . . E۰ A DIPHENHYDRAMINE d00212A B= L29.9 Pruritus, unspecified A0 E۰ A ERYTHROMYCIN d00046A B= L73.9 Follicular disorder, unspecified A0 E۰ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E A . . . E A . . . E A ETODOLAC d00851A C- M54.2 Cervicalgia A E A . . . E A AMLODIPINE; BENAZEPRIL d03829A B I10 Essential (primary) hypertension A E A IBANDRONATE d05357A C M81 Osteoporosis without current pathological fracture A E A . . . E0 A LANSOPRAZOLE d03828A A K30 Functional dyspepsia A E0 A SUCRALFATE d00377A A K27 Peptic ulcer, site unspecified A E@ A . . . EP A . . . E` A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A0 E` A TEMAZEPAM d00384A CDp G47.9 Sleep disorder, unspecified A0 E` A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified A0 Ep A . . . E܀ A ONDANSETRON d00867A Cr 99999 A E܀ A SIMVASTATIN d00746A Cr 99999 A Eܐ A FENOFIBRATE d04286A D E78.1 Pure hyperglyceridemia A0 Eܐ A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 Eܐ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 Eܠ A CETIRIZINE d03827A B T78.40 Allergy, unspecified A Eܰ A ALBUTEROL d00749A C- J45 Asthma AP Eܰ A CETIRIZINE d03827A C- J45 Asthma AP Eܰ A FLUTICASONE d01296A C- J45 Asthma AP Eܰ A MOMETASONE NASAL d04223A C J45 Asthma AP Eܰ A MONTELUKAST d04289A C- J45 Asthma AP E A . . . E A . . . E A COLESEVELAM d04695A B E78.0 Pure hypercholesterolemia A0 E A GLYBURIDE d00248A CDp E11 Type 2 diabetes mellitus A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 E A ASPIRIN d00170A C D75.9P I63.P Prevent blood clots Prevent stroke A E A CETIRIZINE d03827A C- J30.9 Z88 Allergic rhinitis, unspecified Allergy status to drugs, medicaments and biological substances A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A LEVOTHYROXINE d00278A C E04.1 E04.9 Nontoxic single thyroid nodule Nontoxic goiter, unspecified A E A LOSARTAN d03821A C I63.P Prevent stroke A E A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TRAZODONE d00395A C- F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E݀ A COLESEVELAM d04695A Cr E78.0 Pure hypercholesterolemia A@ E݀ A OMEPRAZOLE d00325A Cr R12 Heartburn A@ E݀ A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension A@ E݀ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ Eݐ A . . . Eݠ A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A Eݰ A . . . E A . . . E A . . . E A NAPROXEN d00019A B G43 Migraine A E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C- I10 Essential (primary) hypertension A E A . . . E A DIPHENHYDRAMINE d00212A C- T78.40 Allergy, unspecified A0 E A EZETIMIBE d04824A C[@ E78.0 Pure hypercholesterolemia A0 E A RAMIPRIL d00728A C[@ I10 Essential (primary) hypertension A0 E A ALBUTEROL d00749A C- R06.2 Wheezing A E A AMITRIPTYLINE d00146A CDp G47.0 M79.2 Insomnia Neuralgia and neuritis, unspecified A E A CYCLOBENZAPRINE d00963A Ap M54.2 M79.1 M79.7 Cervicalgia Myalgia Fibromyalgia A E A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A E A IBUPROFEN d00015A Ap M54.9 M79.2 M79.7 Dorsalgia, unspecified Neuralgia and neuritis, unspecified Fibromyalgia A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A LORATADINE d03050A D T78.40 Allergy, unspecified A E A MELOXICAM d04532A C[@ M79.2 Neuralgia and neuritis, unspecified A E A MORPHINE d00308A Cr M25.56 M54.9 M79.7 Pain in knee Dorsalgia, unspecified Fibromyalgia A E A OMEPRAZOLE d00325A C- K25.P Prevent gastric ulcer A E A OXYCODONE d00329A C M54.9 M79.1 M79.7 Dorsalgia, unspecified Myalgia Fibromyalgia A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E0 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E0 A OLMESARTAN d04801A C[@ I10 Essential (primary) hypertension A E@ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A` E@ A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A` E@ A ISOSORBIDE d00653A Cr I10 Essential (primary) hypertension A` E@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E@ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E@ A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A` EP A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture AP EP A ATENOLOL d00004A C I10 I51.9 Essential (primary) hypertension Heart disease, unspecified AP EP A FENOFIBRATE d04286A C"0 E78.0 Pure hypercholesterolemia AP EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP EP A SIMVASTATIN d00746A C"0 E78.0 Pure hypercholesterolemia AP E` A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A Ep A MONTELUKAST d04289A Cr T78.40 Allergy, unspecified A Eހ A . . . Eސ A ARIPIPRAZOLE d04825A D F41.9 Anxiety disorder, unspecified Ap Eސ A BUSPIRONE d00182A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap Eސ A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction Ap Eސ A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap Eސ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap Eސ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified Ap Eސ A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified Ap Eޠ A . . . Eް A OMEPRAZOLE d00325A B 99999 A E A . . . E A . . . E A ALBUTEROL d00749A B J45 Asthma A@ E A BECLOMETHASONE d00760A B J45 Asthma A@ E A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A@ E A TOPIRAMATE d04115A C- G40 Epilepsy and recurrent seizures A@ E A ALBUTEROL d00749A B J45 Asthma A@ E A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A@ E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E A PREGABALIN d05508A Cr M79.2 Neuralgia and neuritis, unspecified A@ E A . . . E A AMOXICILLIN d00088A B K04.7P Prevent tooth infection A0 E A DIPHENHYDRAMINE d00212A B Z88 Allergy status to drugs, medicaments and biological substances A0 E A ISONIAZID d00101A B A15 Respiratory tuberculosis A0 E A . . . E0 A . . . E@ A . . . EP A . . . E` A ALBUTEROL d00749A C"0 R06.2 Wheezing A E` A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A C"0 H66.9 Otitis media, unspecified A Ep A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified AP Ep A ATENOLOL d00004A C I10 Essential (primary) hypertension AP Ep A ENALAPRIL d00013A0 C R01.1 Cardiac murmur, unspecified AP Ep A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP Ep A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol AP E߀ A . . . Eߐ A . . . Eߠ A LISDEXAMFETAMINE d06663A Bz F90 Attention-deficit hyperactivity disorders A E߰ A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C N94.6 Dysmenorrhea, unspecified A E A IBUPROFEN d00015A B M79.1 Myalgia A E A BUPROPION d00181A Dc F99 Mental disorder, not otherwise specified A` E A FLUTICASONE NASAL d04283A C"0 T78.40 Allergy, unspecified A` E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A . . . E0 A . . . E@ A GLIPIZIDE; METFORMIN d04823A C E11 Type 2 diabetes mellitus A EP A PAROXETINE d03157A C- F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A E` A . . . Ep A BUSPIRONE d00182A C 99999 A Ep A DUTASTERIDE; TAMSULOSIN d07634A Cr N40 Enlarged prostate A Ep A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A Ep A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A Ep A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A Ep A METOPROLOL d00134A C I50.9 Heart failure, unspecified A Ep A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Ep A WARFARIN d00022A D D75.9P Prevent blood clots A E A ESOMEPRAZOLE d04749A C- K57 Diverticular disease of intestine A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A@ E A IBUPROFEN d00015A Cr M25.5 Pain in joint A@ E A LORATADINE d03050A C- J00 Acute nasopharyngitis [common cold] A@ E A . . . E A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A Cr I10 Essential (primary) hypertension A E A NAPROXEN d00019A D M13 Other arthritis A E A . . . E A . . . E A . . . E A . . . E A . . . E A SERTRALINE d00880A C"0 F32.9 F41.0 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A C H61.2P Prevent ear wax A E A . . . E0 A . . . E@ A . . . EP A CYCLOBENZAPRINE d00963A B[ M62.83 Muscle spasm A0 EP A MELOXICAM d04532A B= M19.9 Osteoarthritis, unspecified site A0 EP A OLOPATADINE NASAL d07132A C"0 J30.9 Allergic rhinitis, unspecified A0 E` A WARFARIN d00022A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A Ep A . . . E A ALBUTEROL d00749A C- J45 Asthma A E A . . . E A ATORVASTATIN d04105A D I21.P Prevent heart attack/myocardial infarction A@ E A DONEPEZIL d04099A CDp G31.9 Degenerative disease of nervous system, unspecified A@ E A RAMIPRIL d00728A C"0 I50.9 Heart failure, unspecified A@ E A SPIRONOLACTONE d00373A C I50.9 Heart failure, unspecified A@ E A . . . E A ALBUTEROL d00749A Ei R06.02 Shortness of breath A E A ATENOLOL d00004A Ei I10 Essential (primary) hypertension A E A DILTIAZEM d00045A Ei I10 Essential (primary) hypertension A E A FLUTICASONE; SALMETEROL d04611A Ei R06.9 Unspecified abnormalities of breathing A E A GLIMEPIRIDE d03864A Ei R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified A E A LOSARTAN d03821A Ei E87.6 Hypokalemia A E A METFORMIN d03807A Ei R73 Elevated blood glucose level A E A SPIRONOLACTONE d00373A Ei 99999 A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough A E A . . . E A . . . E0 A . . . E@ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EP A . . . E` A . . . Ep A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap Ep A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified Ap Ep A CAPTOPRIL d00006A Cr I10 Essential (primary) hypertension Ap Ep A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified Ap Ep A METOPROLOL d00134A Cr I10 Essential (primary) hypertension Ap Ep A RISPERIDONE d03180A C F41.9 Anxiety disorder, unspecified Ap Ep A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A0 E A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E A . . . E A ATENOLOL; CHLORTHALIDONE d03258A C I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A@ E A NAPROXEN d00019A B M19.9 Osteoarthritis, unspecified site A@ E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E A ALBUTEROL d00749A D ^ J45 Asthma A@ E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A WARFARIN d00022A C[@ D75.9P Prevent blood clots AP E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A . . . E@ A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E@ A LEVOTHYROXINE d00278A C E04.1 Nontoxic single thyroid nodule A0 E@ A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A0 EP A . . . E` A ALBUTEROL d00749A CDp J45 Asthma AP E` A CETIRIZINE d03827A C- T78.40 Allergy, unspecified AP E` A FLUTICASONE; SALMETEROL d04611A C J45 Asthma AP E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E` A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified AP Ep A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A Ep A COLCHICINE d00150A CDp M1A Chronic gout A Ep A FUROSEMIDE d00070A C R60.9 Edema, unspecified A Ep A HYDRALAZINE d00132A C I50.9 Heart failure, unspecified A Ep A ISOSORBIDE d00653A C R07.9 Chest pain, unspecified A Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A Ep A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A Ep A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A E A IMATINIB d04758A C C95.9 Leukemia, unspecified A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A0 E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CP I10 Essential (primary) hypertension A E A . . . E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A ZOLPIDEM d00910A CDp G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A B I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E0 A ACETAMINOPHEN; OXYCODONE d03431A B= M54.9 Dorsalgia, unspecified A E0 A ALBUTEROL d00749A C J45 Asthma A E0 A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E0 A CARISOPRODOL d00960A B= M62.83 Muscle spasm A E0 A METAXALONE d00964A B= M62.83 Muscle spasm A E0 A MONTELUKAST d04289A C J45 Asthma A E0 A NAPROXEN d00019A B M54.9 Dorsalgia, unspecified A E0 A PAROXETINE d03157A CDp F41.9 Anxiety disorder, unspecified A E@ A . . . EP A PREDNISONE d00350A D M35.3 Polymyalgia rheumatica A E` A . . . Ep A . . . E A . . . E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A` E A AMOXICILLIN; CLAVULANATE d00089A Ap J40 Bronchitis, not specified as acute or chronic A` E A FLUTICASONE NASAL d04283A Cr J30.1 Allergic rhinitis due to pollen A` E A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A` E A PREDNISONE d00350A Ap J45 Asthma A` E A RANITIDINE d00021A CDp K30 Functional dyspepsia A` E A . . . E A ARIPIPRAZOLE d04825A Cr F32.9 Major depressive disorder, single episode, unspecified A E A BENZTROPINE d00175A C F41.9 Anxiety disorder, unspecified A E A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A E A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A FUROSEMIDE d00070A CDp I51.9 Heart disease, unspecified A E A HALOPERIDOL d00027A Cr F60.0 Paranoid personality disorder A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E A OXCARBAZEPINE d04513A Cr F39 Unspecified mood [affective] disorder A E A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified A E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A E A CARBOPLATIN d00185A B C50 Malignant neoplasm of breast A E A CARVEDILOL d03847A B= I50.9 Heart failure, unspecified A E A DOCETAXEL d04009A B C50 Malignant neoplasm of breast A E A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A E A LORATADINE d03050A B T78.40 Allergy, unspecified A E A LORAZEPAM d00149A B G47.0 Insomnia A E A PEGFILGRASTIM d04790A Bz C50 Malignant neoplasm of breast A E A TRASTUZUMAB d04357A CDp C50 Malignant neoplasm of breast A E A ZOLPIDEM d00910A B G47.0 Insomnia A E A . . . E A PREDNISONE d00350A A0 R21 Rash and other nonspecific skin eruption A E A . . . E0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E0 A CIPROFLOXACIN d00011A Ap N39.0 N41.0 Urinary tract infection, site not specified Acute prostatitis A0 E0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E@ A . . . EP A . . . E` A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified A E` A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ARIPIPRAZOLE d04825A B[ F32.9 Major depressive disorder, single episode, unspecified A@ E A CEFDINIR d04256A AP H66.9 Otitis media, unspecified A@ E A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A@ E A OFLOXACIN OTIC d04265A AP H60.9 Unspecified otitis externa A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E A NAPROXEN d00019A B[ M45 Ankylosing spondylitis A E A . . . E A . . . E0 A . . . E@ A ALBUTEROL d00749A Cr J45 Asthma AP E@ A ALBUTEROL d00749A Cr J45 Asthma AP E@ A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension AP E@ A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified AP E@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP EP A AMOXICILLIN d00088A B H10 Conjunctivitis A@ EP A EMTRICITABINE; RILPIVIRINE; TENOFOVIR d07796A C[@ B20 Human immunodeficiency virus [HIV] disease A@ EP A IBUPROFEN d00015A C- K08.8 Other specified disorders of teeth and supporting structures A@ EP A TRIAZOLAM d00397A C G47.0 Insomnia A@ E` A . . . Ep A . . . E A ALLOPURINOL d00023A Dc M1A Chronic gout A E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A E A . . . E A . . . E A LORATADINE d03050A B[ R09.81 Nasal congestion A E A 77777 . . A E A . . . E A . . . E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E A MINOCYCLINE d00110A C L70 L71 Acne Rosacea A0 E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A0 E A . . . E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A C M25.56 Pain in knee AP E0 A OXYBUTYNIN d00328A B N32.81 Overactive bladder AP E0 A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia AP E0 A UREA TOPICAL d00651A C- R60.9 Edema, unspecified AP E0 A VALSARTAN d04113A B I10 Essential (primary) hypertension AP E@ A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E@ A CLOPIDOGREL d04258A C I21.P I63.P I80.3 Prevent heart attack/myocardial infarction Prevent stroke Phlebitis and thrombophlebitis of lower extremities, unspecified A E@ A CYCLOSPORINE OPHTHALMIC d04836A B H04.12 Dry eye syndrome A E@ A ESOMEPRAZOLE d04749A C- K25.P Prevent gastric ulcer A E@ A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A E@ A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E@ A ISOSORBIDE MONONITRATE d00269A Cr I21.P Prevent heart attack/myocardial infarction A E@ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E@ A LOTEPREDNOL OPHTHALMIC d04292A B H04.12 Dry eye syndrome A E@ A REPAGLINIDE d04267A C- E11 Type 2 diabetes mellitus A E@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E@ A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E@ A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A EP A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E` A . . . Ep A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A R10.9 Unspecified abdominal pain A` E A FLUOXETINE d00236A B F31.9 Bipolar disorder, unspecified A` E A METRONIDAZOLE d00108A A N30 Cystitis A` E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A` E A PROMETHAZINE d00787A B R11 Nausea and vomiting A` E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N30 Cystitis A` E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A CLOPIDOGREL d04258A C G45.9 Z95.1 Transient cerebral ischemic attack, unspecified Presence of aortocoronary bypass graft AP E A LEVOTHYROXINE d00278A DJ$ E03.9 Hypothyroidism, unspecified AP E A QUINAPRIL d00365A C I10 Essential (primary) hypertension AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A . . . E A . . . E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A . . . E A LOSARTAN d03821A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ALBUTEROL d00749A C J45 Asthma A EP A NAPROXEN d00019A C N94.6 Dysmenorrhea, unspecified A E` A . . . Ep A . . . E A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A . . . E A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A FLUTICASONE; SALMETEROL d04611A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A0 E A IBUPROFEN d00015A CDp M25.51 M54.9 Pain in shoulder Dorsalgia, unspecified A0 E A DILTIAZEM d00045A CP I10 Essential (primary) hypertension A@ E A GLIPIZIDE; METFORMIN d04823A CP R73 Elevated blood glucose level A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CP R60.9 Edema, unspecified A@ E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A@ E A . . . E A ETANERCEPT d04365A Cr L40 Psoriasis A E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A E A ALBUTEROL d00749A CP J45 Asthma A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A POLYETHYLENE GLYCOL 3350 d05350A B= K59.0 Constipation A E0 A . . . E@ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A Bz N94.3 Z79.3 Premenstrual tension syndrome Long term (current) use of hormonal contraceptives A EP A . . . E` A . . . Ep A HYDROXYZINE d00907A B L23.7 Allergic contact dermatitis due to plants, except food A E A . . . E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A@ E A FLUTICASONE NASAL d04283A C"0 J30.1 Allergic rhinitis due to pollen A@ E A MONTELUKAST d04289A C J45 Asthma A@ E A POLYETHYLENE GLYCOL 3350 d05350A C"0 K58 Irritable bowel syndrome A@ E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 M79.2 Dorsalgia, unspecified Neuralgia and neuritis, unspecified A E A CYCLOBENZAPRINE d00963A C M54.9 M62.83 Dorsalgia, unspecified Muscle spasm A E A . . . E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A@ E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A@ E A FLUOXETINE d00236A D F31.9 F41.9 F90 Bipolar disorder, unspecified Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A@ E A IBUPROFEN d00015A A M54.9 N94.6 Dorsalgia, unspecified Dysmenorrhea, unspecified A@ E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A Dc M54.9 T14.9 Dorsalgia, unspecified Unspecified injury A E A DULOXETINE d05355A Dc F32.9 M19.90 Major depressive disorder, single episode, unspecified Unspecified osteoarthritis, unspecified site A E A ESTRADIOL TOPICAL d04210A Cr N95.1 Menopausal and female climacteric states A E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A E A OXYCODONE d00329A C T14.9 Unspecified injury A E A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A ALBUTEROL d00749A C- J45 Asthma A E@ A ALBUTEROL d00749A D J45 Asthma A E@ A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A E@ A DIPHENHYDRAMINE d00212A Cr L23 Z91.01 Allergic contact dermatitis Food allergy status A E@ A ERYTHROMYCIN OPHTHALMIC d03973A C- Z48.810 Encounter for surgical aftercare following surgery on the sense organs A E@ A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A E@ A MONTELUKAST d04289A Cr J45 Asthma A E@ A PREDNISOLONE OPHTHALMIC d03221A C- Z48.810 Encounter for surgical aftercare following surgery on the sense organs A EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 EP A LUBIPROSTONE d05736A B[ K58 Irritable bowel syndrome A0 EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A ALBUTEROL d00749A C- J45 Asthma A E A ATORVASTATIN d04105A D= E78.0 Pure hypercholesterolemia A0 E A DOXAZOSIN d00726A CDp R35.0 Frequency of micturition A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A0 E A ASPIRIN d00170A B[ I21.P Prevent heart attack/myocardial infarction A0 E A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A0 E A IBUPROFEN d00015A B T14.9 Unspecified injury A0 E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A TAMSULOSIN d04121A B R35.0 Frequency of micturition AP E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E A OMEPRAZOLE d00325A C[@ 99999 A@ E A PREDNISONE d00350A B 55555 A@ E A TAMSULOSIN d04121A B[ R39.15 Urgency of urination A@ E A AMOXICILLIN d00088A A J20.9 Acute bronchitis, unspecified A E A PSEUDOEPHEDRINE d00769A A J00 Acute nasopharyngitis [common cold] A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A@ E A LORATADINE d03050A B= T78.40 Allergy, unspecified A@ E A OMEPRAZOLE d00325A B= K25 Gastric ulcer A@ E A ZOLPIDEM d00910A Dc G47.0 Insomnia A@ E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E A DUTASTERIDE d04788A CDp N40 Enlarged prostate AP E A EZETIMIBE; SIMVASTATIN d05348A Cr E78.0 Pure hypercholesterolemia AP E A FUROSEMIDE d00070A B I50.9 Heart failure, unspecified AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A . . . E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A CODEINE d00012A Dc M54.2 M54.9 M79.2 Cervicalgia Dorsalgia, unspecified Neuralgia and neuritis, unspecified A E A DIGOXIN d00210A C I49.9 Cardiac arrhythmia, unspecified A E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A NIFEDIPINE d00051A C[@ I10 Essential (primary) hypertension A E A PRAZOSIN d00138A C- F43.1 Post-traumatic stress disorder (PTSD) A E A . . . E A . . . E A AMITRIPTYLINE d00146A C[@ K58 Irritable bowel syndrome A E A CLOPIDOGREL d04258A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A E A LEVALBUTEROL d04427A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A PROPRANOLOL d00032A C- R25.1 Tremor, unspecified A E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E A TIOTROPIUM d04829A C J43 Emphysema A E A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A@ E A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E A TRAMADOL d03826A C M13 Other arthritis A@ E A VERAPAMIL d00048A C I10 Essential (primary) hypertension A@ E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A A M54.2 Cervicalgia A E0 A ALBUTEROL d00749A Dc J45 Asthma A E0 A AMITRIPTYLINE d00146A Dc M79.2 Neuralgia and neuritis, unspecified A E0 A CELECOXIB d04380A C M54.9 Dorsalgia, unspecified A E0 A EZETIMIBE; SIMVASTATIN d05348A CDp E78.0P Prevent high cholesterol A E0 A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E0 A MOMETASONE d05262A CDp J45 Asthma A E0 A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A E0 A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E@ A . . . EP A . . . E` A . . . Ep A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A . . . E A ASPIRIN d00170A C[@ D75.9P Prevent blood clots A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` E A FAMOTIDINE d00141A C K30 Functional dyspepsia A0 E A METFORMIN; PIOGLITAZONE d05635A C E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A0 E A RISPERIDONE d03180A C- F32.9 Major depressive disorder, single episode, unspecified A0 E A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E A . . . E A AZITHROMYCIN d00091A A0 J02 Acute pharyngitis A E A DEXTROMETHORPHAN; PROMETHAZINE d03360A A0 R05 Cough A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E` A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A Ep A . . . E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A VENLAFAXINE d03181A D F41.9 Anxiety disorder, unspecified A0 E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A PREDNISONE d00350A A L23 Allergic contact dermatitis A0 E A ZOLPIDEM d00910A B G47.9 Sleep disorder, unspecified A0 E A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A CEFUROXIME d00056A A J01.9 Acute sinusitis, unspecified A E A ALBUTEROL d00749A C J45 Asthma A@ E A BUDESONIDE d04276A C J45 Asthma A@ E A MONTELUKAST d04289A B J45 Asthma A@ E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A@ E A . . . E A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia A E A . . . E0 A MOMETASONE NASAL d04223A B= J30.9 Allergic rhinitis, unspecified A E@ A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A E@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A EP A . . . E` A . . . Ep A FLUTICASONE d01296A C J45 Asthma A E A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A` E A DORZOLAMIDE OPHTHALMIC d03805A Cr H40 Glaucoma A` E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A OXYBUTYNIN d00328A Cr R32 Unspecified urinary incontinence A` E A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A0 E A QUETIAPINE d04220A B[ F39 Unspecified mood [affective] disorder A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A FAMOTIDINE d00141A C K30 Functional dyspepsia A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A CLOPIDOGREL d04258A C D75.9P I21.P I48.91 Prevent blood clots Prevent heart attack/myocardial infarction Unspecified atrial fibrillation A E A DESLORATADINE d04785A Dc H10.1 Acute atopic conjunctivitis A E A DICLOFENAC d00848A C[@ M54.9 Dorsalgia, unspecified A E A ESOMEPRAZOLE d04749A Dc K30 Functional dyspepsia A E A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A E A HYDROXYCHLOROQUINE d00817A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A . . . EP A . . . E` A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E` A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Ep A FLUTICASONE d01296A C R06.2 Wheezing A@ Ep A FLUTICASONE; SALMETEROL d04611A C J43 Emphysema A@ Ep A TIOTROPIUM d04829A C J43 Emphysema A@ E A . . . E A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E A . . . E A . . . E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A ENALAPRIL d00013A CDp I50.9 Heart failure, unspecified A@ E A GUAIFENESIN; PHENYLEPHRINE d03381A C[@ R09.81 Nasal congestion A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified A@ E A . . . E A . . . E A BUPROPION d00181A D= F32.9 Major depressive disorder, single episode, unspecified AP E A HYDROCODONE d03075A D M54.9 Dorsalgia, unspecified AP E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP E A SOLIFENACIN d05413A B= R35.0 Frequency of micturition AP E A . . . E A LAMOTRIGINE d03809A B= G40 Epilepsy and recurrent seizures A E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A E` A . . . Ep A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A CDp I10 Essential (primary) hypertension AP Ep A DUTASTERIDE d04788A C N40 Enlarged prostate AP Ep A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP Ep A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP Ep A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A DICLOFENAC d00848A Ap M19.9 Osteoarthritis, unspecified site A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A AMITRIPTYLINE d00146A C[@ F41.9 Anxiety disorder, unspecified A0 E A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E A . . . E A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A E A . . . E A ESOMEPRAZOLE d04749A B= K30 Functional dyspepsia A E A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A E A . . . E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A E A DABIGATRAN d07137A C[@ D75.9P I21 I63 Prevent blood clots ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Cerebral infarction A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A C I50.9 Heart failure, unspecified A E A LOSARTAN d03821A D9 I10 Essential (primary) hypertension A E A METOLAZONE d00299A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A D R73.9 Hyperglycemia, unspecified A E A DIAZEPAM d00148A B, F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E A . . . E A FLUTICASONE; SALMETEROL d04611A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E0 A NITROFURANTOIN d00112A A0 N39.0 Urinary tract infection, site not specified A E@ A . . . EP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E` A . . . Ep A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A Ep A CLOPIDOGREL d04258A C- Z79.02 Long term (current) use of antithrombotics/antiplatelets A Ep A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A Ep A GABAPENTIN d03182A Cr G40 Epilepsy and recurrent seizures A Ep A INSULIN d00262A C- E11 Type 2 diabetes mellitus A Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Ep A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A Ep A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Ep A METOPROLOL d00134A CDp R07.9 Chest pain, unspecified A Ep A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E A FENOFIBRATE d04286A C[@ E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A@ E A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A@ E A NAPROXEN d00019A B[ T14.9 Unspecified injury A@ E A FLUTICASONE d01296A CDp J45 Asthma A0 E A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A0 E A MONTELUKAST d04289A C J45 Asthma A0 E A . . . E A AZITHROMYCIN d00091A A0 J40 Bronchitis, not specified as acute or chronic A E A . . . E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A . . . E A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A0 E A ESTRADIOL d00537A D Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A0 E A GABAPENTIN d03182A Bz M79.2 Neuralgia and neuritis, unspecified A0 E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Bz I10 Essential (primary) hypertension A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E@ A . . . EP A . . . E` A . . . Ep A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A@ Ep A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ Ep A SITAGLIPTIN d05896A Cr R73 Elevated blood glucose level A@ E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A0 E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A0 E A TRIAMTERENE d00396A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A GALANTAMINE d04750A C[@ G30.9 G31.9 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified A0 E A LAMOTRIGINE d03809A B[ G40 Epilepsy and recurrent seizures A0 E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A . . . E A FLUTICASONE NASAL d04283A B[ J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E0 A . . . E@ A . . . EP A GLYBURIDE; METFORMIN d04703A Dc E11 Type 2 diabetes mellitus A EP A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A EP A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A EP A LISINOPRIL d00732A D I10 Essential (primary) hypertension A EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A EP A RANITIDINE d00021A D K30 Functional dyspepsia A EP A TIZANIDINE d04102A Bz M62.83 Muscle spasm A EP A TRAMADOL d03826A CDp M54.9 Dorsalgia, unspecified A E` A . . . Ep A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 Dorsalgia, unspecified A E A AMILORIDE; HYDROCHLOROTHIAZIDE d03193A Cr I10 Essential (primary) hypertension A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A CITALOPRAM d04332A C[@ K58 Irritable bowel syndrome A E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A MINOXIDIL d00135A C- I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A IPRATROPIUM d00265A C J45 Asthma A E A LEVOTHYROXINE d00278A C E04.9 Nontoxic goiter, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A RANITIDINE d00021A C- K30 Functional dyspepsia A E A ATORVASTATIN d04105A C E78.1 Pure hyperglyceridemia A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A ALLOPURINOL d00023A D M1A Chronic gout A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A ATENOLOL d00004A D* I10 Essential (primary) hypertension A E A CAPSAICIN TOPICAL d01321A D* M79.1 Myalgia A E A CLOTRIMAZOLE TOPICAL d04395A D L29.9 Pruritus, unspecified A E A FLUOCINONIDE TOPICAL d01294A D L29.9 Pruritus, unspecified A E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A LOSARTAN d03821A D* I50.9 Heart failure, unspecified A E A LOVASTATIN d00280A D* E78.0 Pure hypercholesterolemia A E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A PENICILLIN V POTASSIUM d07730A D D89.9 Disorder involving the immune mechanism, unspecified A E A . . . E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ALBUTEROL d00749A D# J45 Asthma AP E A ALLOPURINOL d00023A Cr M1A Chronic gout AP E A FAMOTIDINE d00141A B K30 Functional dyspepsia AP E A FLUTICASONE d01296A D# J45 Asthma AP E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia AP E A . . . E A ANTIPYRINE; BENZOCAINE OTIC d03627A CDp H92.0 Otalgia A E A CLONAZEPAM d00197A CDp G40 Epilepsy and recurrent seizures A E A CYPROHEPTADINE d00790A CDp G43 Migraine A E A DOCUSATE d01021A CDp K59.0 Constipation A E A FENTANYL d00233A B= M79.1 Myalgia A E A LACOSAMIDE d07349A CDp G40 Epilepsy and recurrent seizures A E A METHYLNALTREXONE d07135A B= K59.0 Constipation A E A MORPHINE d00308A B= M79.1 R10.9 Myalgia Unspecified abdominal pain A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A OXCARBAZEPINE d04513A CDp G40 Epilepsy and recurrent seizures A E A TRIAMCINOLONE NASAL d04233A CDp J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A0 E A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C Z79.3 Long term (current) use of hormonal contraceptives A0 E A IBUPROFEN d00015A C G43 Migraine A0 E0 A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A ALPRAZOLAM d00168A D* F41.9 Anxiety disorder, unspecified A E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E0 A ATENOLOL d00004A C I49.9 Cardiac arrhythmia, unspecified A E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E0 A CYCLOBENZAPRINE d00963A Dc M54.9 Dorsalgia, unspecified A E0 A DULOXETINE d05355A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E0 A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E0 A FUROSEMIDE d00070A Cr I50.9 Heart failure, unspecified A E0 A IPRATROPIUM d00265A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E@ A AZATHIOPRINE d00024A D"8 T86.9P Prevent transplanted organ and tissue rejection A` E@ A CYCLOSPORINE d00079A D"8 T86.9P Prevent transplanted organ and tissue rejection A` E@ A PREDNISONE d00350A D0z T86.9P Prevent transplanted organ and tissue rejection A` E@ A TERAZOSIN d00386A Cr R35.0 Frequency of micturition A` E@ A VALSARTAN d04113A C I10 Essential (primary) hypertension A` EP A . . . E` A . . . Ep A CITALOPRAM d04332A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A@ Ep A COLESEVELAM d04695A C- K91.5 Postcholecystectomy syndrome A@ Ep A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A@ Ep A NADOLOL d00018A Dc I49.1 Atrial premature depolarization A@ E A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome A0 E A GLATIRAMER d04111A C[@ G35 Multiple sclerosis A0 E A OXYBUTYNIN d00328A CDp R32 Unspecified urinary incontinence A0 E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E A HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OTIC d03543A B H66.9 Otitis media, unspecified A E A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A E A LABETALOL d00016A A I10 Essential (primary) hypertension A E A LANSOPRAZOLE d03828A CDp K21 Gastro-esophageal reflux disease A E A LIRAGLUTIDE d07466A CDp E11 Type 2 diabetes mellitus A E A . . . E0 Ap . . . E@ A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A EP A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A EP A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E` A . . . Ep A . . . E A . . . E A DIAZEPAM d00148A C G47.9 Sleep disorder, unspecified Ap E A GEMFIBROZIL d00245A C 99999 Ap E A LEVETIRACETAM d04499A DGJ G40 Epilepsy and recurrent seizures Ap E A PHENOBARBITAL d00340A DGJ G40 Epilepsy and recurrent seizures Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified Ap E A TIOTROPIUM d04829A C J43 Emphysema Ap E A . . . E A . . . E A LANSOPRAZOLE d03828A B= K21 Gastro-esophageal reflux disease A E A OXYCODONE d00329A Bz S97.8 Crushing injury of foot A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ATENOLOL d00004A C I49.9 Cardiac arrhythmia, unspecified AP EP A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified AP EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EP A LORAZEPAM d00149A C G47.9 Sleep disorder, unspecified AP EP A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E` A . . . Ep A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A TRANEXAMIC ACID d00529A B* N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A E0 A . . . E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E@ A ESTRADIOL d00537A CDp Z90.710 Acquired absence of both cervix and uterus A@ E@ A PROPRANOLOL d00032A D I10 Essential (primary) hypertension A@ E@ A ROPINIROLE d04215A C- G25.81 Restless legs syndrome A@ EP A FLUOXETINE; OLANZAPINE d04917A C[@ F32.9 Major depressive disorder, single episode, unspecified A` EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A` EP A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` EP A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A` EP A SIMVASTATIN d00746A C[@ E78.0P Prevent high cholesterol A` EP A TRAZODONE d00395A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E` A AMLODIPINE d00689A0 C"0 I10 Essential (primary) hypertension A@ E` A LISINOPRIL d00732A0 C"0 I10 Essential (primary) hypertension A@ E` A PRASUGREL d07409A0 C"0 D75.9P Prevent blood clots A@ E` A ROSUVASTATIN d04851A0 C"0 E78.0 Pure hypercholesterolemia A@ Ep A . . . E A . . . E A ALBUTEROL d00749A B[ J45 Asthma A0 E A FLUTICASONE d01296A CDp J45 Asthma A0 E A GRISEOFULVIN d00100A A B35.4 Tinea corporis A0 E A METOPROLOL d00134A C I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A@ E A OMEPRAZOLE d00325A CDp K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A@ E A PRAVASTATIN d00348A C E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A@ E A WARFARIN d00022A CDp I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A@ E A . . . E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A0 E A . . . E A . . . E A AMLODIPINE d00689A C 99999 AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications AP E A PIOGLITAZONE d04442A Ei 99999 AP E A WARFARIN d00022A C[@ D75.9P Prevent blood clots AP E A ASPIRIN d00170A CDp D75.9P Prevent blood clots AP E A FLUTICASONE; SALMETEROL d04611A Cr J44.9 Chronic obstructive pulmonary disease, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified AP E A TAMSULOSIN d04121A CDp N40 Enlarged prostate AP E A TIOTROPIUM d04829A Cr J44.9 Chronic obstructive pulmonary disease, unspecified AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A BACLOFEN d00967A B M79.1 Myalgia AP E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified AP E A HYDROCODONE d03075A CDp T14.9 Unspecified injury AP E A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 E0 A AMLODIPINE d00689A C 99999 A@ E0 A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D I10 Essential (primary) hypertension A@ E0 A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A@ E0 A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A@ E@ A ALOGLIPTIN; PIOGLITAZONE d07965A B[ E11 Type 2 diabetes mellitus A@ E@ A BUPROPION d00181A C F31.9 Bipolar disorder, unspecified A@ E@ A CARISOPRODOL d00960A C M54.9 Dorsalgia, unspecified A@ E@ A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified A@ EP A TEMAZEPAM d00384A B G47.9 Sleep disorder, unspecified A E` A . . . Ep A CELECOXIB d04380A D M06.9 M13 M19.9 Rheumatoid arthritis, unspecified Other arthritis Osteoarthritis, unspecified site A Ep A CHLORTHALIDONE d00192A Cr N28.9 Disorder of kidney and ureter, unspecified A Ep A GABAPENTIN d03182A CP E11.4 Type 2 diabetes mellitus with neurological complications A Ep A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A Ep A OXYBUTYNIN d00328A C N32.81 Overactive bladder A Ep A TRAMADOL d03826A Dc M79.7 Fibromyalgia A Ep A TRAZODONE d00395A C- G47.0 Insomnia A E A AMLODIPINE d00689A A I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A CYCLOPHOSPHAMIDE d00036A B B34.9 Viral infection, unspecified A E A FUROSEMIDE d00070A C- J98.9 R60.9 Respiratory disorder, unspecified Edema, unspecified A E A OMEPRAZOLE d00325A C[@ K44 Diaphragmatic hernia A E A PREDNISONE d00350A B B34.9 D64.9 Viral infection, unspecified Anemia, unspecified A E A VALSARTAN d04113A C[@ I10 Essential (primary) hypertension A E A WARFARIN d00022A D ^ Z95.2 Presence of prosthetic heart valve A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A MESALAMINE d01031A C K51 Ulcerative colitis A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A MERCAPTOPURINE d00289A C K50 Crohn's disease [regional enteritis] A0 E A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] A0 E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A0 E A ALBUTEROL d00749A C9 R06.2 Wheezing A E A . . . E A . . . E A . . . E A ALENDRONATE d03849A D M81 Osteoporosis without current pathological fracture A0 E A ALPRAZOLAM d00168A D* M62.83 Muscle spasm A0 E A SERTRALINE d00880A D* F32.9 Major depressive disorder, single episode, unspecified A0 E0 A . . . E@ A . . . EP A AMIODARONE d00002A D I49.9 Cardiac arrhythmia, unspecified A EP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EP A CARVEDILOL d03847A D I50.9 Heart failure, unspecified A EP A ENALAPRIL d00013A D I50.9 Heart failure, unspecified A EP A MEXILETINE d00300A C[@ I49.9 Cardiac arrhythmia, unspecified A EP A RANOLAZINE d05719A D I20.9 I49.9 Angina pectoris, unspecified Cardiac arrhythmia, unspecified A EP A TAMSULOSIN d04121A C R33.9 Retention of urine, unspecified A EP A WARFARIN d00022A D D75.9P Prevent blood clots A E` A . . . Ep A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A . . . E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus Ap E A INDAPAMIDE d00260A Cr I10 Essential (primary) hypertension Ap E A LABETALOL d00016A C I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E A FORMOTEROL; MOMETASONE d07660A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A HYDROCODONE d03075A C- M79.1 Myalgia A E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E A OMEPRAZOLE d00325A C R12 Heartburn A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A B R25.1 Tremor, unspecified A E A VENLAFAXINE d03181A A F32.9 Major depressive disorder, single episode, unspecified A E A ZOLPIDEM d00910A C G47.0 Insomnia A E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A NEBIVOLOL d05265A D I10 Essential (primary) hypertension A0 E A . . . E A . . . E A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A E A IBUPROFEN d00015A A R50.9 Fever, unspecified A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= Z79.3 Long term (current) use of hormonal contraceptives A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` Ep A DILTIAZEM d00045A C I10 Essential (primary) hypertension A` Ep A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A` Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Bz I10 Essential (primary) hypertension A` Ep A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A` Ep A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A ALBUTEROL d00749A Dc J45 Asthma A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUDESONIDE d04276A Dc J45 Asthma A E A CYCLOSPORINE OPHTHALMIC d04836A C- H04.12 Dry eye syndrome A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A IBANDRONATE d05357A C- M81 Osteoporosis without current pathological fracture A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A Cr R00.0 Tachycardia, unspecified A E A MONTELUKAST d04289A Dc J45 Asthma A E A ZOLPIDEM d00910A C G47.0 Insomnia A E A LISINOPRIL d00732A C[@ I21.P Prevent heart attack/myocardial infarction A0 E A OMEPRAZOLE d00325A C[@ 99999 A0 E A SIMVASTATIN d00746A C[@ I21.P Prevent heart attack/myocardial infarction A0 E A . . . E A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified A E0 A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` E0 A GEMFIBROZIL d00245A CDp E78.0 Pure hypercholesterolemia A` E0 A GLIMEPIRIDE d03864A A E11 Type 2 diabetes mellitus A` E0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E0 A SITAGLIPTIN d05896A A E11 Type 2 diabetes mellitus A` E0 A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified A` E@ A . . . EP A . . . E` A . . . Ep A GABAPENTIN d03182A C"@ M79.2 Neuralgia and neuritis, unspecified AP Ep A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP Ep A SIMVASTATIN d00746A C"@ E78.0 Pure hypercholesterolemia AP Ep A TOPIRAMATE d04115A C"@ G40 Epilepsy and recurrent seizures AP Ep A TRAMADOL d03826A C M25.55 M25.56 M54.9 Pain in hip Pain in knee Dorsalgia, unspecified AP E A . . . E A . . . E A . . . E A MELOXICAM d04532A A G89.18 Other acute postprocedural pain A E A . . . E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A C- I10 Essential (primary) hypertension A@ E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A@ E A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A@ E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A@ E A BENAZEPRIL d00730A Cr I21.P Prevent heart attack/myocardial infarction A@ E A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A WARFARIN d00022A Cr D75.9P Prevent blood clots A@ E A . . . E A . . . E A AMITRIPTYLINE d00146A D# M79.7 Fibromyalgia A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A SERTRALINE d00880A D# F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E0 A . . . E@ A GUANFACINE d00717A C F95.9 Tic disorder, unspecified A0 E@ A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A0 E@ A RISPERIDONE d03180A C F84.0 Autistic disorder A0 EP A . . . E` A NAPROXEN d00019A0 A T14.9 Unspecified injury A Ep A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C I10 Essential (primary) hypertension A0 Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 Ep A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 E A OMEPRAZOLE d00325A C 99999 A0 E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A0 E A SPIRONOLACTONE d00373A C- 99999 A0 E A TOPIRAMATE d04115A CDp G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A HYDRALAZINE d00132A B= I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A C K31.4 Gastric diverticulum A@ E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E A ACETAMINOPHEN; HYDROCODONE d03428A B M25.56 Pain in knee A E A IBUPROFEN d00015A B T14.9 Unspecified injury A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified A Ep A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ZOLPIDEM d00910A C[@ G47.0 Insomnia A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A CITALOPRAM d04332A Ei F32.9 Major depressive disorder, single episode, unspecified A E A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LOVASTATIN d00280A B E78.0 Pure hypercholesterolemia A E A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A E A NABUMETONE d00310A C M19.9 Osteoarthritis, unspecified site A E A NITROGLYCERIN d00321A D I51.9 Heart disease, unspecified A E A OLOPATADINE OPHTHALMIC d04117A C H10.1 Acute atopic conjunctivitis A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A Ei 99999 A E A QUETIAPINE d04220A C G47.0 Insomnia A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A ARIPIPRAZOLE d04825A C F31.9 Bipolar disorder, unspecified AP E A CYCLOBENZAPRINE d00963A C[@ M79.1 Myalgia AP E A LAMOTRIGINE d03809A B F32.9 Major depressive disorder, single episode, unspecified AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A TRAMADOL d03826A C[@ M19.9 M54.9 Osteoarthritis, unspecified site Dorsalgia, unspecified AP E A . . . E A CARBAMAZEPINE d00058A C G40 Epilepsy and recurrent seizures A E A FLUOXETINE d00236A C- F39 Unspecified mood [affective] disorder A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified Ap E A FUROSEMIDE d00070A B I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A NITROFURANTOIN d00112A B I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia Ap E A SPIRONOLACTONE d00373A B I10 Essential (primary) hypertension Ap E A . . . E A ALENDRONATE d03849A Dc M85.80 Other specified disorders of bone density and structure, unspecified site Ap E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E A CELECOXIB d04380A C M54.9 Dorsalgia, unspecified Ap E A DULOXETINE d05355A Cr M54.9 Dorsalgia, unspecified Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A NIACIN d00314A D E78.0 Pure hypercholesterolemia Ap E A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus Ap E A AMOXICILLIN d00088A B J01.9 Acute sinusitis, unspecified A E A . . . E0 A . . . E@ A ALBUTEROL d00749A D ^ J45 Asthma A E@ A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A EP A . . . E` A . . . Ep A LATANOPROST OPHTHALMIC d04017A Bz H26.9 Unspecified cataract A Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A@ E A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A C E11.2 I10 Type 2 diabetes mellitus with kidney complications Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A E A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A E A . . . E A BUPRENORPHINE d00840A B F11.23 Opioid dependence with withdrawal A E A CITALOPRAM d04332A Bz F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E0 A ALPRAZOLAM d00168A CP F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E0 A BUPRENORPHINE; NALOXONE d04819A B F11.23 Opioid dependence with withdrawal A E@ A . . . EP A . . . E` A . . . Ep A BUPROPION d00181A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ Ep A MELOXICAM d04532A B M25.56 Pain in knee A@ Ep A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A D M54.9 R10.9 Dorsalgia, unspecified Unspecified abdominal pain AP E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified AP E A EXEMESTANE d04461A C C50 Malignant neoplasm of breast AP E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia AP E A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A E A . . . E A . . . E A AMLODIPINE; BENAZEPRIL d03829A C[@ I10 Essential (primary) hypertension A` E A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A` E A EXEMESTANE d04461A C[@ C50 Malignant neoplasm of breast A` E A METFORMIN; PIOGLITAZONE d05635A C[@ E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia AP E A FENOFIBRIC ACID d07371A0 CDp E78.0 Pure hypercholesterolemia AP E A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified AP E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E0 A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A0 E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E@ A CARVEDILOL d03847A CDp I21.P Prevent heart attack/myocardial infarction A E@ A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A E@ A FLUTICASONE; VILANTEROL d08100A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A ISOSORBIDE MONONITRATE d00269A C- I21.P Prevent heart attack/myocardial infarction A E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E@ A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E@ A RANOLAZINE d05719A C R07.9 Chest pain, unspecified A EP A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension AP EP A MYCOPHENOLIC ACID d05217A C[@ T86.9P Prevent transplanted organ and tissue rejection AP EP A OMEPRAZOLE d00325A C[@ R12 Heartburn AP EP A PREDNISONE d00350A C[@ T86.9P Prevent transplanted organ and tissue rejection AP EP A TACROLIMUS d03752A C[@ T86.9P Prevent transplanted organ and tissue rejection AP E` A . . . Ep A AMOXICILLIN d00088A A L03.90 Cellulitis, unspecified A E A CODEINE; GUAIFENESIN d03393A A J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A CLONIDINE d00044A B= I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A A I10 Essential (primary) hypertension AP E A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A C- I10 N28.9 Essential (primary) hypertension Disorder of kidney and ureter, unspecified AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A . . . E A RANITIDINE d00021A B K30 Functional dyspepsia A E A ALBUTEROL d00749A Cr J43 J45 Emphysema Asthma A E A BECLOMETHASONE d00760A B J45 Asthma A E A . . . E A . . . E A RANITIDINE d00021A C- K30 Functional dyspepsia A E A . . . E0 A HYDROCODONE d03075A AP M54.9 Dorsalgia, unspecified A E@ A AMOXICILLIN d00088A Ap J00 Acute nasopharyngitis [common cold] A E@ A RANITIDINE d00021A Bz K21 Gastro-esophageal reflux disease A EP A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 EP A OMEPRAZOLE d00325A B[ K30 Functional dyspepsia A0 E` A GLYBURIDE d00248A Dc E11 Type 2 diabetes mellitus A0 E` A LOVASTATIN d00280A B E78.0 Pure hypercholesterolemia A0 E` A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 Ep A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A` Ep A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A` Ep A FORMOTEROL; MOMETASONE d07660A C- J44.9 Chronic obstructive pulmonary disease, unspecified A` Ep A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A` Ep A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A` Ep A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A . . . E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A LORATADINE d03050A Cr T78.40 Allergy, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A MEDROXYPROGESTERONE d00284A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A C I10 Essential (primary) hypertension A E@ A . . . EP A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A@ EP A CONJUGATED ESTROGENS d00541A D N95.1 Menopausal and female climacteric states A@ EP A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A@ EP A LORATADINE d03050A B T78.40 Allergy, unspecified A@ E` A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A Ep A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A C M54.9 Dorsalgia, unspecified A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension A E A IPRATROPIUM NASAL d04235A C R09.81 Nasal congestion A E A OXYCODONE d00329A B[ M54.9 Dorsalgia, unspecified A E A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E A ZOLPIDEM d00910A Cr G47.0 Insomnia A E A ACETAMINOPHEN; TRAMADOL d04766A0 Ei R52 Pain, unspecified A E A AMIODARONE d00002A C 99999 A E A ATORVASTATIN d04105A C 99999 A E A CARVEDILOL d03847A C 99999 A E A CITALOPRAM d04332A C 99999 A E A INSULIN ASPART d04697A0 Ei E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A0 Ei E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C 99999 A E A METFORMIN d03807A C 99999 A E A PANTOPRAZOLE d04514A C 99999 A E A PIOGLITAZONE d04442A C 99999 A E A WARFARIN d00022A C D75.9P Prevent blood clots A E A DRONEDARONE d07458A B[ I48.91 Unspecified atrial fibrillation A E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A . . . E A LORATADINE d03050A C J30.9 Allergic rhinitis, unspecified A E A . . . E A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A0 E A CITALOPRAM d04332A C[@ F41.9 Anxiety disorder, unspecified A0 E A DILTIAZEM d00045A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 E A . . . E A MONTELUKAST d04289A B R09.81 Nasal congestion A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A FUROSEMIDE d00070A0 C R06.02 Shortness of breath A E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A . . . E A DUTASTERIDE d04788A Cr R39.15 Urgency of urination A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E A INSULIN d00262A Cr E11 Type 2 diabetes mellitus A E A METHYLPREDNISOLONE d00293A Cr M06.9 Rheumatoid arthritis, unspecified A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A SULFASALAZINE d00379A Cr M06.9 Rheumatoid arthritis, unspecified A E A ZOLPIDEM d00910A Cr G47.0 Insomnia A E A . . . E A . . . E A . . . E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B L70 Acne A E0 A . . . E@ A IMIPRAMINE d00259A C[@ M79.2 Neuralgia and neuritis, unspecified A@ E@ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E@ A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E@ A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A@ EP A . . . E` A . . . Ep A ATORVASTATIN d04105A C 99999 A` Ep A FAMOTIDINE d00141A Ei 99999 A` Ep A FUROSEMIDE d00070A C- I51.9 Heart disease, unspecified A` Ep A INSULIN GLARGINE d04538A Ei E11 Type 2 diabetes mellitus A` Ep A OXYBUTYNIN d00328A Ei 99999 A` Ep A SERTRALINE d00880A C 99999 A` E A CAPTOPRIL d00006A C[@ 99999 A E A CLOPIDOGREL d04258A C[@ I21.P Prevent heart attack/myocardial infarction A E A INSULIN d00262A C[@ E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C[@ I20.9 Angina pectoris, unspecified A E A PENTOXIFYLLINE d00336A C[@ I70.2 Atherosclerosis of native arteries of extremities A E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E A . . . E A ALLOPURINOL d00023A C E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A E A . . . E A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A` E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A RANITIDINE d00021A C- I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A` E A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A CONJUGATED ESTROGENS d00541A D N95.1P Prevent menopause symptoms A E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A E A CYPROHEPTADINE d00790A D F50.9 Eating disorder, unspecified A E A DIAZEPAM d00148A C F41.0 G47.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Sleep disorder, unspecified A E A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A E A LEVOTHYROXINE d00278A DE E03.9 Hypothyroidism, unspecified A E A OMEPRAZOLE d00325A D K25 Gastric ulcer A E A . . . E A . . . E A AMOXICILLIN d00088A A J20.9 Acute bronchitis, unspecified A E A . . . E 0 A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A@ E 0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E 0 A PREGABALIN d05508A C- E11.4 Type 2 diabetes mellitus with neurological complications A@ E 0 A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E @ A . . . E P A . . . E ` A . . . E p A ANTI-INFECTIVES - UNSPECIFIED c00001A B Z79.2 Long term (current) use of antibiotics A E A 99999 . . A E A . . . E A AMOXICILLIN d00088A A@ H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A ESTRADIOL d00537A CP Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E @ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E P A . . . E ` A . . . E p A VENLAFAXINE d03181A C- F41.9 Anxiety disorder, unspecified A E A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A0 E A INSULIN ISOPHANE (NPH) d04370A CP E11 Type 2 diabetes mellitus A0 E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A0 E A OXYCODONE d00329A C M54.9 Dorsalgia, unspecified A E A OXYCODONE d00329A C- M54.9 M79.1 Dorsalgia, unspecified Myalgia A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C"0 E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A FAMOTIDINE d00141A A R10.9 Unspecified abdominal pain A@ E A HYOSCYAMINE d00985A A0 N32.81 Overactive bladder A@ E A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A@ E A ONDANSETRON d00867A Ap R11 Nausea and vomiting A@ E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A B= E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A Dc E11 Type 2 diabetes mellitus A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E 0 A OLANZAPINE d04050A CDp G47.0 Insomnia A0 E 0 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A0 E 0 A SERTRALINE d00880A A@ F41.9 Anxiety disorder, unspecified A0 E @ A . . . E P A . . . E ` A . . . E p A ALPRAZOLAM d00168A Dc F32.9 Major depressive disorder, single episode, unspecified A` E p A MIRTAZAPINE d04025A C F32.9 Major depressive disorder, single episode, unspecified A` E p A SOTALOL d00371A C- I49.9 Cardiac arrhythmia, unspecified A` E p A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A` E p A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` E p A WARFARIN d00022A C Z95.2 Presence of prosthetic heart valve A` E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C E28.31 Premature menopause A E A CODEINE d00012A C M54.9 Dorsalgia, unspecified A@ E A NAPROXEN d00019A Dc M79.1 Myalgia A@ E A QUETIAPINE d04220A D F31.9 Bipolar disorder, unspecified A@ E A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E 0 A . . . E @ A . . . E P A CITALOPRAM d04332A C"0 F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E P A TRAZODONE d00395A C"0 G47.9 Sleep disorder, unspecified A E ` A . . . E p A . . . E A LEVOTHYROXINE d00278A CDp C73 Malignant neoplasm of thyroid gland A E A . . . E A . . . E A . . . E A . . . E A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A DERMATOLOGICAL AGENTS - UNSPECIFIED c00136. . L70 Acne A E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A HYDROCORTISONE TOPICAL d03205A B L20.9 Atopic dermatitis, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E 0 A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E 0 A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A E 0 A MESALAMINE d01031A D& K64.P Prevent hemorrhoids A E 0 A MESALAMINE d01031A D& K51 Ulcerative colitis A E 0 A MIGLITOL d04110A B E11 Type 2 diabetes mellitus A E 0 A OMEPRAZOLE d00325A D& K21 Gastro-esophageal reflux disease A E 0 A RANITIDINE d00021A D& K21 Gastro-esophageal reflux disease A E 0 A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E @ A . . . E P A ATENOLOL d00004A D I10 Essential (primary) hypertension A0 E P A DULOXETINE d05355A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E P A ROPINIROLE d04215A C- G25.81 Restless legs syndrome A0 E ` Ap . . . E p A . . . E A . . . E A . . . E A ARIPIPRAZOLE d04825A C[@ F41.9 Anxiety disorder, unspecified A` E A BENZONATATE d00796A A0 R05 Cough A` E A BUDESONIDE; FORMOTEROL d04795A A0 R05 Cough A` E A LOPERAMIDE d01025A C- R19.7 Diarrhea, unspecified A` E A LOSARTAN d03821A B I10 Essential (primary) hypertension A` E A OLANZAPINE d04050A C- F41.9 Anxiety disorder, unspecified A` E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A@ E A CARVEDILOL d03847A B[ R00.0 Tachycardia, unspecified A@ E A PANTOPRAZOLE d04514A Dc K30 Functional dyspepsia A@ E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ E A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A BACLOFEN d00967A B= M79.1 Myalgia A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A BK M79.2 Neuralgia and neuritis, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E A RALOXIFENE d04261A C M81 Osteoporosis without current pathological fracture A E A . . . E A . . . E0 A . . . E@ A SELENIUM SULFIDE TOPICAL d03210A B[ L40 Psoriasis A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A MESALAMINE d01031A C[@ K50 Crohn's disease [regional enteritis] A E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A C[@ M79.7 Fibromyalgia Ap E0 A COLESEVELAM d04695A C[@ E78.0 Pure hypercholesterolemia Ap E0 A CYCLOBENZAPRINE d00963A D M79.1 Myalgia Ap E0 A GABAPENTIN d03182A C M79.7 Fibromyalgia Ap E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E0 A TRAZODONE d00395A D G47.0 M79.7 Insomnia Fibromyalgia Ap E@ A . . . EP A . . . E` A ALBUTEROL d00749A C J45 Asthma A Ep A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A@ Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Ep A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A@ Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C"0 M54.9 Dorsalgia, unspecified AP E A AMLODIPINE d00689A C"0 I10 N42.9 Essential (primary) hypertension Disorder of prostate, unspecified AP E A BACLOFEN d00967A B M62.83 Muscle spasm AP E A DOXAZOSIN d00726A C"0 I10 Essential (primary) hypertension AP E A GABAPENTIN d03182A C"0 M79.2 Neuralgia and neuritis, unspecified AP E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Cr F90 Attention-deficit hyperactivity disorders A E A CLONAZEPAM d00197A CDp G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A NIZATIDINE d00322A C K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A AMOXICILLIN d00088A Ap J02 J03 Acute pharyngitis Acute tonsillitis A E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E` A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ E` A MONTELUKAST d04289A C J45 Asthma A@ E` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ Ep A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A BISOPROLOL d00709A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ E A QUINAPRIL d00365A C I10 Essential (primary) hypertension A@ E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A CLOPIDOGREL d04258A D# I63.P Prevent stroke AP E A FUROSEMIDE d00070A CDp I50.9 I51.9 R60.9 Heart failure, unspecified Heart disease, unspecified Edema, unspecified AP E A LOSARTAN d03821A C I21.P Prevent heart attack/myocardial infarction AP E A METOPROLOL d00134A C I48.91 I49.9 Unspecified atrial fibrillation Cardiac arrhythmia, unspecified AP E A WARFARIN d00022A CDp D75.9P Prevent blood clots AP E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A CIPROFLOXACIN OPHTHALMIC d03211A Ap S05 Injury of eye and orbit A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A E A CITALOPRAM d04332A B= F41.9 Anxiety disorder, unspecified A E A ASPIRIN d00170A B= I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A@ E A ATORVASTATIN d04105A B= I63.P Prevent stroke A@ E A BENAZEPRIL d00730A B= I63.P Prevent stroke A@ E A LORAZEPAM d00149A B= F41.9 Anxiety disorder, unspecified A@ E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A MONTELUKAST d04289A C J45 Asthma A E A DICLOFENAC d00848A Dc M13 Other arthritis A E A 77777 . . A E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- R51 Headache A E A DULOXETINE d05355A CDp M79.1 Myalgia A E A METFORMIN d03807A CDp E88.81 Metabolic syndrome A E A METHOCARBAMOL d00965A B M54.9 Dorsalgia, unspecified A E A MODAFINIL d04378A B R53.83 Other fatigue A E A NAPROXEN d00019A B M54.9 Dorsalgia, unspecified A E A OXYCODONE d00329A B[ M54.9 Dorsalgia, unspecified A E A OXYMORPHONE d00833A CDp M54.9 Dorsalgia, unspecified A E A TEMAZEPAM d00384A B G47.0 Insomnia A E A . . . E A . . . E A . . . E0 A ACYCLOVIR d00001A D# B00.1 Herpesviral vesicular dermatitis A` E0 A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A` E0 A DEXLANSOPRAZOLE d07395A C K30 Functional dyspepsia A` E0 A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A D I10 Essential (primary) hypertension A` E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E0 A TOPIRAMATE d04115A C[@ G43 Migraine A` E@ A ACETAMINOPHEN; HYDROCODONE d03428A D R10.9 Unspecified abdominal pain AP E@ A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP E@ A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus AP E@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP EP A . . . E` A . . . Ep A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C"0 M54.9 Dorsalgia, unspecified A E A DESVENLAFAXINE d07113A B F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ADAPALENE; BENZOYL PEROXIDE TOPICAL d07382A Ap L70 Acne A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= N94.6 Dysmenorrhea, unspecified A E A CLONAZEPAM d00197A C F32.9 Major depressive disorder, single episode, unspecified AP E A GABAPENTIN d03182A C F43.9 Reaction to severe stress, unspecified AP E A MIRTAZAPINE d04025A C F41.9 Anxiety disorder, unspecified AP E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified AP E A USTEKINUMAB d07396A B[ L40 Psoriasis AP E A . . . E A . . . E A CLONIDINE d00044A C"0 F84.0 Autistic disorder A E A . . . E A . . . E A . . . E A . . . E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E0 A RALOXIFENE d04261A D* M81 Osteoporosis without current pathological fracture A0 E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A CAPTOPRIL d00006A C I10 Essential (primary) hypertension A E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A DICLOFENAC TOPICAL d04722A B= M19.9 Osteoarthritis, unspecified site A E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A MELOXICAM d04532A B= M25.56 Pain in knee AP E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A Cr E58 K30 Dietary calcium deficiency Functional dyspepsia A@ E A . . . E A . . . E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E0 A WARFARIN d00022A D,3 Z95.2 Presence of prosthetic heart valve A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection A E A . . . E A . . . E A . . . E A . . . E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ E A INDOMETHACIN d00039A C[@ H57.8 Other specified disorders of eye and adnexa A@ E A METOPROLOL d00134A C I50.9 Heart failure, unspecified A@ E A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol A@ E A . . . E A MONTELUKAST d04289A CDp J45 Asthma A E A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E0 A . . . E@ A . . . EP A DIPHENHYDRAMINE d00212A C- Z91.030 Bee allergy status A EP A GEMFIBROZIL d00245A B= E78.0 Pure hypercholesterolemia A EP A GLIMEPIRIDE d03864A B R73 Elevated blood glucose level A EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A EP A MECLIZINE d00859A C- R42 Dizziness and giddiness A EP A METFORMIN d03807A B E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A EP A OMEPRAZOLE d00325A D* K21 Z87.11 Gastro-esophageal reflux disease Personal history of peptic ulcer disease A EP A ORPHENADRINE d00966A C- M62.83 T14.9 Muscle spasm Unspecified injury A EP A ZOLPIDEM d00910A B G47.0 Insomnia A E` A AMOXICILLIN d00088A A0 H66.9 Otitis media, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMPICILLIN d00003A A` B37.9 Candidiasis, unspecified A E@ A . . . EP A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A EP A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E` A . . . Ep A . . . E A . . . E A METHYLPREDNISOLONE d00293A Ap M79.646 Pain in finger A E A . . . E A . . . E A . . . E A CARVEDILOL d03847A C[@ I51.7 Cardiomegaly A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A ETODOLAC d00851A D M19.9 Osteoarthritis, unspecified site A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TOLTERODINE d04294A C N32.81 Overactive bladder A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A Ap J06.9 Acute upper respiratory infection, unspecified A E A . . . E0 A LORATADINE d03050A Cr T78.40 Allergy, unspecified A0 E0 A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E0 A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 E@ A . . . EP A . . . E` A . . . Ep A TAMSULOSIN d04121A Cr N40 Enlarged prostate A E A . . . E A 99999 . . A E A . . . E A ALBUTEROL d00749A B J45 Asthma A0 E A FLUTICASONE d01296A Ap R06.2 Wheezing A0 E A LORATADINE d03050A Ap R06.2 Wheezing A0 E A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified A E A NAPROXEN d00019A A 55555 A E A . . . E A . . . E A . . . E A . . . E A LORATADINE d03050A CDp T78.40 Allergy, unspecified A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A E A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A PIOGLITAZONE d04442A CDp E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A SOLIFENACIN d05413A C N39.4 Other specified urinary incontinence A E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A R52 Pain, unspecified A@ E A IBUPROFEN d00015A A T14.9 Unspecified injury A@ E A PHENAZOPYRIDINE d00337A A R30 Pain associated with micturition A@ E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N39.0 Urinary tract infection, site not specified A@ E A . . . E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 E A DEXLANSOPRAZOLE d07395A B K21 Gastro-esophageal reflux disease A0 E A DOXYCYCLINE d00037A Ap L71 Rosacea A0 E A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A Cr I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A ALBUTEROL d00749A Cr J45 Asthma A E` A BECLOMETHASONE d00760A Cr J45 Asthma A Ep A . . . E A . . . E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A CITALOPRAM d04332A B F41.9 Anxiety disorder, unspecified A E A CLONAZEPAM d00197A C G47.0 Insomnia A E A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A E A LEVOTHYROXINE d00278A C- E04.1 Nontoxic single thyroid nodule A E A MELOXICAM d04532A C- M06.9 Rheumatoid arthritis, unspecified A E A METFORMIN; SAXAGLIPTIN d07709A C R73.9 Hyperglycemia, unspecified A E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A@ E A LINAGLIPTIN; METFORMIN d07825A B E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A@ E A VILAZODONE d07740A B F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A CLINDAMYCIN d00043A AP N39.0 Urinary tract infection, site not specified A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 Ep A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 Ep A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 E A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B[ I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ACETAMINOPHEN; HYDROCODONE d03428A B M25.51 M54.2 Pain in shoulder Cervicalgia A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A AZELASTINE NASAL d04068A C- J30.9 Allergic rhinitis, unspecified A E A CYCLOBENZAPRINE d00963A B= M62.83 Muscle spasm A E A DARIFENACIN d05422A Cr N39.4 Other specified urinary incontinence A E A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A C Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E A LEVOCETIRIZINE d05851A C- T78.40 Allergy, unspecified A E A MELOXICAM d04532A B[ M79.2 Neuralgia and neuritis, unspecified A E A OMEPRAZOLE d00325A B R12 Heartburn A E A TERBINAFINE d04012A B= B35.9 Dermatophytosis, unspecified A E A . . . E A ONDANSETRON d00867A Bz R11 Nausea and vomiting A E A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A VENLAFAXINE d03181A C- M79.2 Neuralgia and neuritis, unspecified A E0 A ALENDRONATE d03849A Bz M81 Osteoporosis without current pathological fracture A E0 A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E0 A CLOPIDOGREL d04258A C I99.9 Unspecified disorder of circulatory system A E0 A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E0 A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E@ A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E@ A HYDRALAZINE d00132A C I50.9 Heart failure, unspecified A E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A E@ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E@ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A EP A . . . E` A . . . Ep A SUMATRIPTAN d03160A0 Cr G43 Migraine A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C"0 M13 M54.9 M79.1 Other arthritis Dorsalgia, unspecified Myalgia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A0 Cr E78.0 Pure hypercholesterolemia A` E A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A` E A FUROSEMIDE d00070A0 Cr R60.9 Edema, unspecified A` E A METFORMIN d03807A0 Cr E11 Type 2 diabetes mellitus A` E A OMEPRAZOLE d00325A0 Cr K21 Gastro-esophageal reflux disease A` E 0 A . . . E @ A CLOPIDOGREL d04258A Dc Z79.02 Long term (current) use of antithrombotics/antiplatelets Ap E @ A ESCITALOPRAM d04812A Bz F41.9 Anxiety disorder, unspecified Ap E @ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap E @ A INSULIN GLULISINE d05278A C- E11 Type 2 diabetes mellitus Ap E @ A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E @ A METOPROLOL d00134A C 99999 Ap E @ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A GRISEOFULVIN d00100A B= B35.9 Dermatophytosis, unspecified A E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A PENICILLIN d00116A Ap K08.4 Partial loss of teeth A E P A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B= R51 Headache AP E P A ACETAMINOPHEN; OXYCODONE d03431A B= T14.9 Unspecified injury AP E P A CLONIDINE d00044A B N95.1 Menopausal and female climacteric states AP E P A METHOCARBAMOL d00965A CDp M62.83 Muscle spasm AP E P A PROMETHAZINE d00787A C[@ R11 Nausea and vomiting AP E ` A . . . E p A . . . E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A FENOFIBRATE d04286A D I21.P Prevent heart attack/myocardial infarction AP E A LISINOPRIL d00732A D E11.2P Prevent diabetic kidney disease AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction AP E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E 0 A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A D* E78.0 Pure hypercholesterolemia A E 0 A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A D1 I51.9 Heart disease, unspecified A E @ A ACETAMINOPHEN; HYDROCODONE d03428A CDp M13 M79.2 T14.9 Other arthritis Neuralgia and neuritis, unspecified Unspecified injury A E @ A TIZANIDINE d04102A C M62.83 Muscle spasm A E P A ARIPIPRAZOLE d04825A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E P A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A@ E P A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A@ E P A TOPIRAMATE d04115A C F32.9 Major depressive disorder, single episode, unspecified A@ E ` A ALBUTEROL d00749A0 Ei J45 R06.2 Asthma Wheezing A E ` A ARIPIPRAZOLE d04825A0 Ei F20 Schizophrenia A E ` A CICLOPIROX TOPICAL d01272A0 Ei B35.1 Tinea unguium A E ` A EZETIMIBE d04824A0 Ei I10 Essential (primary) hypertension A E ` A FLUPHENAZINE d00237A0 Ei F20 Schizophrenia A E ` A FLUTICASONE; SALMETEROL d04611A0 Ei J45 R06.2 Asthma Wheezing A E ` A LINAGLIPTIN d07767A0 Ei E11 Type 2 diabetes mellitus A E ` A METFORMIN d03807A0 Ei E11 Type 2 diabetes mellitus A E p A . . . E A . . . E A TRAMADOL d03826A A@ G89.18 Other acute postprocedural pain A E A . . . E A . . . E A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A E A ALPRAZOLAM d00168A0 CDp F32.9 Major depressive disorder, single episode, unspecified AP E A CLOBETASOL TOPICAL d01288A0 B L64 Androgenic alopecia AP E A DILTIAZEM d00045A0 Cr I10 Essential (primary) hypertension AP E A DOXYCYCLINE d00037A0 B J01.9 L64 Acute sinusitis, unspecified Androgenic alopecia AP E A SERTRALINE d00880A0 CDp F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders A E A DEXTROAMPHETAMINE d00804A C F90 Attention-deficit hyperactivity disorders A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A RALOXIFENE d04261A C- M81.P Prevent bone loss/osteoporosis A E A LANSOPRAZOLE d03828A CDp K21 Gastro-esophageal reflux disease A E A ZOLPIDEM d00910A C- G47.0 Insomnia A E A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A0 E A VENLAFAXINE d03181A B F32.9 Major depressive disorder, single episode, unspecified A0 E A ZOLPIDEM d00910A B G47.0 Insomnia A0 E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B[ R51 Headache A E A . . . E A . . . E A . . . E A . . . E A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A@ E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A CDp E78.0 Pure hypercholesterolemia A@ E A . . . E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E 0 A ALBUTEROL; IPRATROPIUM d04066A0 Ei R06.2 Wheezing A E 0 A FINASTERIDE d00563A0 C- N40 Enlarged prostate A E 0 A HYDROCHLOROTHIAZIDE d00253A0 Ei I10 R60.9 Essential (primary) hypertension Edema, unspecified A E 0 A LISINOPRIL d00732A0 Ei I10 Essential (primary) hypertension A E 0 A LORATADINE d03050A0 Ei T78.40 Allergy, unspecified A E 0 A METOPROLOL d00134A0 Ei I10 Essential (primary) hypertension A E 0 A MOMETASONE d05262A0 Ei J44.9 Chronic obstructive pulmonary disease, unspecified A E 0 A NITROGLYCERIN d00321A0 Ei R07.9 Chest pain, unspecified A E 0 A OMEPRAZOLE d00325A0 C- K21 Gastro-esophageal reflux disease A E 0 A SALMETEROL d03759A0 Ei J44.9 Chronic obstructive pulmonary disease, unspecified A E 0 A SIMVASTATIN d00746A0 Ei E78.0 Pure hypercholesterolemia A E 0 A TERAZOSIN d00386A0 Ei R39.15 Urgency of urination A E @ A GLIPIZIDE d00246A C R73 Elevated blood glucose level A0 E @ A IBUPROFEN d00015A B[ M79.2 Neuralgia and neuritis, unspecified A0 E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E P A . . . E ` A . . . E p A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A Dc 99999 A` E A DULOXETINE d05355A Dc F41.9 Anxiety disorder, unspecified A` E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A` E A SOLIFENACIN d05413A B= N39.4 Other specified urinary incontinence A` E A VERAPAMIL d00048A Dc I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A TAMOXIFEN d00381A CO C50 Malignant neoplasm of breast A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension AP E A CLOPIDOGREL d04258A C- I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E! A ACETAMINOPHEN; HYDROCODONE d03428A B[ M54.9 Dorsalgia, unspecified A E! A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A E! A . . . E! A . . . E!0 A RANITIDINE d00021A B[ K30 Functional dyspepsia A E!@ A . . . E!P A . . . E!` A . . . E!p A . . . E! A . . . E! A . . . E! A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E! A ATENOLOL d00004A C I49.9 Cardiac arrhythmia, unspecified A@ E! A CIPROFLOXACIN d00011A A@ N39.0 Urinary tract infection, site not specified A@ E! A ROPINIROLE d04215A C G25.81 Restless legs syndrome A@ E! A TEMAZEPAM d00384A A G47.9 Sleep disorder, unspecified A@ E! A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A E! A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E! A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E! A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E! A MOMETASONE NASAL d04223A B J30.9 Allergic rhinitis, unspecified A E! A MONTELUKAST d04289A C T78.40 Allergy, unspecified A E! A OXYBUTYNIN d00328A CDp N32.81 Overactive bladder A E! A PRAMIPEXOLE d04145A C- G20 Parkinson's disease A E! A TIZANIDINE d04102A C- G47.9 Sleep disorder, unspecified A E! A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E! A . . . E! A . . . E" A . . . E" A . . . E" A ALISKIREN; HYDROCHLOROTHIAZIDE d07077A Cr I10 Essential (primary) hypertension AP E" A AMLODIPINE; VALSARTAN d06662A Cr I10 Essential (primary) hypertension AP E" A FUROSEMIDE d00070A CDp I51.9 R60.9 Heart disease, unspecified Edema, unspecified AP E" A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension AP E" A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP E"0 A . . . E"@ A . . . E"P A . . . E"` A . . . E"p A . . . E" A . . . E" A . . . E" A . . . E" A . . . E" A CICLESONIDE d05465A C"0 J45 Asthma A E" A TIOTROPIUM d04829A C"0 J45 Asthma A E" A . . . E" A . . . E" A . . . E# A . . . E# A RANITIDINE d00021A B= R10.83 Colic A E# A ALCAFTADINE OPHTHALMIC d07670A C T78.40 Allergy, unspecified A E# A CLOPIDOGREL d04258A C[@ I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E# A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E# A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus A E# A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E# A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E# A TRAVOPROST OPHTHALMIC d04753A C H40 Glaucoma A E# A VALSARTAN d04113A C[@ I10 Essential (primary) hypertension A E#0 A . . . E#@ A FLUTICASONE d01296A CP J45 Asthma A E#P A . . . E#` A . . . E#p A . . . E# A ADALIMUMAB d04835A C- L40 Psoriasis A0 E# A CALCIPOTRIENE TOPICAL d03788A C L40 Psoriasis A0 E# A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E# A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E# A . . . E# A . . . E# A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E# A . . . E# A . . . E# A RANITIDINE d00021A Cr K30 Functional dyspepsia A E$ A . . . E$ A MINOCYCLINE d00110A A L70 Acne A E$ A TRETINOIN TOPICAL d01244A A L70 Acne A E$ A . . . E$0 A . . . E$@ A CETIRIZINE d03827A D* T78.40 Allergy, unspecified A@ E$@ A HYDROCODONE d03075A C M25.5 Pain in joint A@ E$@ A MELOXICAM d04532A C- M79.1 Myalgia A@ E$@ A TIZANIDINE d04102A Cr M79.1 Myalgia A@ E$P A . . . E$` A . . . E$p A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E$ A 99999 . . A` E$ A ALBUTEROL d00749A C J45 R06.02 R07.89 Asthma Shortness of breath Other chest pain A` E$ A ALBUTEROL d00749A D* J45 Asthma A` E$ A BECLOMETHASONE d00760A D* J45 Asthma A` E$ A BUDESONIDE; FORMOTEROL d04795A B[ J45 Asthma A` E$ A NITROGLYCERIN d00321A B[ R07.9 Chest pain, unspecified A` E$ A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E$ A . . . E$ A LISINOPRIL d00732A C[@ I50.9 Heart failure, unspecified A0 E$ A METOPROLOL d00134A C[@ I51.9P Prevent heart disease A0 E$ A SIMVASTATIN d00746A C[@ I21.P Prevent heart attack/myocardial infarction A0 E$ A . . . E$ A APIXABAN d07804A A Z79.02 Long term (current) use of antithrombotics/antiplatelets A E$ A METOPROLOL d00134A C ` I48.91 Unspecified atrial fibrillation A E$ A . . . E$ A . . . E% A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A E% A ANTI-INFECTIVES - UNSPECIFIED c00001A AP J00 Acute nasopharyngitis [common cold] A E% A . . . E%0 A . . . E%@ A . . . E%P A 99999 . . A0 E%P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E%P A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E%` A . . . E%p A . . . E% A HYDROCODONE d03075A A K08.8 Other specified disorders of teeth and supporting structures A E% A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A` E% A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A` E% A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A` E% A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension A` E% A LANSOPRAZOLE d03828A0 CDp K21 Gastro-esophageal reflux disease A` E% A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E% A . . . E% A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E% A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C[@ E11 Type 2 diabetes mellitus A E% A . . . E% A . . . E% A . . . E% A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A@ E% A ESCITALOPRAM d04812A CDp F41.9 Anxiety disorder, unspecified A@ E% A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A@ E% A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E& A ISOTRETINOIN d01245A B L70 Acne A E& A . . . E& A . . . E&0 A . . . E&@ A . . . E&P A ALPRAZOLAM d00168A Cr G47.0 Insomnia A@ E&P A CYCLOBENZAPRINE d00963A C M54.9 Dorsalgia, unspecified A@ E&P A DESOGESTREL; ETHINYL ESTRADIOL d03782A C Z79.3 Long term (current) use of hormonal contraceptives A@ E&P A FLUVOXAMINE d03804A B F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A@ E&` A . . . E&p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E&p A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A E& A ESTRADIOL d00537A C[@ Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E& A 99999 . . A E& A . . . E& A . . . E& A . . . E& A COLESTIPOL d00744A Cr E78.0 Pure hypercholesterolemia A@ E& A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E& A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A@ E& A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A@ E& A CLOPIDOGREL d04258A B Z95.9 Presence of cardiac and vascular implant and graft, unspecified AP E& A FINASTERIDE d00563A C"0 N40 Enlarged prostate AP E& A METOPROLOL d00134A C I48.91 Unspecified atrial fibrillation AP E& A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E& A TAMSULOSIN d04121A C N40 Enlarged prostate AP E& A CETIRIZINE d03827A B L20.9 Atopic dermatitis, unspecified A0 E& A DIPHENHYDRAMINE d00212A C L29.9 Pruritus, unspecified A0 E& A HYDROXYZINE d00907A B L29.9 Pruritus, unspecified A0 E' A . . . E' A . . . E' A . . . E'0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E'@ A . . . E'P A . . . E'` A . . . E'p A ALBUTEROL d00749A C J45 Asthma A E'p A BUDESONIDE d04276A C J45 Asthma A E' A . . . E' A . . . E' A . . . E' A . . . E' A . . . E' A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A E' A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E' A CONJUGATED ESTROGENS d00541A D Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A@ E' A PROPRANOLOL d00032A C G43 Migraine A@ E' A SUMATRIPTAN d03160A C G43 Migraine A@ E' A . . . E( A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A B E78.0 Pure hypercholesterolemia A0 E( A GLIMEPIRIDE d03864A B 99999 A0 E( A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E( A . . . E( A ESCITALOPRAM d04812A A F32.9 Major depressive disorder, single episode, unspecified A@ E( A METFORMIN d03807A A E34.9 Endocrine disorder, unspecified A@ E( A RAMIPRIL d00728A A I10 Essential (primary) hypertension A@ E( A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E(0 A . . . E(@ A AMLODIPINE d00689A C G43.P Prevent migraine A E(P A AMLODIPINE d00689A CDp I51.9 Heart disease, unspecified A0 E(P A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A0 E(P A SIMVASTATIN d00746A C E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A0 E(` A AMLODIPINE d00689A A0 I10 Essential (primary) hypertension A E(` A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E(p A . . . E( A . . . E( A . . . E( A LISINOPRIL d00732A0 C I21.P Prevent heart attack/myocardial infarction A@ E( A LOVASTATIN d00280A0 C E78.0 Pure hypercholesterolemia A@ E( A METOPROLOL d00134A0 Cr I10 Essential (primary) hypertension A@ E( A NIFEDIPINE d00051A0 C I10 Essential (primary) hypertension A@ E( A . . . E( A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A E( A ISOSORBIDE d00653A D I10 Essential (primary) hypertension A E( A LANSOPRAZOLE d03828A D K30 Functional dyspepsia A E( A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E( A METOPROLOL d00134A D I10 Essential (primary) hypertension A E( A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A E( A RANOLAZINE d05719A D I20.9 Angina pectoris, unspecified A E( A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E( A . . . E( A . . . E( A . . . E) A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E) A METOPROLOL d00134A CDp I48.91 Unspecified atrial fibrillation AP E) A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E) A RALOXIFENE d04261A C M81 Osteoporosis without current pathological fracture AP E) A VALSARTAN d04113A D I10 Essential (primary) hypertension AP E) A DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE d07697A C- Z79.3 Long term (current) use of hormonal contraceptives A E) A DEXTROMETHORPHAN; PROMETHAZINE d03360A A R05 Cough A E)0 A HYDROXYCHLOROQUINE d00817A C L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified Ap E)0 A METHOTREXATE d00060A C L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified Ap E)0 A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease Ap E)0 A PHENOBARBITAL d00340A DC G40 Epilepsy and recurrent seizures Ap E)0 A PHENYTOIN d00143A DC G40 Epilepsy and recurrent seizures Ap E)0 A PROPRANOLOL d00032A D# I10 Essential (primary) hypertension Ap E)0 A RAMIPRIL d00728A D# I10 Essential (primary) hypertension Ap E)@ A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified Ap E)@ A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots Ap E)@ A DIGOXIN d00210A Cr I50.9 Heart failure, unspecified Ap E)@ A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified Ap E)@ A LISINOPRIL d00732A Cr I21.P Prevent heart attack/myocardial infarction Ap E)@ A POTASSIUM CHLORIDE d00345A Cr I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap E)@ A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap E)P A . . . E)` A AMLODIPINE; ATORVASTATIN d05048A C E78.0 Pure hypercholesterolemia A E)p A . . . E) A LANSOPRAZOLE d03828A B= K30 Functional dyspepsia A E) A . . . E) A . . . E) A . . . E) A . . . E) A . . . E) A . . . E) A . . . E* A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E* A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E* A ALBUTEROL d00749A C- J45 Asthma A E* A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A E* A . . . E*0 A ALBUTEROL d00749A D J45 Asthma A E*0 A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E*@ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A0 E*@ A TAMSULOSIN d04121A B R35.0 Frequency of micturition A0 E*@ A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A0 E*P A SIMVASTATIN d00746A C N28.9 Disorder of kidney and ureter, unspecified A E*P A VALSARTAN d04113A C N28.9 Disorder of kidney and ureter, unspecified A E*` A . . . E*p A ALBUTEROL d00749A C- J45 Asthma A E*p A BECLOMETHASONE d00760A C- J45 Asthma A E* A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E* A FINASTERIDE d00563A B= N39.4 Other specified urinary incontinence A0 E* A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E* A PANTOPRAZOLE d04514A C[@ K92.2 Gastrointestinal hemorrhage, unspecified A0 E* A ALBUTEROL d00749A C R06.2 Wheezing A E* A BECLOMETHASONE d00760A C R06.2 Wheezing A E* A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E* A VARENICLINE d05807A BZ F17.203 Nicotine dependence unspecified, with withdrawal A E* A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E* A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E* A . . . E* A . . . E+ A FLUTICASONE d01296A B J44.9 Chronic obstructive pulmonary disease, unspecified A0 E+ A OXYCODONE d00329A C- M54.9 Dorsalgia, unspecified A0 E+ A PREDNISOLONE OPHTHALMIC d03221A C- Z48.810 Encounter for surgical aftercare following surgery on the sense organs A0 E+ A . . . E+ A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A@ E+ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E+ A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A@ E+ A TEMAZEPAM d00384A B G47.0 Insomnia A@ E+0 A . . . E+@ A ACETAMINOPHEN; CODEINE d03423A C[@ G43 M13 Migraine Other arthritis A0 E+@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E+@ A POTASSIUM CHLORIDE d00345A C[@ 99999 A0 E+P A . . . E+` A . . . E+p A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E+p A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A` E+p A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E+p A METOPROLOL d00134A C- I10 Essential (primary) hypertension A` E+p A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E+p A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E+ A ACETAMINOPHEN; OXYCODONE d03431A C M54.9 Dorsalgia, unspecified Ap E+ A FENOFIBRATE d04286A0 C- E78.0 Pure hypercholesterolemia Ap E+ A GLIMEPIRIDE d03864A0 C E11 Type 2 diabetes mellitus Ap E+ A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension Ap E+ A MELOXICAM d04532A0 B M19.9 Osteoarthritis, unspecified site Ap E+ A METFORMIN d03807A0 B E11 Type 2 diabetes mellitus Ap E+ A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia Ap E+ A ALBUTEROL d00749A B J45 Asthma A E+ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E+ A AMLODIPINE d00689A C 99999 AP E+ A DIGOXIN d00210A C I48.91 Unspecified atrial fibrillation AP E+ A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified AP E+ A RAMIPRIL d00728A C I10 Essential (primary) hypertension AP E+ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E+ A ONDANSETRON d00867A B R11 Nausea and vomiting A E+ A . . . E+ A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E+ A . . . E, A . . . E, A ACETAMINOPHEN; HYDROCODONE d03428A C M54.9 Dorsalgia, unspecified A E, A ALBUTEROL d00749A B J45 Asthma A E, A AMLODIPINE d00689A Bz 99999 A E, A BUDESONIDE; FORMOTEROL d04795A D J45 Asthma A E, A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E, A CELECOXIB d04380A C- K27 Peptic ulcer, site unspecified A E, A DEXLANSOPRAZOLE d07395A C R12 Heartburn A E, A NITROFURANTOIN d00112A A N12 Tubulo-interstitial nephritis, not specified as acute or chronic A E, A . . . E,0 A . . . E,@ A . . . E,P A ACETAMINOPHEN; HYDROCODONE d03428A D R52 Pain, unspecified AP E,P A CITALOPRAM d04332A C F41.9 F42 Anxiety disorder, unspecified Obsessive-compulsive disorder AP E,P A FEBUXOSTAT d07397A B M1A Chronic gout AP E,P A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E,P A OXYCODONE d00329A C- M25.56 Pain in knee AP E,` A DIVALPROEX SODIUM d03833A Cr F39 Unspecified mood [affective] disorder A0 E,` A FLUOXETINE d00236A Cr F41.9 Anxiety disorder, unspecified A0 E,` A RANITIDINE d00021A C K30 Functional dyspepsia A0 E,p A . . . E, A . . . E, A . . . E, A 99999 . . A E, A OXCARBAZEPINE d04513A C G50.0 Trigeminal neuralgia A E, A CYCLOBENZAPRINE d00963A B[ M79.1 Myalgia A E, A HYDROCHLOROTHIAZIDE d00253A C[@ E87.1 Hypo-osmolality and hyponatremia A E, A . . . E, A . . . E- A LOTEPREDNOL OPHTHALMIC d04292A A H57.8 Other specified disorders of eye and adnexa A E- A . . . E- A FAMOTIDINE d00141A B[ K21 Gastro-esophageal reflux disease A0 E- A MEPROBAMATE d00288A D= F41.9 Anxiety disorder, unspecified A0 E- A NITRAZEPAM a56545A D= G47.0 Insomnia A0 E-0 A . . . E-@ A . . . E-P A . . . E-` A . . . E-p A . . . E- A . . . E- A . . . E- A CONJUGATED ESTROGENS d00541A D= Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E- A ALLOPURINOL d00023A C M1A Chronic gout A E- A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E- A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E- A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A E- A CARVEDILOL d03847A C H40 Glaucoma A E- A ENALAPRIL d00013A CDp I50.9 Heart failure, unspecified A E- A FUROSEMIDE d00070A C[@ I10 Essential (primary) hypertension A E- A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A E- A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E- A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E- A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E- A TIMOLOL d00139A C I50.9 Heart failure, unspecified A E- A WARFARIN d00022A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E- A . . . E- A . . . E- A . . . E- A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E- A CLOPIDOGREL d04258A C- 99999 A E- A DOXYCYCLINE d00037A B 99999 A E- A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B 99999 A E- A MECLIZINE d00859A Cr R42 Dizziness and giddiness A E- A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E- A SITAGLIPTIN d05896A B 99999 A E- A SUCRALFATE d00377A B R10.9 Unspecified abdominal pain A E. A . . . E. A ACETAMINOPHEN; HYDROCODONE d03428A Cr M79.1 Myalgia A0 E. A CELECOXIB d04380A Ei M13 Other arthritis A0 E. A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= I10 Essential (primary) hypertension A0 E. A . . . E.0 A . . . E.@ A . . . E.P A . . . E.` A . . . E.p A CETIRIZINE d03827A A T78.40 Allergy, unspecified A E. A . . . E. A PROGESTERONE d00550A CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E. A . . . E. A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E. A MONTELUKAST d04289A C R05 Cough A E. A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E. A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E. A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ E. A TRAZODONE d00395A B G47.0 Insomnia A@ E. A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A0 E. A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A0 E. A LEVOCETIRIZINE d05851A C- J30.9 Allergic rhinitis, unspecified A0 E. A . . . E. A OXYCODONE d00329A CDp M79.2 Neuralgia and neuritis, unspecified A E. A TRAZODONE d00395A B[ F41.9 Anxiety disorder, unspecified A E/ A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A E/ A . . . E/ A BETAMETHASONE TOPICAL d03197A C L20.9 Atopic dermatitis, unspecified AP E/ A CROTAMITON TOPICAL d01280A C L29.9 Pruritus, unspecified AP E/ A DAPSONE d00098A B M06.9 Rheumatoid arthritis, unspecified AP E/ A LIDOCAINE; PRILOCAINE TOPICAL d03655A C 55555 AP E/ A PREDNISONE d00350A B= M06.9 Rheumatoid arthritis, unspecified AP E/0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E/0 A TERAZOSIN d00386A CDp I10 Essential (primary) hypertension A E/@ A . . . E/P A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E/P A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension AP E/P A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E/P A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia AP E/P A ZOLPIDEM d00910A B G47.0 Insomnia AP E/` A ESTRADIOL; NORETHINDRONE d04375A B N95.1 Menopausal and female climacteric states A E/p A . . . E/ A . . . E/ A . . . E/ A . . . E/ A . . . E/ A . . . E/ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A0 E/ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E/ A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A0 E/ A . . . E/ A . . . E0 A . . . E0 A . . . E0 A . . . E00 A . . . E0@ A . . . E0P A ALBUTEROL d00749A C J45 Asthma A0 E0P A ALBUTEROL d00749A Cr J45 Asthma A0 E0P A FLUTICASONE d01296A C J45 Asthma A0 E0` A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A E0p A . . . E0 A . . . E0 A . . . E0 A ALLOPURINOL d00023A C[@ M1A Chronic gout A E0 A AMLODIPINE; VALSARTAN d06662A C[@ I10 Essential (primary) hypertension A E0 A ATORVASTATIN d04105A C[@ I63.P Prevent stroke A E0 A CITALOPRAM d04332A C[@ F41.9 Anxiety disorder, unspecified A E0 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E0 A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E0 A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A E0 A PRAZOSIN d00138A C[@ N40 Enlarged prostate A E0 A TRAMADOL d03826A C[@ M13 Other arthritis A E0 A . . . E0 A . . . E0 A . . . E0 A ACETAMINOPHEN; BUTALBITAL d03456A C- G43 Migraine A@ E0 A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 M79.7 Dorsalgia, unspecified Fibromyalgia A@ E0 A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A@ E0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E0 A 77777 . . A E1 A . . . E1 A AMPICILLIN d00003A A N12 Tubulo-interstitial nephritis, not specified as acute or chronic A` E1 A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` E1 A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A` E1 A LISINOPRIL d00732A C- E11 Type 2 diabetes mellitus A` E1 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E1 A RANITIDINE d00021A B K30 Functional dyspepsia A` E1 A . . . E10 A CARBAMAZEPINE d00058A Cr R56.9 Unspecified convulsions A0 E10 A HYDROXYZINE d00907A C L23 Allergic contact dermatitis A0 E10 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E1@ A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A` E1@ A FLUTICASONE; SALMETEROL d04611A Cr R06.2 Wheezing A` E1@ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E1@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E1@ A OMEPRAZOLE d00325A Cr R12 Heartburn A` E1@ A RALOXIFENE d04261A Cr M81 Osteoporosis without current pathological fracture A` E1P A . . . E1` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E1p A . . . E1 A ESTRADIOL d00537A Dc Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A E1 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E1 A . . . E1 A . . . E1 A . . . E1 A . . . E1 A . . . E1 A . . . E1 A ACETAMINOPHEN; OXYCODONE d03431A Cr M54.2 M54.9 T14.9 Cervicalgia Dorsalgia, unspecified Unspecified injury A` E1 A DIAZEPAM d00148A B M62.83 Muscle spasm A` E1 A DICLOFENAC TOPICAL d04722A C[@ M54.2 M79.606 Cervicalgia Pain in leg, unspecified A` E1 A METHADONE d00050A C[@ M25.56 M54.2 M54.9 Pain in knee Cervicalgia Dorsalgia, unspecified A` E1 A PROMETHAZINE d00787A Bz R11 Nausea and vomiting A` E1 A WARFARIN d00022A Bz I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` E2 A . . . E2 A . . . E2 A . . . E20 A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54.9 Dorsalgia, unspecified A E20 A AMITRIPTYLINE d00146A D# G47.0 Insomnia A E20 A AZELASTINE OPHTHALMIC d04541A C[@ T78.40 Allergy, unspecified A E20 A CYCLOBENZAPRINE d00963A Cr M54.9 Dorsalgia, unspecified A E20 A ESTRADIOL d00537A D# M81 Osteoporosis without current pathological fracture A E20 A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A E20 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 Essential (primary) hypertension A E20 A MEDROXYPROGESTERONE d00284A D# C54.P Prevent uterine cancer A E20 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E20 A PHENYTOIN d00143A D1 G40 Epilepsy and recurrent seizures A E20 A RIZATRIPTAN d04328A C G43 Migraine A E2@ A . . . E2P A . . . E2` A METHYLPREDNISOLONE d00293A Ap K04.7P Prevent tooth infection A0 E2` A OXYCODONE d00329A Ap K08.8 Other specified disorders of teeth and supporting structures A0 E2` A PENICILLIN V POTASSIUM d07730A Ap K08.4 Partial loss of teeth A0 E2p A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A@ E2p A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A@ E2p A RAMIPRIL d00728A C I21.P Prevent heart attack/myocardial infarction A@ E2p A SIMVASTATIN d00746A C I21.P Prevent heart attack/myocardial infarction A@ E2 A . . . E2 A . . . E2 A LORATADINE d03050A B R09.81 Nasal congestion A E2 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A D F90 Attention-deficit hyperactivity disorders A E2 A METHADONE d00050A Bz F11.23 Opioid dependence with withdrawal A E2 A . . . E2 A . . . E2 A . . . E2 A . . . E3 A . . . E3 A ACETAMINOPHEN; HYDROCODONE d03428A C M79.1 Myalgia Ap E3 A ATORVASTATIN d04105A C G47.9 Sleep disorder, unspecified Ap E3 A DULOXETINE d05355A C M79.2 Neuralgia and neuritis, unspecified Ap E3 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E3 A LISINOPRIL d00732A C 99999 Ap E3 A NEBIVOLOL d05265A B I10 Essential (primary) hypertension Ap E3 A PREGABALIN d05508A C R52 Pain, unspecified Ap E3 A . . . E30 A . . . E3@ A AMLODIPINE; BENAZEPRIL d03829A CDp I10 Essential (primary) hypertension A E3@ A IBUPROFEN d00015A B= M54.9 Dorsalgia, unspecified A E3P A ACETAMINOPHEN; HYDROCODONE d03428A0 B[ M19.9 Osteoarthritis, unspecified site B E3P A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension B E3P A BENAZEPRIL d00730A0 C I10 Essential (primary) hypertension B E3P A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A C B35.3 Tinea pedis B E3P A CARVEDILOL d03847A0 C I10 Essential (primary) hypertension B E3P A CLOPIDOGREL d04258A0 C Z79.02 Long term (current) use of antithrombotics/antiplatelets B E3P A DULOXETINE d05355A0 B[ F41.9 M19.90 M54.9 Anxiety disorder, unspecified Unspecified osteoarthritis, unspecified site Dorsalgia, unspecified B E3P A FUROSEMIDE d00070A0 C I10 Essential (primary) hypertension B E3P A GABAPENTIN d03182A0 B[ M25.5 Pain in joint B E3P A HYDRALAZINE d00132A0 C I10 Essential (primary) hypertension B E3P A IBUPROFEN d00015A0 C M19.9 Osteoarthritis, unspecified site B E3P A ISOSORBIDE MONONITRATE d00269A0 B I20.9 Angina pectoris, unspecified B E3P A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma B E3P A LOVASTATIN d00280A0 C E78.0 Pure hypercholesterolemia B E3P A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus B E3P A MUPIROCIN TOPICAL d01267A0 B L03.90 Cellulitis, unspecified B E3P A NITROGLYCERIN d00321A0 CDp I20.9 Angina pectoris, unspecified B E3P A TRAMADOL d03826A0 C M19.9 Osteoarthritis, unspecified site B E3P A TRAZODONE d00395A0 C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified B E3` A . . . E3p A . . . E3 A . . . E3 A . . . E3 A . . . E3 A . . . E3 A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E3 A ABIRATERONE d07766A CDp C41.9 C61 Malignant neoplasm of bone and articular cartilage, unspecified Malignant neoplasm of prostate A` E3 A ALPRAZOLAM d00168A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E3 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E3 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A` E3 A PREDNISONE d00350A CDp C61 Malignant neoplasm of prostate A` E3 A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified A` E3 A . . . E3 A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E4 A . . . E4 A . . . E4 A . . . E40 A TRAMADOL d03826A Cr M54.9 Dorsalgia, unspecified A E4@ A . . . E4P A DUTASTERIDE d04788A C[@ N40 Enlarged prostate A E4` A . . . E4p A . . . E4 A . . . E4 A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A Ap H10 Conjunctivitis A E4 A . . . E4 A . . . E4 A . . . E4 A ASPIRIN; DIPYRIDAMOLE d04497A0 C Z79.02 Z95.0 Long term (current) use of antithrombotics/antiplatelets Presence of cardiac pacemaker A E4 A CARVEDILOL d03847A0 C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E4 A COLCHICINE d00150A0 C M1A Chronic gout A E4 A EZETIMIBE d04824A0 C E78.0 Pure hypercholesterolemia A E4 A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified A E4 A PROBENECID d00031A0 C M1A Chronic gout A E4 A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A E4 A TERAZOSIN d00386A0 C I10 N40 Essential (primary) hypertension Enlarged prostate A E4 A CARVEDILOL d03847A CDp I49.9 Cardiac arrhythmia, unspecified A` E4 A DIGOXIN d00210A CDp I10 Essential (primary) hypertension A` E4 A FUROSEMIDE d00070A B R60.9 Edema, unspecified A` E4 A RAMIPRIL d00728A CDp I10 Essential (primary) hypertension A` E4 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` E4 A SPIRONOLACTONE d00373A CDp R60.9 Edema, unspecified A` E4 A . . . E5 A . . . E5 A DULOXETINE d05355A CP F32.9 R52 Major depressive disorder, single episode, unspecified Pain, unspecified AP E5 A IBUPROFEN d00015A D G56.0 M54.2 Carpal tunnel syndrome Cervicalgia AP E5 A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia AP E5 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E5 A OMEPRAZOLE d00325A C- R12 Heartburn AP E5 A . . . E50 A 77777 . . A E5@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E5@ A METOPROLOL d00134A D* I10 Essential (primary) hypertension A@ E5@ A TRIAMTERENE d00396A C I10 Essential (primary) hypertension A@ E5@ A ZOLPIDEM d00910A C G47.0 Insomnia A@ E5P A GLIPIZIDE d00246A Dc R73 Elevated blood glucose level A E5P A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E5` A ALBUTEROL d00749A D J45 Asthma A E5p A . . . E5 A . . . E5 A . . . E5 A TERAZOSIN d00386A C- I10 N40 Essential (primary) hypertension Enlarged prostate A E5 A TRAMADOL d03826A B M25.56 Pain in knee A E5 A ALBUTEROL d00749A C J45 Asthma Ap E5 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia Ap E5 A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified Ap E5 A ESTRADIOL d00537A C- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels Ap E5 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension Ap E5 A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E5 A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia Ap E5 A . . . E5 A . . . E5 A . . . E5 A AMOXICILLIN d00088A A J18.9 Pneumonia, unspecified organism A E6 A . . . E6 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E6 A OMEPRAZOLE d00325A C K27 Peptic ulcer, site unspecified A@ E6 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E6 A WARFARIN d00022A C D75.9P Prevent blood clots A@ E6 A . . . E60 A . . . E6@ A . . . E6P A . . . E6` A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A E6` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E6p A IBUPROFEN d00015A Dc M06.9 Rheumatoid arthritis, unspecified A0 E6p A MEDROXYPROGESTERONE d00284A B N85.0 Endometrial hyperplasia A0 E6p A METRONIDAZOLE d00108A B N76.0 Acute vaginitis A0 E6 A . . . E6 A . . . E6 A LAMOTRIGINE d03809A D* G40 Epilepsy and recurrent seizures A E6 A PRIMIDONE d00352A D* G40 Epilepsy and recurrent seizures A E6 A ONDANSETRON d00867A B[ R11 Nausea and vomiting A E6 A . . . E6 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ Z79.3 Long term (current) use of hormonal contraceptives A E6 A . . . E6 A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A0 E6 A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 E6 A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A0 E7 A . . . E7 A ALBUTEROL d00749A C- J45 Asthma A0 E7 A FLUTICASONE d01296A C- J45 Asthma A0 E7 A MONTELUKAST d04289A CDp R06.2 Wheezing A0 E7 A ALFUZOSIN d04797A B R35.0 Frequency of micturition Ap E7 A DULOXETINE d05355A CDp M79.2 Neuralgia and neuritis, unspecified Ap E7 A ESZOPICLONE d05421A C[@ G47.9 Sleep disorder, unspecified Ap E7 A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus Ap E7 A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap E7 A ROPINIROLE d04215A B* G25.81 M62.83 Restless legs syndrome Muscle spasm Ap E7 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E70 A . . . E7@ A . . . E7P A . . . E7` A . . . E7p A . . . E7 A . . . E7 A . . . E7 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A0 CDp I10 Essential (primary) hypertension A0 E7 A INSULIN ISOPHANE (NPH) d04370A0 C R73 Elevated blood glucose level A0 E7 A METFORMIN d03807A0 C[@ R73 Elevated blood glucose level A0 E7 A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E7 A ZOLPIDEM d00910A Cr G47.0 Insomnia A E7 A . . . E7 A . . . E7 A CANAGLIFLOZIN d08080A B E11 Type 2 diabetes mellitus A E7 A LIRAGLUTIDE d07466A B* E11 Type 2 diabetes mellitus A E7 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E7 A ESOMEPRAZOLE d04749A CDp R10.9 Unspecified abdominal pain A0 E7 A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E8 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E8 A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E8 A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E8 A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified A E8 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E8 A METHYLDOPA d00133A D I10 Essential (primary) hypertension A E8 A METOPROLOL d00134A C I10 Essential (primary) hypertension A E8 A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A E8 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E8 A VERAPAMIL d00048A D I10 Essential (primary) hypertension A E8 A . . . E8 A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ E8 A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E8 A LORATADINE d03050A C J45 Asthma A@ E8 A MONTELUKAST d04289A C J45 Asthma A@ E80 A . . . E8@ A AMLODIPINE; VALSARTAN d06662A C"0 Z95.0 Presence of cardiac pacemaker A@ E8@ A FLUDROCORTISONE d00608A D E27.9 Disorder of adrenal gland, unspecified A@ E8@ A HYDROCORTISONE d00254A D E27.9 Disorder of adrenal gland, unspecified A@ E8@ A PRAVASTATIN d00348A C E27.9 Z90.5 Disorder of adrenal gland, unspecified Acquired absence of kidney A@ E8P A . . . E8` A CLONIDINE d00044A C- I10 Essential (primary) hypertension A0 E8` A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E8` A PIOGLITAZONE d04442A CDp E11 Type 2 diabetes mellitus A0 E8p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E8 A . . . E8 A . . . E8 A . . . E8 A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 Dorsalgia, unspecified A` E8 A CELECOXIB d04380A C M54.9 Dorsalgia, unspecified A` E8 A LEVOTHYROXINE d00278A CDp E04.1 Nontoxic single thyroid nodule A` E8 A PREGABALIN d05508A C[@ M79.2 Neuralgia and neuritis, unspecified A` E8 A TIZANIDINE d04102A C[@ M79.1 Myalgia A` E8 A TRAMADOL d03826A C M25.51 M54.9 Pain in shoulder Dorsalgia, unspecified A` E8 A . . . E8 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E8 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E8 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ E8 A PRAVASTATIN d00348A B= E78.0 Pure hypercholesterolemia A@ E8 A . . . E8 A 77777 . . A E9 A BUPROPION d00181A Cr F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified AP E9 A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site AP E9 A DIVALPROEX SODIUM d03833A C F30 F31.9 F39 Manic episode Bipolar disorder, unspecified Unspecified mood [affective] disorder AP E9 A LAMOTRIGINE d03809A CDp F31.9 F39 Bipolar disorder, unspecified Unspecified mood [affective] disorder AP E9 A QUETIAPINE d04220A C F30 F31.9 G47.9 Manic episode Bipolar disorder, unspecified Sleep disorder, unspecified AP E9 A CLOBETASOL TOPICAL d01288A C L40 Psoriasis A@ E9 A DULOXETINE d05355A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E9 A LAMOTRIGINE d03809A B= F32.9 Major depressive disorder, single episode, unspecified A@ E9 A OLANZAPINE d04050A Bz F32.9 Major depressive disorder, single episode, unspecified A@ E9 A . . . E90 A . . . E9@ A . . . E9P A . . . E9` A ALBUTEROL d00749A C- J45 Asthma A@ E9` A FEXOFENADINE d04040A C J30.9 Allergic rhinitis, unspecified A@ E9` A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E9` A TRAMADOL d03826A B[ M79.1 Myalgia A@ E9p A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E9p A OMEPRAZOLE d00325A Ap K21 Gastro-esophageal reflux disease A E9 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E9 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E9 A ESTRADIOL TOPICAL d04210A C 55555 A@ E9 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E9 A PROGESTERONE d00550A C 55555 A@ E9 A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A@ E9 A . . . E9 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E9 A FLUTICASONE; SALMETEROL d04611A C- J45 Asthma A@ E9 A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A@ E9 A TRIAMCINOLONE TOPICAL d03206A Ap L20.9 Atopic dermatitis, unspecified A@ E9 A . . . E9 A . . . E9 A . . . E: A . . . E: A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E: A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E: A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E: A MONTELUKAST d04289A C I10 Essential (primary) hypertension AP E: A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E: A AZELASTINE OPHTHALMIC d04541A C H10.1 Acute atopic conjunctivitis A E: A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma A E: A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A E: A FLUVOXAMINE d03804A Cr F42 Obsessive-compulsive disorder A E: A LORATADINE d03050A C T78.40 Allergy, unspecified A E: A LUBIPROSTONE d05736A C K59.0 Constipation A E: A OFLOXACIN OTIC d04265A C H93.9 Unspecified disorder of ear A E: A OLOPATADINE OPHTHALMIC d04117A C- H10.1 Acute atopic conjunctivitis A E: A PREGABALIN d05508A Cr M79.2 Neuralgia and neuritis, unspecified A E: A PROMETHAZINE d00787A C R11 Nausea and vomiting A E: A SUMATRIPTAN d03160A C- G43 Migraine A E: A SUMATRIPTAN d03160A Cr G43 Migraine A E:0 A . . . E:@ A . . . E:P A . . . E:` A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E:` A NITROGLYCERIN d00321A C[@ R07.9 Chest pain, unspecified AP E:` A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia AP E:` A RAMIPRIL d00728A C[@ I10 Essential (primary) hypertension AP E:` A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia AP E:p A BENAZEPRIL d00730A C- I10 Essential (primary) hypertension A@ E:p A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A@ E:p A FAMOTIDINE d00141A B K21 Gastro-esophageal reflux disease A@ E:p A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A@ E: A ACETAMINOPHEN; HYDROCODONE d03428A Dc M54.9 M79.2 Dorsalgia, unspecified Neuralgia and neuritis, unspecified AP E: A BACLOFEN d00967A B M62.83 Muscle spasm AP E: A CITALOPRAM d04332A B= F32.9 Major depressive disorder, single episode, unspecified AP E: A MELOXICAM d04532A B M62.83 Muscle spasm AP E: A RISPERIDONE d03180A B= F31.9 Bipolar disorder, unspecified AP E: A ATENOLOL d00004A D= I10 Essential (primary) hypertension A E: A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E: A . . . E: A AMLODIPINE d00689A C 99999 A E: A ATORVASTATIN d04105A B I63.P Prevent stroke A E: A DONEPEZIL d04099A C[@ R41.3 Other amnesia A E: A ESZOPICLONE d05421A A G47.0 Insomnia A E: A LISINOPRIL d00732A CDp 99999 A E: A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E: A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C 99999 A E: A RALOXIFENE d04261A C[@ 55555 A E: A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E: A LANSOPRAZOLE d03828A C F41.9 Anxiety disorder, unspecified A0 E: A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A0 E: A . . . E: A . . . E: A . . . E; A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A A49.02 Methicillin resistant Staphylococcus aureus infection, unspecified site A E; A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ N92 Excessive, frequent and irregular menstruation A E; A IBUPROFEN d00015A A N94.6 Dysmenorrhea, unspecified A E; A . . . E;0 A SERTRALINE d00880A A F41.9 Anxiety disorder, unspecified A E;@ A ACETAMINOPHEN; OXYCODONE d03431A B= M54.9 Dorsalgia, unspecified A E;@ A CARVEDILOL d03847A C9 I21.P I49.9 Prevent heart attack/myocardial infarction Cardiac arrhythmia, unspecified A E;@ A DABIGATRAN d07137A C D75.9P Prevent blood clots A E;@ A DIGOXIN d00210A C- I49.9 Cardiac arrhythmia, unspecified A E;@ A MECLIZINE d00859A B R42 Dizziness and giddiness A E;@ A NITROFURANTOIN d00112A C[@ N39.0 Urinary tract infection, site not specified A E;@ A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E;@ A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E;@ A SOLIFENACIN d05413A Bz N39.4 Other specified urinary incontinence A E;@ A TAMSULOSIN d04121A Cr 99999 A E;@ A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A E;@ A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A E;P A . . . E;` A . . . E;p A . . . E; A . . . E; A . . . E; A ACETAMINOPHEN; HYDROCODONE d03428A C M79.1 Myalgia A E; A ADALIMUMAB d04835A C[@ L40.5 Arthropathic psoriasis A E; A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E; A CLONIDINE d00044A C I10 Essential (primary) hypertension A E; A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E; A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E; A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E; A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A E; A METFORMIN d03807A C R73 Elevated blood glucose level A E; A METHOCARBAMOL d00965A C- M62.83 Muscle spasm A E; A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E; A PANTOPRAZOLE d04514A B= K27 Peptic ulcer, site unspecified A E; A . . . E; A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E; A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A0 E; A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A D I10 Essential (primary) hypertension A0 E; A . . . E; A . . . E; A ACETAMINOPHEN; HYDROCODONE d03428A C- Z96.65 Presence of artificial knee joint A` E; A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` E; A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A` E; A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A` E; A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E; A SERTRALINE d00880A DGJ F39 Unspecified mood [affective] disorder A` E< A . . . E< A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E< A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E< A ALBUTEROL d00749A C J45 Asthma AP E< A ALBUTEROL; IPRATROPIUM d04066A Bz J45 Asthma AP E< A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma AP E< A LORATADINE d03050A Bz L50 Urticaria AP E< A MONTELUKAST d04289A C J45 Asthma AP E<0 A . . . E<@ A . . . E
A . . . E> A AMPHETAMINE d00803A B= F90 Attention-deficit hyperactivity disorders A E> A . . . E>0 A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E>0 A ESOMEPRAZOLE d04749A0 C K21 Gastro-esophageal reflux disease A E>0 A INSULIN GLARGINE d04538A0 C E11 Type 2 diabetes mellitus A E>0 A INSULIN LISPRO d04373A0 C 99999 A E>0 A ISOSORBIDE MONONITRATE d00269A0 C 99999 A E>0 A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E>0 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E>0 A NORTRIPTYLINE d00144A0 C 99999 A E>0 A POTASSIUM CHLORIDE d00345A0 C 99999 A E>0 A SOTALOL d00371A0 C I49.9 Cardiac arrhythmia, unspecified A E>0 A TORSEMIDE d03189A0 C I10 Essential (primary) hypertension A E>@ A GUAIFENESIN; HYDROCODONE d03396A B= M54.9 Dorsalgia, unspecified A E>@ A TRAMADOL d03826A C M54.9 Dorsalgia, unspecified A E>P A ACETAMINOPHEN; HYDROCODONE d03428A B R51 Headache A E>P A SUMATRIPTAN d03160A B G43 Migraine A E>` A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia AP E>` A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension AP E>` A CIPROFLOXACIN d00011A C 99999 AP E>` A METOPROLOL d00134A C 99999 AP E>` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP E>p A . . . E> A OMEPRAZOLE d00325A D K21 R12 Gastro-esophageal reflux disease Heartburn A E> A . . . E> A AMOXICILLIN d00088A A J42 Unspecified chronic bronchitis A E> A . . . E> A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E> A . . . E> A . . . E> A . . . E? A HYDROCORTISONE TOPICAL d03205A C- L20.9 Atopic dermatitis, unspecified A E? A TRIAMCINOLONE TOPICAL d03206A C- L20.9 Atopic dermatitis, unspecified A E? A . . . E? A . . . E?0 A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A@ E?0 A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified A@ E?0 A MEPROBAMATE d00288A C F41.9 Anxiety disorder, unspecified A@ E?0 A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A@ E?@ A . . . E?P A . . . E?` A . . . E?p A . . . E? A GUANFACINE d00717A C- I10 Essential (primary) hypertension A E? A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E? A . . . E? A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E? A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E? A . . . E? A . . . E? A . . . E? A . . . E? A . . . E@ A . . . E@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E@ A NYSTATIN; TRIAMCINOLONE TOPICAL d03562A D L40 Psoriasis AP E@ A RANITIDINE d00021A Cr R12 Heartburn AP E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E@ A ANTI-INFECTIVES - UNSPECIFIED c00001A A0 R21 Rash and other nonspecific skin eruption A E@0 A . . . E@@ A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E@P A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E@P A CHLORPHENIRAMINE; HYDROCODONE d03356A Ap R05 Cough A E@` A . . . E@p A ACYCLOVIR d00001A C B00.1 Herpesviral vesicular dermatitis AP E@p A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified AP E@p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension AP E@p A HYDROCODONE d03075A B M25.55 M25.56 M54.9 Pain in hip Pain in knee Dorsalgia, unspecified AP E@p A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease AP E@ A CARVEDILOL d03847A0 C- I10 Essential (primary) hypertension AP E@ A EZETIMIBE d04824A0 Cr E78.0 Pure hypercholesterolemia AP E@ A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified AP E@ A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E@ A ROSUVASTATIN d04851A0 D E78.0 Pure hypercholesterolemia AP E@ A . . . E@ A . . . E@ A CEFUROXIME d00056A B* A69.2 Lyme disease A E@ A LEVOFLOXACIN d04109A C A44.9 Bartonellosis, unspecified A E@ A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction AP E@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E@ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease AP E@ A RIVAROXABAN d07356A C I48.91 Unspecified atrial fibrillation AP E@ A SOTALOL d00371A B I48.91 Unspecified atrial fibrillation AP E@ A . . . E@ A . . . E@ A . . . EA A . . . EA A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A@ EA A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ EA A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ EA A RANITIDINE d00021A C- K30 Functional dyspepsia A@ EA A . . . EA0 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A EA0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A EA@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A EA@ A VERAPAMIL d00048A C I10 Essential (primary) hypertension A EAP A . . . EA` A . . . EAp A ALPRAZOLAM d00168A C G47.0 Insomnia Ap EAp A BUDESONIDE; FORMOTEROL d04795A B J44.9 Chronic obstructive pulmonary disease, unspecified Ap EAp A DILTIAZEM d00045A C I49.9 Cardiac arrhythmia, unspecified Ap EAp A FUROSEMIDE d00070A C I10 Essential (primary) hypertension Ap EAp A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia Ap EAp A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified Ap EAp A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap EA A . . . EA A METOPROLOL d00134A C I10 Essential (primary) hypertension A EA A . . . EA A . . . EA A . . . EA A . . . EA A . . . EA A CLONAZEPAM d00197A B G47.0 Insomnia AP EA A DICLOFENAC d00848A C M06.9 Rheumatoid arthritis, unspecified AP EA A FLUOXETINE d00236A A F39 Unspecified mood [affective] disorder AP EA A HYDROCHLOROTHIAZIDE d00253A A R60.9 Edema, unspecified AP EA A LISINOPRIL d00732A A I10 Essential (primary) hypertension AP EB A . . . EB A . . . EB A . . . EB0 A . . . EB@ A . . . EBP A . . . EB` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia Ap EB` A CLONIDINE d00044A C I10 Essential (primary) hypertension Ap EB` A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified Ap EB` A MELOXICAM d04532A B[ M19.9 M25.51 Osteoarthritis, unspecified site Pain in shoulder Ap EB` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap EB` A TEMAZEPAM d00384A Cr G47.0 G47.9 Insomnia Sleep disorder, unspecified Ap EB` A TOLTERODINE d04294A B= N39.4 Other specified urinary incontinence Ap EBp A . . . EB A CEPHALEXIN d00096A A L03.90 Cellulitis, unspecified A EB A ALBUTEROL d00749A B J45 Asthma A0 EB A ALBUTEROL d00749A Cr J45 Asthma A0 EB A FLUTICASONE d01296A CDp J45 Asthma A0 EB A . . . EB A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EB A . . . EB A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EB A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A@ EB A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A D E11 Type 2 diabetes mellitus A@ EB A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ EB A ASPIRIN d00170A C- M79.1 Myalgia A@ EB A DOXAZOSIN d00726A C C61 Malignant neoplasm of prostate A@ EB A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ EB A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ EB A . . . EC A . . . EC A . . . EC A . . . EC0 A ALPRAZOLAM d00168A0 C F41.9 Anxiety disorder, unspecified A@ EC0 A BUPROPION d00181A0 C F41.9 Anxiety disorder, unspecified A@ EC0 A CLOPIDOGREL d04258A0 C- I21.P Prevent heart attack/myocardial infarction A@ EC0 A PRAVASTATIN d00348A0 C- E78.0 Pure hypercholesterolemia A@ EC@ A . . . ECP A . . . EC` A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A0 EC` A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A0 EC` A TRAMADOL d03826A Cr M54.9 Dorsalgia, unspecified A0 ECp A FAMOTIDINE d00141A B K30 Functional dyspepsia A EC A ARIPIPRAZOLE d04825A Bz F90 Attention-deficit hyperactivity disorders A@ EC A ATOMOXETINE d04827A B F90 Attention-deficit hyperactivity disorders A@ EC A CLONIDINE d00044A Bz G47.0 Insomnia A@ EC A DESMOPRESSIN d00583A Bz F98.0 Enuresis not due to a substance or known physiological condition A@ EC A . . . EC A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A@ EC A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ EC A RAMIPRIL d00728A Cr I21.P Prevent heart attack/myocardial infarction A@ EC A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A@ EC A . . . EC A . . . EC A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A@ EC A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ EC A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ EC A NIACIN d00314A C"0 R01.1 Cardiac murmur, unspecified A@ EC A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A Cr 99999 Ap EC A INSULIN GLARGINE d04538A C"0 E11 Type 2 diabetes mellitus Ap EC A LEVOTHYROXINE d00278A D"8 E03.9 Hypothyroidism, unspecified Ap EC A MELOXICAM d04532A C M13 Other arthritis Ap EC A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap EC A TAMOXIFEN d00381A C9 C50.P Prevent barest cancer Ap EC A VENLAFAXINE d03181A CP F41.9 Anxiety disorder, unspecified Ap EC A . . . ED A . . . ED A . . . ED A ATORVASTATIN d04105A D"8 E78.0 Pure hypercholesterolemia A@ ED A DILTIAZEM d00045A C 99999 A@ ED A FUROSEMIDE d00070A C E87.7 Fluid overload A@ ED A LISINOPRIL d00732A D"8 I10 Essential (primary) hypertension A@ ED0 A . . . ED@ A . . . EDP A ALBUTEROL d00749A C J45 Asthma A EDP A ATENOLOL d00004A D1 I49.9 Cardiac arrhythmia, unspecified A EDP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EDP A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A EDP A TEMAZEPAM d00384A D* G47.9 Sleep disorder, unspecified A EDP A TIOTROPIUM d04829A CDp J42 Unspecified chronic bronchitis A EDP A TRIAMCINOLONE TOPICAL d03206A A L50 Urticaria A EDP A WARFARIN d00022A D* D75.9P Prevent blood clots A ED` A . . . EDp A . . . ED A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A0 ED A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A0 ED A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A0 ED A AMOXICILLIN d00088A Ap B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A ED A . . . ED A ACETAMINOPHEN; HYDROCODONE d03428A Cr L93 Lupus erythematosus A ED A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A ED A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A ED A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A ED A GABAPENTIN d03182A B G47.9 Sleep disorder, unspecified A ED A HYDROCHLOROTHIAZIDE d00253A C[@ N28.9 Disorder of kidney and ureter, unspecified A ED A HYDROXYCHLOROQUINE d00817A C[@ L93 Lupus erythematosus A ED A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A ED A LISINOPRIL d00732A B I10 Essential (primary) hypertension A ED A NORTRIPTYLINE d00144A C- G47.0 Insomnia A ED A PREDNISONE d00350A D* L93 Lupus erythematosus A ED A TOLTERODINE d04294A C N39.4 Other specified urinary incontinence A ED A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` ED A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A` ED A OXCARBAZEPINE d04513A Dc G40 Epilepsy and recurrent seizures A` ED A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus A` ED A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A` ED A VERAPAMIL d00048A CDp I10 Essential (primary) hypertension A` ED A . . . ED A FLUOXETINE d00236A C- F41.9 Anxiety disorder, unspecified A ED A . . . EE A . . . EE A . . . EE A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A@ EE A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ EE A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ EE A PRAVASTATIN d00348A Cr E78.0P Prevent high cholesterol A@ EE0 A . . . EE@ A . . . EEP A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified A EE` A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A EEp A . . . EE A CLONIDINE d00044A B G47.0 Insomnia A0 EE A DESMOPRESSIN d00583A C F98.0 Enuresis not due to a substance or known physiological condition A0 EE A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A0 EE A ACETAMINOPHEN; HYDROCODONE d03428A C- M13 M19.9 M54.2 Other arthritis Osteoarthritis, unspecified site Cervicalgia AP EE A CANDESARTAN d04322A C I10 Essential (primary) hypertension AP EE A CARVEDILOL d03847A C I10 Essential (primary) hypertension AP EE A LEFLUNOMIDE d04349A A M06.9 Rheumatoid arthritis, unspecified AP EE A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia AP EE A . . . EE A LORATADINE d03050A C L23 Allergic contact dermatitis A EE A . . . EE A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D% I10 Essential (primary) hypertension A0 EE A LEVOTHYROXINE d00278A D% E03.9 Hypothyroidism, unspecified A0 EE A SERTRALINE d00880A C- N95.1 Menopausal and female climacteric states A0 EE A . . . EE A . . . EF A . . . EF A . . . EF A . . . EF0 A . . . EF@ A MINOCYCLINE d00110A B L70 Acne A EFP A . . . EF` A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A0 EF` A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 EF` A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A0 EFp A . . . EF A ALPRAZOLAM d00168A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP EF A AMLODIPINE d00689A C I10 R07.9 Essential (primary) hypertension Chest pain, unspecified AP EF A ESCITALOPRAM d04812A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP EF A OLMESARTAN d04801A C I10 Essential (primary) hypertension AP EF A ZOLPIDEM d00910A C[@ G47.9 Sleep disorder, unspecified AP EF A . . . EF A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A EF A . . . EF A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 EF A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 EF A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 EF A . . . EF A . . . EF A . . . EG A . . . EG A LISDEXAMFETAMINE d06663A Bz F90 Attention-deficit hyperactivity disorders A EG A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A EG0 A . . . EG@ A . . . EGP A ESOMEPRAZOLE d04749A C M19.90 Unspecified osteoarthritis, unspecified site A@ EGP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ EGP A LIRAGLUTIDE d07466A B[ E11 Type 2 diabetes mellitus A@ EGP A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A@ EG` A CETIRIZINE d03827A A T78.40 Allergy, unspecified A EGp A . . . EG A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP EG A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus AP EG A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP EG A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP EG A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension AP EG A ALBUTEROL d00749A C J45 Asthma A0 EG A SERTRALINE d00880A D ^ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 EG A TRAZODONE d00395A D ^ F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A0 EG A FLUTICASONE; SALMETEROL d04611A B J45 Asthma A EG A LEVALBUTEROL d04427A Ap J45 Asthma A EG A LIRAGLUTIDE d07466A C[@ E11 Type 2 diabetes mellitus A@ EG A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ EG A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ EG A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ EG A LOSARTAN d03821A C I10 Essential (primary) hypertension A EG A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EG A . . . EG A COLESTIPOL d00744A CDp E78.0 Pure hypercholesterolemia A@ EG A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ EG A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EG A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A CDp E78.1 Pure hyperglyceridemia A@ EG A . . . EH A . . . EH A . . . EH A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D Z79.3 Long term (current) use of hormonal contraceptives A EH0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EH0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EH@ A . . . EHP A . . . EH` A . . . EHp A . . . EH A . . . EH A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A` EH A LIRAGLUTIDE d07466A C- R73 Elevated blood glucose level A` EH A METFORMIN; SITAGLIPTIN d06720A Cr R73 Elevated blood glucose level A` EH A SOTALOL d00371A C I10 Essential (primary) hypertension A` EH A TRAMADOL d03826A C- M54.9 Dorsalgia, unspecified A` EH A WARFARIN d00022A C Z79.02 Long term (current) use of antithrombotics/antiplatelets A` EH A . . . EH A . . . EH A . . . EH A ISOTRETINOIN d01245A B[ L73.0 Acne keloid A EH A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 EH A ONDANSETRON d00867A A R11 Nausea and vomiting A0 EH A POLYETHYLENE GLYCOL 3350 d05350A Ap K59.0 Constipation A0 EH A . . . EI A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A EI A . . . EI A . . . EI0 A . . . EI@ A . . . EIP A . . . EI` A METFORMIN d03807A B E11 Type 2 diabetes mellitus A EIp A . . . EI A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EI A ETHINYL ESTRADIOL; NORGESTREL d03241A C- Z79.3 Long term (current) use of hormonal contraceptives A EI A AZITHROMYCIN d00091A A0 J40 Bronchitis, not specified as acute or chronic A EI A LEVOTHYROXINE d00278A DU E04.9 Nontoxic goiter, unspecified A0 EI A OXAPROZIN d00853A C M19.9 Osteoarthritis, unspecified site A0 EI A OXYCODONE d00329A CDp M19.9 Osteoarthritis, unspecified site A0 EI A . . . EI A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 R60.9 Essential (primary) hypertension Edema, unspecified A EI A . . . EI A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A EI A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 EI A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 EI A TRAMADOL d03826A C T14.9 Unspecified injury A0 EJ A FLUTICASONE; SALMETEROL d04611A C- J44.9 Chronic obstructive pulmonary disease, unspecified A EJ A . . . EJ A . . . EJ0 A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B R05 Cough A EJ0 A PREDNISOLONE d00084A AP J45 Asthma A EJ@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 EJ@ A PROPRANOLOL d00032A C I49.9 Cardiac arrhythmia, unspecified A0 EJ@ A PROPYLTHIOURACIL d00361A C E05.9 Thyrotoxicosis, unspecified A0 EJP A . . . EJ` A . . . EJp A . . . EJ A . . . EJ A . . . EJ A . . . EJ A . . . EJ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 EJ A DIPHENHYDRAMINE d00212A Cr R63.0 Anorexia A0 EJ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 EJ A . . . EJ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EJ A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A EJ A . . . EK A . . . EK A . . . EK A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54.9 Dorsalgia, unspecified A EK A BECLOMETHASONE d00760A B J44.9 Chronic obstructive pulmonary disease, unspecified A EK A CETIRIZINE d03827A C R09.81 Nasal congestion A EK A CONJUGATED ESTROGENS d00541A CDp Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A EK A IBUPROFEN d00015A Cr M54.9 Dorsalgia, unspecified A EK A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A EK A METHOCARBAMOL d00965A B F41.9 M62.83 Anxiety disorder, unspecified Muscle spasm A EK A MONTELUKAST d04289A C R09.81 Nasal congestion A EK A OXYBUTYNIN d00328A CDp N32.81 Overactive bladder A EK A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A EK A ZOLPIDEM d00910A B G47.0 Insomnia A EK0 A AMLODIPINE; OLMESARTAN d06905A C I10 Essential (primary) hypertension AP EK0 A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP EK0 A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus AP EK0 A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP EK0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP EK@ A . . . EKP A . . . EK` A . . . EKp A . . . EK A . . . EK A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EK A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus A` EK A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A` EK A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A` EK A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` EK A RAMIPRIL d00728A C[@ I10 Essential (primary) hypertension A` EK A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A` EK A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EK A . . . EK A . . . EK A . . . EK A . . . EL A . . . EL A ATENOLOL d00004A D I50.9 Heart failure, unspecified A EL A FUROSEMIDE d00070A D R60.9 Edema, unspecified A EL A CITALOPRAM d04332A B F41.9 Anxiety disorder, unspecified A EL A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A EL A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A EL A LABETALOL d00016A Dc I10 Essential (primary) hypertension A EL A LOSARTAN d03821A C- I10 Essential (primary) hypertension A EL A NIFEDIPINE d00051A Dc I10 Essential (primary) hypertension A EL A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A EL A WARFARIN d00022A CP D75.9P Prevent blood clots A EL0 A . . . EL@ A . . . ELP A . . . EL` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EL` A TAMOXIFEN d00381A B C50.P Prevent barest cancer A0 EL` A VENLAFAXINE d03181A D* F32.9 Major depressive disorder, single episode, unspecified A0 ELp A ATORVASTATIN d04105A0 Ei E78.0 Pure hypercholesterolemia A@ ELp A CLOZAPINE d00199A0 Ei F20 Schizophrenia A@ ELp A METOPROLOL d00134A0 Ei I10 Essential (primary) hypertension A@ ELp A NITROGLYCERIN d00321A0 Ei R07.9 Chest pain, unspecified A@ EL A ALBUTEROL d00749A D* J42 J45 R06.02 Unspecified chronic bronchitis Asthma Shortness of breath A EL A FLUTICASONE; SALMETEROL d04611A C J42 J45 R07.89 Unspecified chronic bronchitis Asthma Other chest pain A EL A . . . EL A . . . EL A . . . EL A 99999 . . A@ EL A PANTOPRAZOLE d04514A B K92.2 Gastrointestinal hemorrhage, unspecified A@ EL A PREDNISOLONE OPHTHALMIC d03221A C- H33 Retinal detachments and breaks A@ EL A TRAMADOL d03826A B M54.9 M79.2 Dorsalgia, unspecified Neuralgia and neuritis, unspecified A@ EL A . . . EL A ARIPIPRAZOLE d04825A Cr F32.9 Major depressive disorder, single episode, unspecified A@ EL A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A@ EL A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ EL A ZOLPIDEM d00910A Cr G47.0 Insomnia A@ EL A . . . EM A . . . EM A AMOXICILLIN d00088A A0 L03.90 Cellulitis, unspecified A EM A . . . EM0 A . . . EM@ A . . . EMP A . . . EM` A . . . EMp A OLANZAPINE d04050A C[@ F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified A EM A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` EM A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A` EM A FEXOFENADINE d04040A CDp T78.40 Allergy, unspecified A` EM A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` EM A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` EM A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` EM A . . . EM A . . . EM A . . . EM Ap . . . EM A . . . EM A . . . EM A GRISEOFULVIN d00100A B B35.4 Tinea corporis A EN A . . . EN A . . . EN A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` EN A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` EN A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A` EN A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` EN A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` EN A PAROXETINE d03157A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EN0 A ESTRADIOL d00537A B Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels A0 EN0 A TRAZODONE d00395A D G47.0 M79.7 Insomnia Fibromyalgia A0 EN0 A TRIAZOLAM d00397A D G47.0 Insomnia A0 EN@ A . . . ENP A . . . EN` A . . . ENp A . . . EN A . . . EN A CYCLOSPORINE OPHTHALMIC d04836A B H04.12 Dry eye syndrome A EN A . . . EN A ALBUTEROL d00749A C J43 Emphysema A EN A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EN A ASPIRIN d00170A C D75.9P Prevent blood clots A EN A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia A EN A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A EN A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C- E11 Type 2 diabetes mellitus A EN A TICAGRELOR d07721A C I99.9 Unspecified disorder of circulatory system A EN A TRAZODONE d00395A C- G47.0 Insomnia A EN A ZIPRASIDONE d04747A C- F32.9 Major depressive disorder, single episode, unspecified A EN A . . . EN A . . . EN A VENLAFAXINE d03181A C- F41.9 Anxiety disorder, unspecified A EN A 99999 . . A EN A LOSARTAN d03821A Ei 99999 A EO A . . . EO A AZITHROMYCIN d00091A AP J01.9 Acute sinusitis, unspecified A0 EO A CHLORPHENIRAMINE; HYDROCODONE d03356A A0 J00 R05 Acute nasopharyngitis [common cold] Cough A0 EO A DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE d07697A C Z79.3 Long term (current) use of hormonal contraceptives A0 EO A . . . EO0 A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A0 EO0 A INSULIN GLARGINE d04538A Ap E11 Type 2 diabetes mellitus A0 EO0 A METFORMIN d03807A Ap E11 Type 2 diabetes mellitus A0 EO@ A . . . EOP A . . . EO` A DOXAZOSIN d00726A CP I10 Essential (primary) hypertension A0 EO` A FINASTERIDE d00563A C N40 Enlarged prostate A0 EO` A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A0 EOp A GLYBURIDE; METFORMIN d04703A B E11 Type 2 diabetes mellitus A EO A . . . EO A CARVEDILOL d03847A CP I48.91 Unspecified atrial fibrillation Ap EO A DONEPEZIL d04099A CP G30.9 Alzheimer's disease, unspecified Ap EO A FUROSEMIDE d00070A CP I50.9 Heart failure, unspecified Ap EO A LOSARTAN d03821A CP I50.9 Heart failure, unspecified Ap EO A POTASSIUM CHLORIDE d00345A CP E87.6 Hypokalemia Ap EO A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia Ap EO A WARFARIN d00022A C- I26 Pulmonary embolism Ap EO A . . . EO A . . . EO A COLCHICINE d00150A Ap M1A Chronic gout AP EO A HYDROCHLOROTHIAZIDE d00253A B[ R10.9 Unspecified abdominal pain AP EO A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D1 I10 Essential (primary) hypertension AP EO A INDOMETHACIN d00039A Ap L29.9 Pruritus, unspecified AP EO A PREDNISONE d00350A Ap M10.9 Gout, unspecified AP EO A . . . EO A . . . EO A . . . EP A . . . EP A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A EP A ATENOLOL d00004A Ei 99999 A0 EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Ei 99999 A0 EP A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A0 EP0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A EP0 A ENALAPRIL d00013A C[@ I10 Essential (primary) hypertension A EP0 A HYDROXYCHLOROQUINE d00817A C- M35.0 Sicca syndrome [Sjgren] A EP0 A IBANDRONATE d05357A C[@ M81 Osteoporosis without current pathological fracture A EP0 A LORAZEPAM d00149A CDp F41.9 G47.0 G47.9 Anxiety disorder, unspecified Insomnia Sleep disorder, unspecified A EP0 A METFORMIN d03807A C[@ E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A EP0 A METOPROLOL d00134A B I10 Essential (primary) hypertension A EP0 A OMEPRAZOLE d00325A C[@ K21 K27 Gastro-esophageal reflux disease Peptic ulcer, site unspecified A EP0 A PREGABALIN d05508A CDp E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A EP@ A . . . EPP A . . . EP` A . . . EPp A ACETAMINOPHEN; HYDROCODONE d03428A B[ L93 M13 M79.7 Lupus erythematosus Other arthritis Fibromyalgia Ap EPp A CELECOXIB d04380A C L93 M79.1 M79.7 Lupus erythematosus Myalgia Fibromyalgia Ap EPp A DOXYCYCLINE d00037A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Ap EPp A DULOXETINE d05355A B F32.9 M79.1 M79.7 Major depressive disorder, single episode, unspecified Myalgia Fibromyalgia Ap EPp A HYDROXYCHLOROQUINE d00817A B[ M79.7 Fibromyalgia Ap EPp A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus Ap EPp A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap EP A . . . EP A . . . EP A CONJUGATED ESTROGENS d00541A C N95.1 Menopausal and female climacteric states A EP A . . . EP A . . . EP A . . . EP A . . . EP A . . . EQ A . . . EQ A . . . EQ A . . . EQ0 A . . . EQ@ A . . . EQP A ONDANSETRON d00867A A R11.P Prevent nausea or vomiting A EQ` A . . . EQp A . . . EQ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EQ A . . . EQ A . . . EQ A . . . EQ A . . . EQ A . . . EQ A . . . EQ A . . . ER A . . . ER A . . . ER A . . . ER0 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Cr F90 Attention-deficit hyperactivity disorders A ER@ A . . . ERP A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A ERP A CHLORDIAZEPOXIDE d00189A B= F41.9 Anxiety disorder, unspecified A ERP A CITALOPRAM d04332A B= F32.9 F41.0 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia A ERP A FLUCONAZOLE d00071A A B37.3 Candidiasis of vulva and vagina A ERP A MOMETASONE NASAL d04223A A H66.9 Otitis media, unspecified A ERP A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A ERP A SULFAMETHOXAZOLE d00119A A H66.9 Otitis media, unspecified A ERP A SUMATRIPTAN d03160A B= G43 Migraine A ER` A . . . ERp A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension AP ERp A CLOPIDOGREL d04258A C D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction AP ERp A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified AP ERp A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP ERp A TAMSULOSIN d04121A C[@ N40 Enlarged prostate AP ER A METHYLPHENIDATE d00900A Ap F90 Attention-deficit hyperactivity disorders A ER A IBUPROFEN d00015A C M54.9 Dorsalgia, unspecified A ER A . . . ER A . . . ER A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A@ ER A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ ER A METOPROLOL d00134A CDp I20.9 Angina pectoris, unspecified A@ ER A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ ER A . . . ER A . . . ER A PREDNISONE d00350A Ap B35.4 Tinea corporis A ES A . . . ES A ADAPALENE; BENZOYL PEROXIDE TOPICAL d07382A B[ L70 Acne A0 ES A ALPRAZOLAM d00168A B F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A0 ES A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C Z79.3 Long term (current) use of hormonal contraceptives A0 ES A . . . ES0 A . . . ES@ A . . . ESP A AZITHROMYCIN d00091A A R09.81 T78.40 Nasal congestion Allergy, unspecified A ESP A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A ES` A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A ESp A ALENDRONATE d03849A Ei M81.P Prevent bone loss/osteoporosis A ESp A AMLODIPINE d00689A D1 99999 A ESp A ESOMEPRAZOLE d04749A D1 99999 A ESp A FUROSEMIDE d00070A D1 99999 A ESp A LEVOTHYROXINE d00278A D1 99999 A ESp A LISINOPRIL d00732A D1 99999 A ESp A METOPROLOL d00134A D1 99999 A ESp A MONTELUKAST d04289A D1 99999 A ESp A PRAVASTATIN d00348A D1 99999 A ES A . . . ES A . . . ES A IBUPROFEN d00015A C- G56.0 Carpal tunnel syndrome A ES A . . . ES A . . . ES A . . . ES A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A ES A SIMVASTATIN d00746A D# E78.0 Pure hypercholesterolemia A ES A . . . ET A . . . ET A . . . ET A . . . ET0 A . . . ET@ A . . . ETP A . . . ET` A . . . ETp A RIZATRIPTAN d04328A CDp G43 Migraine A ET A . . . ET A . . . ET A . . . ET A . . . ET A . . . ET A LISINOPRIL d00732A C I10 Essential (primary) hypertension A ET A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A0 ET A LEVOTHYROXINE d00278A D E03.9 E06.9 Hypothyroidism, unspecified Thyroiditis, unspecified A0 ET A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A0 ET A . . . EU A AMLODIPINE; VALSARTAN d06662A C- I10 Essential (primary) hypertension A EU A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EU A . . . EU A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EU A RAMIPRIL d00728A C I10 Essential (primary) hypertension A EU0 A . . . EU@ A . . . EUP A AMOXICILLIN; CLAVULANATE d00089A A W54.0 Bitten by dog A0 EUP A IBUPROFEN d00015A C M25.56 Pain in knee A0 EUP A SERTRALINE d00880A C F43.1 Post-traumatic stress disorder (PTSD) A0 EU` A . . . EUp A . . . EU A . . . EU A ALBUTEROL d00749A CDp J45 Asthma A EU A . . . EU A . . . EU A SERTRALINE d00880A Ap F32.9 Major depressive disorder, single episode, unspecified A EU A . . . EU A ASPIRIN d00170A B J18.9 Pneumonia, unspecified organism A0 EU A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 EU A OMEPRAZOLE d00325A Cr K22.1 Ulcer of esophagus A0 EU A 99999 . . A EV A NORETHINDRONE d00555A B= Z79.3 Long term (current) use of hormonal contraceptives A EV A AMLODIPINE; BENAZEPRIL d03829A A I10 Essential (primary) hypertension A@ EV A LEVOTHYROXINE d00278A DGJ E03.9 E04.1 Hypothyroidism, unspecified Nontoxic single thyroid nodule A@ EV A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ EV A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A CDp N39.0 Urinary tract infection, site not specified A@ EV A . . . EV0 A AMLODIPINE; BENAZEPRIL d03829A B[ I10 Essential (primary) hypertension A EV0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A EV@ A ATENOLOL d00004A C I10 Essential (primary) hypertension AP EV@ A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP EV@ A BUSPIRONE d00182A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP EV@ A OMEPRAZOLE d00325A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia AP EV@ A SOLIFENACIN d05413A C N39.4 Other specified urinary incontinence AP EVP A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B R51 Headache A EVP A ALLOPURINOL d00023A B N20.0 Calculus of kidney A EVP A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EVP A BENAZEPRIL d00730A B I10 Essential (primary) hypertension A EVP A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A EVP A CLONAZEPAM d00197A B[ F32.9 Major depressive disorder, single episode, unspecified A EVP A DICLOFENAC d00848A B= R52 Pain, unspecified A EVP A FLUTICASONE NASAL d04283A C- T78.40 Allergy, unspecified A EVP A VERAPAMIL d00048A B I10 Essential (primary) hypertension A EV` A . . . EVp A . . . EV A . . . EV A ATENOLOL d00004A D I10 Essential (primary) hypertension A EV A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A EV A . . . EV A . . . EV A . . . EV A . . . EV A . . . EV A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A@ EV A DIVALPROEX SODIUM d03833A Cr G40 Epilepsy and recurrent seizures A@ EV A SULINDAC d00033A B M79.2 Neuralgia and neuritis, unspecified A@ EV A TOLTERODINE d04294A C N32.9 Bladder disorder, unspecified A@ EW A . . . EW A . . . EW A LISINOPRIL d00732A B I10 Essential (primary) hypertension A EW0 A . . . EW@ A . . . EWP A . . . EW` A . . . EWp A . . . EW A DICLOFENAC d00848A C[@ M25.56 Pain in knee A EW A ACETAMINOPHEN; HYDROCODONE d03428A B= M54.9 Dorsalgia, unspecified A EW A ALENDRONATE d03849A B= M81 Osteoporosis without current pathological fracture A EW A ATENOLOL d00004A C I10 Essential (primary) hypertension A EW A CLOPIDOGREL d04258A B= I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EW A FAMOTIDINE d00141A B K21 Gastro-esophageal reflux disease A EW A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A EW A INSULIN ISOPHANE; INSULIN REGULAR d04374A C[@ E11 Type 2 diabetes mellitus A EW A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A EW A METHOTREXATE d00060A B L40 Psoriasis A EW A PREDNISONE d00350A B= R19.7 Diarrhea, unspecified A EW A SERTRALINE d00880A B= M79.2 Neuralgia and neuritis, unspecified A EW A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A EW A . . . EW A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A C- I10 Essential (primary) hypertension A EW A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A EW A . . . EW A . . . EW A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A EW A . . . EX A . . . EX A PROMETHAZINE d00787A A@ R11.1 Vomiting A EX A . . . EX0 A . . . EX@ A . . . EXP A . . . EX` A . . . EXp A . . . EX A . . . EX A . . . EX A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EX A . . . EX A . . . EX A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A C I10 Essential (primary) hypertension A EX A BISOPROLOL d00709A C[@ I10 Essential (primary) hypertension A EX A CELECOXIB d04380A Cr M13 Other arthritis A EX A CLONIDINE d00044A C I10 Essential (primary) hypertension A EX A MINOCYCLINE d00110A C M06.9 Rheumatoid arthritis, unspecified A EX A ORPHENADRINE d00966A Cr M79.1 Myalgia A EX A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A EX A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A EX A . . . EX A MONTELUKAST d04289A B[ J45 Asthma A EY A ALBUTEROL d00749A D J45 Asthma A0 EY A BUDESONIDE; FORMOTEROL d04795A B[ J45 Asthma A0 EY A MONTELUKAST d04289A CDp J45 Asthma A0 EY A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 EY A SERTRALINE d00880A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 EY A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 EY A . . . EY0 A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A0 EY0 A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified A0 EY0 A POTASSIUM CHLORIDE d00345A C E87.6P Prevent hypokalemia A0 EY@ A . . . EYP A . . . EY` A . . . EYp A CELECOXIB d04380A Dc M19.9 Osteoarthritis, unspecified site A EYp A DICYCLOMINE d00999A D K92.9 Disease of digestive system, unspecified A EYp A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A EYp A HYDROCODONE d03075A D M54.9 Dorsalgia, unspecified A EYp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EYp A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EYp A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A EYp A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A EYp A TAMSULOSIN d04121A D N32.9 Bladder disorder, unspecified A EY A . . . EY A . . . EY A . . . EY A . . . EY A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A EY A TOPIRAMATE d04115A CDp G43 Migraine A EY A . . . EY A IBUPROFEN d00015A Ap K08.8 Other specified disorders of teeth and supporting structures A EY A BRIMONIDINE OPHTHALMIC d04048A0 C H40 Glaucoma A` EY A INSULIN ISOPHANE (NPH) d04370A0 C[@ E11 Type 2 diabetes mellitus A` EY A INSULIN REGULAR d04369A0 C[@ E11 Type 2 diabetes mellitus A` EY A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma A` EY A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus A` EY A QUINAPRIL d00365A0 C[@ I10 Essential (primary) hypertension A` EZ A . . . EZ A AMOXICILLIN; CLAVULANATE d00089A CDp L70 Acne A EZ A . . . EZ0 A . . . EZ@ A . . . EZP A . . . EZ` A . . . EZp A WARFARIN d00022A Cr I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EZ A . . . EZ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A EZ A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A EZ A . . . EZ A 99999 . . A EZ A AMOXICILLIN d00088A A J40 Bronchitis, not specified as acute or chronic A EZ A . . . EZ A ALLOPURINOL d00023A D= M1A Chronic gout Ap EZ A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia Ap EZ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap EZ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 N28.9 Essential (primary) hypertension Disorder of kidney and ureter, unspecified Ap EZ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EZ A OMEPRAZOLE d00325A D= K21 Gastro-esophageal reflux disease Ap EZ A PAROXETINE d03157A Dc F32.9 Major depressive disorder, single episode, unspecified Ap EZ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 EZ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 EZ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E[ A HYDROXYCHLOROQUINE d00817A C ` M06.9 Rheumatoid arthritis, unspecified A0 E[ A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A0 E[ A MILNACIPRAN d06635A C M79.7 Fibromyalgia A0 E[ A CLONIDINE d00044A C G47.0 Insomnia A E[ A . . . E[0 A . . . E[@ A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E[P A 99999 . . AP E[P A 99999 . . AP E[P A INSULIN DETEMIR d05436A B[ R73 Elevated blood glucose level AP E[P A METFORMIN d03807A C- R73 Elevated blood glucose level AP E[P A TRAZODONE d00395A CDp F32.9 Major depressive disorder, single episode, unspecified AP E[` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E[` A DICLOFENAC d00848A A@ M54.2 Cervicalgia A@ E[` A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia A@ E[` A TRAMADOL d03826A A@ M54.2 Cervicalgia A@ E[p A . . . E[ A CLONIDINE d00044A C F91.3 Oppositional defiant disorder A E[ A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E[ A ACYCLOVIR d00001A D* A60.9 Anogenital herpesviral infection, unspecified A` E[ A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A` E[ A DARUNAVIR d05825A C- B20 Human immunodeficiency virus [HIV] disease A` E[ A EMTRICITABINE; TENOFOVIR d05352A C- B20 Human immunodeficiency virus [HIV] disease A` E[ A ETRAVIRINE d07076A C- B20 Human immunodeficiency virus [HIV] disease A` E[ A RITONAVIR d03984A C- B20 Human immunodeficiency virus [HIV] disease A` E[ A . . . E[ A DIVALPROEX SODIUM d03833A C[@ G40 Epilepsy and recurrent seizures A E[ A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E[ A . . . E[ A . . . E[ A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E[ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D% I10 Essential (primary) hypertension A E[ A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E[ A IBUPROFEN d00015A Bz M79.1 Myalgia A@ E[ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E[ A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E\ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E\ A . . . E\ A ACETAMINOPHEN; HYDROCODONE d03428A B M54.9 T14.9 Dorsalgia, unspecified Unspecified injury A0 E\ A BUMETANIDE d00179A B I10 Essential (primary) hypertension A0 E\ A WARFARIN d00022A D* D75.9P I26 Prevent blood clots Pulmonary embolism A0 E\0 A . . . E\@ A LITHIUM d00061A B= F32.9 Major depressive disorder, single episode, unspecified A E\@ A QUETIAPINE d04220A B F31.9 Bipolar disorder, unspecified A E\P A . . . E\` A . . . E\p A . . . E\ A . . . E\ A . . . E\ A . . . E\ A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E\ A . . . E\ A . . . E\ A ACETAMINOPHEN; HYDROCODONE d03428A D M19.9 Osteoarthritis, unspecified site A E\ A ANTACIDS - UNSPECIFIED c00088A C R10.9 Unspecified abdominal pain A E\ A CITALOPRAM d04332A Cr 99999 A E\ A DENOSUMAB d07640A C- M81 Osteoporosis without current pathological fracture A E\ A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E\ A FENTANYL d00233A C- M54.9 Dorsalgia, unspecified A E\ A LEVOTHYROXINE d00278A CDp 99999 A E\ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E\ A MEMANTINE d04899A C- G30.9 Alzheimer's disease, unspecified A E\ A OMEPRAZOLE d00325A CDp 99999 A E\ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E\ A . . . E] A BENZTROPINE d00175A C T88.7 Unspecified adverse effect of drug or medicament A E] A HALOPERIDOL d00027A C F29 Unspecified psychosis not due to a substance or known physiological condition A E] A . . . E] A . . . E]0 A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A E]@ A . . . E]P A . . . E]` A CLINDAMYCIN d00043A Ap K04.7 Periapical abscess without sinus A E]p A DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE d07697A C Z79.3 Long term (current) use of hormonal contraceptives A E] A . . . E] A . . . E] A . . . E] A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E] A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A0 E] A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A0 E] A PANCRELIPASE d01002A D K86.8 K86.9 Other specified diseases of pancreas Disease of pancreas, unspecified A0 E] A . . . E] A CEFDINIR d04256A A0 H66.9 Otitis media, unspecified A E] A IBUPROFEN d00015A C- M13 Other arthritis A E^ A EXEMESTANE d04461A C- C50 Malignant neoplasm of breast AP E^ A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E^ A NADOLOL d00018A B= I10 Essential (primary) hypertension AP E^ A RAMIPRIL d00728A C I10 Essential (primary) hypertension AP E^ A TRIAMTERENE d00396A C I10 Essential (primary) hypertension AP E^ A . . . E^ A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A E^ A ATENOLOL d00004A D# I10 Essential (primary) hypertension A E^ A CEFDINIR d04256A A R09.81 Nasal congestion A E^ A DULOXETINE d05355A D"8 F32.9 Major depressive disorder, single episode, unspecified A E^ A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E^ A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E^ A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E^ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E^ A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E^ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E^ A NIACIN d00314A D E78.0 Pure hypercholesterolemia A E^0 A . . . E^@ A . . . E^P A ALLOPURINOL d00023A CDp 99999 A0 E^P A ATORVASTATIN d04105A CDp 99999 A0 E^P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A0 E^` A CYCLOBENZAPRINE d00963A B= T14.9 Unspecified injury A E^` A IBUPROFEN d00015A B M54.9 Dorsalgia, unspecified A E^p A AMITRIPTYLINE d00146A D* G43 Migraine AP E^p A AZELASTINE NASAL d04068A Cr J30.9 Allergic rhinitis, unspecified AP E^p A BISOPROLOL d00709A Cr I49.9 Cardiac arrhythmia, unspecified AP E^p A FLUTICASONE NASAL d04283A B R09.81 Nasal congestion AP E^p A LANSOPRAZOLE d03828A C- K21 Gastro-esophageal reflux disease AP E^ A GLIMEPIRIDE d03864A B[ E11 Type 2 diabetes mellitus A@ E^ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E^ A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E^ A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A@ E^ A . . . E^ A . . . E^ A . . . E^ A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E^ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E^ A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A E^ A FUROSEMIDE d00070A Cr I10 N18.9 Essential (primary) hypertension Chronic kidney disease, unspecified A E^ A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E^ A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A E^ A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A E^ A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A E^ A LEVOTHYROXINE d00278A C[@ E03.9 E04.9 Hypothyroidism, unspecified Nontoxic goiter, unspecified A E^ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E^ A PENTOXIFYLLINE d00336A C 55555 A E^ A AMLODIPINE d00689A C- I10 I63.P Essential (primary) hypertension Prevent stroke Ap E^ A ATENOLOL d00004A C- I21.P Prevent heart attack/myocardial infarction Ap E^ A CELECOXIB d04380A B= M06.9 Rheumatoid arthritis, unspecified Ap E^ A CLOPIDOGREL d04258A C- D75.9P I63.P Prevent blood clots Prevent stroke Ap E^ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension Ap E^ A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap E^ A SIMVASTATIN d00746A C- E78.0 E78.1 I63.P Pure hypercholesterolemia Pure hyperglyceridemia Prevent stroke Ap E^ A . . . E_ A . . . E_ A . . . E_ A . . . E_0 A TRIPROLIDINE d00786A B= T78.40 Allergy, unspecified A E_@ A . . . E_P A AMITRIPTYLINE d00146A D9 G43 Migraine A0 E_P A LOSARTAN d03821A C[@ 99999 A0 E_P A ROSUVASTATIN d04851A Bz Z79.02 Long term (current) use of antithrombotics/antiplatelets A0 E_` A AMLODIPINE d00689A Ei 99999 A E_` A ASPIRIN d00170A Ei 99999 A E_` A ATENOLOL d00004A Ei 99999 A E_` A BACLOFEN d00967A Ei 99999 A E_` A LEVETIRACETAM d04499A Ei 99999 A E_` A LISINOPRIL d00732A Ei 99999 A E_` A LOVASTATIN d00280A Ei 99999 A E_` A METFORMIN d03807A Ei 99999 A E_` A PANTOPRAZOLE d04514A Ei 99999 A E_p A . . . E_ A . . . E_ A . . . E_ A . . . E_ A . . . E_ A . . . E_ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz Z79.3 Long term (current) use of hormonal contraceptives A E_ A . . . E_ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E` A HYDROXYCHLOROQUINE d00817A CDp L93 Lupus erythematosus A0 E` A LEVOTHYROXINE d00278A A E03.9 E04.9 Hypothyroidism, unspecified Nontoxic goiter, unspecified A0 E` A TRAMADOL d03826A B M25.56 M54.9 M79.2 Pain in knee Dorsalgia, unspecified Neuralgia and neuritis, unspecified A0 E` A . . . E` A . . . E`0 A . . . E`@ A FINASTERIDE d00563A CDp N40 Enlarged prostate A E`@ A TERAZOSIN d00386A CDp N40 Enlarged prostate A E`P A . . . E`` A . . . E`p A BUDESONIDE d04276A C- J45 Asthma A E`p A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified A E` A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E` A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap E` A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified Ap E` A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E` A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia Ap E` A RANITIDINE d00021A C K30 Functional dyspepsia Ap E` A SPIRONOLACTONE d00373A CDp E87.6 R60.9 Hypokalemia Edema, unspecified Ap E` A . . . E` A . . . E` A ALBUTEROL d00749A D J45 Asthma A E` A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A A H10 Conjunctivitis A E` A ALBUTEROL d00749A CDp J45 Asthma A0 E` A FLUTICASONE d01296A CDp J45 Asthma A0 E` A PREDNISONE d00350A CDp J45 Asthma A0 E` A . . . E` A . . . E` A . . . Ea A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A Ea A . . . Ea A . . . Ea0 A . . . Ea@ A . . . EaP A . . . Ea` A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A Eap A . . . Ea A FAMOTIDINE d00141A CDp K30 Functional dyspepsia A Ea A TERBINAFINE d04012A B[ B35.3 Tinea pedis A Ea A ATENOLOL d00004A C I10 Essential (primary) hypertension A Ea A DIURETICS - UNSPECIFIED c00049A C R60.9 Edema, unspecified A Ea A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ea A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A@ Ea A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia A@ Ea A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ Ea A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A@ Ea A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 Ea A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 Ea A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A0 Ea A . . . Ea A . . . Ea A . . . Eb A . . . Eb A . . . Eb A . . . Eb0 A MELOXICAM d04532A C- M13 Other arthritis A Eb0 A SULFASALAZINE d00379A C M19.90 Unspecified osteoarthritis, unspecified site A Eb@ A . . . EbP A . . . Eb` A DESOXIMETASONE TOPICAL d01291A B L20.9 Atopic dermatitis, unspecified A Eb` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A Ebp A . . . Eb A . . . Eb A . . . Eb A . . . Eb A . . . Eb A . . . Eb A CLONIDINE d00044A C F90 Attention-deficit hyperactivity disorders A0 Eb A DIVALPROEX SODIUM d03833A C F39 Unspecified mood [affective] disorder A0 Eb A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A0 Eb A . . . Eb A . . . Ec A . . . Ec A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture AP Ec A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP Ec A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension AP Ec A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified AP Ec A METFORMIN d03807A C R73.9 Hyperglycemia, unspecified AP Ec A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A Ec0 A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A@ Ec0 A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A@ Ec0 A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus A@ Ec0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Ec@ A . . . EcP A . . . Ec` A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A Ecp A CITALOPRAM d04332A C 99999 A` Ecp A LOSARTAN d03821A C E87.6 Hypokalemia A` Ecp A LOVASTATIN d00280A C- 99999 A` Ecp A METOPROLOL d00134A C- K31.9 Disease of stomach and duodenum, unspecified A` Ecp A OMEPRAZOLE d00325A C K25 Gastric ulcer A` Ecp A SUCRALFATE d00377A C[@ 99999 A` Ec A AZITHROMYCIN d00091A A J02 Acute pharyngitis A Ec A . . . Ec A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A Ec A . . . Ec A AMLODIPINE; VALSARTAN d06662A D I10 Essential (primary) hypertension A0 Ec A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A0 Ec A MELOXICAM d04532A CDp M54.9 Dorsalgia, unspecified A0 Ec A . . . Ec A . . . Ec A . . . Ed A . . . Ed A . . . Ed A . . . Ed0 A . . . Ed@ A . . . EdP A ALBUTEROL d00749A B J20.9 Acute bronchitis, unspecified A EdP A BECLOMETHASONE d00760A B J20.9 Acute bronchitis, unspecified A Ed` A ASPIRIN d00170A B[ D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A Ed` A ATORVASTATIN d04105A Ap E78.0 Pure hypercholesterolemia A Edp A . . . Ed A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 Ed A CLONIDINE d00044A C I10 Essential (primary) hypertension A0 Ed A LABETALOL d00016A CDp I10 Essential (primary) hypertension A0 Ed A . . . Ed A ALBUTEROL; IPRATROPIUM d04066A D J42 Unspecified chronic bronchitis B Ed A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia B Ed A DESLORATADINE d04785A Cr R09.81 Nasal congestion B Ed A DULOXETINE d05355A Ei M54.9 Dorsalgia, unspecified B Ed A FELODIPINE d00231A CDp I20.9 Angina pectoris, unspecified B Ed A FENTANYL d00233A Dc M79.2 Neuralgia and neuritis, unspecified B Ed A FUROSEMIDE d00070A D# I50.9 Heart failure, unspecified B Ed A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified B Ed A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified B Ed A LOPERAMIDE d01025A Cr R19.7 Diarrhea, unspecified B Ed A METOPROLOL d00134A C I10 Essential (primary) hypertension B Ed A NITROGLYCERIN d00321A D I20.9 Angina pectoris, unspecified B Ed A NORTRIPTYLINE d00144A Dc M79.2 Neuralgia and neuritis, unspecified B Ed A OMEPRAZOLE d00325A D:u R12 Heartburn B Ed A TRIMETHOPRIM d00123A Bz N30 Cystitis B Ed A ZOLPIDEM d00910A CP G47.0 Insomnia B Ed A . . . Ed A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A Ed A AMIODARONE d00002A C I49.9 Cardiac arrhythmia, unspecified A` Ed A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` Ed A DILTIAZEM d00045A D I10 Essential (primary) hypertension A` Ed A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` Ed A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ed A SUCRALFATE d00377A B K27 Peptic ulcer, site unspecified A` Ed A . . . Ed A ACETAMINOPHEN; OXYCODONE d03431A C M54.9 Dorsalgia, unspecified A@ Ed A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ Ed A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A Cr H40 Glaucoma A@ Ed A TRAVOPROST OPHTHALMIC d04753A C H40 Glaucoma A@ Ee A . . . Ee A . . . Ee A . . . Ee0 A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A@ Ee0 A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ Ee0 A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A@ Ee0 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ Ee@ A . . . EeP A . . . Ee` A 77777 . . I10 Essential (primary) hypertension A0 Ee` A 99999 . . A0 Ee` A 99999 . . A0 Eep A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A0 Eep A RAMIPRIL d00728A C I10 Essential (primary) hypertension A0 Eep A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 Ee A ASPIRIN d00170A Dc I63.P Prevent stroke A@ Ee A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease A@ Ee A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ Ee A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Ee A . . . Ee A DOXYCYCLINE d00037A C- L71 Rosacea A0 Ee A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A0 Ee A METRONIDAZOLE TOPICAL d03208A C- L71 Rosacea A0 Ee A . . . Ee A . . . Ee A . . . Ee A . . . Ee A . . . Ef A . . . Ef A CYCLOSPORINE OPHTHALMIC d04836A C H04.12 Dry eye syndrome Ap Ef A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified Ap Ef A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap Ef A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap Ef A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease Ap Ef A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap Ef A TRAMADOL d03826A CDp T14.9 Unspecified injury Ap Ef A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A Ef0 A . . . Ef@ A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A Ef@ A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A EfP A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` EfP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B= I10 Essential (primary) hypertension A` EfP A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` EfP A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A` EfP A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A` EfP A PREGABALIN d05508A Cr M79.2 Neuralgia and neuritis, unspecified A` Ef` A . . . Efp A DEXAMETHASONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC d03537A A H57.9 Unspecified disorder of eye and adnexa A Ef A . . . Ef A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A Ef A . . . Ef A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Ef A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A Ef A . . . Ef A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A Ef A . . . Ef A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ Ef A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A@ Ef A OMEPRAZOLE d00325A Dc 99999 A@ Ef A PRAVASTATIN d00348A C[@ R06.6 Hiccough A@ Eg A . . . Eg A . . . Eg A . . . Eg0 A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A Eg@ A . . . EgP A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A Eg` A . . . Egp A . . . Eg A ALBUTEROL d00749A D J45 Asthma A Eg A ALBUTEROL d00749A D J45 Asthma A Eg A AMOXICILLIN; CLAVULANATE d00089A A J18.9 Pneumonia, unspecified organism A Eg A CYCLOSPORINE OPHTHALMIC d04836A C- H04.12 Dry eye syndrome A Eg A FORMOTEROL; MOMETASONE d07660A C J98.4 Other disorders of lung A Eg A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A Eg A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A Eg A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A Eg A MOMETASONE NASAL d04223A C[@ J30.9 Allergic rhinitis, unspecified A Eg A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A Eg A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A Eg A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A Eg A ROFLUMILAST d07684A B T78.40 Allergy, unspecified A Eg A . . . Eg A AMITRIPTYLINE d00146A D G47.0 Insomnia A0 Eg A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Eg A ZALEPLON d04452A D G47.0 Insomnia A0 Eg A . . . Eg A . . . Eg A . . . Eg A . . . Eg A . . . Eh A ALBUTEROL d00749A C J45 Asthma Ap Eh A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified Ap Eh A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified Ap Eh A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified Ap Eh A LANSOPRAZOLE d03828A CDp K21 K30 Gastro-esophageal reflux disease Functional dyspepsia Ap Eh A LORATADINE d03050A B T78.40 Allergy, unspecified Ap Eh A QUETIAPINE d04220A B G47.9 Sleep disorder, unspecified Ap Eh A FENOFIBRIC ACID d07371A B[ E78.0 Pure hypercholesterolemia A@ Eh A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ Eh A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Eh A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A@ Eh A . . . Eh0 A . . . Eh@ A MONTELUKAST d04289A C J45 Asthma A EhP A . . . Eh` A ALLOPURINOL d00023A C- E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A0 Eh` A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Dc I10 Essential (primary) hypertension A0 Eh` A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension A0 Ehp A . . . Eh A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eh A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 Pure hyperglyceridemia A Eh A . . . Eh A . . . Eh A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ Eh A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ Eh A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ Eh A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A@ Eh A . . . Eh A . . . Eh A . . . Eh A . . . Ei A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A0 Ei A DILTIAZEM d00045A B I10 Essential (primary) hypertension A0 Ei A FLUTICASONE NASAL d04283A B J44.9 Chronic obstructive pulmonary disease, unspecified A0 Ei A . . . Ei A . . . Ei0 A . . . Ei@ A . . . EiP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap EiP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap EiP A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap EiP A EZETIMIBE d04824A CDp E78.0 Pure hypercholesterolemia Ap EiP A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap EiP A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap EiP A WARFARIN d00022A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified Ap Ei` A . . . Eip A . . . Ei A . . . Ei A . . . Ei A . . . Ei A . . . Ei A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A@ Ei A DULOXETINE d05355A CDp M79.1 M79.2 M79.7 Myalgia Neuralgia and neuritis, unspecified Fibromyalgia A@ Ei A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A CP I10 Essential (primary) hypertension A@ Ei A PREGABALIN d05508A CDp M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A@ Ei A . . . Ei A . . . Ei A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ei A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A Ej A GEMFIBROZIL d00245A Cr E78.0 Pure hypercholesterolemia AP Ej A LOSARTAN d03821A C I10 Essential (primary) hypertension AP Ej A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP Ej A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP Ej A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension AP Ej A . . . Ej A . . . Ej0 A . . . Ej@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A0 Ej@ A LAMOTRIGINE d03809A CDp F39 Unspecified mood [affective] disorder A0 Ej@ A QUETIAPINE d04220A CDp F30 Manic episode A0 EjP A . . . Ej` A . . . Ejp A DOXAZOSIN d00726A Cr N40 Enlarged prostate Ap Ejp A FINASTERIDE d00563A B= N40 Enlarged prostate Ap Ejp A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap Ejp A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap Ejp A PROPRANOLOL d00032A C I10 R25.1 Essential (primary) hypertension Tremor, unspecified Ap Ejp A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap Ejp A TADALAFIL d04896A C N52.9 Male erectile dysfunction, unspecified Ap Ej A . . . Ej A . . . Ej A . . . Ej A . . . Ej A ALBUTEROL d00749A Cr J45 Asthma A Ej A TOPIRAMATE d04115A A E66.9 Obesity, unspecified A Ej A . . . Ej A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture AP Ej A AMITRIPTYLINE d00146A Dc G47.0 Insomnia AP Ej A DONEPEZIL d04099A C R41.3 Other amnesia AP Ej A LOSARTAN d03821A B* I10 Essential (primary) hypertension AP Ej A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP Ej A . . . Ek A . . . Ek A ACETAMINOPHEN; HYDROCODONE d03428A B M54.9 Dorsalgia, unspecified A@ Ek A BISOPROLOL d00709A C ` I10 Essential (primary) hypertension A@ Ek A DULOXETINE d05355A B F41.9 Anxiety disorder, unspecified A@ Ek A RANITIDINE d00021A C K30 Functional dyspepsia A@ Ek A . . . Ek0 A . . . Ek@ A . . . EkP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 EkP A LEVOTHYROXINE d00278A C E06.3 Autoimmune thyroiditis A0 EkP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 Ek` A AMITRIPTYLINE d00146A Cr F32.9 Major depressive disorder, single episode, unspecified A Ek` A CLONAZEPAM d00197A C G47.0 Insomnia A Ek` A FLUTICASONE NASAL d04283A C R09.82 Postnasal drip A Ek` A LANSOPRAZOLE d03828A D K30 Functional dyspepsia A Ek` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ek` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ek` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Ek` A TAMSULOSIN d04121A C N40 Enlarged prostate A Ekp A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A Ekp A AZELASTINE NASAL d04068A C- J30.9 Allergic rhinitis, unspecified A Ekp A CALCITONIN d00598A C M81 Osteoporosis without current pathological fracture A Ekp A DRONABINOL d00866A C R42 Dizziness and giddiness A Ekp A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia A Ekp A GABAPENTIN d03182A Cr M62.83 Muscle spasm A Ekp A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified A Ekp A TRAMADOL d03826A Cr M54.9 Dorsalgia, unspecified A Ek A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` Ek A ATENOLOL d00004A C I10 Essential (primary) hypertension A` Ek A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A` Ek A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A` Ek A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A` Ek A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A . . . El A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C- Z79.3 Long term (current) use of hormonal contraceptives A El A . . . El A CARVEDILOL d03847A C- I21.P Prevent heart attack/myocardial infarction A El A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A El A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A El A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A El A LOSARTAN d03821A C- I10 Essential (primary) hypertension A El A METFORMIN d03807A D* E11 Type 2 diabetes mellitus A El A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A El A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A El A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A El0 A . . . El@ A . . . ElP A . . . El` A . . . Elp A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Elp A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A El A . . . El A . . . El A TOPIRAMATE d04115A C G43 Migraine A El A . . . El A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` El A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A` El A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A` El A FLUTICASONE NASAL d04283A Cr J33.9 Nasal polyp, unspecified A` El A PRAVASTATIN d00348A . E78.0 Pure hypercholesterolemia A` El A TAMSULOSIN d04121A C N40 Enlarged prostate A` El A . . . El A LEVOTHYROXINE d00278A B 55555 A0 El A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 El A TAMSULOSIN d04121A B< R35.0 Frequency of micturition A0 El A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap El A FAMOTIDINE d00141A C R12 Heartburn Ap El A METFORMIN d03807A C E11.P Prevent diabetes Ap El A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap El A NIFEDIPINE d00051A C I10 Essential (primary) hypertension Ap El A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap El A TRIAMTERENE d00396A C I10 R42 Essential (primary) hypertension Dizziness and giddiness Ap Em A . . . Em A . . . Em A . . . Em0 A . . . Em@ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp L70 Acne A EmP A . . . Em` A . . . Emp A . . . Em A . . . Em A BECLOMETHASONE d00760A B= J45 Asthma A Em A . . . Em A FLUOXETINE d00236A C[@ F42 Obsessive-compulsive disorder A Em A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Em A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A Em A . . . Em A LAMOTRIGINE d03809A C"0 F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder AP Em A LORAZEPAM d00149A C"0 F41.9 Anxiety disorder, unspecified AP Em A RANITIDINE d00021A Cr K30 Functional dyspepsia AP Em A SERTRALINE d00880A C"0 F41.9 Anxiety disorder, unspecified AP Em A TRAZODONE d00395A C"0 G47.0 Insomnia AP Em A . . . En A . . . En A . . . En A . . . En0 A . . . En@ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A0 En@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 En@ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 EnP A . . . En` A . . . Enp A ATORVASTATIN d04105A CDp I21.P Prevent heart attack/myocardial infarction A0 Enp A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A0 Enp A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified A0 En A . . . En A . . . En A FLUTICASONE NASAL d04283A Dc J30.9 Allergic rhinitis, unspecified A En A . . . En A . . . En A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A En A . . . En A . . . Eo A 99999 . . A Eo A . . . Eo A . . . Eo0 A . . . Eo@ A . . . EoP A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A0 EoP A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A0 EoP A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 Eo` A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A0 Eo` A METOPROLOL d00134A Cr I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A0 Eo` A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 Eop A . . . Eo A . . . Eo A . . . Eo A . . . Eo A . . . Eo A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eo A CLONIDINE d00044A C I10 Essential (primary) hypertension A Eo A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A Eo A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A Eo A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A Eo A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Eo A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Eo A WARFARIN d00022A C- D75.9P Prevent blood clots A Eo A . . . Eo A . . . Eo A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP Eo A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified AP Eo A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified AP Eo A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP Eo A TRAZODONE d00395A B[ G47.0 Insomnia AP Ep A BUSPIRONE d00182A Dc F41.9 Anxiety disorder, unspecified Ap Ep A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified Ap Ep A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia Ap Ep A FLUOXETINE d00236A Dc F41.9 Anxiety disorder, unspecified Ap Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap Ep A MOMETASONE NASAL d04223A Cr J30.9 Allergic rhinitis, unspecified Ap Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap Ep A . . . Ep A . . . Ep0 A . . . Ep@ A FLUORIDE TOPICAL d04397A C- K02.P Prevent tooth decay A0 Ep@ A MINOCYCLINE d00110A C L70 Acne A0 Ep@ A TRETINOIN TOPICAL d01244A C L70 Acne A0 EpP A BENAZEPRIL d00730A B[ I10 Essential (primary) hypertension A EpP A OMEPRAZOLE d00325A B[ R10.9 Unspecified abdominal pain A Ep` A ACETAMINOPHEN; OXYCODONE d03431A Cr R52 Pain, unspecified AP Ep` A ALBUTEROL d00749A CDp R06.2 R06.9 Wheezing Unspecified abnormalities of breathing AP Ep` A BUDESONIDE; FORMOTEROL d04795A CDp J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified AP Ep` A CARISOPRODOL d00960A CDp M48.0 Spinal stenosis AP Ep` A ZOLPIDEM d00910A CDp G47.0 Insomnia AP Epp A . . . Ep A . . . Ep A TAMSULOSIN d04121A B[ N40 Enlarged prostate A Ep A . . . Ep A . . . Ep A LOSARTAN d03821A D* I10 Essential (primary) hypertension AP Ep A MESALAMINE d01031A B K52.9 Noninfective gastroenteritis and colitis, unspecified AP Ep A ROPINIROLE d04215A Dc G25.81 M79.2 Restless legs syndrome Neuralgia and neuritis, unspecified AP Ep A TERAZOSIN d00386A C I10 N40 Essential (primary) hypertension Enlarged prostate AP Ep A TRIAZOLAM d00397A C G25.81 G47.9 Restless legs syndrome Sleep disorder, unspecified AP Ep A . . . Ep A . . . Ep A . . . Eq A . . . Eq A . . . Eq A . . . Eq0 A . . .